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ABSTRACT 
Evidence is growing that diet, lifestyle factors and chronic inflammation 
influence sarcopenia. Sarcopenia is the progressive decline of muscle mass, 
strength and function that occurs with healthy ageing. The ageing process is 
also associated with a gradual increasing production of pro-inflammatory 
cytokines, which may potentially enhance the development of sarcopenia. 
Dietary longitudinal studies have shown associations between protein intake 
and muscle mass in older people but results of supplementation studies in 
enhancing muscle mass and strength are equivocal. Additionally, short-term 
dietary interventions with essential amino acid supplementation have shown 
promising effects on muscle protein synthesis. Emerging evidence suggests 
that a number of nutrients may be associated with muscle mass and strength 
either due to their anti-inflammatory properties or their involvement in 
muscle biology. However, there are currently few population studies 
examining the relative importance of specific nutrients in association with 
muscle mass, muscle strength and muscle quality. Therefore, this thesis 
aimed to examine associations between the habitual dietary intake of a range 
of micronutrients, and diet quality (assessed by five predefined diet quality 
scores) and indexes of muscle mass, strength and muscle quality in female 
participants aged 18-79 years from the TwinsUK cohort. An additional aim 
was to examine associations between diet and biomarkers of inflammation 
and to investigate whether diet could also influence the relationship between 
muscle mass and inflammation. The results suggested a significant positive 
association between intakes of vitamins C and E, magnesium, potassium 
and a range of carotenoids and indexes of muscle mass with scale of 
associations ranging between 1.5-4.6%. However, no associations were 
observed for protein and essential amino acid intakes. Higher adherence to 
the Mediterranean Diet score (MDS), Healthy Diet Indicator (HDI), Diet 
Quality Index (DQI), Alternate Healthy Eating Index (AHEI), and DASH-
style score was significantly associated with measurements of muscle mass, 
with associations ranging between 1-3% between quintiles. Furthermore, a 
number of nutrients and the HDI and AHEI scores were inversely associated 
with plasma levels of the inflammatory marker C-reactive protein (CRP). 
Interestingly, intakes of magnesium, potassium, vitamin C, carotene, β-
carotene, glutamine, and the MDS, HDI and AHEI scores attenuated the 
association between indexes of muscle mass and CRP by 1-8%, inferring 
that these components mediate the relationship between muscle mass and 
inflammation. In conclusion, the findings of this thesis emphasise the 
importance of consumption of a variety of plant-based nutrients and of 
overall diet quality for the conservation of muscle mass, and shed new light 
on the influence of these dietary components on sarcopenia related 
inflammation.  
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Chapter 1 
General Introduction
 2 
 
1.0 Introduction 
1.0.1 The ageing population 
Life expectancy has been considerably improved over the past century and 
in recent years these increases in life expectancy have been attributed to a 
decline in later-life mortality (Oeppen and Vaupel 2002) (Figure 1.1). 
However, despite the population living longer, this greater number of life 
years has been associated with increases in chronic morbidity and mortality, 
including cardiovascular disease (Wald et al. 2011), diabetes (Fagot-
Campagna A et al. 2005), and cancer (Vasto S et al. 2009), for which age is 
an independent risk factor (Fontana 2009).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1: Life expectancy increase over the last 200 years
1
. 
 
There is a trajectory in ageing worldwide, which will to lead to an increase 
in age-related diseases with profound implications both socially and 
economically. Globally the number of people aged over 60 years was 11 % 
of the total population in 2011 and the UK is following a similar pattern. 
 
1 Adapted from Oeppen J & Vaupel JW (2002) Science 296, 1029-1031.  
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It is predicted that this rate is going to increase globally and by 2050 the 
number of people aged 60 and over will rise to 22% of the total population 
(approximately 2 billion). There will be concurrent increases for the number 
of people aged 80 years and over with numbers expected to double to 4% of 
the world population (approximately 400 million) (Figure 1.2) (Beard JR et 
al. 2011). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2: Population aged 60 years and over (world and development regions), 
1950-2050
2
.  
 
 
Ageing is associated with significant declines in physical, cognitive and 
social function that contribute to loss of independence and quality of life, 
which can further lead to substantial economic costs (Gonyea 2005). It has 
been suggested that better living standards, improved lifestyle (by 
promoting a healthy diet, physical activity and non-smoking), better 
education, and greater access to quality healthcare services could effectively 
contribute to the improvement of quality of life in the elderly (Britton et al. 
2008). Therefore, examining influences on the ageing process is important 
for social and economic reasons. 
2 Adapted from Beard JR et al (2011) Geneva: World Economic Forum.  
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1.0.2 Determinants of successful ageing 
Given the global trends in population ageing, a multitude of epidemiological 
observations have focused on identifying risk factors that lead to functional 
decline (Stuck et al. 1999), mortality and morbidity (Strawbridge et al. 
1996), and hence to diminished health and low quality of life. Suggested 
risk factors associated with poor health and quality of life include cognitive 
impairment, depression and comorbidities. Changes in body composition 
have been suggested as an issue in terms of health risk, as well as low levels 
of physical activity, smoking, poor self-perceived health, low frequency of 
social contacts and vision impairment (Stuck et al. 1999). However, 
nutrition has not always been included as a factor that might influence 
health and quality of life, although  research has shown that nutrition 
interacts with genotype to influence health and ageing (Mathers 2002). 
 
To date, few epidemiological studies have examined modifiable behavioural 
factors that positively predict healthy living in older cohorts (Khaw et al. 
2008, Peel et al. 2005). In a systematic review determinants that were 
associated with healthy ageing included not smoking, being physically 
active, maintaining body mass index (BMI, kg/m
2
) within normal ranges, 
and moderate intake of alcohol. Moreover, positive health behaviours and 
practices such as combined increased physical activity and not smoking 
were shown to enhance healthy ageing. In the same systematic review 
findings for the influence of diet on healthy ageing were inconclusive as 
dietary intake was measured in only three of the eight selected studies (Peel 
et al. 2005). Findings showed that a high quality diet, based on the 
 5 
 
Mediterranean diet, was associated with maintenance of health status in a 
European study among men and women aged 70 to 75 years from the 
SENECA cohort (Haveman‐Nies et al. 2003). Moreover, lower values for a 
Japanese diet score (based on questions concerning usual intake of ten 
common Japanese foods and ten Western foods, calculated as the ratio of 
intake of Japanese foods to total intake) were associated with healthy ageing 
among men aged 85 years after 12 years follow-up (Reed et al. 1998). 
However, the frequency of eating breakfast or snacking was not a predictor 
of healthy ageing in this systematic review.         
 
Considering that ageing and overall health are influenced strongly by 
lifestyle, more recent, results from the Norfolk arm of the European 
Prospective Investigation into Cancer and Nutrition (EPIC) study have 
shown that combined health behaviors, including non-smoking, 
consumption of five or more servings of fruit and vegetable per day, 
consumption of less than 14 units alcohol per week, and physical activity 
predicted a four-fold difference in total mortality over an average 11 years 
of follow-up in men and women (Khaw et al. 2008). This equated to an 
estimated impact of 14 years in chronological age (Figure 1.3).  
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Figure 1.3: Survival curves according to the number of health behaviours in men 
and women aged 45-79 years from the EPIC-Norfolk study. Analysis was adjusted 
for age, sex, body mass index and social class and the participants were free from 
cardiovascular disease and cancer. Cumulative survival was about 75% for those 
scoring zero and increased to 95% for those scoring four
3
.  
 
Therefore, there is a major challenge for research to investigate how to 
improve the quality of life and how diet may promote healthy and 
successful ageing. Research in this direction will inform public health 
policies to implement evidence-based research findings for the development 
of prevention plans and interventions for lifestyle modification, including 
dietary changes with a focus on improving the well-being and quality of life 
in the elderly.   
 
1.0.3 Healthy ageing 
Healthy ageing is a complex and multifactorial process, characterised by 
progressive physiological and pathological deterioration over time, it can 
however be influenced by environmental changes, including nutrition. 
Indeed, there is evidence that greater adherence to healthy dietary patterns, 
3 Adapted from Khaw K-T et al. (2008) PLoS Med 5(1), e12.  
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such as the Mediterranean diet (high in consumption of fruits and vegetable, 
legumes, cereals, fish, moderate red wine and low in consumption of red 
and processed meats and dairy products) have been associated with lower 
risk of overall mortality (Trichopoulou et al. 2005) and age-related diseases, 
including cardiovascular disease, cancer, Parkinson’s and Alzheimer’s 
disease (Sofi et al. 2008). Ageing is also associated with progressive 
increased susceptibility to disease risk and mortality (Gil del Valle 2011), 
and there are many physiological alterations that occur with ageing and 
influence health status, including changes in body composition (Cruz-
Jentoft et al. 2010). 
 
Two parallel trends occur with physiological ageing, sarcopenia and chronic 
inflammation. Sarcopenia is a condition characterised by progressive loss of 
skeletal muscle mass, strength and muscle quality (muscle strength 
corrected for muscle mass) with physiological ageing, and has been 
associated with an increased risk of adverse outcomes, such as physical 
disability, poor quality of life and death (Baumgartner 2000, Cesari et al. 
2009, Cruz-Jentoft et al. 2010). The second factor, chronic inflammation, 
has been clearly established in large epidemiological studies in older adults 
as having an influence on the ageing process and age-related diseases (Singh 
and Newman 2011). Notably, it is evident that there is a link between 
sarcopenia and age-related chronic inflammation, as it has been shown that 
increased levels of inflammation can be detrimental for muscle mass in both 
humans (Anker et al. 1999) and in animal models (Hoshino et al. 1991), 
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suggesting that age-related chronic inflammation is an important underlying 
mechanisms of sarcopenia (Chung et al. 2009). 
 
Diet is one environmental factor that can potentially influence sarcopenia 
and inflammation. Although physical activity and smoking are known 
influences on sarcopenia, to date, diet has been less investigated at a 
population level (Houston et al. 2008, Robinson SM et al. 2008, Scott et al. 
2010, Stookey JD et al. 2005). Given that sarcopenia and inflammation 
associated with the ageing process can lead to increased morbidity and low 
quality of life, it is emerging that targeting sarcopenia and inflammation 
through healthy dietary modifications, to potentially compress morbidity 
and delay the onset of disability, may promote successful and healthy 
ageing and quality of life.    
 
1.1 Mechanisms associated with the ageing process 
Ageing process is driven by a progressive, lifelong accumulation of a 
variety of molecular and cellular damage, which leads to age-related frailty, 
disability, disease and eventually death (Kirkwood 2005). This damage is 
essentially random, but as it is accumulated with age and it is regulated by 
complex maintenance and repair pathways, which may be modulated by 
metabolic factors (Figure 1.4) (Kirkwood 2008). These pathways are 
further enhanced by stress, inflammation, poor diet and adverse 
environment and can be delayed by better diet, lifestyle and a favourable 
environment. 
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Figure 1.4: Schematic illustrating suggested mechanisms associated with the 
ageing process
4
. 
 
 
In addition, the ageing phenotype is linked to a reduced function at a 
cellular and molecular level, because of inter-cell differences in gene 
expression in older individuals due to altered epigenetic marks, which lead 
to low tissue function  (Mathers and Ford 2009). 
 
It is thought that major contributors that underpin cellular and molecular 
damage are oxidative stress and inflammation (Chung et al. 2009, Gil Del 
Valle 2010). There is already plenty of evidence that supports the theory of 
oxidative damage by reactive oxygen species (ROS) or by the dysfunction 
of mitochondria – the organelles within cells that generate energy - on the 
ageing process (Finkel and Holbrook 2000). Specifically, it is suggested that 
DNA damage accumulates with ageing possibly due to enhanced generation 
4 
Adapted from Kirkwood (2008) Nature 451, 644-647.  
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in ROS and a decreased capacity of DNA repair with age (Burkle et al. 
2002, Promislow 1994). 
Interestingly, studies in long-lived genetic mouse models have shown that 
under optimal conditions with minimum stress, oxidative stress and damage 
have been shown to play little role in ageing, whereas, under chronic stress 
associated with diseases, such as Alzheimer disease, type II diabetes, and 
cardiovascular disease, oxidative stress and damage plays an important role 
in ageing, suggesting that ageing and age-related diseases share the common 
pathway of cumulative oxidative stress (Salmon et al. 2010, Selman and 
Withers 2011).  
 
Accumulation of oxidative stress and damage as well as oxidative stress-
induced redox imbalances can further activate a range of inflammatory 
mediators and increase systemic inflammation (Chung et al. 2009). 
Therefore, both the deregulation of the immune system and the redox 
imbalance with ageing implement the age-related inflammatory hypothesis 
(Chung et al. 2011). Notably, a number of epidemiological studies have 
examined the influence of inflammation in the process of ageing and age-
related diseases in older adults, suggesting that markers of inflammation 
were elevated in older adults, and particularly interleukin-6 (IL-6) most 
robustly predicted various age-related diseases, disability, and mortality 
(Singh and Newman 2011).  
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Overall, the complexity of the ageing process is highlighted by the 
multiplicity of the mechanisms which contribute to its aetiology and should 
be considered in synergy in future research on ageing.  
 
1.2 Sarcopenia 
Since the ageing population is projected to increase, there is an emerging 
interest in examining environmental influences on sarcopenia. Sarcopenia is 
described by a progressive decline of muscle mass, strength and function as 
a consequence of healthy ageing, and accompanied by a number of adverse 
outcomes, including physical disability, decreased mobility, increased 
frailty and incidence of falls and increased risk of mortality (Cruz-Jentoft et 
al. 2010).   
 
1.2.1 Importance of muscle mass and strength  
Conservation of muscle mass is important for health. Skeletal muscle plays 
a major role in the body’s movement and maintenance of stability and in 
protein metabolism, because it serves as a source of amino acids to maintain 
protein synthesis in essential tissues and vital organs when amino acid 
absorption from the gut is limited (Lang et al. 2010). Furthermore, in the 
fasting state, muscle mass can serve as a precursor for hepatic 
gluconeogenesis by supplying blood amino acids (Wolfe 2006). In addition, 
alterations in muscle metabolism can importantly affect chronic diseases, 
such as heart disease and cancer, which are often associated with extensive 
 12 
 
loss of muscle mass and strength as well as metabolic function and this can 
be crucial in determining survival (Kadar et al. 2000). 
 
Preservation of muscle strength and muscle quality is also important as low 
muscle strength and muscle quality have been related with increased 
physical disability, frailty, incidence of falls, and morbidity, and also with 
lower functional performance, and quality of life (Bassey 1997). Low 
muscle strength and muscle quality have also been shown to be predictive of 
mortality and disability (Clark 2008, Giampaoli et al. 1999, Newman et al. 
2006, Rantanen et al. 1999, Rantanen et al. 2003). 
 
1.2.2 Fat free mass and ageing 
It is known that ageing is associated with changes in body composition 
characterised by increases in body weight and changes in the distribution of 
adipose tissue, and decreases in fat free mass, which start after young 
adulthood (Nooyens et al. 2009, Stenholm et al. 2008). Fat free mass is 
composed of non-fat lean soft tissues and bone mineral content and is an 
important metabolically active component of body composition (Nelson et 
al. 1992). Skeletal muscle mass represents the largest fraction of the fat free 
body mass (Heymsfield et al. 1990) and therefore, whole body fat free mass 
is commonly used in epidemiological studies (Jourdan et al. 2012). 
 
Previous cross-sectional studies have shown that advanced age was 
associated with lower fat free mass (Janssen et al. 2000, Kyle et al. 2001). 
Longitudinal studies have also shown a similar trend with increased age 
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associated with lower fat free mass and higher fat mass over time of follow-
up (Ding et al. 2007, Guo et al. 1999, Kyle et al. 2006). However, most of 
these studies were in older populations aged 60 years and over, where 
changes in body composition are expected (Ding et al. 2007, Kyle et al. 
2001). Presently, only one cross-sectional study has evaluated age-related 
body composition differences in a cohort including younger adults (aged 18 
to 88 years) (Janssen et al. 2000). The results showed that differences in 
muscle mass started at age thirty years, but differences in absolute muscle 
mass were more noticeable after fifty years of age in both men and women 
(an example of this effect is shown in Figure 1.5 A and B). One 
retrospective study among a representative healthy Italian population of men 
and women also, included younger adults (aged 20 to 80 years) and it 
showed that fat free mass index was decreased only in the oldest group of 
women (70-80 years) (Coin et al. 2008).  
 
Figure 1.5 Adapted from Janssen et al. 2000 A) Curvilinear relationship between 
muscle mass (kilograms) and age in men and women aged 18-88 years, with 
changes in muscle mass occurring at ~ 45 years in both men and women. B) Linear 
relationship between relative muscle mass with age, which was greater in men (p < 
0.01) than in women.          
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Overall, body composition differences are known to occur with age more 
likely as a result of an imbalance between energy intake and energy 
expenditure, which are associated with an increased sedentary lifestyle, and 
characterised by progressive increases in fat mass and decline in fat free 
mass, but other aspects of nutrition may also influence fat free mass (Kyle et 
al. 2001). Moreover, prevalence rates of sarcopenia may vary between 
different studies because of differences in methods used to assess fat free 
mass, but dual-energy x-ray absorptiometry scan (DEXA) has shown to be a 
reliable method for measuring fat free mass and this method was used for 
the purposes of this project (Cruz-Jentoft et al. 2010). 
 
Therefore, it is important that studies examine body composition differences 
in cohorts including younger adults, as age-related decline of muscle mass 
starts to develop in the third decade and continuously throughout the rest of 
life (Cesari and Pahor 2008). This might be a useful consideration for future 
clinical interventions on sarcopenia, including participants of a wider age 
range and target the progress of sarcopenia earlier in adult life.        
 
1.2.3 Muscle strength and ageing 
Muscle strength is another important component of sarcopenia and ageing 
has been associated with lower muscle strength in a number of 
epidemiological studies (an example of this effect is shown in Figure 1.6) 
(Frontera et al. 1991, Hughes et al. 2002, Lynch et al. 1999, Rantanen et al. 
1998). The most common measurements used in epidemiological studies 
assessing muscle strength are grip, hip and knee strength. Grip strength is an 
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important measurement for overall health, as it has been associated with an 
increased risk of disability, morbidity and mortality in both men and 
women, with declined quality of life in older individuals, and has been 
suggested as a useful marker of muscle function and sarcopenia (Gale et al. 
2007, Laukkanen et al. 1995, Rantanen 2003, Rantanen et al. 1999, 
Rantanen et al. 2003, Sayer et al. 2006, Syddall et al. 2003).  
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6 Adapted from Forrest et al. 2012 Changes in hand grip strength 
during 4.5 years of follow-up in Afro-Caribbean men aged 29 to 89 years, with 
considerable decreases starting after fifty years of age.   
 
1.2.4 Relationship between muscle mass and strength 
Epidemiological studies have shown that after the age of 50 years muscle 
mass  declines of 1-2 % per year on average, and muscle strength declines at 
a rate of 1.5 % per year,  increasing to 3 % per year after the age of 60 years 
(Evans 1997, Hughes et al. 2002, Morley et al. 2001, Roubenoff and 
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Hughes 2000). The relationship between muscle mass and strength is well 
established (Baumgartner et al. 1998, Janssen et al. 2000, Rolland et al. 
2008, Rosenberg 1997) however it may not necessarily be linear. It has been 
reported that older adults with greater muscle mass did not exhibit greater 
muscle strength (Park et al. 2006). Similarly, there is evidence that increases 
in muscle strength with resistance training in women were not followed by 
increases in muscle mass (Raue et al. 2009). Interestingly, recent data from 
the National Health and Nutrition Examination Survey (NHANES, 1999-
2002) showed that in US men and women (aged >50 years) muscle mass 
and muscle strength were positively correlated (r = 0.365, P < 0.001) after 
adjusting for age and gender (Chen et al. 2013). In the same study, muscle 
mass explained 13.3 % of variance in muscle strength independent of the 
effect of age and gender (Chen et al. 2013).  Comorbidity (e.g. obesity) may 
also modify the relationship between muscle mass and muscle strength 
(Chen et al. 2013) and therefore it is important that studies on sarcopenia 
examine both dimensions (Newman et al. 2003).  
 
1.2.5 Muscle quality and ageing  
Muscle quality which is defined as the ratio of muscle strength per unit of 
muscle mass has been used as an approach to measure the quality of 
muscles. Lower muscle quality has been associated with greater age (Lynch 
et al. 1999) and functional incapacities (Goodpaster et al. 2006). Although 
the preservation of muscle mass may be considerably important for the 
prevention of muscle strength loss during ageing, muscle quality may also 
be important in determining the loss of muscle strength with ageing (Barbat-
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Artigas et al. 2012). To date, muscle quality has not been widely studied in 
relation to diet as such.  
 
Therefore, it is important to examine body composition changes/differences 
with age, because it is believed that these changes will have significant 
implications for health status as they are associated with the development of 
chronic disease, and moreover are risk factors for physical disability, 
function, morbidity and early mortality, and consequently impaired quality 
of life (Atlantis et al. 2008, Baumgartner 2000). 
 
1.2.6 Prevalence and epidemiology of sarcopenia 
The increase in the average age of the population will ultimately increase 
the prevalence of sarcopenia, which appears to vary between different 
cohorts from 5-13 % on average in people aged 60-70 years and 11-50 % in 
people aged more than 80 years. This  suggests that the prevalence of 
sarcopenia is considerably higher in the elderly (von Haehling et al. 2010). 
The estimates of the prevalence of sarcopenia are not well established and 
vary widely, due to differences among cohorts relating to the study 
population, the definition, and the different methods employed to assess 
muscle mass, including dual-energy x-ray absorptiometry scans (DEXA), 
magnetic resonance imaging, computed tomography (CT scan), and 
bioelectrical impedance analysis (BIA) (Abellan Van Kan 2009, Morley 
2008). Since the prevalence rates are higher in the elderly, it might be 
important to prevent sarcopenia earlier in adult life.  
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Notably, the decline of muscle strength is higher in sedentary people and 
males with rates almost two times higher in men compared to women 
(Gallagher et al. 1997). Moreover, although men have on average greater 
amounts of muscle mass than women, they also have lower survival 
compared to women, implying that sarcopenia may potentially become a 
greater public health concern among female than male populations (Abellan 
Van Kan 2009, Roubenoff and Hughes 2000). 
 
1.2.7 Aetiology and mechanisms of sarcopenia 
The primary cause of sarcopenia is as yet unclear but multiple factors and 
mechanisms are involved in its aetiology. Age-related loss of muscle mass 
and strength can be attributed to an interaction of age-related 
environmental/lifestyle factors and genetic factors (Jones et al. 2009, Weber 
et al. 2010). These factors include hormonal changes, such as decreased 
levels of growth hormone – GH with age, insulin-like growth factor 1 – 
IGF-1, and testosterone, hormones that help to the growth and development 
of muscles (Baumgartner et al. 1999), insulin resistance (Park et al. 2009), 
chronic diseases (McDermott et al. 2004), increased catabolic activity and 
circulating levels of pro-inflammatory cytokines (such as interleukin 6 - IL-
6 and tumor necrosis factor a - TNF-a) (Morley and Baumgartner 2004). 
Also, other factors including physical inactivity (Hughes et al. 2002, 
Peterson et al. 2010, Peterson et al. 2011), and altered nutritional status 
(such as decreased protein intake and malnutrition of ageing) (Chapman 
2007, Katsanos et al. 2006, Volpi et al. 2003). Suggested mechanisms 
involve changes in muscle protein turnover, synthesis, loss of alpha-motor 
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neurons, and apoptosis (Baumgartner and Waters 2006). In addition, genetic 
heritability may partly explain the aetiology of sarcopenia as the heritability 
of muscle mass and strength may be up to 50-60%, suggesting that genetic 
factors control significantly the development of sarcopenia (Carey et al. 
2007). 
 
However, evidence is scarce on whether components of sarcopenia, 
including muscle mass, strength and muscle quality differ in relation to 
these risk factors. Each factor of the aetiology of sarcopenia potentially 
influences differently losses of muscle mass, strength, and therefore muscle 
quality. It is argued that improvements in muscle mass are more relevant for 
outcomes such as improvement of protein stores, but a contrary explanation 
is that improvements in muscle strength and function are more important for 
outcomes such as disability and mobility (Rolland et al. 2008). Findings 
from observational, intervention and experimental studies support the 
argument that different risk factors affect differently muscle mass and 
strength (Baumgartner et al. 1999, Goodpaster et al. 2006, Malbut et al. 
2002, Morley and Baumgartner 2004). Notably, changes in lifestyle factors 
such as increased physical activity have shown to be beneficial for both 
muscle mass and strength (Roubenoff 2007). In contrast, administration of 
GH supplementation has shown increases in muscle mass, but not 
significant changes in muscle strength (Papadakis et al. 1996, Thompson et 
al. 1998). Moreover, it is seems that certain underlying mechanisms 
influence differently sarcopenia when age, gender or associated 
comorbidities are considered, highlighting the multiplicity of factors that 
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contribute to the development, progression and aetiology of sarcopenia 
(Doherty 2003). 
 
Additionally, oxidative stress plays a major role in the pathogenesis of 
muscle mass and strength with age, caused by elevated damage of DNA, 
proteins and lipids of the ageing muscle (Jackson 2009). Chronic low-grade 
inflammation is also considered detrimental to skeletal muscle mass and 
strength in both humans and animal models (Howard et al. 2007, Siu et al. 
2008). The underlying mechanisms involve enhancement of the redox-
sensitive transcription factors such as Nuclear Factor kappa-light-chain 
enhancer of activated B cells (NF-kB), and Activator Protein 1 (AP-1) from 
reactive oxygen species (ROS). These two signaling pathways are involved 
in the regulation of pro-inflammatory cytokines, such as IL-6 and TNF-, 
up-regulation of acute phase proteins, such as C-reactive protein, and 
inflammatory mediators, such as interleukin-10 (IL-10) (Janssen-Heininger 
et al. 2000). 
 
Indeed, a number of epidemiological studies have shown an inverse 
relationship between muscle mass, strength and function and inflammatory 
cytokines (Barbieri et al. 2003, Payette et al. 2003, Schaap et al. 2009, 
Visser et al. 2002). These findings were also supported by animal studies 
showing that administration of IL-6 and TNF-a in rats were associated with 
changes in muscle metabolism, including increased skeletal muscle protein 
breakdown, decreased protein synthesis rate, decreased amino acid 
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concentration of skeletal muscle, and muscle wasting (Goodman 1991, 
Hoshino et al. 1991). 
 
1.3 Diet and sarcopenia  
The rate of age-related changes in muscle mass, strength and muscle quality 
varies across different populations. This implies that other factors such as 
diet, lifestyle, and genetics could influence muscle mass, strength, and 
function not only in the elderly, but throughout  adult life (Robinson S et al. 
2012). However, the influence of nutrition and better quality of diet on 
sarcopenia is not well studied (Robinson SM et al. 2008, Scott et al. 2010).  
In  recent years, it has been suggested that research should focus on 
examining associations between the “whole” diet, alongside individual 
foods and nutrients, and health status, as we consume a variety of foods and 
not simply nutrients, and therefore benefits in health status are more likely 
to be determined by the total diet (Jacobs et al. 2009). Diet scores 
examining dietary patterns of a population have being used for more than a 
decade as an approach to study the relationship between diet and chronic 
disease risk, because they examine nutrient and food synergies and 
interactions instead of examining a single nutrient’s effect in relation to 
disease risk (Hu 2002).  Despite this, the role of the “whole” diet, in terms 
of healthy eating patterns, on sarcopenia has not been researched yet. 
 
A number of nutrients may be associated with muscle mass and strength 
either because they have been shown to be beneficial in supplementation 
studies, such as protein (Campbell et al. 2001, Castaneda et al. 1995), amino 
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acids (Borsheim et al. 2008, Scognamiglio et al. 2004, Solerte et al. 2008), 
and vitamin D (Dawson-Hughes 2008), or because they may play a role in 
muscle metabolism, such as magnesium and potassium, or due to their 
potential against oxidative stress and their anti-inflammatory properties, 
such as vitamins C and E, selenium, and carotenoids (Frassetto et al. 1998, 
Song et al. 2007, Song et al. 2005). However, little evidence exists on the 
influence of habitual dietary intake (either for nutrients or dietary patterns) 
on muscle mass, muscle strength and muscle quality (Robinson SM et al. 
2008, Scott et al. 2010) and this will be discussed in the following sections. 
 
1.3.1 Protein and amino acids 
The importance of protein and amino acids, particularly the branched-chain 
amino acids in skeletal muscle protein synthesis and anabolic processes are 
evident (Fujita and Volpi 2006, Koopman and van Loon 2009, Volpi et al. 
2003). Moreover, protein synthesis can be increased by higher essential 
amino acid intake or protein availability in both younger and older 
individuals (regardless of the fact that muscle mass decreases with age) 
(Paddon-Jones et al. 2004, Symons et al. 2007, Volpi et al. 2003). A 
disruption in the regulation of protein turnover in skeletal muscle can cause 
further imbalances in muscle protein synthesis. Hence, the role of protein 
intake and amino acids in the development of sarcopenia is of particular 
interest. 
 
Observational studies have focused on associations between total protein 
intake and muscle mass mainly in populations aged more than 50 years. One 
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previous prospective study among women aged 75 ± 3 years found that 
those in the highest tertile of protein intake (> 87 g/d) had 5.3% and 6.6% 
higher whole body and appendicular lean mass, respectively compared with 
those in the lowest tertile (< 66g/d) after five years follow-up (Meng et al. 
2009). A second prospective study among participants aged 70-79 years 
from the Health, Aging and Body Composition study (Health ABC) showed 
that those in the highest quintile of energy-adjusted protein intake (18.2% 
protein as a percentage of energy) lost ≈ 40%  less lean mass and 
appendicular lean mass over three years follow-up, than did those in the 
lowest quintile (11.2% protein as a percentage of energy) (Houston et al. 
2008).  Similarly, an analysis of the China Health and nutrition Survey 
among older adults aged 50-70 years showed that those with higher protein 
intake (> 12.1% of energy) lost less midarm muscle area compared with 
those who had lower protein intake (< 10.4% of energy) over four years 
follow-up, although midarm muscle area is considered as an imprecise 
measure of lean mass (Stookey et al. 2005). Another previous prospective 
study found that energy-adjusted protein intake was a positive predictor of 
muscle mass over 2.6 years follow-up in participants aged 50 to 79 years, 
however no association was observed for muscle strength in this study 
(Scott et al. 2010). Only one previous cross-sectional study found that 
energy-adjusted protein intake was positively associated with grip strength 
in women aged 59 to 73 years, however in this study in the multivariate 
models limited adjustment for confounding factors was  considered, as only 
age, height and gender were included in the regression models but not other 
 24 
 
lifestyle factors that potentially influence the relationship (Robinson et al. 
2008).  
 
Two short-term intervention studies have examined the effects of protein 
intake on muscle mass and strength. One small study in 12 elderly women 
reported that after nine weeks those who consumed the higher protein diet 
0.92 g/kg body weight/day had maintained muscle mass and function 
compared with those with an intake of 0.45 g/kg body weight/day 
(Castaneda et al. 1995). The other small study was a 14-week controlled 
dietary intake trial (where all feeds were supplied to the volunteers) 
providing the RDA for protein intake of 0.8 g protein/kg body weight/d) 
among 10 men and women aged 55 to 77 years. The intervention had no 
effect on whole body composition (% body fat, fat free mass, protein and 
mineral mass)  although mid-thigh muscle area was decreased at the end of 
the 14 week intervention (Campbell et al. 2001). Nevertheless, 
supplementation with protein (after or separate from physical activity) in 
older subjects who frequently consumed adequate amounts of protein (  0.8 
g/kg body weight/day) did not further benefit  the improvements in muscle 
mass and strength due to exercise (Campbell 2007). 
 
However, supplementation studies that used essential amino acids were 
beneficial for muscle mass and muscle strength (Borsheim et al. 2008, 
Scognamiglio et al. 2004, Solerte et al. 2008). Indeed, amino acid 
supplementation (essential and non essential mix consisting of: 3.8 g/d 
leucine, 2 g/d lysine, 1.9 g/d isoleusine, 1.9 g/d valine, 1.1 g/d threonine, 0.4 
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g/d cysteine, 0.4 g/d histidine, 0.3 g/d phenylalanine, 0.2 g/d Methionine, 
0.1 g/d tyrosine, 0.1 g/d tryptophan) at 12.2 g/d, three times per day  for 
three months improved walking function by 48 m, and isometric hand grip 
strength by 2.6 kg in 44 sedentary and frail individuals aged > 65 years 
(Scognamiglio et al. 2004). Another small intervention study (n=12, males 
and females) showed that supplementation with two daily doses of 11 g/day 
of essential amino acids (including: 0.36 g/d histidine, 0.94 g/d isoleucine, 
3.95 g/d leucine, 1.88 g/d lysine, 0.39 g/d methionine, 0.51 g/d 
phenylalanine, 1.05 g/d threonine, 0.82 g/d valine) plus 1.10 g/d arginine, in 
the form of capsules, for 16 weeks, improved lean body mass by 0.60 kg, 
and muscle strength by 22.2 % on average, in glucose intolerant subjects 
with mean (±SD) age 67 (±5.6) years (Borsheim et al. 2008). However, 
these two studies were poorly controlled and were not randomised as pre-
intervention/baseline data were used as a “control” group, limiting the 
robustness of the study. In a third intervention study, among 41 subjects 
with sarcopenia aged 66-88 years, after supplementation with 8 g of 
essential amino acids twice per day for 18 months, significant increases in 
whole body lean mass were observed, although the magnitude of the effect  
was not reported (Solerte et al. 2008). These data suggest an association 
between amino acids and muscle mass and strength and provide evidence 
for further long-term randomised controlled trials, with large sample sizes, a 
wider age range and appropriately powered for the end points of interest. 
These data suggest an association between amino acids and muscle mass 
and strength and provide evidence for further long-term randomised 
controlled trials, including bigger sample size and a wider age range. 
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1.3.2 Minerals (magnesium, potassium and selenium) 
Magnesium is essential for muscle metabolism (Maguire and Cowan 2002). 
Poor magnesium intake may trigger the production and release of pro-
inflammatory cytokines, such as interleukin-1ß (IL-1ß) and TNF-, and 
contribute in the activation of low grade chronic inflammation (Kramer et 
al. 2003, Lukaski 2004). There is only one cross-sectional study in the 
literature reporting that energy-adjusted magnesium intake was a positive 
predictor of muscle mass over 2.6 years follow-up in participants aged 50 to 
79 years (Scott et al. 2010). One study has shown a strong correlation 
between circulating magnesium and muscle performance and significant 
associations with hand grip strength (Dominguez et al. 2006). These 
findings are supported by studies applying supplementation with 
magnesium, which have been shown to significantly increase muscle 
strength in young subjects (Brilla and Haley 1992).  
Muscle mass contains the major body pool of potassium and is critical for  
potassium
 
homeostasis, and consequently depletion affects the activity of 
muscles (McDonough et al. 2002). It has been suggested that long-term 
supplementation with potassium bicarbonate from fruits and vegetables may 
benefit anabolism, including improvement of calcium, phosphorus and 
nitrogen balance, and an increase of bone formation markers, implying that 
this might be beneficial for muscle wasting too (Frassetto et al. 1997, 
Sebastian et al. 1994).  
 
Selenium plays various functions in muscles and deficiency is associated 
with skeletal myopathy and cardiomyopathy (Keshan’s disease) (Rederstorff 
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et al. 2006). One cross-sectional study found that energy-adjusted selenium 
intake was associated with significantly higher hand grip strength in 2983 
men and women aged 59 to 73 years from the Hertfordshire cohort (UK) 
(Robinson SM et al. 2008). One cross-sectional study in older men and 
women ( 65 years) has also shown that low plasma selenium concentration 
was independently associated with poor skeletal muscle strength (defined as 
the lowest quartile of hip flexion, grip and knee extension strength) 
(Lauretani F et al. 2007).  
 
1.3.3 Vitamins C and E, and carotenoids 
There has been an increased interest on the associations between dietary 
intake and serum levels of nutrients that have the potential to reduce the risk 
of developing sarcopenia, because oxidative stress is involved in the 
pathogenesis of sarcopenia and has also catabolic effects on skeletal muscle 
(Jackson et al. 2004, Schwartz and Weindruch 1995).  
 
Skeletal muscle contains about 67 % of whole-body’s vitamin C content. In 
muscle cells, ascorbic acid plays a protective role against oxidative stress, 
and sustains the activity of ε-N-trimethyllysine hydroxylase – a key enzyme 
for carnitine biosynthesis. Fatigue is an early clinical sign of vitamin C 
deficiency, which is caused by deregulation of this enzyme’s activity 
triggering depletion of muscle carnitine (Savini et al. 2005). Cross-sectional 
analyses have shown positive associations between lower intakes and /or 
plasma vitamin C with reduced muscle strength, reduced performance and 
frailty (Bartali B et al. 2006, Cesari et al. 2004, Robinson SM et al. 2008). 
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More recently, it has been shown that human skeletal muscle comprises a 
relatively labile pool of ascorbate and is likely to be affected by ascorbate 
depletion with inadequate vitamin C intake (Carr et al. 2013).  
 
Vitamin E deficiency in experimental animals can affect the skeletal muscle 
causing necrotizing myopathy. Although dietary vitamin E deficiency is 
unknown, patients with severe fat malabsorption, cystic fibrosis, some 
forms of chronic liver disease are unable to absorb or transport the vitamin 
E around the body, and may suffer from muscle membranes damage 
(Gibney MJ et al. 2009). Cross-sectional studies have not shown any 
associations between vitamin E intake and muscle strength, however, low 
plasma levels of a-tocopherol and γ-tocopherol have been associated with 
low muscle strength in older adults (Cesari et al. 2004, Robinson SM et al. 
2008, Semba et al. 2003). 
 
Dietary carotenoids may be protective against reactive oxygen species, 
which are accumulated with ageing and may also act as preventive agents 
against oxidative damage which contributes to losses of muscle mass and 
strength (Kim et al. 2010). Recent epidemiological studies in community-
dwelling older individuals have shown that low serum and/or plasma 
carotenoid levels were independently associated with low muscle strength 
and the development of walking disability over time (Lauretani et al. 2008, 
Semba et al. 2007). In addition, in the InCHIANTI study low intake of β-
carotene was marginally associated with knee extension strength (β = 0.311, 
P = 0.05) (Cesari et al. 2004). Yet, one cross-sectional study in adults aged 
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53-73 years showed that grip strength was positively associated with 
energy-adjusted carotene intake, in both women and men (Robinson SM et 
al. 2008).  
 
1.3.4 Vitamin D 
It has been suggested that vitamin D plays an important role in muscle 
function and physical performance, and that its deficiency is followed by 
muscle weakness and pain (Hamilton 2010). The underlying mechanism 
may be mediated by de novo protein synthesis, which affects muscle cell 
growth through the highly specific nuclear vitamin D receptor which is 
expressed in human muscle tissue (Bischoff et al. 2001). Longitudinal 
studies have consistently shown an association between vitamin D status 
and muscle strength, frailty and physical performance among older adults 
(Scott et al. 2010, Visser et al. 2003). Also, low serum 25-OH vitamin D 
level has been suggested as an independent predictor of falls (Dawson-
Hughes 2008). In cross-sectional studies a positive association between 25-
OHD (a plasma metabolite used to assess vitamin D status) and muscle 
strength has been reported (Gerdhem et al. 2005, Houston et al. 2007). Yet, 
one cross-sectional study has shown that among men and women aged 53-
73 years, grip strength was positively associated with energy-adjusted 
vitamin D intake, but only in women (Robinson SM et al. 2008). Evidence 
from double-blind randomised controlled trials suggests that 
supplementation with vitamin D increased muscle strength and physical 
performance, and also associated with a decline in the risk of falls among 
both community-dwelling older individuals and residents in nursing homes 
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with low vitamin D status (Annweiler et al. 2009, Bischoff-Ferrari et al. 
2009, Dawson-Hughes 2008, Lisa 2008). 
 
1.3.5 Summary 
In summary, there are currently limited population studies examining 
associations between habitual dietary intake and indexes of muscle mass 
and muscle strength and the available data are inconsistent (Robinson SM et 
al. 2008, Scott et al. 2010). These previous studies have also been 
conducted in a narrow age range (50 to 79 years), and they have not 
examined the range of nutrients potentially important for muscle mass. 
Cross-sectional studies have not shown any associations between protein 
intake and muscle mass, although positive associations have been found in 
longitudinal studies (Baumgartner et al. 1999, Houston et al. 2008, Mitchell 
et al. 2003, Stookey JD et al. 2005). However, these studies were also 
limited to older populations and some of them measured a narrow range of 
lean mass (appendicular lean mass in the four limbs) and not whole body fat 
free mass, although  appendicular lean mass accounts for more than 75 % of 
the total skeletal muscle mass (Gallagher et al. 1997). Moreover, 
intervention trials using amino acid supplementation suggest beneficial 
effects on muscle mass and strength in the elderly (Børsheim et al. 2008, 
Ferrando et al. 2010). Indeed, amino acid supplementation (essential and 
non-essential) ranging from 11 to 16 g/d increased total body lean mass and 
muscle strength among individuals aged more than 65 years (Borsheim et 
al. 2008, Scognamiglio et al. 2004, Solerte et al. 2008). However, two of 
these studies were poorly controlled and pre-intervention data were used as 
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a control group, limiting the robustness of the study, and in the third 
intervention study, although there was an increase in total body lean mass, 
data were not shown. Nevertheless, these data suggest an association 
between amino acids and muscle mass and strength providing evidence for 
further long-term randomised controlled trials, including bigger sample size 
and a wider age range. 
 
There are however limited studies examining the influence of habitual 
dietary intake of a range of nutrients that might be relevant for muscle mass 
in cohorts including younger adults, and there are no studies examining the 
relationship between  the overall diet quality and indexes of muscle mass, 
muscle strength and muscle quality in population-based studies. There is 
evidence that nutrients, such as protein, essential amino acids, and vitamin 
D are not only important for muscle biology (Fujita and Volpi 2006, 
Koopman and van Loon 2009), but have been shown to be beneficial in 
supplementation studies. However, in relation to protein, supplementation 
did not further benefit  the improvements in muscle mass and strength due 
to exercise (Campbell 2007), and in relation to amino acids the studies were 
poorly controlled, short term, and limited in older subjects aged more than 
65 years (Borsheim et al. 2008, Scognamiglio et al. 2004, Solerte et al. 
2008). Other micronutrients, such as magnesium (Maguire and Cowan 
2002), potassium (McDonough et al. 2002), and selenium (Rederstorff et al. 
2006) have been shown to be essential for muscle metabolism, however, 
little evidence exists for their habitual intake in association with muscle 
mass and strength in population studies (Robinson et al. 2008, Scott et al. 
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2010). In addition, vitamins C (Savini et al. 2005), E (Semba et al. 2003), 
and carotenoids (Kim et al. 2010) are also important for muscle mass 
through their potential to act against oxidative stress, which has catabolic 
effects on skeletal muscle, however, little evidence is available for the 
influence of intake of these nutrients in association with indexes of muscle 
mass, muscle strength and muscle quality (Robinson et al. 2008, Scott et al. 
2010). 
Therefore, given these gaps in the current literature, it is important to further 
understand associations between dietary intake of mentioned range of 
nutrients potentially important for muscle mass in order to appreciate the 
influence of habitual dietary intake of nutrients and diet quality on muscle 
mass and muscle strength in a population including younger adults. Notably, 
it is important to examine dietary associations with muscle mass in 
individuals of all ages, as changes in skeletal muscle mass start to occur 
earlier in adult life (between 30 and 45 years of age) (Cesari and Pahor 
2008, Janssen et al. 2000). 
1.4 Sarcopenia and inflammation 
As mentioned briefly in section 1.1, ongoing research on ageing and 
sarcopenia suggests a link between sarcopenia and inflammation (Chung et 
al. 2009). It is well known that the ageing process is associated with a 
gradual, chronic production and increase of pro-inflammatory cytokines 
(Roubenoff et al. 1998). The age-related cytokine production is a risk factor 
leading to the predisposition to sarcopenia, as the pro-inflammatory 
environment triggers catabolism and protein breakdown and therefore leads 
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to imbalances in the synthesis of muscle tissue (Morley and Baumgartner 
2004, Roubenoff and Hughes 2000).  
 
Epidemiological evidence have shown an inverse relationship between 
muscle mass, strength and function and inflammatory cytokines (Barbieri et 
al. 2003, Cesari et al. 2005, Payette et al. 2003, Schaap et al. 2006, Schaap 
et al. 2009, Visser et al. 2002). Indeed, in the Health, Aging and Body 
Composition (Health ABC) study among men and women aged 70-79 years, 
it was observed that per standard deviation increase in IL-6, grip strength 
was 1.1 to 2.4 kg lower, and participants with high levels of IL-6 (> 1.80 
pg/ml) and TNF-a (> 3.20 pg/ml) had a smaller muscle area, less 
appendicular muscle mass, lower knee extensor strength and grip strength 
(Visser et al. 2002). A report from the InCHIANTI cohort found that among 
men and women aged 20-102 years, IL-6 was an independent predictor of 
hand grip strength and muscle power (Barbieri et al. 2003). In a cohort of 
older adults aged 72 to 92 years, from the Framingham Heart study, IL-6 
was a significant predictor of fat free mass over two years follow-up 
(Payette et al. 2003). In another report from the InCHIANTI cohort among 
men and women aged more than 65 years it has been shown that there was 
an independent association between IL-6 and CRP and muscle strength and 
poor physical performance (Cesari et al. 2004). In the Longitudinal Aging 
Study Amsterdam (LASA) among men and women with a mean age of 74.6 
years, high IL-6 and CRP were associated with a two to three fold higher 
risk of losing greater than 40 % of muscle strength, however no associations 
were found with appendicular muscle mass (Schaap et al. 2006). Similarly, 
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in the Health, Aging and Body Composition (Health ABC) study among 
men and women aged 70-79 years, it was observed that TNF-a levels and its 
soluble receptors were associated with five year decline in cross-sectional 
muscle area and hand grip strength (Schaap et al. 2009).   
 
These findings were also supported by animal studies showing that 
administration of IL-6 and TNF-a in rats was associated with changes in 
muscle metabolism, including increased skeletal muscle protein breakdown, 
decreased protein synthesis rate, decreased amino acid concentration of 
skeletal muscle, and muscle wasting (Goodman 1991, Hoshino et al. 1991).  
 
Chronic low-grade inflammation is considered detrimental to skeletal 
muscle mass and strength in both humans and animal models (Howard et al. 
2007, Siu et al. 2008). It has been suggested that the underlying mechanism 
involves enhancement of the redox-sensitive transcription factors NF-kB, 
and AP-1 from reactive oxygen species (ROS). These two signaling 
pathways are involved in the regulation of pro-inflammatory cytokines, such 
as IL-6 and TNF-, up-regulation of acute phase proteins, such as C-
reactive protein, and inflammatory mediators, such as IL-10 (Janssen-
Heininger et al. 2000). It has also been suggested that redox-sensitive NF-
kB (which induces many inflammatory mediator gene expressions) is 
activated by the ubiquitin-proteasome system causing an imbalance between 
protein synthesis and degradation in skeletal muscle, leading to loss of 
muscle mass and muscle atrophy (Chung et al. 2009). 
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The most commonly studied marker of inflammation is C-reactive protein 
(CRP), which is an acute phase protein and which has the highest increases 
during an acute phase response in man (Heinrich et al. 1990). CRP is 
synthesised in the liver, and may be mediated by a number of cytokines, but 
mainly IL-6 (Shoelson et al. 2007). In addition to liver derived CRP, data 
have shown that adipose tissue itself may contribute to obesity associated 
increase of CRP levels (Berg and Scherer 2005). It has also been reported 
that CRP levels are higher in obese individuals who are insulin resistant and 
decrease with weight loss and improvement of insulin sensitivity (Kopp et 
al. 2003, McLaughlin et al. 2002). It is well known that a potential 
mechanism underlying these observations is that IL-6 production by human 
adipose tissue increases during obesity, thus it may induce the hepatic CRP 
synthesis and may promote the onset of insulin resistance (Bastard et al. 
2006, de Luca and Olefsky 2008). The epidemiologic association between 
elevated levels of circulating CRP and increased cardiovascular risk is quite 
robust with to date more than 20 prospective epidemiologic studies 
providing evidence that high-sensitivity CRP is an independent predictor of 
a number of CVD events, such as myocardial infarction, stroke, peripheral 
arterial disease, and sudden cardiac death, even in apparently healthy 
subjects (Calabrò et al. 2009).  
The recent literature refers to the term ‘high-sensitivity’ or ‘highly sensitive’ 
CRP (hs-CRP). This term is used for the measurement of CRP in plasma or 
serum using sufficiently sensitive immunoassay methods to quantify CRP 
throughout its normal range compared to older commercial assays which 
 36 
 
were less sensitive and had detection limits in the range of 2-10 mg/L and 
were used to measure acute phase responses of CRP instead of baseline 
values (Casas et al. 2008). These high sensitivity assays can detect 
concentrations of <0.3 mg/L accurately and reproducibly (Zaninotto et al. 
2007). 
 
1.5 Diet and inflammation 
Diet is one factor that plays a major role in the regulation of chronic 
inflammation. Dietary constituents have the potential to exert anti-
inflammatory as well as pro-inflammatory effects (Cavicchia et al. 2009). 
Diverse dietary components, such as n-3 fatty acids, antioxidant vitamins 
and plant flavonoids exert anti-inflammatory effects via a range of 
mechanisms including decreasing inflammatory mediator production 
through effects on cell signaling and gene expression and by reducing 
production of oxidants (Calder et al. 2009). Dietary patterns such as the 
Mediterranean diet which consist of high intake of vegetables, fruits and 
nuts, legumes, fish and seafood, cereals and whole grains, high ratio of 
monounsaturated to saturated lipids, and low intake of meat, meat and dairy 
products may reduce chronic inflammatory status and prevent the 
occurrence of diseases mediated by inflammation, such as CVD and type II 
diabetes (Esposito et al. 2004, Trichopoulou et al. 2009).  
 
In contrast, there are dietary components suggested to have pro-
inflammatory effects, such as diets high in saturated and trans-fatty acids, 
sugar and refined starches and low in fruits and vegetables, polyphenols and 
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other antioxidants (Calder et al. 2009). This is most likely a result of 
increased production of pro-inflammatory cytokines followed by a reduced 
production of anti-inflammatory cytokines. Available evidence suggests that 
saturated and trans fatty acids have an effect on the acute phase proteins, 
such as CRP and on inflammatory cytokines, such as IL-6 and TNF-a (Basu 
et al. 2006). Thus, high intake of saturated fatty acids through consumption 
of a more Western dietary pattern high in fast foods, processed foods, high-
fat dairy products, red meat and pork act as a pro-inflammatory factors 
(Lundman et al. 2007). 
 
Although there are a number of studies that have examined the role of diet 
on chronic inflammation, these were mainly focused on inflammatory status 
which mediates cardiovascular diseases and diabetes (Esposito et al. 2004, 
Trichopoulou et al. 2009). However, there are no population studies in the 
literature examining whether habitual diet may influence chronic 
inflammation associated with sarcopenia. Therefore, further understanding 
potential influences of the habitual diet on inflammation related sarcopenia, 
associations between the habitual diet and the inflammatory marker C-
reactive protein is important.   
 
1.6 Research gaps 
Although the importance of healthy eating patterns on mortality and chronic 
disease risk is well documented in adults (Akbaraly et al. 2011, Huijbregts 
et al. 1997, McCullough et al. 2002, Patterson et al. 1994, Seymour et al. 
2003, Trichopoulou et al. 2005), to date, there are no studies that have 
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examined the relative importance of diet as a whole on muscle mass, 
strength and muscle quality and consequently sarcopenia with physiological 
ageing. In addition, there are limited population-based studies on 
associations between habitual dietary intake and indexes of muscle mass 
(Houston et al. 2008, Scott et al. 2010, Stookey JD et al. 2005), muscle 
strength (Robinson SM et al. 2008, Scott et al. 2010) and no studies on 
muscle quality as outlined in Chapter 1, section 1.3.  
 
Also, it is well reported  that a diet high in fruit and vegetables, whole 
grains, nuts and polyunsaturated fatty acids, as well as dietary patterns high 
in these food components, may exert anti-inflammatory properties and is 
associated with lower concentrations of inflammatory markers including 
CRP (Chacko et al. 2010, de Oliveira et al. 2011, Esmaillzadeh et al. 2006, 
Fung et al. 2005, Galland 2010, Lopez-Garcia et al. 2005, Lutsey et al. 
2007, Mozaffarian et al. 2004, Song et al. 2005). Also, there is evidence that 
higher levels of inflammatory markers negatively influence muscle mass 
and strength, potentially increasing  the development of sarcopenia (Barbieri 
et al. 2003, Cesari et al. 2005, Payette et al. 2003, Schaap et al. 2006, 
Schaap et al. 2009, Visser et al. 2002). However, to our knowledge there are 
no studies examining whether dietary constituents could influence the 
association between inflammation and muscle mass, strength or muscle 
quality, and subsequently sarcopenia. 
 
The current thesis will address these research gaps in a population-based 
study of women by evaluating associations between the habitual diet and 
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muscle mass, muscle strength and muscle quality, diet and inflammation, 
and examining whether diet mediates the relationship between muscle mass 
and inflammation. 
 
1.7 Aims and hypotheses 
Therefore, given the lack of previous research, the overall aim of this thesis 
was to examine associations between habitual diet and muscle mass, 
strength and muscle quality in adult women from the TwinsUK cohort. The 
TwinsUK cohort is an ongoing study examining a wide range of age-related 
phenotypes, behavioural and disease risk markers, and participants are a 
national sample of healthy adult twin volunteers from the UK (a detailed 
description of the cohort follows in Chapter 2) (Spector and Williams 2006). 
An additional aim was to examine associations between habitual diet and 
inflammation to determine whether diet influences the relationship between 
muscle mass, strength, muscle quality and inflammation in women.  
It was specifically hypothesised that higher dietary intakes of a range of 
antioxidant micronutrients, protein and amino acids, and higher adherence 
to a better diet quality were associated with i) higher indexes of muscle 
mass, muscle strength and muscle quality and ii) lower inflammation levels 
(as assessed by CRP). We also hypothesised that higher CRP levels were 
associated with lower indexes of muscle mass. We additionally 
hypothesised that higher dietary intakes of a range of antioxidant 
micronutrients, amino acids, and higher adherence to a better diet quality 
would attenuate the negative impact of CRP on muscle mass. 
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1.8 Objectives 
1) To examine whether habitual dietary intakes of a range of 
antioxidant micronutrients and protein and amino acids influence 
indexes of muscle mass, including fat free mass (FFM, kg), 
percentage fat free mass (FFM %) and fat free mass index (FFMI, 
kg/m
2
), muscle strength (assessed by hand grip strength (kg), and 
muscle quality calculated as the ratio of muscle strength divided by 
fat free mass (kg/kg).   
2) To develop five predefined diet quality scores: the Mediterranean 
Diet Score (MDS), Healthy Diet Indicator (HDI), Diet Quality Index 
(DQI), Alternate Healthy Eating Index (AHEI), and the Dietary 
Approach to Stop Hypertension score (DASH-style score) using data 
on dietary intake from the TwinsUK cohort. 
3) To examine associations between adherence to a better diet quality 
(assessed by the diet quality scores) and indexes of muscle mass, 
muscle strength and muscle quality.  
4) To evaluate whether a range of antioxidant nutrients, protein and 
amino acids and diet as a whole (assessed by five predefined diet 
quality scores) influences inflammation markers, specifically C-
reactive protein (CRP). 
5) To develop an analytical strategy to investigate the relationship 
between muscle mass and inflammation (assessed by CRP) to 
evaluate whether dietary constituents and diet quality scores mediate 
the relationship between muscle mass and inflammation. 
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Chapter 2 
Subjects and Methods  
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2.0 Subjects and methods 
2.1 Subjects 
2.1.1 The TwinsUK cohort 
The TwinsUK cohort is an ongoing study examining a wide range of age-
related phenotypes, behavioural and disease risk markers. The cohort is a 
national sample of healthy adult twin volunteers from the UK recruited 
through a series of media campaigns. All the twins were brought up together 
and lived apart in adult life in the UK. Recruitment started in 1992 and 
focused on middle-aged females, because the diseases under investigation, 
including osteoarthritis and osteoporosis, are more prevalent in women 
(Spector and MacGregor 2002). From 1995 onwards, men were also invited 
to participate. 
Between 1992 and 2004, twins invited for a comprehensive baseline visit. 
More than 7000 twins responded to annual health questionnaires and 5725 
of them (out of about 10000 registered twins) attended a comprehensive 
visit. One thousand three hundred forty seven twins were added to the 
TwinsUK registry and all the 6740 active twins on the registry (not 
deceased, withdrawn or not contactable) attended the first follow-up visit (a 
1-day clinical visit) between 2004 and 2007. The second follow-up visit was 
conducted between 2007 and 2010. This visit included only women aged 
more than 40 years with at least one previous clinical visit. From the 4610 
women that were invited, 3125 attended the clinic, 53 were deceased, 646 
declined to attend and 786 were not contactable. 
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Participants in the second follow-up visit appeared to have higher socio-
economic status, lower self-rated health status and be more health aware 
according to their level of alcohol intake and smoking.  
The main objectives of the study were to estimate the heritability for 
common diseases and traits in adults, discover associated genes, and provide 
a framework for epidemiological studies using the twin design (Spector and 
Williams 2006). More recently, the TwinsUK cohort has focused on 
“healthy ageing”, since ageing is a multifactorial complex process, which 
involves multiple organs and multiple molecular pathways (Viña et al. 
2007).    
The Registry contains now approximately 12,000 twins (51% monozygotic 
and 49% dizygotic), males and females (83%), aged 18 to 103 years 
(Moayyeri et al. 2012). Ethical approval for the study was obtained from the 
St. Thomas Hospital Research Ethics committee and informed consent was 
obtained from all participants. 
 
A variety of data are available from the TwinsUK Registry, including 
demographic and lifestyle data (such as physical activity, medication 
history, cognitive function and food frequency questionnaires), clinical 
outcomes (anthropometrics, whole body dual energy x-ray absorptiometry 
scans, and grip strength) and biological samples (such as fasting blood and 
urine samples, DNA extraction, and lipid and metabolic profiles). The 
cohort also benefits from advanced technologies and available data on 
genetic measurements (genome wide scans, epigenetic analysis, and gene 
expression – RNA sequencing) and specialised tests (for example telomere 
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length analysis, metabolomic profiles, fat and muscle biopsies among 
others) (Moayyeri et al. 2012, Spector and Williams 2006). 
 
Some of the major earlier research findings of the cohort were associated 
with studies examining the heritability of diseases and associated genes that 
influence diseases and traits in adults. Indicative research findings have 
shown that osteoarthritis of knee, hand, hip, and spine were all strongly 
heritable (Spector and MacGregor 2004). In addition, risk factors that were 
associated with osteoporotic fractures, including bone density, bone quality, 
hip axis length, vitamin D levels, bone turnover markers and muscle 
strength were strongly and independently genetic (Arden et al. 1996). 
Moreover, many studies have found that cardiovascular disease outcomes, 
such as hypertension, pulse rate, blood pressure, arterial resistance, and 
cardiovascular disease have shared genetic influences (Snieder et al. 2000, 
Williams et al. 2004).  
  
In this framework, the Department of Nutrition at the University of East 
Anglia in collaboration with the Twins Unit (King’s College London) was 
involved in the analyses of datasets incorporating nutritional data and a 
number of phenotypes. To date, collected research findings from this 
collaboration have shown that in female twins from the TwinsUK registry 
habitual total flavonoids intake was positively associated with bone mineral 
density, with effects observed for anthocyanins and flavones at both the hip 
and spine (Welch et al. 2012); higher anthocyanin intake was associated 
with lower arterial stiffness and central blood pressure (Jennings et al. 
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2012); wine intake was positively associated with spine bone mineral 
density and a traditional English diet pattern had a negative association with 
hip bone mineral density (Fairweather-Tait et al. 2011); and plasma 
adiponectin concentrations were associated with body composition and 
plant-based dietary factors (Cassidy et al. 2009). The above findings support 
a role of dietary constituents present in plant-based foods on a number of 
health related outcomes in female twins from the TwinsUK cohort.    
 
2.1.2 Study population 
For the purposes of this thesis, analyses were performed for twins as 
singletons/individuals, because previous studies have shown that 
participants from the TwinsUK registry were not different from age-
matched singleton women in the distribution of common traits and 
outcomes and therefore data were well characterised (Andrew et al. 2001). 
Moreover, characteristics and energy intake from the TwinsUK cohort has 
shown to be similar with those from UK singleton populations (Henderson 
et al. 2004, Sproston and Primatesta 2004). Data from two subsets of this 
cohort examined at two different time points, initially in 1996 and then 
again in 2005, were used for my analyses. For the first subset, data on 
dietary assessment, body composition parameters, and other covariates were 
available for n = 2570 women, aged 18 to 79 years, representing 792 
monozygotic (MZ) females and 1778 dizygotic (DZ) females, who had 
completed a food frequency questionnaire (FFQ) and attended for dual-
energy X-ray absorptiometry (DEXA) scans between 1996 and 2000 
(Teucher B 2007). This subset also included those who had fasting blood 
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samples taken, to measure C-reactive protein (CRP); n = 1658 individuals, 
representing 582 monozygotic (MZ) females and 1076 dizygotic (DZ) 
females, aged 18 to 79 years (Moayyeri et al. 2012). For the second subset 
focusing on data available for grip strength, data on dietary assessment, 
body composition parameters, and other covariates were available for n = 
949 individuals, representing 415 monozygotic (MZ) females and 534 
dizygotic (DZ) females, aged 34 to 83 years, who had completed a food 
frequency questionnaire (FFQ) and attended for hand grip strength 
measurements and DEXA scans between 2005 and 2008 (Moayyeri et al. 
2012). 
Statistical analysis was subdivided into two subsets as measurements on 
body composition parameters, including fat free mass and hand grip strength 
were taken at two different time points. Data on fat free mass were initially 
collected in 1996, whereas data on hand grip strength were initially 
collected in 2005. Therefore, the analyses in this thesis included two subsets 
of the cohort according to the availability of data from the two different 
visits.   
 
2.2 Methods 
2.2.1 Zygosity 
Zygosity was derived by questionnaire and confirmed by supplemented 
multiplex-DNA fingerprinting in cases with disputed or uncertain zygosity 
(PE Applied Biosystems) (Spector and Williams 2006). 
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2.2.2 Assessment of anthropometry variables and body composition 
Height and weight were measured, BMI was calculated as weight in 
kilograms (kg) divided by height in meters squared (m
2
), and overweight 
status was defined using categories based on WHO criteria (WHO 1998). 
 
Fat free mass: Fat free mass (FFM, kg) and fat mass (FM, kg) were 
assessed by dual-energy X-ray absorptiometry scans with a Hologic QDR-
2000 DXA scanner (Hologic Inc., Waltham, MA, U.S.A.). The percentage 
fat free mass (FFM %) was calculated as the ratio of fat free mass in 
kilograms (kg) divided by total body weight in kilograms (kg) and 
multiplied by 100. The fat free mass index (FFMI, kg/m
2
) was calculated as 
the ratio of fat free mass in kilograms (kg) divided by height in metres 
squared (m
2
). The fat free mass index is a useful index in evaluating body 
composition parameters as it eliminates differences in fat free mass 
associated with height. It also gives the advantage of having one set of 
recommended ranges, independent of age and height, and is an important 
marker of nutritional status in health and disease (Kyle et al. 2003). Fat free 
mass in kilograms and percentage fat free mass were also included in the 
current thesis to enable comparison of the findings with other studies. 
 
Hand grip strength and muscle quality: Grip strength of the dominant arm 
was assessed using a Jamar hand grip dynamometer (Sammons, Preston, 
UK). Repeated measurement on 24 individuals was used to assess 
reproducibility, with a coefficient of variation (CV) of 11.4 % (Arden and 
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Spector 1997). Muscle quality was calculated as the ratio of hand grip 
strength in kilograms (kg) divided by muscle mass in kilograms (kg). 
 
2.2.3 Assessment of C-reactive protein (CRP) 
C-reactive protein was measured using a highly sensitive automated 
microparticle capture enzyme immunoassay, previously standardized by the 
World Health Organization International Reference Standard for CRP 
immunoassay 85/506 (WHO 1987, Wilkins et al. 1998).    
 
Subjects were excluded from the analysis if there were differences greater 
than six kilograms between body weight measured used DEXA and 
calibrated scales, or if BMI was less than 16 kg/m
2, or if the subject’s twin 
did not have measurement.  
 
2.2.4 Assessment of dietary intake 
Participants completed a 131-item FFQ previously used in the European 
Prospective Investigation into Cancer and Nutrition (EPIC) study, which has 
been validated against urinary biomarkers and plasma biomarkers of intake 
(urinary nitrogen, potassium, sodium, ascorbic acid and n-3 PUFAs) 
(Bingham et al. 1997, McKeown et al. 2001, Welch et al. 2006). Daily 
nutrient intake was determined using nutrient values from McCance and 
Widdowson food composition tables and the EPIC database of the 
carotenoid content of foods (McCance et al. 1991, Pattison et al. 2005). In 
relation to the amino acid intakes a new database was developed with 78% 
of the data from McCance and Widdowson food composition tables and the 
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remainder from the United States Department of Agriculture (USDA) 
database. 
Frequencies of the different food items from the FFQ were transformed to 
intakes in grams per day by multiplying the frequency of weekly 
consumption of each food item by the appropriate portion size of each item 
and then dividing by seven (APPENDIX I for portion sizes of different 
food items). Gram amounts of foods were classified into key food groups, 
such as fruit and vegetables, whole grains; complex carbohydrates, meat 
group, fish group, and dairy products group (there were small differences 
between the two food frequency questionnaires and both sets of 
classifications are shown in APPENDICES II and III for food groups’ 
definition). Gram amounts of macronutrients from the FFQ were converted 
to percentage of total energy intake using the following conversion factors: 
protein intake: 4 kilocalories per gram (kcal/g), fat intake: 9 kilocalories per 
gram (kcal/g), and for carbohydrate intake: 3.75 kilocalories per gram 
(kcal/g) (McCance et al. 1991). Subjects’ FFQs were excluded if answers 
for more than 10 food items were left blank; the subject’s twin did not 
complete a FFQ; and if the subject’s ratio of the estimated total energy 
intake (derived from the FFQ) to the subject’s estimated basal metabolic 
rate (based on the Harris-Benedict equation) was two standard deviations 
away from the mean of this ratio (<0.52 or >2.58) (Frankenfield et al. 1998, 
Teucher B 2007). Therefore, extreme over- and under-reporters were 
excluded a priori to any other exclusion. The numbers that fall into these 
categories were: for subset 1 (n = 2570 women, aged 18 to 79 years): 172 
out of 5415 women (3.2 %) were over-reporters and 29 out of 5415 women 
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were under-reporters (0.54 %); and for subset 2 (n = 949 women, aged 34 to 
83 years): 112 out of 3370 women (3.3 %) were over-reporters and 26 out of 
3370 women (0.77 %) were under-reporters. To further evaluate whether 
misreporting was influencing associations between diet and indexes of 
muscle mass and estimate energy requirements, the ratio of reported energy 
intake (EI:EER) to estimate energy expenditure was calculated and this was 
included as a covariate for adjustment in the statistical analyses (Otten et al. 
2006, Rennie et al. 2007) (Chapter 3, section 3.2, p. 87). Estimated energy 
requirements (EER) for each subject were calculated using the 2002 
Institute of Medicine of the National Academies published Default ((2002)). 
These equations are sex-and age-specific and are based on the age, weight 
and height of the subject and are derived from collated doubly labelled 
water energy expenditure data. They also allow for three levels of activity: 
low activity (PAL ≥ 1.4 and <1.6), active (PAL ≥ 1.6 and < 1.9) and very 
active (PAL ≥ 1.9 and <2.5) with a corresponding physical activity 
coefficient in the EER equations. For example, the EER equation for women 
aged over 19 years was derived by the following formula: 
EER = 354 – (6.91 x age) + PA x [(9.36 x weight (kg)) + (726 x height 
(m)]  
Misreporting of energy is a common issue in population studies, and the 
implications of under-reporting are that they are very likely to attenuate any 
diet and disease relationships. Previous studies have suggested that the 
probability of under-reporting increases with increasing BMI (Livingstone 
and Black 2003). Also, the selective reporting of foods has hampered the 
definition of food patterns and the subsequent derivation of food based 
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guidelines (Becker et al. 1999). Indeed, assessment of dietary intake using 
FFQs has shown that foods perceived as “good” are often over-reported, 
whilst foods perceive as “bad” are under-reported. Socioeconomic and 
education determinants have also been implicated in under-reporting 
(Poslusna et al. 2009). The most commonly used method to identify under-
reporting of energy intake is the use of the Goldberg cut-offs (Goldberg et 
al. 1991), which have been used inappropriately or without a thorough 
understanding of their principles (Livingstone and Black 2003). However, 
this method is also subject to limitations and it has been suggested that 
excluding on the basis of misreporting too much data from a dataset does 
not remove all or the majority of under-reporters (McCrory et al. 2002), and 
this may distort the data further (Stubbs 2009). Nevertheless, despite the 
issues with identifying and finding solutions to the issues of misreporting, 
improvements in methods evaluating misreporting of energy intake will 
further help the interpretation of diet and health relationships.  
 
An overview of the methodology used to derive the five predefined diet 
scores used in the current analyses is presented in Table 2.1.  
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Table 2.1 Diet score components, and scoring criteria 
Components Scoring 
Criteria for minimum and 
maximum score 
Mediterranean diet score (MDS)   
Fruit and nuts (g/d) 0 / 1 Below median / Above median 
Vegetables (g/d) 0 / 1 Below median / Above median 
Legumes (g/d) 0 / 1 Below median / Above median 
Fish (g/d) 0 / 1 Below median / Above median 
Cereals (g/d) 0 / 1 Below median / Above median 
Ratio of mono- and poly- to 
saturated fat 
0 / 1 Below median / Above median 
Dairy products (g/d) 0 / 1 Above median / Below median 
Meat group (g/d) 0 / 1 Above median / Below median  
Alcohol (g/d) 0 / 1 <5 and >25 / 5-25 
   
Healthy diet indicator (HDI)    
Fruit and vegetables (g/d) 0 / 1  <400 / >400 
Complex carbohydrates 
(%energy/d) 
0 / 1 <50 or >70 / 50-70 
Dietary fiber (g/d) 0 / 1 <27 or >40 / 27-40 
Pulses and nuts (g/d) 0 / 1 <30 / >30 
Mono- and disaccharides 
(%energy/d) 
0 / 1 >10 / 0-10 
Protein (%energy/d) 0 / 1 <10 or >15 / 10-15 
Saturated fat (%energy/d) 0 / 1 >10 / 0-10 
Polyunsaturated fat (%energy/d) 0 / 1 <3 or >7 / 3-7 
Cholesterol (mg/d) 0 / 1 >300 / 0-300 
   
Diet quality index (DQI)   
Fruit and vegetables (servings/d) 0 / 1 / 2 0-2 / 3-4 / 5+  
Total fat (%energy/d) 0 / 1 / 2 >40 / 30-40 / 30 
Complex carbohydrates (servings/d) 0 / 1 / 2 0-3 / 4-5 / 6+ 
Saturated fat (%energy/d) 0 / 1 / 2 >13 / 10-13 / <10 
Cholesterol (mg/d) 0 / 1 / 2 >400 / 300-400 / <300>  
Protein (% RDA) 0 / 1 / 2 150 / 100-150 / <100 
Sodium (mg/d) 0 / 1 / 2 >3400 / 2400-3400 / <2400 
Calcium (% RDA) 0 / 1 / 2 <67% / 67-100% / 100% 
   
Alternate Healthy Eating Index 
(AHEI) 
  
Vegetables (servings/d) 0 / 10 0 / 5 
Fruit (servings/d) 0 / 10 0 / 4 
Nuts and soy protein (servings/d) 0 / 10 0 / 1 
Ratio of white to red meat 0 / 10 0 / 4 
Dietary fiber (g/d) 0 / 10 0 / 18 
Trans fat (% energy/d) 0 / 10 4 / 0.5 
Polyunsaturated to saturated fat 
ratio 
0 / 10 0.1 / 1 
Vitamin supplement use (no/yes) 2.5 / 7.5 No / Yes 
Alcohol (servings/d) 0 / 10 0 or 2.5 / 0.5-1.5 
   
DASH-style score   
Fruits (servings/d) 1/2/3/4/5 Quartile 1/2/3/4/5 
Vegetables (servings/d) 1/2/3/4/5 Quartile 1/2/3/4/5 
Nuts and legumes (servings/d) 1/2/3/4/5 Quartile 1/2/3/4/5 
Whole grains (servings/d) 1/2/3/4/5 Quartile 1/2/3/4/5 
Low fat dairy products (servings/d) 1/2/3/4/5 Quartile 1/2/3/4/5 
Sodium (mg/d) 5/4/3/2/1 Quartile 1/2/3/4/5 
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Red and processed meat 
(servings/d) 
5/4/3/2/1 Quartile 1/2/3/4/5 
Sweetened beverages (servings/d) 5/4/3/2/1 Quartile 1/2/3/4/5 
 
2.2.4.1 Development of dietary scores 
MDS: For the derived MDS, one point was given for intake at or above the 
median for components considered as healthy (fruits and nuts, vegetables-
excluding potatoes, legumes, fish, cereals and monounsaturated + 
polyunsaturated to saturated fat ratio), otherwise, a value of zero was given. 
In addition, one point was given for intake less than the median for 
components considered to be unhealthy (dairy products and meat), 
otherwise a value of zero was assigned. A value of one was assigned to 
women with daily alcohol consumption from five grams to 25 grams and a 
value of zero for consumptions less than five grams or more than 25 grams 
per day (Trichopoulou et al. 2003). In the current analyses, fruit juice was 
excluded from the fruit and nuts group as fruit juice consumption is not 
associated with lower risk of CVD, cancer or diabetes (Hung et al. 2004, 
Palmer 2008). Potato products were also excluded from the vegetable group 
as potatoes (including French fries) are not associated with chronic disease 
risk and are associated with higher risk of diabetes (Halton et al. 2006, 
WCRF/AICR 2007).  
For the MDS, a scale from zero (minimum conformity) to nine (maximum 
conformity) was constructed from the TwinsUK dataset, indicating the 
degree of adherence to the derived Mediterranean score. The MDS score is 
population specific and was generated according to the distribution of foods 
within the TwinsUK participants. 
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HDI: For the derived HDI, a dichotomous variable was generated for each 
food group or nutrient outlined in Table 2.1, including intakes of fruit and 
vegetables, complex carbohydrates (breads, cereals, legumes, and peas), 
dietary fiber, pulses and nuts, mono- and disaccharides (total sugars), 
protein, saturated fatty acids, polyunsaturated fatty acids, and cholesterol 
(Huijbregts et al. 1997). If an individual’s intake was within the 
recommended range, the variable was coded as one; otherwise, it was coded 
as zero. The final HDI score was the sum of all these variables, creating a 
scale of zero to nine, with a higher score indicating a better diet quality.  
 
DQI: The components of the derived score included fruit and vegetables, 
total fat, complex carbohydrates, saturated fatty acids, cholesterol, protein, 
sodium and calcium (Patterson et al. 1994). The scoring of the original 
score was reversed, so intakes were rated as two (good), one (satisfactory), 
or zero (poor), to enable comparison with the other four scores. The 
Recommended daily allowances (RDAs) for protein and calcium (dietary 
components which were based on percentage of recommended intakes) were 
derived using the UK report of the Panel on Dietary Reference Values of the 
Committee on Medical Aspects of Food Policy instead of U.S. 
recommendations. After summing across all dietary components, scores 
were ranged from five to sixteen with a higher score indicating higher 
quality. 
 
AHEI: The original AHEI, included vegetables, fruit, nuts and soy protein, 
the ratio of white to red meat, cereal fiber, trans fatty acids (as percentage of 
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total energy intake), the ratio of polyunsaturated to saturated fatty acids, the 
duration of multivitamin use, and alcohol intake (McCullough et al. 2002). 
In the current analysis, for the derived AHEI, cereal fiber was adapted in the 
way another UK study did as NSP (as percentage of total energy intake) 
from our data (Akbaraly et al. 2011). Also, our dataset provided data on 
vitamin supplement use as a dichotomous variable asking for use or non-
use. Therefore, we adapted this variable in place of the duration of 
multivitamin use from the original AHEI. 
All components contributed zero to ten points to the total score; with a score 
of ten indicating that the recommendations were fully met and a score of 
zero indicating minimum conformity to the recommendations. Intermediate 
intakes were scored proportionally between zero and ten. For the ratio of 
white to red meat a value of ten was assigned to those who never consumed 
red meat or to those who consumed red meat less than once per month, as 
well as to those who were vegetarians, using the frequencies from the FFQ. 
For the NSP component we based our scoring on the daily reference value 
(DRV) for adults in the UK, which is 18 grams per day, and assigned a 
value of ten to those who had maximum conformity and a value of zero to 
those who had minimum conformity. For the vitamin supplement use, a 
value of 7.5 was assigned to those who had used vitamin supplements; 
otherwise 2.5 points were assigned (non-use). After summing across all 
dietary components, scores were ranged from 16.5 to 87.5 with a higher 
score indicating higher quality.  
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DASH-style score: The derived DASH-style score was based on the original 
DASH score, which included foods and nutrients, emphasized or minimised 
in the DASH diet (Appel et al. 1997). For the purpose of our study we used 
the DASH-style score and not the original DASH score, as the DASH-style 
score highlights the key components of the DASH diet. Moreover, the 
DASH-style score was used as it ranks individuals according to intake 
therefore it is population specific and was more suitable to examine 
potential associations with muscle mass and strength in this cohort. For each 
of the dietary components, we classified women into quintiles according to 
their intake for fruits, vegetables, nuts and legumes, low fat dairy products, 
and whole grains, so that individuals in quintile one were assigned one point 
and individuals in quintile five were assigned five points. For the remaining 
components, including sodium, red and processed meats and sweetened 
beverages, the scoring was reversed so low intake indicated a higher score. 
We then summed the scores for all components and a total DASH-style 
score from eight to 40 was constructed, with lower score indicating lower 
conformity to the DASH diet and higher score indicating higher conformity 
to the DASH diet, respectively. 
 
The diet scores had a few differences in the way they were constructed. The 
MDS used the median intake of dietary components as the cut-off between 
healthy and unhealthy intakes, whereas the DASH-style score used quintiles 
to classify intakes of dietary components, with a “healthy” point assigned 
only if the quantity consumed was in the highest quintile.  In contrast, the 
HDI, DQI, and the AHEI were cut-point specific scores based on healthy 
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eating guidelines. Moreover, different foods were included in the cereal, 
whole grains and complex carbohydrate groups in the construction of the 
scores between subset 1 (see APPENDIX II) and subset 2 (see APPENDIX 
III) according to availability of data in the two datasets.  
 
2.2.5 Assessment of covariates used for the multivariate statistical 
analysis models  
Age 
Associations between diet and muscle mass, muscle strength and muscle 
quality 
As age has a great influence on muscle mass, strength, and muscle quality 
all analyses were adjusted for age (in years) (Cruz-Jentoft et al. 2010, Lynch 
et al. 1999). In the current analysis higher mean age was correlated with 
lower indexes of muscle mass (for FFM, r = -0.15, P < 0.001; for percentage 
FFM, r = -0.35, P <0.001; and for FFMI, r = -0.06, P = 0.76), lower hand 
grip strength (r = -0.47, P < 0.001) and lower muscle quality (r = -0.39, P < 
0.001).       
 
Associations between diet and C-reactive protein (CRP); and associations 
between diet, muscle mass and CRP  
Chronic low-grade inflammatory status may contribute to age-associated 
morbidity and mortality (Franceschi et al. 2007). Ageing is also strongly 
associated with an increased low grade inflammatory status (Chung et al. 
2009). Therefore, CRP was adjusted for age. Since age was inversely and 
significantly correlated with indexes of muscle mass, this analysis for 
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evaluating associations between diet, muscle mass and CRP was stratified 
by age using two categories, less than 50 years (Tables 8.2, 8.5 and 8.8) 
and more than 50 years (Tables 8.3, 8.6 and 8.9) to examine associations in 
the older age. 
 
Physical activity 
Associations between diet and muscle mass, muscle strength and muscle 
quality 
Regular physical activity, involving both aerobic and resistance exercise has 
been associated with increased muscle mass and strength and decreased rate 
of fat accumulation, contributing to the improvement of fat free mass, and to 
the prevention of physical disability and frailty (Frankel et al. 2006, Heath 
and Stuart 2002, Kuh et al. 2002, Roubenoff 2007, van Kan et al. 2008, 
Wolfe 2006). For this thesis, lifetime physical activity was assessed using a 
physical activity questionnaire, which previously shown to strongly 
correlate with more in-depth assessment of time spent in physical activity 
(more detailed questionnaire) in the cohort (Cherkas et al. 2008). For 
participants in the second subset who had missing data on physical activity, 
the General Practice Physical Activity Questionnaire (GPPAQ) was used 
and coding was performed as shown in Table 2.2. The GPPAQ was based 
on the original physical activity index developed by the European 
Prospective Investigation into Cancer and Nutrition (EPIC) cohort. The 
EPIC physical activity index was previously validated against heart rate 
monitoring in two independent studies (Wareham et al. 2002, Wareham et 
al. 2003) and was inversely related to all-cause mortality and cardiovascular 
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disease incidence in men and women of a wide range of age and social class 
from the EPIC-Norfolk study (Khaw et al. 2006). 
Participants of this cohort were allocated into three categories: physically 
inactive (sedentary job and no physical exercise and/or cycling per week), 
moderately active (sedentary job and one to two point nine hours physical 
exercise and/or cycling per week, or standing job but less than one hour 
physical exercise and/or cycling per week, or physical job and no physical 
exercise or cycling), and physically active (any category with activity levels 
above the latter).     
 
Table 2.2 Description of physical activity coding based on the GPPAQ
1
  
 
1 Questions concerning walking, Housework and Gardening have been included to allow 
participants to record their physical activity in these categories; however these questions 
have not been shown to yield data of a sufficient reliability to contribute to an 
understanding of overall physical activity levels. 
http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/@ps/documents
/digitalasset/dh_112134.pdf  
 
In the current data those who were active had a greater mean FFM (P = 
0.64), percentage FFM (P < 0.001) and FFMI (P = 0.79) compared to those 
who were moderately active or inactive. Also, those who were active had a 
greater mean hand grip strength (P < 0.001) and muscle quality (P = 0.0006) 
compared to those who were moderately active or inactive.  
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Associations between diet and C-reactive protein (CRP); and associations 
between diet, muscle mass and CRP  
Evidence has shown that physical activity induces a decrease in the systemic 
levels of a number of cytokines with anti-inflammatory properties (Gleeson 
et al. 2011, Petersen and Pedersen 2005). This is more likely because 
inflammation is lower in physically active individuals primarily because of 
lower absolute amount of total and visceral body fat. However, more studies 
that accounted for this by using a direct measure of fat mass are needed 
before definitive conclusions (Beavers et al. 2010). 
 
Smoking status 
Associations between diet and muscle mass, muscle strength and muscle 
quality 
It has been suggested that smoking may increase the risk of sarcopenia 
(Morse et al. 2007, Petersen et al. 2007, Wüst et al. 2008). Interestingly, in 
this analysis those who never smoked had lower mean FFM (P < 0.001) and 
FFMI (P = 0.0003) compared to those who were current and former 
smokers; and those who were former smokers had lower percentage FFM 
compared with those who had never smoked or were current smokers (P < 
0.001). Also, those who were current smokers had higher mean hand grip 
strength and muscle quality compared to those who were not current 
smokers, although associations were not significant (P = 0.26 and 0.16, 
respectively). However, as smoking may influence muscle mass and 
strength, smoking status was taken into account in the analyses. Data on 
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smoking status was collected by questionnaire and defined as never, current, 
and former smoking. 
 
Associations between diet and C-reactive protein (CRP); and associations 
between diet, muscle mass and CRP  
Cigarette smoking increases oxidative stress and inflammation (Lee et al. 
2012). Therefore, analyses were adjusted for smoking. 
 
Energy intake  
Associations between diet and muscle mass, muscle strength and muscle 
quality; and C-reactive protein (CRP); and associations between diet, 
muscle mass and CRP  
In free-living human populations, total energy intake is attributed largely in 
variations to physical activity, body size and metabolic efficiency (Willett 
1986). In epidemiological studies, total energy intake is often associated 
with disease risk because of associations between physical activity or body 
size and the probability of disease. As, intakes of most nutrients, particularly 
macronutrients, are correlated with total energy intake they may be non-
causally associated with disease as a result of confounding by total energy 
intake. Also, extraneous variation in nutrient intake resulting from variation 
in total energy intake that is unrelated to disease risk may weaken 
associations if energy intake is not taken into account (Jakes et al. 2004). 
Moreover, individuals or populations must alter their intake of specific 
nutrients primarily by altering the composition of their diets rather than by 
changing their total energy intake, unless physical activity or body weight is 
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changed substantially (Willett et al. 1997). In addition, measurement errors 
are inevitable in epidemiological studies and errors in reporting food intake 
translates into errors in energy  and nutrient intake (Poslusna et al. 2009). 
Thus, adjustment for total energy intake is important in epidemiological 
studies to control for confounding, and reduce extraneous variation induced 
by physical activity, body size, and metabolic efficiency and partially 
misreporting.  
Most nutrients are associated with total energy intake either because they 
contribute directly to energy intake or because individuals who consume 
more total energy also eat, on average, more of all specific nutrients 
(Mackerras 1996). So, controlling for confounding by total energy intake 
forms an important issue for the statistical analysis plans (Willett et al. 
1997). 
As energy is not derived from micronutrients, most micronutrients are not 
highly correlated with energy intake. However, in this cohort some 
micronutrients were highly correlated to energy intake, such as vitamin D (r 
= 0.51, P < 0.001), vitamin E (r = 0.74, P < 0.001), selenium (r = 0.54, P < 
0.001), magnesium (r = 0.77, P < 0.001) and potassium (r = 0.75, P < 
0.001). It is likely that these correlations were due to the fact that some of 
the main sources of these nutrients were relatively high in energy. Vitamin 
E, for example, is found in olive oil, nuts (almonds, hazelnuts), mackerel, 
salmon; selenium is found in Brazil nuts, wheat products-cereals, bread; 
magnesium is found in whole grain products, and nuts; potassium is found 
in nuts, banana, melon, avocado, cereals and dairy products. Although, 
some other micronutrients were not very strongly associated with total 
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energy intake, such as carotenoids (α-carotene, r = 0.18, P < 0.001; β-
carotene, r = 0.18, P < 0.001; total carotene, r = 0.27, P < 0.001; β-
cryptoxanthin, r = 0.19, P < 0.001; lycopene, r = 0.33, P < 0.001; lutein, r = 
0.21, P < 0.001; zeaxanthin, r = 0.22, P < 0.001), and vitamin C (r = 0.35, P 
< 0.001), energy intake was included in the multivariate model in order to 
control for any additional confounding. Energy intake (kcal/d) was also 
included in the multivariate models for the MDS (Trichopoulou et al. 1995), 
AHEI (McCullough et al. 2002) and the DASH-style scores (Fung et al. 
2008) as these scores do not take into account energy intake, in contrast to 
the HDI and DQI which do (Huijbregts et al. 1997, Patterson et al. 1994). 
 
Total body mass 
Associations between diet and muscle mass 
In order to undertake informative comparisons of a population’s body 
composition, normalization for total body mass is required. It is suggested 
that lean mass has a linear relation with body mass (Harris 1997). There is 
also evidence that heavier people are taller, and because an increase in fat 
mass is associated with an increase in fat free mass, total body mass was 
considered as a confounding variable for both fat free mass and fat free 
mass index (Wells JCK et al. 2002, Wolfe 2006). The percentage fat free 
mass was not adjusted for total body mass, because this means it already 
takes into account total body mass in its calculation.  
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Height 
Associations between diet and muscle strength and muscle quality 
Height has been previously suggested as a determinant of grip strength and 
isokinetic muscle strength (Jerome et al. 1991, Neder et al. 1999). Higher 
hand grip strength has also been associated with increased height in 
epidemiological studies (Inskip HM et al. 2007, Robinson SM et al. 2008). 
In this study those who were taller had significantly higher mean hand grip 
strength (r = 0.36, P < 0.001). Therefore, the analyses were adjusted for 
height. 
 
Body mass index (BMI) 
Associations between diet and C-reactive protein (CRP); and associations 
between diet, muscle mass and CRP  
There is evidence that increased adipose tissue is related to increased 
chronic systemic inflammation through the increased release of cytokines 
(Festa et al. 2001). Specifically, increases in fat mass, and particularly in 
visceral fat, may trigger the secretion of a number of pro-inflammatory 
cytokines, indicating that central obesity is more important when studying 
obesity in association with inflammation, because it is in general considered 
more pro-inflammatory (Santos et al. 2005, Tilg and Moschen 2006, You et 
al. 2008).  
There is strong evidence from epidemiological studies on the association 
between markers of obesity and CRP (Festa et al. 2001, Hodge et al. 2010, 
Khoo et al. 2011, Pannacciulli et al. 2001). These studies have evaluated 
obesity including a variety of obesity indices, such as BMI and total body 
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fat and central obesity including waist and hip circumferences, and waist to 
hip ratio. There is evidence of a strong relationship between plasma levels 
of CRP and both total and central abdominal fat (CAF) measured by DEXA 
scans in the Twins UK cohort (Greenfield et al. 2004). In the current subset 
there was a significant positive correlation between plasma levels of CRP 
with both total obesity (assessed by BMI) and central obesity (assessed by 
% central fat of regional mass), and % central fat of regional mass and BMI 
were highly correlated. Therefore, BMI was included in the multivariate 
adjusted model.    
 
Menopausal status 
Associations between diet and muscle strength and muscle quality 
Menopause is followed by a natural decline in estrogens and it is likely that 
hormonal changes due to menopause contribute to muscle weakness. A 
number of studies have suggested that a loss in muscle strength has been 
associated with menopause (Carville et al. 2006, Cooper et al. 2008, 
Greeves et al. 1999, Kurina et al. 2004). Although the underlying 
mechanisms have not been fully elucidated, it has been proposed that 
estrogens have anabolic effects on muscle because they stimulate insulin 
growth factor 1 (IGF-1) receptors (Sitnick et al. 2006). Evidently human 
skeletal muscle contains the largest amount of estrogen receptors (expressed 
in the mRNA level) (Lemoine et al. 2003), however, not only circulating 
estrogen but also IGF-1 can also activate estrogen receptors (Ciana et al. 
2002). During the menopause both estrogen and IGF-1 decrease, which is 
likely to negatively influence muscle strength. In the current cohort, data on 
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menopausal status was collected by questionnaire and recorded as 
premenopausal or postmenopausal. Premenopausal women had significantly 
higher mean hand grip strength and muscle quality compared with 
postmenopausal women (P < 0.001, respectively). However, it needs to be 
acknowledged that although menopause is related to muscle strength, it is 
also strongly associated with age making it difficult to know if differences 
in muscle strength are due to the menopause or age.  
 
Hormone replacement therapy (HRT) 
Associations between diet and muscle strength and muscle quality 
Following the argument from the menopausal status section above, there is a 
working hypothesis that estrogens benefit muscle strength loss (Lowe et al. 
2010). Results from a systematic review from 23 studies on muscle strength 
that included 10.000 post-menopausal women who were or were not on 
HRT showed that women who had received HRT had approximately five 
percent greater strength compared with those who had not received HRT 
(effect size = 0.23, P = 0.003). This effect might be due to the improvement 
of muscle quality rather or more than quantity or muscle hypertrophy 
(Greising et al. 2009). In the TwinsUK cohort data on hormone replacement 
therapy (HRT) was collected by questionnaire and recorded as no or yes. 
For participants with missing data on HRT the following assumptions were 
considered when imputing values: women aged less than 50 years were 
assumed to be not taking HRT, premenopausal women aged over 50 years 
were assumed to be not taking HRT, and postmenopausal women aged over 
50 years were assumed to be taking HRT. The age of 50 years was used, 
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because this was the median age of menopause in this cohort (Aviv et al. 
2006). In the current analysis, women on HRT had a higher mean hand grip 
strength and muscle quality compared with women who were not in HRT, 
although the trend was not significant (P = 0.30 and 0.43, respectively). 
Although HRT alone is not likely to be beneficial on muscle strength it was 
included in the overall model in combination with other potential factors 
that influence muscle strength, as there is evidence that combined with 
physical exercise it has shown to improve physical function (Sipila et al. 
2001).       
 
Associations between diet and C-reactive protein (CRP); and associations 
between diet, muscle mass and CRP  
A number of studies in the literature have shown that hormone replacement 
therapy has been associated with higher CRP, and may contribute to higher 
levels of CRP seen in women (Ford et al. 2004, Hung et al. 2008, Khera et 
al. 2005, Woodward et al. 2003). In the TwinsUK cohort it has been shown 
previously that HRT users had higher plasma CRP levels compared with 
nonusers, which supports findings from epidemiological and randomised 
controlled trials showing that oral HRT, and particularly estrogen, increases 
CRP levels (Davison and Davis 2003, Fröhlich et al. 2003, Greenfield et al. 
2004, Manns et al. 2003). In the same cohort HRT use remained a 
significant determinant of increased CRP, even after adjusting for adiposity 
in multiple regression models. The mechanism through which HRT use 
influences plasma CRP concentrations has not yet been established. 
However, results from oral HRT use have shown that there is a 
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consequential increased synthesis of CRP by the liver and therefore 
increased plasma concentrations (Luyer et al. 2001).  
 
Medication 
Associations between diet and C-reactive protein (CRP) 
Anti-inflammatory medication (including statins, non-steroid anti-
inflammatory drugs - NSAIDS, and aspirin) was used as a covariate to 
control for its influence on inflammation. 
 
2.3 Statistical analysis 
All analyses were performed in STATA statistical software (version 11.0; 
STATA Corp, USA). The analyses were performed treating twins as 
individuals as previous studies have shown that participants from the 
TwinsUK registry were similar to age-matched singleton women in the 
distribution of common traits and outcomes (Andrew et al. 2001). The 
normality of the variables was assessed and CRP concentrations were 
subsequently natural log-transformed. Quintiles of each nutrient intake and 
quartiles of each diet quality score were derived. The distribution of nutrient 
intake was divided into quintiles, and the diet quality scores into quartiles to 
ensure equal numbers of participants in each of the categories. One-way 
ANOVA was applied for continuous variables (such as age, BMI, FFM) and 
Chi-squared test for categorical variables (such as physical activity and 
smoking history) to examine differences in anthropometric characteristics, 
body composition and lifestyle factors by each quartile of the diet quality 
scores. In addition to unadjusted analysis, multivariate robust cluster 
 69 
 
regression models were used to assess indexes of muscle mass, hand grip 
strength and muscle quality (dependent variables) across quintiles of 
micronutrient, protein and amino acid intakes and quartiles of diet quality 
scores to evaluate statistical differences in muscle mass, muscle strength and 
muscle quality after adjustment for relevant confounders outlined in Chapter 
3 (section 3.2, p. 84) and Chapter 4 (section 4.2, p. 129), respectively. Age 
was  strongly and inversely correlated with hand grip strength (r = -0.5, P < 
0.001) and muscle quality (r = -0.4, P < 0.001) analysis in the second subset 
of 949 women was further stratified by age using two categories, less than 
50 years and more than 50 years. To assess whether associations were 
determined by the genetic background, the statistical analyses for the 
association between one nutrient intake that was strongly and another 
nutrient intake that was not strongly associated with indexes of muscle mass 
was performed using the within twins approach (Chapter 3). To examine 
associations within-twin pairs, the model was extended to take into account 
the twin pair mean: 
E(Yij) = β0+βi(Xij)+βtXi, where Ẋi is the mean value of X for twin pair i. 
The βi gives the expected mean in Y for a 1-unit deviation from the pair 
change in the outcome variable (within-pair). The βt gives the expected 
change in Y for a 1-unit change in the twin pair average X (between-pair) 
while holding constant the individual deviation from the average. Thus, βi 
(the within-pair effect) represents the strength of the association within pairs 
and is free from the confounding influence of factors that are common to the 
twin pair. βt (the between-pair effect) reflects further variation in Y that is 
accounted for by factors in the shared environment or genetic background of 
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twins and which do not account for individual differences. In general, a 
strong within-pair effect with a small or absent between-pair effect is 
consistent with an individual specific mechanism/causal mechanism or a 
direct/real effect (Carlin et al. 2005). Moreover, a strong between-pair 
association, with a less strong or no within-pair effect, suggests that 
potential shared lifestyle and genetic factors confound associations between 
an exposure and an outcome (Carlin et al. 2005).     
  
Multivariate robust cluster regression models were also fitted between the 
inflammation marker CRP across quintiles of different nutrient intakes and 
quartiles of diet quality scores to evaluate statistical differences in CRP in 
these groups after accounting for confounding factors outlined in Chapters 6 
(section 6.2, p. 206) and 7 (section 7.2, p. 237). Multivariate adjusted 
analysis was further used to examine whether diet mediates the association 
between muscle mass and inflammation assessed by CRP (see Chapter 8, 
section 8.2, p. 265).  This analysis was further stratified by age using two 
categories, less than 50 years and more than 50 years to investigate whether 
diet mediates the association between muscle mass and inflammation 
assessed by CRP in the older group of women. Multivariate model analyses 
were performed using the robust cluster regression option in STATA. These 
models take into account clustering of individuals when calculating standard 
errors of the mean (Richards et al. 2007) to ensure familial aggregation 
within twin pairs was accounted for.  
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2.3.1 Sensitivity analysis 
Secondary or sensitivity analyses were performed for the association 
between nutrient intakes and fat free mass index (FFMI) in order to: i) 
assess the collinearity of the various nutrients in this analysis, and ii) to 
model the nutrients that were significantly associated with fat free mass 
index in a single multivariate regression analysis, to assess whether each 
was independently predictive (Chapter 3, p.89). 
2.4 Comparison with other cohorts (representativeness of the cohort) 
There is a concern that association studies may not be representative of the 
general population, and therefore it is important that sample populations 
from cohort studies are representative of the general population to ensure 
generalisability of the results (Paolo 2011). Data from the TwinsUK cohort 
has shown that participants were not different from age-matched singletons 
for measures or disease outcomes, such as height, bone mineral density, 
osteoarthritis, blood pressure, use of hypertensive medication, alcohol 
consumption, menopausal, hysterectomy and ovariectomy status, supporting 
that twins are representative of singleton populations (Andrew et al. 2001, 
Henderson et al. 2004, Sproston and Primatesta 2004). To assess the 
representativeness of the participants in the current analysis, the baseline 
characteristics and body composition parameters of the two subsets outlined 
in section 2.1.2 are presented in Table 2.3, and were compared with data 
from the National Diet and Nutrition Survey (NDNS 2009/10). 
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Table 2.3 Characteristics of two subsets of 2570 and 949 women from the TwinsUK cohort 
examined in 1996 and 2005, respectively
1
 
Characteristic  
1996-2000 (n=2570) 
18-79 yrs 
2005-2008 (n=949) 
34-83 yrs 
NDNS 2009/10 
Women 
19-64 yrs 
Age (yrs) 48.3±12.7 (18-79) 59.1±9.3 (34-83) 41.5 
Height (cm) 162±6.1 (143-183) 162±5.9 (143-182)
 
 
Weight (kg) 65.6±11.2 (39-118) 69.2±12.5 (37-121)
 
 
BMI (kg/m
2
) 24.9±4.1 (16.3-46.1) 26.5±4.7 (17.4-49.7) 27.0±0.34 (SE) 
Fat mass (kg) 22.7±7.9 (6.37-64.9)   
Fat mass percentage (%) 33.9±7.2 (13.1-56.9)   
Fat free mass (kg) 39.6±5.3 (20.9-66.9)   
Fat free mass percentage 
(%) 
61.1±6.5 (38.8-87.3)  
 
Fat free mass index 
(kg/m
2
) 
15.0±1.7 (9.79-24.6)  
 
Hand grip strength (kg)  28.8±5.9 (6-51)  
Muscle quality (kg/kg)  0.69±0.14 (0.15-1.08)  
Physical activity % 
Inactive 
Moderate 
Active 
 
21.9 
53.9 
24.2 
 
39.6 
34.2 
26.2 
 
30 
52 
17 
Smoking history % 
Never 
Current 
Former 
 
50.2 
18.2 
31.6 
 
 
90.21 (yes) 
9.79 (no) 
 
59.6 
20.6 
19.6 
Hormone replacement 
therapy % 
Yes 
No 
 
 
 
 
9.38 
90.63 
 
Menopausal status % 
Premenopausal  
Postmenopausal  
  
10.3 
89.7 
 
Anti-inflammatory 
medication %
2
 
Yes 
No 
  
 
6.15 
93.85 
 
1
 Values are means and standard deviations (means ± SD) unless indicated; interquartlile 
range in parentheses 
2 
Subset analysis for 1658 participants 
  
 
2.4.1 Results 
The results indicated that the cohort was similar to the NDNS regarding 
physical activity and smoking status, although there were differences in 
BMI, which might be explained by the age difference between the cohorts, 
as the NDNS is a younger cohort. Notably, obesity based on BMI is shown 
to more prevalent in older adults aged more than 65 years (Bouchard et al. 
2009). Fat free mass index was 15.0 kg/m
2 
± 1.7 (range 9.79-24.6) in the 
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TwinsUK cohort, which was within the normal range of 14.6 – 16.8 kg/m2, 
reported for healthy Caucasian women with normal BMI ranges (Kyle et al. 
2003). 
 
To further assess representativeness of this cohort data on body composition 
parameters, including fat free mass (kg), fat free mass index (kg/m
2
), hand 
grip strength (kg) and muscle quality (kg/kg) were stratified by 10 year age 
bands, to enable comparison with other cohorts assessing body composition 
differences with age.    
 
Differences in body composition parameters, such as fat free mass – FFM 
(kg) and fat free mass index – FFMI (kg/m2) by 10 years age bands are 
presented in Figures 2.1 and 2.2. Mean FFM was significantly lower by 
7.23 % (P < 0.001) in the 70
th
 compared with the 20
th
 decade (Figure 2.1). 
Mean FFMI showed a peak at the 30
th
 decade, but it was generally similar 
across age categories and was higher by 1.35 % (P = 0.01) in the 70
th
 decade 
compared with the 20
th
 decade (Figure 2.2). 
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Figure 2.1: Fat free mass - FFM (kg) by 10 years of age in 2570 women 
from the TwinsUK cohort  
 
 
 
Figure 2.2: Fat free mass index - FFMI (kg/m
2
) by 10 years of age in 2570 
women from the TwinsUK cohort 
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Differences in hand grip strength (kg) and muscle quality (kg/kg) by 10 
years age bands are presented in Figures 2.3 and 2.4. Mean hand grip 
strength was lower by 30.1 % between the 70
th
 and the 30
th
 decade (P < 
0.001) (Figure 2.3). Mean muscle quality was lower by 27.7 % (P < 0.001), 
in the 70
th
 compared with the 30
th
 decade (Figure 2.4). 
 
 
 
 
Figure 2.3: Hand grip strength (kg) by 10 years of age in 949 women from 
the TwinsUK cohort 
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Figure 2.4: Muscle quality (kg/kg) by 10 years of age in 949 women from 
the TwinsUK cohort  
 
2.4.2 Discussion 
Findings from this analysis showed that older age was associated with 
progressively lower FFM (kg). However, differences in FFMI (kg/m
2
) were 
small across age categories. These findings were similar to observations 
from previous cross-sectional studies and longitudinal studies in women 
(Coin et al. 2008, Ding et al. 2007, Guo et al. 1999, Janssen et al. 2000, 
Kyle et al. 2001, Kyle et al. 2006).  
 
In one of two previous cross-sectional studies that have examined age-
related body composition differences, among women aged 60-94 years, 
body composition parameters were measured using dual-energy X-ray 
absorptiometry scans (DEXA) (Kyle et al. 2001) as in the TwinsUK 
participants. The study found that mean fat free mass was 2.9 kilograms (6.8 
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%) lower in women 80 years and over compared to those aged 60-70 years. 
In the TwinsUK cohort mean fat free mass was 1.3 kilograms (3.38 %) 
lower in women aged 70-79 compared to that aged 60-69.9 (Figure 2.1). 
This difference might suggest that after the age of 80 years further loss of 
fat free mass occurs, and therefore because the maximum age of the first 
subset of the Twins data was 79 years we were not able to detect a 
difference as high as Kyle et al. (2001), who included subjects aged up to 94 
years. 
 
In a second cross-sectional study, among women aged 18-88 years body 
composition was measured by Magnetic Resonance Imaging (MRI) 
(Janssen et al. 2000). Mean skeletal muscle mass in this study was 3.8 
kilograms lower in women aged more than 70 years compared to those aged 
between 18 to 29 years. This study also showed that absolute skeletal 
muscle mass was lower after the fifth decade in their cohort of women 
(Janssen et al. 2000). Data from TwinsUK cohort showed similar trends in 
the association between muscle mass indexes and age in women aged 18 to 
79 years that had their body composition measured by DEXA scans. Mean 
fat free mass was found to be 2.9 kilograms lower in women aged 70-79 
years compared to those aged 18-29.9 years. Janssen et al. (2000), showed 
that absolute skeletal muscle mass was lower after the fifth decade in their 
cohort of women, confirming findings from TwinsUK cohort showing that 
muscle mass started to decline from the fifth decade (Figure 2.1). 
Results of a multicentre, retrospective study among a representative healthy 
Italian population of men and women, between 20 and 80 years, showed 
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that mean fat free mass index was 16.1 ± 1.8 (kg/m
2
), which was lower in 
the oldest group of women (70-80 years) (16.0 ± 1.5, kg/m
2
) (Coin et al. 
2008). In the TwinsUK cohort among women, mean fat free mass index was 
15.0 ± 1.7 (kg/m
2
) (Table 2.1). Body composition was assessed by DEXA 
scans, in both studies. The trend for fat free mass index was also very 
similar across the age categories in the TwinsUK cohort (Figure 2.2), and 
this was probably due to age-related height reductions occurring with a 
decrease in fat free mass and an increase in body weight. 
 
The inverse associations between indexes of muscle mass and age that 
observed in the TwinsUK participants were also supported by longitudinal 
studies showing that greater age range was associated with lower fat free 
mass and higher fat mass over time of follow-up (Ding et al. 2007, Guo et 
al. 1999, Kyle et al. 2006). 
 
The results also indicated that muscle strength was lower with higher age 
categories (Figure 2.3), although the percentage difference between extreme 
age bands was different to that of other studies (Lynch et al. 1999). This 
might be because muscle strength was assessed by a different method in the 
TwinsUK study (muscle strength was defined as hand grip strength 
measured by hand dynamometer) compared with other cross-sectional 
studies that have defined muscle strength as concentric and eccentric peak 
torque measured in the elbow and the knee flexors and extensors and 
measured by isokinetic dynamometer (Lynch et al. 1999). 
 79 
 
Muscle quality was included as an additional measurement in this thesis to 
further understand the association between muscle mass and strength, and 
was considerably lower by 27.7 % in the 70-83 years group compared to 
individuals aged 34-39.9 years (Figure 2.4).  
 
Findings from this cohort showed that it is representative of national studies 
and further confirmed other longitudinal and cross-sectional studies (using 
different methods to assess body composition and different populations and 
age ranges) showing that fat free mass was lower with age in women, with a 
peak at the age of 30 years (Coin et al. 2008, Kyle et al. 2003) and 
considerable differences from the 50
th
 decade of life, as previously reported 
(Hughes et al. 2002). 
 
Overall, this analysis highlighted the great influence of age on body 
composition, with significant differences between lower indexes of muscle 
mass, muscle strength and muscle quality and higher age bands 
(Baumgartner 2000). However, age is a natural process which cannot be 
modified, and to date, current literature poorly describes the influence of 
factors other than age on muscle mass, muscle strength and muscle quality 
in population-based studies. Thus, in order to appreciate the influence of 
other important factors that may be easily modifiable, the role of diet and 
inflammation on muscle mass, muscle strength and muscle quality, after 
accounting for age and other confounding factors will be investigated in the 
following chapters. Therefore, the next chapter will be focused on 
associations between a number of dietary components and indexes of 
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muscle mass, muscle strength and muscle quality in women from the 
TwinsUK cohort. Within this chapter a review of the current literature will 
be provided, with some narrative highlighting the gaps in present 
knowledge, followed by results, discussion and concluding remarks.      
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Chapter 3 
Associations between micronutrient intakes 
and indexes of muscle mass, muscle strength 
and muscle quality 
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3.0 Introduction 
Emerging evidence suggests that a number of nutrients are associated with 
muscle mass and strength due to their potential to act against oxidative 
stress and inflammation, such as vitamins C and E, selenium, and 
carotenoids (Ferrucci et al. 2005, Helmersson et al. 2005, Young et al. 
2004). Moreover, other nutrients have been shown to be beneficial in 
supplementation studies such as vitamin D (Dawson-Hughes 2008), or they 
play a role in muscle metabolism, such as magnesium and potassium 
(Frassetto et al. 1998, Song et al. 2007, Song et al. 2005). Recent data 
showed that although  several observational studies have examined 
associations between plasma/serum nutrient levels and different 
measurements of muscle strength (Cesari et al. 2004, Dominguez et al. 
2006, Lauretani et al. 2008, Semba et al. 2007)  there are limited studies on 
associations between habitual dietary intake and muscle mass and strength 
and no studies on muscle quality (Robinson SM et al. 2008, Scott et al. 
2010). This might be due to a lack of consensus on the definition of 
sarcopenia. Notably, only recently the European Working Group on 
Sarcopenia in Older People developed a clinical definition for age-related 
sarcopenia (Cruz-Jentoft et al. 2010). 
 
One previous prospective study found that energy-adjusted iron, 
magnesium, phosphorus and zinc intakes were positive predictors of muscle 
mass over 2.6 years follow-up in participants aged 50 to 79 years. A positive 
association was found for vitamin C intake and muscle mass only at follow 
up and not at baseline; however, the authors did not offer an explanation for 
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this finding. No associations were observed between any nutrient intakes 
and muscle strength in this study (Scott et al. 2010). Another cross-sectional 
study found that energy-adjusted carotene and selenium were associated 
with higher grip strength in men, and energy-adjusted vitamin C, carotene, 
selenium and vitamin D were associated with higher grip strength in women 
aged 59 to 73 years (Robinson et al. 2008). However, to our knowledge, 
there are currently no studies examining associations between a range of 
nutrients and muscle mass in cohort studies specifically including also 
younger adults. It is likely that this would provide a useful insight into the 
potential role of a range of nutrients contributing to the overall diet quality 
(highlighted in Chapter 1, section 1.3, p. 21), to potentially maintain muscle 
mass, strength and muscle quality.  
 
3.1 Aims 
The aim of this study was to test the hypothesis that habitual dietary intake 
of a range of micronutrients with the potential to act against oxidative stress 
and with potential anti-inflammatory properties (shown in Table 3.1) or are 
known to be involved in the biology of human muscle are associated with 
muscle mass as assessed by 3 indexes, fat free mass (FFM, kg), percentage 
fat free mass (FFM%) and fat free mass index (FFMI, kg/m
2
), among 
women aged 18-79 years from the TwinsUK cohort (subset 1). An 
additional aim of this study was to examine the hypothesis that habitual 
dietary intake of these nutrients is associated with muscle strength assessed 
by hand grip strength (kg) and muscle quality (muscle strength divided by 
muscle mass) (kg/kg) in women aged 34-83 years from the TwinsUK cohort 
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(subset 2). Moreover, in secondary analyses, additional aims were to 
examine the hypotheses that i) the nutrients that were significantly 
associated with indexes of muscle mass (subset 1) were independently 
predictive when analyses were performed in a single regression model, and 
ii) the genetic background determines the association between nutrient 
intake and indexes of muscle mass. 
 
The nutrients included are presented in (Table 3.1). 
Table 3.1 Nutrients included in the analysis 
Vitamins Minerals Carotenoids 
Vitamin C (mg/d) Magnesium (mg/d) -carotene (µg/d) 
Vitamin E (mg/d) Potassium (mg/d) ß-carotene (µg/d) 
Vitamin D (µg/d) Selenium (µg/d) Total carotene (µg/d) 
  ß-cryptoxanthin (µg/d) 
  Lycopene (µg/d) 
  Lutein (µg/d) 
  Zeaxanthin (µg/d) 
 
3.2 Covariate plan and statistical analysis 
All analyses were performed using STATA statistical software (version 
11.0; STATA Corp, USA). Means and standard deviations for the two 
subsets of the cohort were calculated (Table 3.2) and quintiles of each 
micronutrient intake were derived. Pearson correlation coefficients were 
used to evaluate associations between age and indexes of muscle mass, hand 
grip strength and muscle quality; nutrient intakes and energy intake; height 
and hand grip strength; and between the various nutrients that were included 
in this analysis. The analyses were performed treating twins as individuals 
as previous studies have shown that participants from the TwinsUK registry 
were similar to age-matched singleton women in the distribution of common 
traits and outcomes (Andrew et al. 2001). Muscle quality was calculated as 
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the ratio of hand grip strength (kg) to lean mass (kg). Data on muscle mass 
were collected in 1996 (subset 1) and data on hand grip strength ten years 
later in 2005 (subset 2). For the first subset, data on dietary intake (FFQ), 
body composition parameters, and other covariates were available for n = 
2570 women, aged 18 to 79 years, who had completed a food frequency 
questionnaire (FFQ) and attended for dual-energy X-ray absorptiometry 
(DEXA) scans between 1996 and 2000. For the second subset, data on 
dietary intake (FFQ), body composition parameters, and other covariates 
were available for n = 949 women, aged 34 to 83 years, who had completed 
a food frequency questionnaire (FFQ) and attended for hand grip strength 
measurements and DEXA scans between 2005 and 2008. Secondary 
analyses were also performed using a co-twin design within-twin pair 
analyses to assess whether the shared environment of the twins influences 
the associations between nutrients that were previously associated with 
indexes of muscle mass in our analyses where twins were considered as 
singletons in women aged 18 to 79 years (subset 1). For that an example of 
a strong and an example of a poor association was illustrated. 
 
Prior to conducting statistical analysis,  an analysis plan with justification 
for each confounding factor in the multivariate model was developed as 
described in Chapter 2, section 2.2.5, p. 57. Multivariate regression analysis 
was used to assess associations between micronutrient intakes and indexes 
of muscle mass, hand grip strength and muscle quality using the robust 
cluster regression option in STATA. These models take into account 
clustering of individuals when calculating standard errors of the mean 
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(Richards et al. 2007) to ensure familial aggregation within twin pairs was 
accounted for. 
  
As age has a great influence on muscle mass, strength, and muscle quality 
all analyses were adjusted for age (in years) (Cruz-Jentoft et al. 2010, Lynch 
et al. 1999). Models were then also adjusted for  physical activity and 
smoking status, as regular physical activity has been associated with 
increased muscle mass and strength (Frankel et al. 2006, Heath and Stuart 
2002, Kuh et al. 2002, Roubenoff 2007, van Kan et al. 2008, Wolfe 2006), 
and smoking has been shown to increase the risk of sarcopenia (Morse et al. 
2007, Petersen et al. 2007, Wüst et al. 2008). Energy intake (kcal/d) was 
also included in the multivariate models. Total body mass was included as a 
covariate in the evaluation of associations between diet and FFM and FFMI 
as described in Chapter 2, section 2.2.5, p. 63 (Subset 1) (Tables 3.3, 3.4, 
3.5). Additional adjustments were made for hand grip strength and muscle 
quality including height, menopausal status (premenopausal or 
postmenopausal), and hormone replacement therapy use (HRT) (no or yes), 
as these factors have been previously shown to affect muscle strength and 
muscle quality (Subset 2) (Tables 3.6, 3.7, 3.8, 3.9, 3.10, 3.11) (Carville et 
al. 2006, Cooper et al. 2008, Greeves et al. 1999, Greising et al. 2009, 
Jerome et al. 1991, Kurina et al. 2004, Neder et al. 1999, Sipila et al. 2001). 
Since age was inversely correlated with hand grip strength and muscle 
quality, this analysis was stratified by age using two categories, less than 50 
years and more than 50 years (Tables 3.7, 3.8, 3.10 and 3.11). Further 
adjustments were made to account for the impact of protein intake on the 
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association between diet and muscle mass, muscle strength and muscle 
quality, as protein is a nutrient which is strongly associated with muscle 
mass, and for misreporting using the ratio of reported energy intake to 
estimate energy expenditure. 
 
3.3 Results 
Descriptive characteristics of the two subsets of the TwinsUK cohort and 
the mean intake of micronutrients are shown in Table 3.2. For the first 
subset (n = 2570 women) the mean (±SD) age of participants was 48.3 ± 
12.7 years and mean (±SD) BMI was 24.9 ± 4.14 kg/m
2
. Mean FFM (±SD) 
was 39.6 ± 5.30 kg, percentage FFM 61.1 ± 6.49 %, and FFMI 15 ± 1.71 
kg/m
2
. More than one-half of the participants were moderately active (54 
%), and in relation to smoking status, 18.2 % were current smokers. Mean 
(±SD) energy intake was 1979 ± 524 kcal/d (Table 3.2). 
 
For the second subset (n = 949 women) the mean (±SD) age of participants 
was 59.1 ± 9.30 years and the mean (±SD) BMI was 26.5 ± 4.73 kg/m
2
. 
Mean hand grip strength was 28.8 ± 5.95 kg, and muscle quality [calculated 
as the ratio of hand grip strength (kg) to lean mass (kg)] was 0.69 ± 0.14 
kg/kg. Mean (±SD) percentage FM was 35.7 ± 6.28 %, and percentage FFM 
was 61.4 ± 6.18 %. In relation to physical activity, 39.6 % of participants 
were inactive and few of them were current smokers (9.8 %). Mean energy 
intake (±SD) was 1917 ± 637 kcal/d (Table 3.2).  
Notable differences were observed in body composition between the two 
subsets of this cohort, participants in the second subset were heavier, had 
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higher BMI and fat mass, percentage fat mass and fat free mass compared to 
the first subset of the cohort which might be because increases in fat mass 
are associated with increases in fat free mass (Wells JCK et al. 2002, Wolfe 
2006) (Table 3.2). Concerning percentage fat free mass there were no 
differences in the two subsets measured ten years apart. This finding might 
be because although fat free mass and body weight were higher in the 
second subset compared to the first subset of the cohort the ratio which 
defines the percentage fat free mass was similar.     
 
In this cohort fat free mass was positively correlated with hand grip strength 
(r = 0.35, P < 0.001). The relationships between indexes of muscle mass 
(FFM, percentage FFM, and FFMI) (Tables 3.3, 3.4, 3.5), hand grip 
strength (Table 3.6) and muscle quality (Table 3.9) with different nutrient 
intakes were also examined in unadjusted and multivariate adjusted models. 
 
Subset 1 (2570 women, 18-79 years) 
Fat free mass (FFM, kg) 
In multivariate analyses, when comparing extreme quintiles of nutrient 
intakes, FFM was positively and significantly associated with vitamin C 
intake by 1.2 kg, magnesium by 1.8 kg, potassium by 1.1 kg, ß-carotene by 
0.8 kg, total carotene by 0.6 kg, lutein by 0.8 kg, and ß-cryptoxanthin by 0.7 
kg, compared to the lowest quintile of each nutrient (P for difference < 0.05 
for all). No significant associations were found for the other nutrients 
(Table 3.3).  
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Percentage fat free mass (FFM %) 
In the multivariate model, when compared extreme quintiles of nutrient 
intake, percentage FFM was positively and significantly associated with 
vitamin E by 2.18 %, magnesium by 1.58 %, and lutein by 0.93 %, 
compared to the lowest quintile of each nutrient (P for difference < 0.05 for 
all). However, intakes of vitamin D and lycopene were significantly 
associated with lower mean percentage FFM by 0.9 % (P for difference = 
0.037 and 0.022, respectively). No associations were observed for the other 
nutrients (Table 3.4).  
 
Fat free mass index (FFMI, kg/m
2
) 
After multivariate adjustment, vitamin C, magnesium and potassium were 
significantly associated with mean FFMI with a difference of association of 
0.5 kg/m
2
 between extreme quintiles of intake (P for difference < 0.001 for 
all). Higher FFMI was also significantly associated with intakes of -
carotene, ß-carotene, total carotene, ß-cryptoxanthin, and lycopene with 
differences of association of 0.3 kg/m
2
 between extreme quintiles of intake 
(P for difference < 0.05 for all). No associations were observed for the other 
nutrients (Table 3.5).  
 
Sensitivity analysis 
After assessing the collinearity of the all the nutrients included in this 
chapter, the strongest correlation coefficients (> 0.8) were found between 
magnesium and potassium (r = 0.91), a-carotene and β-carotene (r = 0.88), 
 90 
 
a-carotene and total carotene (r = 0.91), β-carotene and total carotene (r = 
0.99), and zeaxanthin and ß-cryptoxanthin (r = 0.71). 
Therefore, the nutrients that included in the single multivariate regression 
model were those which were not collinear (i.e. magnesium, vitamin C, total 
carotene and ß-cryptoxanthin). After multivariate adjustment only 
magnesium intake was significantly and independently associated with all 
indexes of muscle mass. The difference in FFM, percentage FFM and FFMI 
per quintile of magnesium intake was 0.30 (kg), 0.39 %, and 0.08 (kg/m
2
) - 
[ß coefficient (95 % CI): 0.30 (0.08, 0.52), P = 0.007], [ß coefficient (95 % 
CI): 0.39 (0.09, 0.68), P = 0.009], and [ß coefficient (95 % CI): 0.08 (0.006, 
0.15), P = 0.033], respectively.    
 
Within twins analysis 
After multivariate adjustment for age, physical activity, smoking, energy 
intake and total body fat, within-pair associations between magnesium 
intake and the fat free mass index [ß coefficient (95 % CI): 0.06 (-0.003, 
0.12), P = 0.064] were towards significance, and between pair associations 
were strongly significant [ß coefficient (95 % CI): 0.12 (0.05, 0.20), P = 
0.0014]. There were no significant within-pair associations between 
selenium intake and the fat free mass index [ß coefficient (95 % CI): 0.03 (-
0.02, 0.08), P = 0.305]. 
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Subset 2 (949 women, 34-83 years) 
Hand grip strength 
In the multivariate model, although there was a positive trend between 
vitamin D, magnesium, selenium, potassium, ß-carotene, and lycopene 
intakes and hand grip strength, however the associations were not 
significant (P > 0.05, for all).  Intakes of vitamin C, vitamin E, α-carotene, 
total carotene, lutein, zeaxanthin, and ß-cryptoxanthin were not significantly 
associated with lower mean hand grip strength (P > 0.05, for all) (Table 
3.5). Even after stratification for age, associations between nutrient intakes 
and hand grip strength remained non-significant (Tables 3.7 and 3.8).   
 
Muscle quality 
In multivariate analyses, although there was a positive trend between   
vitamin E, selenium, ß-carotene, and lycopene intakes and muscle quality 
(kg/kg), the associations were not significant (P > 0.05, for all) (Table 3.9). 
After stratification for age, selenium intake was positively and significantly 
associated with muscle quality by 0.13 kg/kg between extreme quintiles of 
intake (P for difference = 0.023) in participants aged less than 50 years 
(Table 3.10). However, no associations were observed in participants aged 
more than 50 years (Table 3.11).      
 
3.4 Discussion  
In this study using two subsets of a large population-based sample of 
women aged 18 to 79 years and 34 to 83 years, respectively, we evaluated 
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the association between a range of micronutrients present in the habitual diet 
and indexes of muscle mass, hand grip strength and muscle quality. This is 
one of the first cross-sectional studies to show that higher consumption of 
vitamins C and E, magnesium, potassium, -carotene, ß-carotene, total 
carotene, lutein, ß-cryptoxanthin and lycopene were significantly associated 
with muscle mass in a cohort of women across a wide age range. In 
addition, magnesium intake was significantly and independently associated 
with all indexes of muscle mass, even after taking into account intakes of 
other nutrients (i.e. vitamin C, total carotene and ß-cryptoxanthin), and 
adjusting for misreporting. Associations were towards significance in the 
within-pair analysis between magnesium intake and fat free mass index, 
suggesting that potential shared lifestyle and genetic factors were driving 
this apparent relationship. Few previous studies have examined this range of 
micronutrients in association with measurements of muscle mass and have 
been focused in older cohorts (Robinson SM et al. 2008, Scott et al. 2010). 
However, the current study highlighted the influence of a range of 
micronutrients on estimates of muscle mass in a cohort of young to older 
aged women. 
 
Micronutrients and indexes of muscle mass 
Vitamins  
The current study observed positive  associations between vitamin C intake 
and FFM and FFMI; and between vitamin E intake and percentage fat free 
mass (FFM %). The greatest association was observed between vitamin C 
intake and FFMI, with a difference of 3.11 % of the population mean for 
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FFMI, between extreme quintiles of intake. The difference in FFMI per 
quintile of vitamin C intake was 0.09 (kg/m
2
) [ß coefficient (95 % CI): 0.09 
(0.05, 0.14), P < 0.001]. The magnitude of association was similar to the 
only previous prospective study, in which, vitamin C intake was positively 
associated with muscle mass (ß coefficient: 0.06, P = 0.002) but only at 
follow up (2.6 years) in men and women aged 50 to 79 years (Scott et al. 
2010). The difference of 3.11 % in FFMI observed in the current study 
between extreme quintiles of vitamin C intake equated to a 207 mg/d mean 
difference in vitamin C intake between the lower (68 mg/d) and the higher 
(275 mg/d) quintile. This finding corresponded to consumption of two 
oranges (assuming one portion of oranges to be 120 g for adults) and one 
portion of strawberries (100 g/d), highlighting the importance of 
incorporating more plant-based food components into the habitual diet. 
 
Even though findings from this study showed modest cross-sectional 
associations between vitamin C and indexes of muscle mass, the results 
could provide a further explanation for the role of vitamin C on sarcopenia, 
through its potential to act against reactive oxygen species (ROS) and 
oxidative stress, which directly mediates muscle damage (Meng and Yu 
2010). The observed association between vitamin C intake and muscle mass 
is supported by in vitro (Silveira et al. 2006), animal (Gomez-Cabrera et al. 
2005), and human study findings (Gomez-Cabrera et al. 2006, Ristow et al. 
2009), in which supplementation with vitamin C has shown to suppress 
some adaptive responses of skeletal muscle mass to oxidants during exercise 
(Khassaf et al. 2003). In addition, vitamin C has been shown to exert anti-
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inflammatory properties. Indeed, one randomised controlled trial has shown 
that supplementation with 1000 mg/d vitamin C for two months reduced the 
inflammation marker C-reactive protein (CRP) by 25.27 % among 
participants with elevated baseline CRP more than 1 mg/L (Block et al. 
2009). Findings from the current study are also in contrast with one cross-
sectional study from the InCHIANTI cohort where higher vitamin C intake 
was significantly associated with knee extension strength (β = 0.383, P = 
0.02) and physical performance (β = 0.029, P = 0.04) (Cesari et al. 2004). 
Although dietary interventions on muscle mass and sarcopenia have not 
addressed this important issue yet, these findings may suggest that adequate 
intake of nutrients with potential anti-inflammatory properties may play a 
critical role in the maintenance of healthy muscles.         
 
In the current study vitamin D intake was not associated with muscle 
strength and was negatively related to FFM %. This finding contrasts with 
other cross-sectional and supplementation studies reporting that low vitamin 
D intake and status were associated with low muscle strength, physical 
performance and frailty, although supplementation studies have not always 
shown improvements in muscle function (Annweiler et al. 2009, Bartali B et 
al. 2006, Lisa 2008). There is currently a lack of high-quality observational 
data from large cohorts on associations between vitamin D status and 
physical performance (Institute of Medicine 2010). In addition, evidence 
from meta-analysis of randomised controlled trials (RCTs) suggested that 
there was a non-significant dose-response relationship between 
supplementation of vitamin D (even in high doses at or more than 20 µg/d) 
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or achieved serum 25(OH)D and the risk of sustaining at least one fall 
(Millward 2012).  
Nevertheless, the relative contribution of sun exposure on vitamin D status 
should be acknowledged, as  sun exposure is the most important contributor 
to vitamin D status with 80-90 % vitamin D obtained from the sunlight and 
diet contributing to a much lesser extent (Holick 1994). Longitudinal data 
suggest that UVB exposure (according to season) contributes mainly to 
changes in plasma 25-hydroxy vitamin D (25-OHD) levels (a plasma 
metabolite used to assess vitamin D status), with measurements being lower 
among two groups of Caucasian women in the north compared with those in 
the south of the UK (Macdonald et al. 2011). It is possible that the lack of 
association in the current study was the result of the fact that the sunlight 
contribution was not considered in the current analysis. Additionally, the 
lack of association might be because the mean (±SD) vitamin D intake was 
only 2.61 (±1.42) µg/d, which is lower compared to the usual daily intake of 
vitamin D in the UK (which is relatively low), of around 3.5 µg/d (Scientific 
Advisory Committee on Nutrition, 2007). 
 
Minerals 
In relation to minerals, the current analysis found that magnesium intake 
was positively associated with all three indexes of muscle mass, when 
women were considered as individuals, and were towards significance in the 
within-pair analysis, suggesting that potential shared lifestyle and genetic 
factors were driving this apparent association. These factors are not yet 
known and it would be interesting to be investigated in future genetic 
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studies. When twins were considered as singletons, the greatest associations 
were observed for FFM with differences of 4.63 % (P < 0.001) of the 
population mean, and 3.39 % (P = 0.001) of the population mean for FFMI, 
between extreme quintiles of intake after adjustment for all the other 
confounders. Alternatively, the difference in FFM per quintile of 
magnesium intake was 0.41 (kg) [ß coefficient (95 % CI): 0.41 (0.21, 0.61), 
P < 0.001], and the difference in FFMI per quintile of magnesium intake 
was 0.12 (kg/m
2
) [ß coefficient (95 % CI): 0.12 (0.05, 0.19), P < 0.001]. 
Findings were of a similar trend  although of a greater magnitude to a 
previous prospective study reporting that energy-adjusted magnesium intake 
was a positive predictor of change in appendicular lean mass over 2.6 years 
follow-up among older people (ß coefficient = 0.07, P = 0.02) (Scott et al. 
2010). This difference may be explained by the fact that the study from 
Scott et al. was longitudinal, included fewer participants (n = 740 men and 
women) compared with the current study (n = 2570) and a narrower age 
range (50 to 79 years). It also used a much more limited FFQ (74 food 
items) and it measured only appendicular lean mass (although this accounts 
for more than 75 % of the total skeletal muscle mass) (Gallagher et al. 
1997), whereas the current cohort measured total body fat free mass. A 
difference of 3.4 % in FFMI reported between extreme quintiles of 
magnesium intake equated to a 256 mg/d mean difference in magnesium 
intake between the lower (225 mg/d) and the higher (481 mg/d) quintile. In 
food terms, this difference corresponded to consumption of 1.8 portions of 
all bran per day (108 g/d) from the habitual diet (assuming 1 portion of all 
bran to be 60 g for adults). Interestingly, magnesium intake was 
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significantly and independently associated with all indexes of muscle mass, 
even after taking into account intakes of vitamin C, total carotene and ß-
cryptoxanthin, indicating its importance for muscle mass.  
 
The observed associations between magnesium intake and indexes of 
muscle mass is supported by previous studies in humans showing a strong 
effect of magnesium status on muscle performance, possibly through its role 
in energetic metabolism and trans-membrane transport in muscles (Lukaski 
2004). Indeed, adequate availability of magnesium may lead to increased 
muscle mitochondrial efficiency for which magnesium is critical (Wolf and 
Cittadini 2003), and also to reduced production of reactive oxygen species, 
which mediate muscle damage (Meng and Yu 2010). Therefore, magnesium 
availability is important for the function of muscle mitochondria and for the 
control of oxidative stress. In addition, results from the current study 
provide a potential explanation to support the anti-inflammatory properties 
of magnesium. Poor magnesium status may trigger a pro-inflammatory state 
accompanied by production and release of pro-inflammatory cytokines, such 
as interleukin 1ß (IL-1ß) and tumor necrosis factor- (TNF-), which 
activates a low-grade chronic inflammation, which has been suggested as a 
major pathway in the aetiology of age-related muscle loss (Meng and Yu 
2010) (Kramer et al. 2003, Lukaski 2004). In previous cross-sectional 
studies dietary magnesium intake was modestly and inversely associated 
with C-reactive protein (a marker of systemic inflammation) in women 45 
years (Song et al. 2007, Song et al. 2005). Therefore, adequate magnesium 
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intake is not only essential for muscle metabolism (Maguire and Cowan 
2002), but it is also important due to its anti-inflammatory properties.   
An interesting finding of this study was the significant association between 
higher potassium intake and indexes of muscle mass with percentage 
differences in FFM of 2.80 % and in FFMI of 3.32 % between extreme 
quintiles of intake (P = 0.004 and < 0.001, respectively). There are no 
studies in the literature examining associations between habitual potassium 
intake and muscle mass, however, potassium may be an important 
micronutrient as muscle mass is involved in potassium homeostasis, and 
therefore inadequate dietary potassium intake may have a subsequent effect 
on the activity of muscles (McDonough et al. 2002). Moreover, dietary 
potassium may protect against acidosis, which has strong catabolic 
influences on muscle (May et al. 1987). From previous studies it is evident 
that consumption of a Western-style diet leads to a chronic low-grade 
acidosis through the release of noncarbonic acids into the systemic 
circulation (e.g. protein metabolism releases sulphuric acid) in greater 
amounts than that of the simultaneous release of bases (e.g. bicarbonate 
from the oxidization of organic salts of potassium from vegetable sources) 
(Lennon et al. 1966). Potassium bicarbonate has been suggested to 
neutralise net acid load and therefore may also neutralize the diet and age 
dependent metabolic acidosis. Potassium bicarbonate is a natural base 
generated endogenously from the metabolism of organic salts of potassium, 
such as potassium citrate, which is found mainly in fruits and vegetables. It 
has been suggested that long-term supplementation of the diet with 
potassium bicarbonate may benefit anabolism and may be beneficial to 
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muscle wasting (Frassetto et al. 1997, Sebastian et al. 1994). Therefore, it is 
important to incorporate foods high in potassium, such as fruits and 
vegetables, in the habitual diet. 
 
In the current analysis an association between habitual selenium intake and 
indexes of muscle mass was not observed although there are previous cross-
sectional studies suggesting positive associations between low plasma 
selenium and poor skeletal muscle strength among older adults with 
selenium intake found to associated with higher grip strength in women 59 
to 73 years (Lauretani F et al. 2007, Robinson SM et al. 2008). The lack of 
associations in the current study may be because the selenium content of 
foods varies depending on the soil content and other environmental 
conditions (especially the quantity and species of selenium to which the 
animal/plant is exposed) (Fairweather-Tait et al. 2010). This affects the 
form of selenium present in plant and animal food sources. This may impact 
on the absorption and use of selenium and consequently influence 
selenium’s protective role in muscle functions (Rederstorff et al. 2006).   
 
Carotenoids 
In relation to carotenoids, findings from the current analysis showed 
positive associations between carotenoid intakes and indexes of muscle 
mass. The greatest associations were observed between FFMI and higher 
intakes of total carotene, -carotene, ß-carotene, and ß-cryptoxanthin with 
associations of approximately 2 %. For lycopene a difference of 1.54 % of 
the population mean for FFMI was seen between extreme quintiles of 
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intake. Associations were not observed for lutein and zeaxanthin in 
association with FFMI and this might be explained by the fact that higher 
sources of lutein and zeaxanthin, such as kale and tangerines were not 
included in the FFQ used to assess dietary intake. 
These findings are supported by recent epidemiological studies in 
community-dwelling older individuals which have shown that low serum 
and/or plasma carotenoid levels were independently associated with low 
muscle strength and the development of walking disability over time 
(Lauretani et al. 2008, Semba et al. 2007). In addition, in the InCHIANTI 
study low intake of β-carotene was marginally associated with knee 
extension strength (β = 0.311, P = 0.05) (Cesari et al. 2004). The underlying 
mechanisms which explain these associations are speculated to be oxidative 
stress and inflammation, which are implicated in the ageing process and the 
pathogenesis of sarcopenia (Meng and Yu 2010). Although, mechanistic 
studies have not shown beneficial effects of β-carotene supplementation on 
the responses of skeletal muscle to exercise induced oxidative stress 
(Jackson et al. 2004) population-based studies have shown that low serum 
carotenoid levels were inversely associated with serum protein carbonyl 
concentrations (indicator of oxidative protein damage) (Alipanah et al. 
2007). Moreover, although there is a lack of mechanistic studies regarding 
the effects of carotenoids on inflammation associated sarcopenia, there is 
evidence from population-based cohorts that low serum carotenoid levels 
were associated with higher levels of the inflammatory marker IL-6, and 
women with low levels of a-carotene, β-carotene, total carotene, 
lutein/zeaxanthin were more likely to have increased IL-6 over a period of 
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two years (Walston et al. 2006). However, this is the first study to examine 
associations between dietary intake of a range of carotenoids and indexes of 
muscle mass, giving an insight to their potential role in sarcopenia.  
 
Of interest, the proportion of women aged 18 to 79 years (subset 1) with 
intakes below the Reference Nutrient Intake (RNI) was 1.2 % for vitamin C 
(RNI = 40 mg/d), 21.4 % for magnesium (RNI = 270 mg/d), and 33.4 % for 
potassium (RNI = 3500 mg/d). In contrast the proportion of women of the 
same subset with intakes below the RNI was 73.1 % for selenium (RNI = 60 
µg/d). The proportion of women below the Estimated Average 
Requirements (EAR) for vitamin D was 99.8 % (EAR = 10 µg/d); and the 
proportion of women below the Recommended Daily Amount of vitamin E 
was 81.2 % (RDA = 15 mg/d) (National Research Council 2011). These 
proportions were very similar for subset 2 (women aged 34 to 83 years). 
 
Micronutrients and hand grip strength and muscle quality 
In the current study we did not observe any cross-sectional associations 
between habitual nutrient intake and hand grip strength. Although, mean 
hand grip strength was higher with higher intakes of vitamin D, magnesium, 
selenium, potassium, ß-carotene, and lycopene, the associations were not 
significant. Mean muscle quality was also higher with higher vitamin E, ß-
carotene, and lycopene intakes, but the associations were not significant. 
Even after stratification by age, associations between nutrient intakes and 
hand grip strength and muscle quality did not reach statistical significance.  
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To date, there are only two previous epidemiological studies examining 
associations between nutrient intakes and muscle strength measurements 
with conflicting results (Robinson SM et al. 2008, Scott et al. 2010). One of 
these studies was a prospective cohort study among 740 older women and 
men (mean age 62 ± 7 years), and muscle strength was assessed by a seated 
isometric contraction of the knee extensors at baseline and after 2.6 years of 
follow-up. Findings from this study showed that there was no association 
between nutrient intake (protein, saturated fat, calcium, magnesium, niacin, 
niacin equivalents, phosphorus, potassium, riboflavin, zinc) and muscle 
strength of the knee extensors over 2.6 years of follow-up (Scott et al. 
2010). 
 
The second study was a cross-sectional examination within the 
Hertfordshire UK cohort among 2983 women and men aged between 59 to 
73 years, in which muscle strength was assessed by hand grip strength. 
Results from this study showed that in women, after adjustment for energy 
intake, the proportional difference in hand grip strength per unit of nutrient 
intake was: 14.75 kg for selenium intake [ß coefficient (95 % CI): 14.75 
(4.27, 50.93), P < 0.001], 4.17 kg for vitamin D intake [ß coefficient (95 % 
CI): 4.17 (2.15, 8.07), P < 0.001], 3.44 kg for vitamin C intake [ß coefficient 
(95 % CI): 3.44 (1.70, 6.96), P = 0.001], and 2.25 kg for carotene intake [ß 
coefficient (95 % CI): 2.25 (1.16, 4.36), P = 0.016] (Robinson SM et al. 
2008).    
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Notably, the assessment measurements used for muscle strength were 
different between these two previous cohorts. In the first study the lack of 
associations might be due to the fact that there was an increase in muscle 
strength over the 2.6 years of follow-up compared with baseline, most likely 
because of inadequate use of the test as it was not previously validated 
(Phillips et al. 2004). In the second study, muscle strength was assessed by 
hand grip strength, which has been suggested as a commonly used proxy for 
global muscle strength (Abellan Van Kan et al. 2009, Lauretani et al. 2003). 
  
The highest association observed in the current study was between selenium 
intake and hand grip strength although the association was not statistically 
significant. The magnitude of association in this study was smaller 
compared with that from the Hertfordshire cohort with a difference in hand 
grip strength per quintile of selenium intake of 0.07 kg [ß coefficient (95 % 
CI): 0.07 (- 0.21, 0.34), P = 0.64] compared with 14.75 kg [ß coefficient (95 
% CI): 14.75 (4.27, 50.93), P < 0.001] in the Hertfordshire cohort. Although 
both studies use the same method used to assess muscle strength and a 
number of covariates that may mediate the relationship between nutrient 
intake and muscle strength and muscle quality were considered in the 
current analysis, the findings did not reach significance. It should be 
acknowledged that the Hertfordshire cohort was an older cohort (59-73 
years), with lower mean hand grip strength (26.5 kg) compared to the 
second subset of the current analysis which included younger individuals 
(34-83 years), with subsequently higher hand grip strength (28.8 kg). Our 
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cohort was younger and therefore might be less likely to observe changes in 
muscle strength in association with diet.   
 
The lack of significant associations observed in the current study might be 
due to the fact that other lifestyle factors than diet have a greater influence 
on muscle strength and muscle quality. Interestingly, in this cohort, physical 
activity had a greater effect on hand grip strength, and age had a greater 
effect on muscle quality for all the nutrients. For example, after multivariate 
adjustment for relevant confounders, the effect of physical activity [ß 
coefficient (SEM): 1.05 (0.414), P = 0.01] was 5.25 times greater of that of 
vitamin C intake [ß coefficient (SEM): - 0.2 (0.122), P = 0.14] on hand grip 
strength. This finding was observed even after stratification for age. 
Notably, intervention programs have shown that exercise and strength 
training was beneficial for muscle strength, and epidemiological studies 
suggested that increased customary physical activity was associated with 
improved muscle strength and physical performance (Haight et al. 2005, 
Martin et al. 2008, McDermott et al. 2002, Puggaard 2003). The observed 
effect of age [ß coefficient (SEM): - 0.006 (0.0006), P < 0.001] was two-
fold greater than the effect of vitamin C intake [ß coefficient (SEM): - 0.003 
(0.003), P = 0.27] on muscle quality and these findings are supported by a 
number of studies which have previously described decreases in muscle 
quality with age (Newman et al. 2003).  
 
Overall, this study showed that higher consumption of vitamins C and E, 
magnesium, potassium, -carotene, ß-carotene, total carotene, lutein, ß-
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cryptoxanthin and lycopene were significantly associated with increased 
muscle mass in a cohort of women including younger adults, after 
accounting for age and other lifestyle factors, such as physical activity and 
smoking status. Findings remained significant with no substantial 
differences between the association of the above mentioned nutrient intakes 
and indexes of muscle mass, when protein intake was added in the 
multivariate model. This finding suggested that although protein intake is 
important for maintenance of muscle mass, other nutrients in the diet with 
the potential to act against oxidative stress and exert anti-inflammatory 
properties, such as vitamin C and E, magnesium and carotenoids, and also 
nutrients with the potential to benefit age-dependent metabolic acidosis and 
muscle wasting, such as potassium, may also be relevant for muscle mass. 
Among the nutrients studied, magnesium appeared to be independently 
predictive for all three indexes of muscle mass on top of intakes of vitamin 
C, total carotene and ß-cryptoxanthin, indicating its importance for muscle 
mass. Findings were not significant for associations between nutrient intake 
and muscle strength and quality possibly because other lifestyle factors, 
such as physical activity and the ageing process itself, had a greater effect in 
this cohort.  
 
3.5 Strengths and limitations 
The strengths of this study include the large sample size, and the wide age 
range of participants as most previous studies on sarcopenia examined only 
older individuals (Robinson SM et al. 2008, Scott et al. 2010). Moreover, 
this is the first study, to our knowledge, that accounted for familial or 
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genetic influences that may be shared. An additional strength was that body 
composition was objectively assessed by DEXA scans and an objective 
measurement was used to assess muscle strength, which allowed calculation 
of muscle quality. Furthermore, this study was focused in women, although 
men have on average greater amounts of muscle mass than women, but they 
have shorter survival, which implies that sarcopenia may potentially become 
a greater public health concern in women than men (Abellan Van Kan 
2009). Moreover, this was the first study that examined associations 
between intakes of an extended range of carotenoids, using the EPIC 
database of the carotenoid content of food (Pattison et al. 2005). Data from 
the TwinsUK cohort has shown that participants were representative of the 
general population in terms of measures or disease outcomes, such as 
height, bone mineral density, osteoarthritis, blood pressure, use of 
hypertensive medication, alcohol consumption, menopausal, hysterectomy 
and ovariectomy status and diet (Andrew et al. 2001, Henderson et al. 2004, 
Sproston and Primatesta 2004, Teucher et al. 2007). Also, the FFQ used in 
the current study was previously compared and validated against a 7-day 
weighed record in the EPIC Norfolk study, and although the two approaches 
to measure dietary intake were different, both methods identified similar 
intakes of macronutrients when these expressed as percentage of total 
energy intake (Bingham et al. 2001). Moreover, this FFQ was previously 
validated  against urinary and plasma biomarkers of intake, such as urinary 
nitrogen for protein intake, urinary potassium and sodium, plasma ascorbic 
acid and plasma n-3 PUFAs, and in addition, it has been shown previously 
that serum ß-carotene, ß-cryptoxanthin, and zeaxanthin concentrations were 
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moderately correlated with dietary carotenoid intakes measured by an FFQ 
(McKeown et al. 2001, Tucker et al. 1999, Welch et al. 2006). Furthermore, 
in order to examine associations between dietary intake and health outcomes 
participants need to be ranked according to their usual dietary intake and 
FFQs have been shown to rank individuals well (Molag et al. 2007). 
 
In the current analyses multiple corrections were not performed as the 
hypothesis of the study was well defined a priori, and the mechanisms 
linking the associations between different micronutrients and indexes of 
muscle mass, strength and muscle quality were independent. Multiple 
testing is an important consideration in exploratory studies is  (Benjamini 
2010). However, since our hypotheses were well defined a priori, and the 
mechanisms linking the different exposures and the outcome were 
independent, then correction for multiple testing is not strictly necessary 
(Bender and Lange 2001).  
 
This study also has a number of limitations. The cross-sectional nature of 
the study limits causal inference, but enables us to generate hypotheses 
regarding associations between specific nutrient intakes and indexes of 
muscle mass, strength and muscle quality based on plausible mechanisms. 
High intakes of vitamins C and E, magnesium, potassium and carotenoids 
may be indicators of a healthy lifestyle, and even though all analyses were 
adjusted for lifestyle and dietary protein intake, residual confounding may 
still be present because of the observational nature of the study. In addition, 
as in all observational studies, measurement error in self-reported dietary 
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intakes is inevitable. It is also widely acknowledged that the use of FFQs for 
measuring dietary intake has its own limitations related to memory errors, 
they provide relative than absolute intake, they introduce bias due to over- 
or under-reporting, and they may introduce systematic errors as preparation 
methods are inadequately considered (McNeill et al. 2009). Also, FFQs 
measure food intake over a period of one year and reflect the habitual diet 
over this period of time but not lifetime dietary habits (Teucher et al. 2007). 
The observed findings relate to women and further work is needed to 
investigate if these findings are replicated in a male population of the same 
country or in populations from different ethnic backgrounds.   
 
3.6 Concluding remarks   
This is one of the first studies to our knowledge to show that consumption 
of a range of micronutrients is associated with muscle mass in women of 
different ages, and to account for familial or genetic influences that may be 
shared. This is also one of the first studies to examine cross-sectional 
associations between a range of micronutrients and muscle strength and 
muscle quality. Our findings extended the results from few previous studies 
by examining simultaneously associations between a range of nutrients 
relevant for muscle mass in a cohort including younger adults. It is evident 
that notable changes in skeletal muscle mass may occur earlier in adult life 
(between 30 and 45 years of age), and it is important to examine dietary 
associations with muscle mass in individuals of all ages (Cesari and Pahor 
2008, Janssen et al. 2000). Additionally, our findings extended the existing 
literature by evaluating the relative importance of diet in terms of nutrients 
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and muscle quality to further understand the association between muscle 
strength and muscle mass with diet. 
 
In conclusion, there was a positive association between intakes of vitamin 
C, magnesium, potassium, ß-carotene, total carotene, lutein, and ß-
cryptoxanthin and fat free mass (FFM, kg); vitamin E, magnesium, and 
lutein and percentage fat free mass (FFM %); and vitamin C, magnesium, 
potassium, -carotene, ß-carotene, total carotene, ß-cryptoxanthin, and 
lycopene and fat free mass index (FFMI, kg/m
2
). Also, although there was a 
positive association between intakes of vitamin D, magnesium, potassium, 
selenium, ß-carotene, and lycopene intakes with muscle strength (kg), and 
vitamin E, ß-carotene, and lycopene intakes with muscle quality (kg/kg), 
these associations were not statistically significant.  
 
A consistent significant association was observed between higher 
magnesium intakes with all three indexes of muscle mass when women 
were considered as singletons. These associations were observed after 
adjustments for age, physical activity, smoking, energy intake and total 
body mass. Additionally, among the nutrients studied, magnesium appeared 
to be independently predictive for all three indexes of muscle mass on top of 
intakes of vitamin C, total carotene and ß-cryptoxanthin, indicating its 
importance for muscle mass. Of interest, the effect of different categories of 
physical activity (moderately active vs. inactive and active vs. inactive) on 
FFMI was [ß coefficient (95% CI): 0.16 (0.06-0.26), P = 0.002], which was 
similar to the effect of each quintile of magnesium intake on FFMI [ß 
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coefficient (95% CI): 0.12 (0.05-0.19), P < 0.001]. Even though the effect of 
physical activity (a factor important for muscle mass) was similar to that of 
diet, our findings regarding magnesium intake showed that there was a 
significant influence of micronutrient intake on FFMI after adjusting for all 
relevant confounders (including physical activity). Therefore, the magnitude 
of association of magnesium intake was comparable to that of physical 
activity, indicating its importance for muscle mass after accounting for all 
other confounders. Although the strength of the associations was modest, 
our results supported the initial hypothesis that higher intake of nutrients 
relevant for muscle mass may be important in maintaining fat free mass. 
Associations were towards significance in the within-pair analysis, 
suggesting that potential shared lifestyle and genetic factors other than 
dietary intake of magnesium were driving this apparent association. 
However, these findings need to be verified in other twin studies.  
 
Nevertheless, not all the nutrients under study were positively associated 
with indexes of muscle mass, strength and muscle quality in this study. This 
was possibly due to the fact that other factors, such as physical activity may 
be more important than diet in terms of nutrients to preserve or maintain 
muscle mass (as assessed by the relevant indexes) and improve or maintain 
muscle strength and quality. Yet, it is possible that a longitudinal study 
design might be a more suitable approach to detect associations between 
nutrient intake and muscle mass indexes. Although further work is needed 
to examine associations between overall diet quality (assessed by diet 
quality scores) and muscle mass, muscle strength and muscle quality, results 
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from the current analysis suggest that it is important for adult women to 
consume a variety of foods high in vitamins C and E, magnesium, 
potassium and a range of carotenoids to ensure greater muscle mass and 
strength. From a public health perspective, these findings will help to 
improve the knowledge and understanding of the effects of dietary and 
lifestyle factors on muscle mass and strength and also provide useful 
information in the development and planning dietary intervention trials to 
improve conservation of muscle mass and strength in adult life. 
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TABLES 
Table 3.2 Baseline characteristics of female participants from the TwinsUK cohort
1 
Characteristic 
Subset 1 
N=2570, 18-79 yrs 
Subset 2 
N=949, 34-83 yrs 
Age (y) 48.3±12.7
 
59.1±9.30
 
Weight (kg) 65.6±11.2
 
69.2±12.5
 
Height (cm) 162±6.07
 
162±5.93
 
BMI (kg/m
2
) 24.9±4.14
 
26.5±4.73
 
Fat mass (kg) 22.7±7.87
 
25.2±8.30
 
Fat mass % 33.9±7.17
 
35.7±6.28
 
Fat free mass (kg) 39.6±5.30
 
42.0±5.47
 
Fat free mass % 61.1±6.49
 
61.4±6.18
 
Fat free mass index (kg/m
2
) 15.0±1.71
 
 
Hand grip strength (kg)  28.8±5.95 
Muscle quality (kg/kg)  0.69±0.14 
Physical activity % 
Inactive 
Moderate 
Active 
 
21.9 
53.9 
24.2 
 
39.6 
34.2 
26.2 
Smoking history % 
Never 
Current 
Former 
 
50.2 
18.2 
31.6
 
 
Current smoking % 
Yes 
No 
 
 
 
9.79 
90.21 
Menopausal status % 
Premenopausal   
Postmenopausal  
 
 
 
10.3 
89.7 
Hormone replacement therapy % 
No 
Yes 
 
 
 
90.63 
9.38 
Dietary components 
  
Total energy intake (kcal/d) 1979±524
 
1917±637
 
Vitamins    
Vitamin C intake (mg/d) 155±80.2
 
177±87.9
 
Vitamin E intake (mg/d) 11.4±4.57
 
11.5±5.46
 
Vitamin D intake (µg/d) 2.61±1.42
 
2.63±1.67
 
Minerals    
Magnesium intake (mg/d) 344±92.3
 
351±110
 
Potassium intake (mg/d) 3973±1004
 
4005±1177
 
Selenium intake (µg/d) 44.9±16.0
 
51.8±24.5
 
Carotenoids    
-carotene intake (µg/d) 559±416 633±542 
ß-carotene intake (µg/d) 3091±1757 3767±2630 
Total carotene intake (µg/d)  3448±1944
 
4227±2907
 
Lycopene intake (µg/d) 1347±958
 
1896±1549
 
Lutein intake (µg/d) 2183±1450
 
2906±2401
 
Zeaxanthin intake (µg/d) 83.4±70.9
 
78.8±66.4
 
ß-cryptoxanthin intake (µg/d) 200±194
 
286±320
 
1
 Values are unadjusted means ± standard deviations (mean ± SDs) unless indicated 
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Table 3.3 The associations between nutrient intakes and fat free mass (kg) in 2570 
women from the TwinsUK cohort aged 18-79 years
1
 
 Fat free mass (kg) 
Quintiles of 
nutrient intake 
Q1 Q2 Q3 Q4 Q5 
P for 
trend 
Vitamin C (mg/d) 
Unadjusted  
Adjusted model
2
  
 
38.9±0.3 
39.0±0.2 
 
39.7±0.3 
39.6±0.2 
 
39.6±0.2 
39.6±0.2 
 
39.9±0.3 
39.9±0.2 
 
40.1±0.2 
40.2±0.2 
 
0.001 
0.001 
Vitamin D (µg/d) 
Unadjusted  
Adjusted model 
 
39.6±0.3 
39.9±0.2 
 
39.8±0.3 
39.9±0.2 
 
39.3±0.2 
39.4±0.2 
 
39.8±0.3 
39.6±0.2 
 
39.8±0.3 
39.4±0.2 
 
0.71 
0.057 
Vitamin E (mg/d) 
Unadjusted  
Adjusted model 
 
39.2±0.3 
39.2±0.3 
 
39.5±0.3 
39.5±0.2 
 
39.9±0.2 
39.9±0.2 
 
39.9±0.3 
39.8±0.2 
 
39.7±0.2 
39.7±0.3 
 
0.06 
0.23 
Magnesium 
(mg/d) 
Unadjusted  
Adjusted model 
 
 
39.1±0.3 
38.9±0.3 
 
 
39.3±0.3 
39.2±0.2 
 
 
39.6±0.2 
39.6±0.2 
 
 
39.7±0.2 
39.8±0.2 
 
 
40.5±0.3 
40.7±0.3 
 
<0.001 
<0.001 
Selenium (µg/d) 
Unadjusted  
Adjusted model 
 
39.1±0.3 
39.5±0.3 
 
39.5±0.3 
39.5±0.2 
 
39.5±0.3 
39.5±0.2 
 
39.9±0.2 
39.9±0.2 
 
40.3±0.3 
39.9±0.2 
 
0.001 
0.11 
Potassium (mg/d) 
Unadjusted  
Adjusted model 
 
39.3±0.3 
39.3±0.3 
 
39.2±0.2 
39.2±0.2 
 
39.4±0.2 
39.4±0.2 
 
40.0±0.2 
39.9±0.2 
 
40.4±0.3 
40.4±0.3 
 
<0.001 
0.004 
Total carotene 
(µg/d) 
Unadjusted  
Adjusted model 
 
 
39.1±0.3 
39.2±0.2 
 
 
39.4±0.2 
39.4±0.2 
 
 
39.8±0.3 
39.7±0.2 
 
 
40.2±0.3 
40.2±0.2 
 
 
39.7±0.3 
39.8±0.2 
 
0.012 
0.008 
-carotene (µg/d) 
Unadjusted  
Adjusted model 
 
39.4±0.3 
39.4±0.2 
 
39.6±0.2 
39.6±0.2 
 
39.4±0.3 
39.6±0.2 
 
39.9±0.2 
39.7±0.2 
 
40.0±0.3 
40.0±0.2 
 
0.09 
0.17 
ß-carotene (µg/d) 
Unadjusted  
Adjusted model 
 
39.1±0.3 
39.1±0.2 
 
39.3±0.2 
39.5±0.2 
 
40.0±0.3 
39.8±0.2 
 
40.1±0.3 
40.0±0.2 
 
39.8±0.3 
39.9±0.2 
 
0.006 
0.007 
Lutein (µg/d) 
Unadjusted  
Adjusted model 
 
39.0±0.3 
39.1±0.2 
 
39.4±0.2 
39.3±0.2 
 
40.3±0.3 
40.1±0.2 
 
39.9±0.3 
39.9±0.2 
 
39.7±0.2 
39.9±0.2 
 
0.019 
0.004 
Zeaxanthin (µg/d) 
Unadjusted  
Adjusted model 
 
39.0±0.3 
39.1±0.2 
 
39.7±0.2 
39.8±0.2 
 
40.0±0.2 
40.1±0.2 
 
39.5±0.3 
39.7±0.2 
 
40.1±0.3 
39.7±0.2 
 
0.010 
0.17 
ß-cryptoxanthin 
(µg/d) Unadjusted  
Adjusted model 
 
39.0±0.3 
39.2±0.2 
 
39.8±0.3 
39.7±0.2 
 
39.7±0.3 
39.7±0.2 
 
39.8±0.3 
39.8±0.2 
 
40.0±0.2 
39.9±0.2 
 
0.015 
0.032 
Lycopene  (µg/d) 
Unadjusted  
Adjusted model 
 
38.9±0.3 
39.3±0.2 
 
39.3±0.3 
39.6±0.2 
 
40.0±0.3 
39.9±0.2 
 
39.7±0.2 
39.7±0.2 
 
40.3±0.3 
39.7±0.2 
 
<0.001 
0.34 
1 
All values are means and SEM for fat free mass (kg) by quintiles of nutrient intake 
2
 Adjusted for age (years), physical activity (inactive, moderately active, active), smoking history 
(never, former, current), energy intake (kcal/d), and total body mass (kg)   
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Table 3.4 The associations between nutrient intakes and percentage fat free mass in 2570 
women from the TwinsUK cohort aged 18-79 years
1
 
 Percentage fat free mass 
Quintiles of 
nutrient intake  
Q1 Q2 Q3 Q4 Q5 
P for 
trend 
Vitamin C (mg/d) 
Unadjusted  
Adjusted model
2
 
 
61.09±0.3 
60.63±0.3 
 
61.09±0.3 
60.99±0.3 
 
61.18±0.3 
61.14±0.3 
 
60.93±0.3 
61.14±0.3 
 
61.17±0.3 
61.57±0.3 
 
0.99 
0.07 
Vitamin D (µg/d) 
Unadjusted  
Adjusted model 
 
61.79±0.3 
61.55±0.3 
 
61.11±0.3 
61.16±0.3 
 
61.28±0.3 
61.14±0.3 
 
60.98±0.3 
61.02±0.3 
 
60.30±0.3 
60.61±0.3 
 
0.002 
0.037 
Vitamin E (mg/d) 
Unadjusted  
Adjusted model 
 
60.71±0.3 
59.99±0.4 
 
60.92±0.3 
60.62±0.3 
 
61.36±0.3 
61.36±0.3 
 
61.05±0.3 
61.33±0.3 
 
61.42±0.3 
62.17±0.4 
 
0.11 
<0.001 
Magnesium 
(mg/d) 
Unadjusted  
Adjusted model 
 
 
61.08±0.3 
60.35±0.4 
 
 
60.66±0.3 
60.49±0.3 
 
 
61.21±0.3 
61.17±0.3 
 
 
61.26±0.3 
61.53±0.3 
 
 
61.25±0.3 
61.93±0.4 
 
 
0.34 
0.004 
Selenium (µg/d) 
Unadjusted  
Adjusted model 
 
61.51±0.3 
61.44±0.3 
 
60.84±0.3 
60.77±0.3 
 
60.59±0.3 
60.82±0.3 
 
61.58±0.3 
61.56±0.3 
 
60.94±0.3 
60.88±0.3 
 
0.68 
0.79 
Potassium (mg/d) 
Unadjusted  
Adjusted model 
 
61.45±0.3 
61.04±0.4 
 
60.93±0.3 
60.85±0.3 
 
61.34±0.3 
61.37±0.3 
 
61.14±0.3 
61.28±0.3 
 
60.61±0.3 
60.94±0.4 
 
0.13 
0.93 
-carotene (µg/d) 
Unadjusted  
Adjusted model 
 
61.77±0.3 
61.36±0.3 
 
61.54±0.3 
61.24±0.3 
 
60.37±0.3 
60.76±0.3 
 
60.92±0.3 
60.88±0.3 
 
60.86±0.3 
61.24±0.3 
 
0.011 
0.40 
ß-carotene (µg/d) 
Unadjusted  
Adjusted model 
 
61.50±0.3 
60.96±0.3 
 
61.53±0.3 
61.42±0.3 
 
60.72±0.3 
60.70±0.3 
 
60.97±0.3 
61.15±0.3 
 
60.78±0.3 
61.24±0.3 
 
0.049 
0.95 
Total carotene 
(µg/d) 
Unadjusted  
Adjusted model 
 
 
61.58±0.3 
61.06±0.3 
 
 
61.29±0.3 
61.09±0.3 
 
 
60.69±0.3 
60.76±0.3 
 
 
61.16±0.3 
61.32±0.3 
 
 
60.76±0.3 
61.25±0.3 
 
 
0.07 
0.70 
Lutein (µg/d) 
Unadjusted  
Adjusted model 
 
61.21±0.3 
60.77±0.3 
 
60.99±0.3 
60.75±0.3 
 
60.96±0.3 
61.06±0.3 
 
60.95±0.3 
61.19±0.3 
 
61.36±0.3 
61.70±0.3 
 
0.79 
0.031 
Zeaxanthin (µg/d) 
Unadjusted  
Adjusted model 
 
60.32±0.3 
60.59±0.3 
 
60.94±0.3 
61.14±0.3 
 
61.15±0.3 
61.29±0.3 
 
61.24±0.3 
61.51±0.3 
 
61.82±0.3 
60.93±0.3 
 
0.001 
0.35 
ß-cryptoxanthin 
(µg/d) 
Unadjusted  
Adjusted model 
 
 
60.84±0.3 
60.86±0.3 
 
 
60.91±0.3 
60.92±0.3 
 
 
61.19±0.3 
61.09±0.3 
 
 
61.45±0.3 
61.41±0.3 
 
 
61.09±0.3 
61.18±0.3 
 
 
0.29 
0.32 
Lycopene  (µg/d) 
Unadjusted  
Adjusted model 
 
60.89±0.3 
61.25±0.3 
 
61.06±0.3 
61.42±0.3 
 
61.22±0.3 
61.26±0.3 
 
61.29±0.3 
61.19±0.3 
 
60.99±0.3 
60.35±0.3 
 
0.65 
0.022 
1 
All values are means and SEM for percentage fat free mass by quintiles of nutrient intake  
2
 Adjusted for age (years), physical activity (inactive, moderately active, active), smoking history 
(never, former, current), and energy intake (kcal/d) 
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Table 3.5 The associations between nutrient intakes and fat free mass index (kg/m
2
) in 
2570 women from the TwinsUK cohort aged 18-79 years
1
 
 Fat free mass index (kg/m
2
) 
Quintiles of 
nutrient intake 
Q1 Q2 Q3 Q4 Q5 
P for 
trend 
Vitamin C 
(mg/d) 
Unadjusted  
Adjusted model
2
 
 
 
14.79±0.1 
14.79±0.1 
 
 
15.05±0.1 
15.01±0.1 
 
 
14.97±0.1 
14.98±0.1 
 
 
15.09±0.1 
15.07±0.1 
 
 
15.22±0.1 
15.25±0.1 
 
 
<0.001 
<0.001 
Vitamin D (µg/d) 
Unadjusted  
Adjusted model 
 
14.98±0.1 
15.05±0.1 
 
15.06±0.1 
15.06±0.1 
 
14.93±0.1 
14.97±0.1 
 
15.09±0.1 
15.07±0.1 
 
15.06±0.1 
14.96±0.1 
 
0.46 
0.40 
Vitamin E 
(mg/d) 
Unadjusted  
Adjusted model 
 
 
14.97±0.1 
14.94±0.1 
 
 
15.06±0.1 
15.04±0.1 
 
 
15.04±0.1 
15.07±0.1 
 
 
15.06±0.1 
15.04±0.1 
 
 
14.99±0.1 
15.02±0.1 
 
 
0.84 
0.88 
Magnesium 
(mg/d) 
Unadjusted  
Adjusted model 
 
 
14.87±0.1 
14.77±0.1 
 
 
14.97±0.1 
14.91±0.1 
 
 
15.03±0.1 
15.03±0.1 
 
 
15.08±0.1 
15.13±0.1 
 
 
15.17±0.1 
15.27±0.1 
 
 
0.008 
0.001 
Selenium (µg/d) 
Unadjusted  
Adjusted model 
 
14.89±0.1 
14.95±0.1 
 
15.01±0.1 
14.99±0.1 
 
14.99±0.1 
14.98±0.1 
 
15.05±0.1 
15.08±0.1 
 
15.17±0.1 
15.11±0.1 
 
0.027 
0.12 
Potassium 
(mg/d) 
Unadjusted  
Adjusted model 
 
 
14.85±0.1 
14.78±0.1 
 
 
14.88±0.1 
14.87±0.1 
 
 
15.01±0.1 
15.03±0.1 
 
 
15.14±0.1 
15.06±0.1 
 
 
15.21±0.1 
15.27±0.1 
 
 
<0.001 
<0.001 
-carotene 
(µg/d) 
Unadjusted  
Adjusted model 
 
 
14.85±0.1 
14.89±0.1 
 
 
14.98±0.1 
14.99±0.1 
 
 
15.05±0.1 
15.03±0.1 
 
 
15.05±0.1 
15.03±0.1 
 
 
15.18±0.1 
15.17±0.1 
 
 
0.004 
0.019 
ß-carotene 
(µg/d) 
Unadjusted  
Adjusted model 
 
 
14.81±0.1 
14.82±0.1 
 
 
14.92±0.1 
14.98±0.1 
 
 
15.09±0.1 
15.03±0.1 
 
 
15.19±0.1 
15.18±0.1 
 
 
15.10±0.1 
15.10±0.1 
 
 
0.001 
0.003 
Total carotene 
(µg/d) 
Unadjusted  
Adjusted model 
 
 
14.82±0.1 
14.84±0.1 
 
 
14.94±0.1 
14.96±0.1 
 
 
15.08±0.1 
15.03±0.1 
 
 
15.18±0.1 
15.19±0.1 
 
 
15.09±0.1 
15.10±0.1 
 
 
0.001 
0.003 
Lutein (µg/d) 
Unadjusted  
Adjusted model 
 
14.84±0.1 
14.88±0.1 
 
14.99±0.1 
14.98±0.1 
 
15.15±0.1 
15.09±0.1 
 
15.09±0.1 
15.09±0.1 
 
15.03±0.1 
15.07±0.1 
 
0.07 
0.08 
Zeaxanthin 
(µg/d) 
Unadjusted  
Adjusted model 
 
 
14.93±0.1 
14.91±0.1 
 
 
14.98±0.1 
14.97±0.1 
 
 
15.09±0.1 
15.09±0.1 
 
 
14.99±0.1 
15.05±0.1 
 
 
15.12±0.1 
15.08±0.1 
 
 
0.14 
0.12 
ß-cryptoxanthin 
(µg/d) 
Unadjusted  
Adjusted model 
 
 
14.87±0.1 
14.87±0.1 
 
 
14.97±0.1 
14.97±0.1 
 
 
15.08±0.1 
15.08±0.1 
 
 
15.05±0.1 
15.05±0.1 
 
 
15.15±0.1 
15.15±0.1 
 
 
0.014 
0.014 
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Lycopene  
(µg/d) 
Unadjusted  
Adjusted model 
 
 
14.87±0.1 
14.92±0.1 
 
 
14.91±0.1 
14.95±0.1 
 
 
15.03±0.1 
15.01±0.1 
 
 
15.05±0.1 
15.08±0.1 
 
 
15.26±0.1 
15.15±0.1 
 
 
<0.001 
0.027 
1 
All values are means and SEM for fat free mass index by quintiles of nutrient intake  
2
 Adjusted for age (years), physical activity (inactive, moderately active, active), smoking history 
(never, former, current), energy intake (kcal/d), and total body mass (kg)   
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Table 3.6 The associations between nutrient intakes and hand grip strength (kg) in 949 
women from the TwinsUK cohort aged 34-83 years
1
 
 Hand grip strength (kg) 
Quintiles of 
nutrient intake 
Q1 Q2 Q3 Q4 Q5 
P for 
trend 
Vitamin C (mg/d) 
Unadjusted  
Adjusted model
2
 
 
28.76±0.5 
29.02±0.4 
 
29.48±0.5 
29.47±0.4 
 
28.82±0.5 
28.50±0.4 
 
27.80±0.4 
28.07±0.4 
 
27.80±0.4 
28.85±0.4 
 
0.44 
0.14 
Vitamin D (µg/d) 
Unadjusted  
Adjusted model 
 
29.19±0.5 
29.07±0.4 
 
28.83±0.5 
28.52±0.4 
 
29.19±0.4 
29.09±0.4 
 
27.91±0.4 
28.13±0.4 
 
28.80±0.4 
29.11±0.4 
 
0.24 
0.75 
Vitamin E (mg/d) 
Unadjusted  
Adjusted model 
 
28.44±0.5 
29.00±0.5 
 
29.43±0.5 
29.42±0.4 
 
28.94±0.5 
28.56±0.4 
 
28.52±0.4 
28.73±0.4 
 
28.58±0.4 
28.20±0.4 
 
0.66 
0.18 
Magnesium 
(mg/d) 
Unadjusted  
Adjusted model 
 
25.50±0.4 
28.74±0.4 
 
28.79±0.5 
28.77±0.4 
 
28.51±0.4 
28.44±0.4 
 
28.77±0.5 
29.16±0.4 
 
29.34±0.4 
28.80±0.5 
 
0.24 
0.71 
Selenium (µg/d) 
Unadjusted  
Adjusted model 
 
28.16±0.5 
28.47±0.4 
 
29.34±0.5 
29.22±0.4 
 
27.95±0.5 
28.39±0.4 
 
28.80±0.4 
28.69±0.3 
 
29.66±0.4 
29.15±0.4 
 
0.08 
0.64 
Potassium (mg/d) 
Unadjusted  
Adjusted model 
 
29.05±0.5 
28.81±0.4 
 
28.93±0.5 
29.11±0.4 
 
28.06±0.5 
27.99±0.4 
 
28.96±0.5 
28.96±0.4 
 
28.91±0.4 
29.03±0.5 
 
0.86 
0.99 
-carotene (µg/d) 
Unadjusted  
Adjusted model 
 
29.22±0.5 
29.36±0.4 
 
28.75±0.4 
28.39±0.3 
 
28.96±0.5 
28.91±0.4 
 
28.70±0.5 
28.56±0.4 
 
28.29±0.5 
28.69±0.4 
 
0.20 
0.38 
ß-carotene (µg/d) 
Unadjusted  
Adjusted model 
 
29.11±0.5 
28.88±0.4 
 
28.60±0.4 
28.57±0.4 
 
29.09±0.5 
28.89±0.4 
 
28.38±0.5 
28.65±0.4 
 
28.72±0.5 
28.92±0.4 
 
0.51 
0.91 
Carotene (µg/d) 
Unadjusted  
Adjusted model 
 
28.86±0.5 
28.92±0.4 
 
28.84±0.4 
28.68±0.4 
 
29.06±0.4 
28.99±0.4 
 
28.38±0.5 
28.44±0.4 
 
28.78±0.5 
28.88±0.4 
 
0.67 
0.80 
Lutein (µg/d) 
Unadjusted  
Adjusted model 
 
29.04±0.5 
29.29±0.4 
 
29.05±0.5 
28.70±0.4 
 
28.93±0.4 
28.67±0.4 
 
28.19±0.5 
28.55±0.4 
 
28.70±0.5 
28.71±0.4 
 
0.29 
0.31 
Zeaxanthin (µg/d) 
Unadjusted  
Adjusted model 
 
28.41±0.5 
28.84±0.4 
 
28.98±0.4 
29.25±0.4 
 
28.84±0.5 
28.78±0.4 
 
28.11±0.4 
28.30±0.4 
 
29.57±0.5 
28.74±0.4 
 
0.32 
0.38 
ß-cryptoxanthin 
(µg/d) 
Unadjusted  
Adjusted model 
 
28.16±0.5 
28.69±0.4 
 
29.21±0.5 
29.40±0.4 
 
28.91±0.4 
28.94±0.4 
 
28.43±0.4 
28.48±0.4 
 
29.19±0.5 
28.40±0.4 
 
0.36 
0.21 
Lycopene  (µg/d) 
Unadjusted  
Adjusted model 
 
27.81±0.5 
28.39±0.4 
 
29.03±0.5 
29.43±0.4 
 
29.45±0.4 
28.98±0.4 
 
28.24±0.5 
28.02±0.4 
 
29.38±0.4 
29.09±0.4 
 
0.09 
0.98 
1 
All values are means and SEM for hand grip strength (kg) by quintiles of nutrient intake  
2
 Adjusted for age (years),
 
physical activity (inactive, moderately active, active), current smoking 
(yes/no), energy intake (kcal/d), height (m), menopausal status (premenopausal/postmenopausal) 
and for HRT use (no/yes)  
 
 118 
 
Stratification by age 
Table 3.7 The associations between nutrient intakes and hand grip strength (kg) in 132 
women, aged less than 50 years, from the TwinsUK cohort
1
 
 Hand grip strength (kg) 
Quintiles of 
nutrient intake 
Q1 Q2 Q3 Q4 Q5 
P for 
trend 
Vitamin C (mg/d) 
Unadjusted  
Adjusted model
2
 
 
32.87±0.9 
33.41±0.9 
 
33.21±1.3 
32.61±1.2 
 
31.00±0.9 
31.25±0.9 
 
32.19±1.2 
32.59±1.1 
 
34.72±1.2 
34.07±0.9 
 
0.40 
0.56 
Vitamin D (µg/d) 
Unadjusted  
Adjusted model 
 
34.28±0.9 
34.13±1.0 
 
31.77±1.1 
31.49±0.9 
 
33.66±0.9 
33.50±0.9 
 
31.72±0.9 
31.42±0.9 
 
32.95±1.5 
34.16±1.4 
 
0.48 
0.94 
Vitamin E (mg/d) 
Unadjusted  
Adjusted model 
 
33.73±0.9 
34.75±1.0 
 
33.58±0.8 
33.81±0.9 
 
32.69±1.2 
32.92±1.1 
 
34.05±1.1 
32.85±1.0 
 
30.36±1.2 
29.90±1.2 
 
0.05 
0.02 
Magnesium 
(mg/d) 
Unadjusted  
Adjusted model 
 
33.37±0.7 
33.09±1.2 
 
33.96±1.0 
33.72±0.9 
 
32.07±0.9 
31.60±0.9 
 
32.09±1.8 
33.64±1.5 
 
32.57±1.4 
32.41±1.7 
 
0.37 
0.60 
Selenium (µg/d) 
Unadjusted  
Adjusted model 
 
32.32±1.1 
31.51±1.2 
 
34.85±1.3 
33.66±1.0 
 
31.18±1.0 
31.25±0.9 
 
32.48±1.2 
33.71±1.1 
 
33.09±1.0 
33.64±1.1 
 
0.83 
0.36 
Potassium (mg/d) 
Unadjusted  
Adjusted model 
 
34.00±0.8 
34.08±1.0 
 
33.48±0.9 
33.11±0.9 
 
31.95±1.1 
31.47±1.1 
 
31.80±1.2 
32.37±1.2 
 
33.12±1.5 
33.05±1.7 
 
0.24 
0.46 
-carotene (µg/d) 
Unadjusted  
Adjusted model 
 
34.31±1.2 
33.97±0.9 
 
31.26±0.8 
31.75±0.7 
 
34.00±1.1 
32.97±1.2 
 
32.96±1.6 
32.55±1.4 
 
32.43±1.2 
33.58±1.0 
 
0.71 
0.93 
ß-carotene (µg/d) 
Unadjusted  
Adjusted model 
 
32.49±1.0 
32.50±0.8 
 
32.55±0.8 
32.88±0.6 
 
33.40±1.3 
32.40±1.2 
 
32.82±1.2 
32.64±1.2 
 
33.30±1.3 
34.12±1.1 
 
0.59 
0.39 
Carotene (µg/d) 
Unadjusted  
Adjusted model 
 
32.47±1.1 
32.74±0.9 
 
32.22±0.8 
32.35±0.6 
 
33.04±1.1 
32.74±1.0 
 
33.23±1.4 
32.91±1.2 
 
33.54±1.3 
33.69±1.1 
 
0.42 
0.49 
Lutein (µg/d) 
Unadjusted  
Adjusted model 
 
32.88±0.8 
33.44±0.9 
 
33.03±0.9 
32.96±0.7 
 
32.25±1.1 
32.15±1.0 
 
33.46±1.5 
33.56±1.4 
 
32.70±1.3 
32.23±1.1 
 
0.98 
0.67 
Zeaxanthin (µg/d) 
Unadjusted  
Adjusted model 
 
33.30±0.9 
32.15±0.8 
 
33.80±1.2 
34.19±1.1 
 
31.60±1.0 
31.19±1.0 
 
31.75±1.4 
33.33±1.3 
 
33.47±1.1 
33.59±1.0 
 
0.98 
0.43 
ß-cryptoxanthin 
(µg/d) 
Unadjusted  
Adjusted model 
 
32.40±1.0 
32.53±0.8 
 
32.45±1.4 
34.11±1.1 
 
31.88±0.9 
30.49±1.0 
 
32.33±1.2 
32.54±1.0 
 
34.20±1.0 
33.64±0.8 
 
0.21 
0.56 
Lycopene  (µg/d) 
Unadjusted  
Adjusted model 
 
33.14±1.2 
33.34±1.2 
 
33.58±1.3 
33.07±0.7 
 
32.79±1.2 
31.95±1.0 
 
33.58±1.0 
32.23±1.0 
 
31.71±1.1 
33.78±1.1 
 
0.40 
0.89 
1 
All values are means and SEM for hand grip strength (kg) by quintiles of nutrient intake  
2
 Adjusted for age (years),
 
physical activity (inactive, moderately active, active), current smoking 
(yes/no), energy intake (kcal/d), height (m), menopausal status (premenopausal/postmenopausal) 
and for HRT use (no/yes)   
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Table 3.8 The associations between nutrient intakes and hand grip strength (kg) in 817 
women, aged more than 50 years, from the TwinsUK cohort
1
 
 Hand grip strength (kg) 
Quintiles of 
nutrient intake 
Q1 Q2 Q3 Q4 Q5 
P for 
trend 
Vitamin C (mg/d) 
Unadjusted  
Adjusted model
2
 
 
27.97±0.5 
28.32±0.4 
 
28.95±0.5 
28.90±0.4 
 
28.51±0.5 
28.01±0.4 
 
27.11±0.4 
27.43±0.4 
 
28.04±0.4 
27.93±0.4 
 
0.23 
0.08 
Vitamin D (µg/d) 
Unadjusted  
Adjusted model 
 
28.43±0.5 
28.18±0.5 
 
28.26±0.5 
28.06±0.5 
 
28.29±0.5 
28.39±0.4 
 
27.34±0.5 
27.61±0.4 
 
28.29±0.4 
28.37±0.4 
 
0.44 
0.90 
Vitamin E (mg/d) 
Unadjusted  
Adjusted model 
 
27.76±0.5 
28.13±0.5 
 
28.57±0.5 
28.61±0.5 
 
28.19±0.5 
27.91±0.4 
 
27.80±0.4 
28.07±0.4 
 
28.32±0.4 
27.90±0.4 
 
0.80 
0.57 
Magnesium 
(mg/d) 
Unadjusted  
Adjusted model 
 
 
27.59±0.5 
27.94±0.5 
 
 
27.91±0.5 
27.91±0.5 
 
 
27.92±0.5 
27.88±0.4 
 
 
28.36±0.5 
28.60±0.4 
 
 
28.79±0.4 
28.25±0.5 
 
 
0.05 
0.39 
Selenium (µg/d) 
Unadjusted  
Adjusted model 
 
27.54±0.5 
27.90±0.4 
 
28.44±0.5 
28.40±0.4 
 
27.53±0.5 
27.90±0.5 
 
28.20±0.4 
27.95±0.4 
 
28.95±0.4 
28.46±0.4 
 
0.08 
0.74 
Potassium (mg/d) 
Unadjusted  
Adjusted model 
 
28.09±0.5 
27.91±0.5 
 
28.12±0.5 
28.40±0.5 
 
27.55±0.5 
27.41±0.4 
 
28.33±0.5 
28.58±0.4 
 
28.50±0.5 
28.33±0.5 
 
0.49 
0.62 
-carotene (µg/d) 
Unadjusted  
Adjusted model 
 
28.42±0.5 
28.59±0.5 
 
28.19±0.4 
27.94±0.4 
 
28.27±0.5 
28.20±0.4 
 
28.00±0.5 
27.86±0.4 
 
27.72±0.5 
27.99±0.4 
 
0.29 
0.37 
ß-carotene (µg/d) 
Unadjusted  
Adjusted model 
 
28.36±0.6 
28.34±0.5 
 
27.90±0.5 
27.89±0.4 
 
28.45±0.5 
28.24±0.4 
 
27.81±0.5 
27.99±0.4 
 
28.10±0.5 
28.15±0.4 
 
0.70 
0.85 
Carotene (µg/d) 
Unadjusted  
Adjusted model 
 
28.14±0.6 
28.34±0.5 
 
28.28±0.4 
28.09±0.4 
 
28.47±0.5 
28.33±0.4 
 
27.61±0.5 
27.76±0.4 
 
28.09±0.5 
28.09±0.4 
 
0.62 
0.56 
Lutein (µg/d) 
Unadjusted  
Adjusted model 
 
28.49±0.5 
28.66±0.4 
 
28.23±0.5 
28.00±0.4 
 
28.36±0.4 
28.10±0.4 
 
27.37±0.5 
27.74±0.4 
 
28.16±0.5 
28.09±0.4 
 
0.33 
0.33 
Zeaxanthin (µg/d) 
Unadjusted  
Adjusted model 
 
27.75±0.5 
28.27±0.4 
 
28.42±0.4 
28.47±0.4 
 
28.33±0.5 
28.31±0.4 
 
27.78±0.4 
27.60±0.4 
 
28.37±0.5 
27.94±0.5 
 
0.71 
0.27 
ß-cryptoxanthin 
(µg/d) 
Unadjusted  
Adjusted model 
 
 
27.53±0.5 
28.05±0.4 
 
 
28.80±0.5 
28.76±0.4 
 
 
28.62±0.5 
28.47±0.4 
 
 
27.71±0.5 
27.82±0.4 
 
 
27.88±0.4 
27.38±0.4 
 
 
0.80 
0.10 
Lycopene  (µg/d) 
Unadjusted  
Adjusted model 
 
27.12±0.5 
27.59±0.4 
 
28.53±0.5 
28.80±0.4 
 
28.88±0.5 
28.47±0.4 
 
27.21±0.5 
27.20±0.4 
 
28.88±0.4 
28.51±0.4 
 
0.12 
0.85 
1 
All values are means and SEM for hand grip strength (kg) by quintiles of nutrient intake  
2
 Adjusted for age (years),
 
physical activity (inactive, moderately active, active), current smoking 
(yes/no), energy intake (kcal/d), height (m), menopausal status (premenopausal/postmenopausal) 
and for HRT use (no/yes)   
 120 
 
Table 3.9 The associations between nutrient intakes and muscle quality (kg/kg) in 949 
women from the TwinsUK cohort aged 34-83 years
1
 
 Muscle quality (kg/kg) 
Quintiles of 
nutrient intake 
Q1 Q2 Q3 Q4 Q5 
P for 
trend 
Vitamin C (mg/d) 
Unadjusted  
Adjusted model
2
 
 
0.69±0.01 
0.69±0.01 
 
0.71±0.01 
0.71±0.01 
 
0.69±0.01 
0.68±0.01 
 
0.67±0.01 
0.67±0.01 
 
0.70±0.01 
0.69±0.01 
 
0.45 
0.27 
Vitamin D (µg/d) 
Unadjusted  
Adjusted model 
 
0.69±0.01 
0.69±0.01 
 
0.70±0.01 
0.69±0.01 
 
0.70±0.01 
0.70±0.01 
 
0.68±0.01 
0.68±0.01 
 
0.69±0.01 
0.69±0.01 
 
0.25 
0.86 
Vitamin E (mg/d) 
Unadjusted  
Adjusted model 
 
0.68±0.01 
0.68±0.01 
 
0.71±0.01 
0.70±0.01 
 
0.69±0.01 
0.69±0.01 
 
0.68±0.01 
0.69±0.01 
 
0.70±0.01 
0.70±0.01 
 
0.99 
0.77 
Magnesium 
(mg/d) 
Unadjusted  
Adjusted model 
 
 
0.69±0.01 
0.70±0.01 
 
 
0.69±0.01 
0.69±0.01 
 
 
0.68±0.01 
0.68±0.01 
 
 
0.69±0.01 
0.69±0.01 
 
 
0.69±0.01 
0.69±0.01 
 
 
0.80 
0.51 
Selenium (μg/d) 
Unadjusted  
Adjusted model 
 
0.68±0.01 
0.68±0.01 
 
0.71±0.01 
0.70±0.01 
 
0.67±0.01 
0.68±0.01 
 
0.70±0.01 
0.70±0.01 
 
0.70±0.01 
0.69±0.01 
 
0.28 
0.69 
Potassium (mg/d) 
Unadjusted  
Adjusted model 
 
0.70±0.01 
0.70±0.01 
 
0.71±0.01 
0.71±0.01 
 
0.67±0.01 
0.67±0.01 
 
0.69±0.01 
0.69±0.01 
 
0.68±0.01 
0.68±0.01 
 
0.20 
0.18 
-carotene (µg/d) 
Unadjusted  
Adjusted model 
 
0.69±0.01 
0.70±0.01 
 
0.69±0.01 
0.68±0.01 
 
0.69±0.01 
0.69±0.01 
 
0.69±0.01 
0.69±0.01 
 
0.68±0.01 
0.69±0.01 
 
0.66 
0.97 
ß-carotene (µg/d) 
Unadjusted  
Adjusted model 
 
0.69±0.01 
0.69±0.01 
 
0.69±0.01 
0.68±0.01 
 
0.69±0.01 
0.69±0.01 
 
0.69±0.01 
0.69±0.01 
 
0.69±0.01 
0.70±0.01 
 
0.82 
0.54 
Carotene (µg/d) 
Unadjusted  
Adjusted model 
 
0.69±0.01 
0.69±0.01 
 
0.69±0.01 
0.69±0.01 
 
0.69±0.01 
0.69±0.01 
 
0.69±0.01 
0.69±0.01 
 
0.69±0.01 
0.69±0.01 
 
0.99 
0.66 
Lutein (µg/d) 
Unadjusted  
Adjusted model 
 
0.70±0.01 
0.70±0.01 
 
0.69±0.01 
0.68±0.01 
 
0.70±0.01 
0.69±0.01 
 
0.69±0.01 
0.69±0.01 
 
0.69±0.01 
0.69±0.01 
 
0.57 
0.74 
Zeaxanthin (µg/d) 
Unadjusted  
Adjusted model 
 
0.69±0.01 
0.70±0.01 
 
0.69±0.01 
0.69±0.01 
 
0.70±0.01 
0.69±0.01 
 
0.68±0.01 
0.69±0.01 
 
0.70±0.01 
0.68±0.01 
 
0.64 
0.21 
ß-cryptoxanthin 
(µg/d) 
Unadjusted  
Adjusted model 
 
 
0.68±0.01 
0.68±0.01 
 
 
0.70±0.01 
0.70±0.01 
 
 
0.69±0.01 
0.70±0.01 
 
 
0.69±0.01 
0.69±0.01 
 
 
0.70±0.01 
0.68±0.01 
 
 
0.28 
0.59 
Lycopene  (µg/d) 
Unadjusted  
Adjusted model 
 
0.68±0.01 
0.68±0.01 
 
0.70±0.01 
0.71±0.01 
 
0.70±0.01 
0.70±0.01 
 
0.68±0.01 
0.67±0.01 
 
0.70±0.01 
0.70±0.01 
 
0.25 
0.84 
1 
All values are means and SEM for muscle quality (kg/kg) by quintiles of nutrient intake  
2
 Adjusted for age (years), physical activity (inactive, moderately active, active), current smoking 
(yes/no), energy intake (kcal/d), height (m), menopausal status (premenopausal/postmenopausal) 
and for HRT use (no/yes)   
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Stratification by age 
Table 3.10 The associations between nutrient intakes and muscle quality (kg/kg) in 132 
women aged less than 50 years from the TwinsUK cohort
1
 
 Muscle quality (kg/kg) 
Quintiles of 
nutrient intake 
Q1 Q2 Q3 Q4 Q5 
P for 
trend 
Vitamin C (mg/d) 
Unadjusted  
Adjusted model
2
 
 
0.76±0.02 
0.76±0.02 
 
0.82±0.03 
0.80±0.04 
 
0.74±0.02 
0.75±0.02 
 
0.74±0.03 
0.76±0.03 
 
0.80±0.03 
0.79±0.02 
 
0.88 
0.70 
Vitamin D (µg/d) 
Unadjusted  
Adjusted model 
 
0.78±0.03 
0.77±0.03 
 
0.75±0.03 
0.75±0.02 
 
0.80±0.03 
0.79±0.03 
 
0.78±0.02 
0.78±0.02 
 
0.73±0.04 
0.75±0.04 
 
0.57 
0.87 
Vitamin E (mg/d) 
Unadjusted  
Adjusted model 
 
0.81±0.02 
0.84±0.03 
 
0.79±0.02 
0.78±0.03 
 
0.77±0.03 
0.78±0.03 
 
0.74±0.03 
0.74±0.02 
 
0.74±0.03 
0.71±0.03 
 
0.026 
0.013 
Magnesium 
(mg/d) 
Unadjusted  
Adjusted model 
 
 
0.82±0.02 
0.84±0.03 
 
 
0.77±0.03 
0.78±0.03 
 
 
0.77±0.02 
0.77±0.02 
 
 
0.73±0.03 
0.75±0.03 
 
 
0.73±0.04 
0.70±0.04 
 
 
0.017 
0.043 
Selenium (μg/d) 
Unadjusted  
Adjusted model 
 
0.70±0.04 
0.69±0.03 
 
0.80±0.03 
0.80±0.03 
 
0.77±0.03 
0.77±0.03 
 
0.76±0.02 
0.76±0.02 
 
0.82±0.03 
0.82±0.03 
 
0.027 
0.023 
Potassium (mg/d) 
Unadjusted  
Adjusted model 
 
0.81±0.02 
0.84±0.03 
 
0.81±0.02 
0.79±0.02 
 
0.73±0.03 
0.73±0.03 
 
0.74±0.03 
0.74±0.03 
 
0.73±0.04 
0.71±0.05 
 
0.018 
0.026 
-carotene (µg/d) 
Unadjusted  
Adjusted model 
 
0.77±0.04 
0.78±0.03 
 
0.76±0.02 
0.76±0.02 
 
0.77±0.03 
0.75±0.03 
 
0.78±0.03 
0.78±0.03 
 
0.77±0.03 
0.79±0.03 
 
0.93 
0.58 
ß-carotene (µg/d) 
Unadjusted  
Adjusted model 
 
0.76±0.03 
0.76±0.03 
 
0.79±0.02 
0.78±0.02 
 
0.76±0.02 
0.74±0.03 
 
0.78±0.03 
0.76±0.03 
 
0.77±0.04 
0.80±0.03 
 
0.84 
0.54 
Carotene (µg/d) 
Unadjusted  
Adjusted model 
 
0.75±0.03 
0.76±0.03 
 
0.78±0.02 
0.77±0.01 
 
0.76±0.02 
0.75±0.02 
 
0.79±0.03 
0.78±0.03 
 
0.77±0.04 
0.79±0.03 
 
0.67 
0.50 
Lutein (µg/d) 
Unadjusted  
Adjusted model 
 
0.78±0.03 
0.80±0.03 
 
0.76±0.02 
0.77±0.02 
 
0.76±0.03 
0.76±0.03 
 
0.78±0.03 
0.77±0.03 
 
0.76±0.04 
0.75±0.03 
 
0.74 
0.35 
Zeaxanthin (µg/d) 
Unadjusted  
Adjusted model 
 
0.77±0.03 
0.77±0.03 
 
0.80±0.03 
0.81±0.03 
 
0.76±0.02 
0.74±0.02 
 
0.74±0.03 
0.77±0.04 
 
0.77±0.03 
0.77±0.02 
 
0.86 
0.85 
ß-cryptoxanthin 
(µg/d) 
Unadjusted  
Adjusted model 
 
 
0.75±0.03 
0.75±0.03 
 
 
0.78±0.03 
0.79±0.03 
 
 
0.73±0.03 
0.72±0.02 
 
 
0.78±0.03 
0.78±0.03 
 
 
0.78±0.02 
0.78±0.02 
 
 
0.37 
0.51 
Lycopene  (µg/d) 
Unadjusted  
Adjusted model 
 
0.76±0.03 
0.75±0.03 
 
0.79±0.03 
0.79±0.03 
 
0.75±0.03 
0.74±0.02 
 
0.77±0.02 
0.76±0.02 
 
0.77±0.03 
0.80±0.01 
 
0.88 
0.35 
1 
All values are means and SEM for muscle quality (kg/kg) by quintiles of nutrient intake  
2
 Adjusted for age (years), physical activity (inactive, moderately active, active), current smoking 
(yes/no), energy intake (kcal/d), height (m), menopausal status (premenopausal/postmenopausal) 
and for HRT use (no/yes)   
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Table 3.11 The associations between nutrient intakes and muscle quality (kg/kg) in 817 
women aged more than 50 years from the TwinsUK cohort
1
 
 Muscle quality (kg/kg) 
Quintiles of 
nutrient intake 
Q1 Q2 Q3 Q4 Q5 
P for 
trend 
Vitamin C (mg/d) 
Unadjusted  
Adjusted model
2
 
 
0.68±0.01 
0.68±0.01 
 
0.70±0.01 
0.70±0.01 
 
0.68±0.01 
0.67±0.01 
 
0.66±0.01 
0.66±0.01 
 
0.68±0.01 
0.68±0.01 
 
0.39 
0.20 
Vitamin D (µg/d) 
Unadjusted  
Adjusted model 
 
0.68±0.01 
0.68±0.01 
 
0.69±0.01 
0.68±0.01 
 
0.68±0.01 
0.68±0.01 
 
0.66±0.01 
0.67±0.01 
 
0.68±0.01 
0.68±0.01 
 
0.42 
0.95 
Vitamin E (mg/d) 
Unadjusted  
Adjusted model 
 
0.67±0.01 
0.66±0.01 
 
0.69±0.01 
0.68±0.01 
 
0.67±0.01 
0.67±0.01 
 
0.67±0.01 
0.68±0.01 
 
0.69±0.01 
0.69±0.01 
 
0.41 
0.26 
Magnesium 
(mg/d) 
Unadjusted  
Adjusted model 
 
 
0.67±0.01 
0.68±0.01 
 
 
0.68±0.01 
0.68±0.01 
 
 
0.68±0.01 
0.67±0.01 
 
 
0.68±0.01 
0.69±0.01 
 
 
0.69±0.01 
0.68±0.01 
 
 
0.32 
0.63 
Selenium (μg/d) 
Unadjusted  
Adjusted model 
 
0.69±0.01 
0.69±0.01 
 
0.67±0.01 
0.67±0.01 
 
0.66±0.01 
0.66±0.01 
 
0.67±0.01 
0.67±0.01 
 
0.70±0.01 
0.69±0.01 
 
0.62 
0.98 
Potassium (mg/d) 
Unadjusted  
Adjusted model 
 
0.68±0.01 
0.68±0.01 
 
0.69±0.01 
0.69±0.01 
 
0.67±0.01 
0.66±0.01 
 
0.68±0.01 
0.68±0.01 
 
0.68±0.01 
0.68±0.01 
 
0.95 
0.72 
-carotene (µg/d) 
Unadjusted  
Adjusted model 
 
0.68±0.01 
0.68±0.01 
 
0.67±0.01 
0.67±0.01 
 
0.68±0.01 
0.68±0.01 
 
0.68±0.01 
0.67±0.01 
 
0.67±0.01 
0.68±0.01 
 
0.76 
0.89 
ß-carotene (µg/d) 
Unadjusted  
Adjusted model 
 
0.68±0.01 
0.68±0.01 
 
0.67±0.01 
0.67±0.01 
 
0.68±0.01 
0.68±0.01 
 
0.68±0.01 
0.68±0.01 
 
0.68±0.01 
0.68±0.01 
 
0.90 
0.71 
Carotene (µg/d) 
Unadjusted  
Adjusted model 
 
0.68±0.01 
0.68±0.01 
 
0.68±0.01 
0.67±0.01 
 
0.68±0.01 
0.68±0.01 
 
0.68±0.01 
0.68±0.01 
 
0.68±0.01 
0.68±0.01 
 
0.94 
0.88 
Lutein (µg/d) 
Unadjusted  
Adjusted model 
 
0.68±0.01 
0.68±0.01 
 
0.67±0.01 
0.67±0.01 
 
0.69±0.01 
0.68±0.01 
 
0.67±0.01 
0.68±0.01 
 
0.68±0.01 
0.68±0.01 
 
0.72 
0.88 
Zeaxanthin (µg/d) 
Unadjusted  
Adjusted model 
 
0.68±0.01 
0.69±0.01 
 
0.67±0.01 
0.68±0.01 
 
0.69±0.01 
0.68±0.01 
 
0.68±0.01 
0.68±0.01 
 
0.67±0.01 
0.66±0.01 
 
0.95 
0.23 
ß-cryptoxanthin 
(µg/d) 
Unadjusted  
Adjusted model 
 
0.67±0.01 
0.67±0.01 
 
0.69±0.01 
0.69±0.01 
 
0.69±0.01 
0.69±0.01 
 
0.67±0.01 
0.68±0.01 
 
0.68±0.01 
0.66±0.01 
 
0.82 
0.40 
Lycopene  (µg/d) 
Unadjusted  
Adjusted model 
 
0.66±0.01 
0.67±0.01 
 
0.69±0.01 
0.69±0.01 
 
0.69±0.01 
0.69±0.01 
 
0.66±0.01 
0.66±0.01 
 
0.69±0.01 
0.68±0.01 
 
0.46 
0.70 
1 
All values are means and SEM for muscle quality (kg/kg) by quintiles of nutrient intake  
2 
Adjusted for age (years), physical activity (inactive, moderately active, active), current smoking 
(yes/no), energy intake (kcal/d), height (m), menopausal status (premenopausal/postmenopausal) 
and for HRT use (no/yes) 
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Chapter 4 
Associations between protein, essential 
amino acid intakes and indexes of muscle 
mass, muscle strength and muscle quality 
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4.0 Introduction 
Muscle is the main pool of protein in humans (containing 50 to 75 % of all 
proteins in the body) (Matthews 1999) and also serves as the main store of 
amino acids (Welle 1999). Moreover, it is evident that higher essential 
amino acid or protein availability can increase muscle protein synthesis and 
anabolic processes in both younger and older individuals (regardless of the 
fact that muscle mass decreases with age) (Paddon-Jones et al. 2004, 
Symons et al. 2007, Volpi et al. 2003). Among the essential amino acids, 
the branched-chain amino acids (BCAAs) (leucine, isoleucine and valine) 
have been suggested to regulate muscle protein synthesis in acute studies in 
both young and older adults (Fujita and Volpi 2006). Leucine, isoleucine 
and valine appear to directly stimulate muscle protein synthesis as they act 
as major carriers of nitrogen in the skeletal muscle tissue (Laviano et al. 
2005). Among the BCAAs leucine has been suggested as the most efficient 
for muscle protein synthesis. It has been shown that acutely, leucine (a 
insulin secretagogue) activates the mammalian target of rapamycin (mTOR) 
signalling pathway in skeletal muscle (Fujita et al. 2007). The mammalian 
target of rapamycin (mTOR) pathway is affected by amino acid deprivation. 
Therefore, BCAAs supplementation, specifically leucine, through activation 
of several proteins that are involved in the mTOR signalling pathway is able 
to modulate protein translation initiation and synthesis in muscle mass 
(Anthony et al. 2002, Dickinson et al. 2011). As decreased protein synthesis 
is a major risk factor in the aetiology of sarcopenia and muscle protein 
synthesis can be stimulated by dietary protein and essential amino acid 
intake (mainly BCAAs), it is of particular interest that studies examine the 
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influence of protein and essential amino acid intake on muscle mass, 
strength and muscle quality. 
Observational studies have focused on associations between total protein 
intake and muscle mass mainly in populations aged more than 50 years. One 
previous prospective study among women aged 75 ± 3 years found that 
those in the highest tertile of protein intake (> 87 g/d) had 5.3% and 6.6% 
higher whole body and appendicular lean mass, respectively compared with 
those in the lowest tertile (< 66g/d) after five years follow-up (Meng et al. 
2009). A second prospective study among participants aged 70-79 years 
from the Health, Aging and Body Composition study (Health ABC) showed 
that those in the highest quintile of energy-adjusted protein intake (18.2% 
protein as a percentage of energy) lost ≈ 40%  less lean mass and 
appendicular lean mass over three years follow-up, than did those in the 
lowest quintile (11.2% protein as a percentage of energy) (Houston et al. 
2008).  Similarly, an analysis of the China Health and nutrition Survey 
among older adults aged 50-70 years showed that those with higher protein 
intake (> 12.1% of energy) lost less midarm muscle area compared with 
those who had lower protein intake (< 10.4% of energy) over four years 
follow-up, although midarm muscle area is considered as an imprecise 
measure of lean mass (Stookey et al. 2005). Another previous prospective 
study found that energy-adjusted protein intake was a positive predictor of 
muscle mass over 2.6 years follow-up in participants aged 50 to 79 years, 
however no association was observed for muscle strength in this study 
(Scott et al. 2010). Only one previous cross-sectional study found that 
energy-adjusted protein intake was positively associated with grip strength 
 126 
 
in women aged 59 to 73 years, however in this study in the multivariate 
models limited adjustment for confounding factors was  considered, as only 
age, height and gender were included in the regression models but not other 
lifestyle factors that potentially influence the relationship (Robinson et al. 
2008).  
 
Two short-term intervention studies have examined the effects of protein 
intake on muscle mass and strength. One small study in 12 elderly women 
reported that after nine weeks those who consumed the higher protein diet 
0.92 g/kg body weight/day had maintained muscle mass and function 
compared with those with an intake of 0.45 g/kg body weight/day 
(Castaneda et al. 1995). The other small study was a 14-week controlled 
dietary intake trial (where all feeds were supplied to the volunteers) 
providing the RDA for protein intake of 0.8 g protein/kg body weight/d) 
among 10 men and women aged 55 to 77 years. The intervention had no 
effect on whole body composition (% body fat, fat free mass, protein and 
mineral mass)  although mid-thigh muscle area was decreased at the end of 
the 14 week intervention (Campbell et al. 2001). Nevertheless, 
supplementation with protein (after or separate from physical activity) in 
older subjects who frequently consumed adequate amounts of protein (  0.8 
g/kg body weight/day) did not further benefit  the improvements in muscle 
mass and strength due to exercise (Campbell 2007). 
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However, supplementation studies that used essential amino acids were 
beneficial for muscle mass and muscle strength (Borsheim et al. 2008, 
Scognamiglio et al. 2004, Solerte et al. 2008). Indeed, amino acid 
supplementation (essential and non essential mix consisting of: 3.8 g/d 
leucine, 2 g/d lysine, 1.9 g/d isoleusine, 1.9 g/d valine, 1.1 g/d threonine, 0.4 
g/d cysteine, 0.4 g/d histidine, 0.3 g/d phenylalanine, 0.2 g/d Methionine, 
0.1 g/d tyrosine, 0.1 g/d tryptophan) at 12.2 g/d, three times per day  for 
three months improved walking function by 48 m, and isometric hand grip 
strength by 2.6 kg in 44 sedentary and frail individuals aged > 65 years 
(Scognamiglio et al. 2004). Another small intervention study (n=12, males 
and females) showed that supplementation with two daily doses of 11 g/day 
of essential amino acids (including: 0.36 g/d histidine, 0.94 g/d isoleucine, 
3.95 g/d leucine, 1.88 g/d lysine, 0.39 g/d methionine, 0.51 g/d 
phenylalanine, 1.05 g/d threonine, 0.82 g/d valine) plus 1.10 g/d arginine, in 
the form of capsules, for 16 weeks, improved lean body mass by 0.60 kg, 
and muscle strength by 22.2 % on average, in glucose intolerant subjects 
with mean (±SD) age 67 (±5.6) years (Borsheim et al. 2008). However, 
these two studies were poorly controlled and were not randomised as pre-
intervention/baseline data were used as a “control” group, limiting the 
robustness of the study. In a third intervention study, among 41 subjects 
with sarcopenia aged 66-88 years, after supplementation with 8 g of 
essential amino acids twice per day for 18 months, significant increases in 
whole body lean mass were observed, although the magnitude of the effect  
was not reported (Solerte et al. 2008). These data suggest an association 
between amino acids and muscle mass and strength and provide evidence 
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for further long-term randomised controlled trials, with large sample sizes, a 
wider age range and appropriately powered for the end points of interest. 
 
Although prospective studies have shown associations between protein 
intake and muscle mass in older participants, available small scale 
intervention studies involving supplementation of protein have produced 
limited evidence of efficacy but supplementation studies involving essential 
amino acids have shown interesting preliminary results. Therefore, more 
long-term well designed dietary intervention trials needed to confirm and 
extend existing findings on the effectiveness of protein and amino acid 
supplementation on sarcopenia. Currently there is only one previous cross-
sectional study on associations between habitual dietary protein intake and 
muscle strength which also  adjusted for a limited number of potential 
confounding factors, including age, height and birth weight (Robinson et al. 
2008). Moreover, to our knowledge, there are currently no population 
studies on associations between habitual essential amino acid intake, 
including BCCAs, and muscle mass, strength and muscle quality in adult 
women. It is likely that this would provide a useful insight into the potential 
role of protein and essential amino acid intakes, to potentially maintain 
muscle mass, strength and muscle quality.    
 
4.1 Aims 
The aim of this study was to test the hypothesis that habitual dietary intake 
of protein and essential amino acids including BCCAs are associated with 
muscle mass as assessed by 3 indexes, fat free mass (FFM, kg), percentage 
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fat free mass (FFM%) and fat free mass index (FFMI, kg/m
2
), among 
women aged 18-79 years from the TwinsUK cohort (subset 1). An 
additional aim of this study was to examine the hypothesis that habitual 
dietary intake of these nutrients is associated with muscle strength assessed 
by hand grip strength (kg) and muscle quality (muscle strength divided by 
muscle mass) (kg/kg) in women aged 34-83 years from the TwinsUK cohort 
(subset 2). 
 
The nutrients included are presented in (Table 4.1). 
 
Table 4.1 Nutrients included in the analysis 
Macronutrients  Amino acids  
Protein (% Energy) Arginine (% Energy) 
 Glutamine (% Energy) 
 Histidine (% Energy) 
 Isoleucine (% Energy) 
 Leucine (% Energy) 
 Lysine (% Energy) 
 Methionine (% Energy) 
 Phenylalanine (% Energy/d) 
 Threonine (% Energy/d) 
 Tryptophan (% Energy/d) 
 Valine (% Energy) 
 
 
4.2 Covariate plan and statistical analysis 
All analyses were performed using STATA statistical software (version 
11.0; STATA Corp, USA). Means and standard deviations were calculated 
(Table 4.2) and quintiles of each nutrient intake were derived. Pearson 
correlation coefficients were used to evaluate associations between age and 
indexes of muscle mass, hand grip strength and muscle quality; protein and 
amino acid intakes and energy intake; and between height and hand grip 
strength. The analysis were performed treating twins as individuals as 
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previous studies have shown that participants from the TwinsUK registry 
were similar to age-matched singleton women in the distribution of common 
traits and outcomes (Andrew et al. 2001). Data on muscle mass were 
collected in 1996 (subset 1) and data on hand grip strength ten years later in 
2005 (subset 2). For the first subset, data on dietary intake (FFQ), body 
composition parameters, and other covariates were available for n = 2570 
women, aged 18 to 79 years, who had completed a food frequency 
questionnaire (FFQ) and attended for dual-energy X-ray absorptiometry 
(DEXA) scans between 1996 and 2000. For the second subset, data on 
dietary intake (FFQ), body composition parameters, and other covariates 
were available for n = 960 women, aged 34 to 83 years, who had completed 
a food frequency questionnaire (FFQ) and attended for hand grip strength 
measurements and DEXA scans between 2005 and 2008. 
 
Prior to conducting statistical analysis, an analysis plan with justification for 
each confounding factor in the multivariate model was developed as 
described in Chapter 2, section 2.2.5, p. 57. Multivariate regression analysis 
was used to assess associations between protein, essential amino acid 
intakes and indexes of muscle mass, hand grip strength and muscle quality 
using the robust cluster regression option in STATA. These models take 
into account clustering of individuals when calculating standard errors of 
the mean  (Richards et al. 2007) to ensure familial aggregation within twin 
pairs was accounted for. Amino acid intakes were expressed as percentage 
of energy intake rather than total intakes to enable comparisons between 
people with different total food and energy intakes. 
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As age has a great influence on muscle mass, strength, and muscle quality 
all analyses were adjusted for age (in years) (Cruz-Jentoft et al. 2010, Lynch 
et al. 1999). Even though we found no associations with the age stratified 
analyses in the previous chapter (Chapter 3) we chose a priori not to stratify 
by age for these analyses. Models were then also adjusted for physical 
activity and smoking status, as regular physical activity has been associated 
with increased muscle mass and strength (Frankel et al. 2006, Heath and 
Stuart 2002, Kuh et al. 2002, Roubenoff 2007, van Kan et al. 2008, Wolfe 
2006), and smoking has been shown to increase the risk of sarcopenia 
(Morse et al. 2007, Petersen et al. 2007, Wüst et al. 2008). Protein and 
amino acid intakes were expressed as percentage of total energy intake as 
protein and amino acid intakes are highly correlated with energy intake. 
Total body mass was included as a covariate in the evaluation of 
associations between diet and FFM and FFMI as described in Chapter 2, 
section 2.2.5 (Subset 1) (Tables 4.3, 4.4, 4.5). Additional adjustments were 
made for hand grip strength and muscle quality including height as it has 
been previously suggested as a determinant of grip strength (Jerome et al. 
1991, Neder et al. 1999); menopausal status (premenopausal or 
postmenopausal), as a number of studies have suggested that a loss in 
muscle strength has been associated with ageing in women (Carville et al. 
2006, Cooper et al. 2008, Greeves et al. 1999, Kurina et al. 2004); and 
hormone replacement therapy (HRT) (no or yes), as it has been previously 
shown that HRT use in postmenopausal women has been associated with 
improvements in muscle strength and muscle quality (Greising et al. 2009) 
(Subset 2) (Tables 4.6, 4.7). Moreover HRT use combined with physical 
 132 
 
exercise has been suggested to improve physical function (Sipila et al. 
2001).   
For Subset 1 (2570 women, aged 18-79 years), age was inversely correlated 
with FFM (r = -0.2, P < 0.001) and percentage FFM (r = -0.4, P < 0.001), 
but not with FFMI (r = -0.006, P = 0.76). Therefore, this analysis was not 
further stratified by age. However, since age was highly inversely correlated 
with hand grip strength (r = -0.5, P < 0.001) and muscle quality (r = -0.4, P 
< 0.001) analysis in Subset 2 (949 women, aged 34-83 years) was further 
stratified by age using two categories, less than 50 years and more than 50 
years. 
 
4.3 Results 
Descriptive characteristics of the two subsets of the TwinsUK cohort were 
very similar (Table 4.2) and were described in previous chapter (see 
Chapter 3, section 3.3, p. 82). Briefly, for the first subset (n = 2570 women) 
the mean (±SD) age of participants was 48.3 ± 12.7 years and mean (±SD) 
BMI was 24.9 ± 4.14 kg/m
2
. Mean FFM (±SD) was 39.6 ± 5.30 kg, 
percentage FFM 61.1 ± 6.49 %, and FFMI 15 ± 1.71 kg/m
2
 (Table 4.2). 
 
For the second subset (n = 960 women) the mean (±SD) age of participants 
was 59.1 ± 9.30 years and the mean (±SD) BMI was 26.5 ± 4.73 kg/m
2
. 
Mean hand grip strength was 28.8 ± 5.95 kg, and muscle quality [calculated 
as the ratio of hand grip strength (kg) to lean mass (kg)] was 0.69 ± 0.14 
kg/kg. Mean (±SD) percentage FM was 35.7 ± 6.28 %, and percentage FFM 
was 61.4 ± 6.18 % (Table 4.2).  
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Subset 1 (2570 women, 18-79 years) 
In the multivariate analyses, no significant associations were found between 
protein and essential amino acid intakes and FFM (Table 4.3) and FFMI 
(Table 4.5). Mean percentage FFM was inversely and significantly 
associated with protein and all essential amino acid intakes (P < 0.001 for 
all) (Table 4.4).  
 
Subset 2 (949 women, 34-83 years) 
After multivariate adjustment, no significant associations were found 
between protein and essential amino acid intakes and hand grip strength and 
muscle quality (Tables 4.6 and 4.7). Stratification by age did not alter these 
findings.   
 
4.4 Discussion 
In this study using two subsets from a large population-based sample of 
women aged 18 to 83 years, we evaluated the association between protein 
intake and essential amino acids present in the habitual diet and indexes of 
muscle mass, hand grip strength and muscle quality. Only one previous 
cross-sectional study has examined associations between habitual dietary 
protein intake and muscle strength which only adjusted for a few potential 
confounding factors including age, height and birth weight, and has focused 
only on older adults (Robinson et al. 2008). The current study cross-
sectionally evaluated the relationship between protein intake and a range of 
essential amino acids present in the habitual diet and estimates of muscle 
mass, hand grip strength and muscle quality in a cohort across a wide age 
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range. Significant negative associations were observed between protein and 
essential amino acid intakes and percentage FFM, even after adjustment for 
age, physical activity and smoking. However, although positive trends were 
observed between protein and essential amino acid intakes and FFMI the 
associations were not significant after multivariate adjustment for relevant 
confounders.  
 
Findings from the current study in relation to protein and FFMI were non-
significant. Nevertheless, previous prospective studies have reported that 
higher protein intake was associated with high muscle mass in people older 
than 50 years, even though supplementation studies have not always shown 
improvements on muscle mass (Campbell et al. 2001, Campbell 2007, 
Castaneda et al. 1995, Houston et al. 2008, Meng et al. 2009, Scott et al. 
2010, Stookey et al. 2005). It has been suggested that this might be partly 
explained due to the fact that in supplementation studies providing protein-
containing supplements older individuals tended to simultaneously reduce 
their energy intake to accommodate the supplement (Fiatarone Singh et al. 
2000). 
 
The recommended dietary allowance for protein intake (0.8/kg body 
weight/d) in US studies may not be sufficient for the preservation of muscle 
mass (Campbell et al. 2001, Campbell 2007). Therefore, the Society for 
Sarcopenia, Cachexia, and Wasting Disease in their review in 2010 has 
recommended that older adults may ingest between 1.0 and 1.5 g/kg/d of 
protein for the preservation of muscle mass, however this report does not 
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clarify the corresponding age range for the suggested dietary protein intake 
(Morley et al. 2010). In the TwinsUK cohort the average protein intake per 
kg body weight per day was 1.3 g protein/kg/d which was higher compared 
to the average recommended nutrient intake (0.8 g protein/kg/d) for the UK 
population in accordance with the UK report of the Panel on Dietary 
Reference Values of the Committee on Medical Aspects of Food Policy. 
Therefore there is a need of more robust recommendations on protein intake 
for optimal skeletal muscle health in both young and older adults.  
 
In the TwinsUK study the range of protein intake was higher compared to 
previous studies. The mean daily protein intake in the TwinsUK participants 
in the lowest quintile was 13.1 ± 1.1 % energy (or 69.9 ± 19.3 g/d) and in 
the highest quintile 20.5 ± 1.6 % energy (or 88.2 ± 22.8 g/d). These intakes 
were higher than previous prospective cohort studies where protein intake in 
the lowest tertile was 66 g/d and in the highest tertile 87 g/d (Meng et al. 
2009), or protein intake in the lowest quintile was 11.2 % and in the highest 
quintile 18.2 % (Houston et al. 2008), or lower protein intake was < 10.4 % 
energy and higher protein intake was > 12.1 % energy (Stookey et al. 2005) 
highlighting the differences in dietary protein intake between different 
populations. Moreover, all the above cohorts focused on older participants 
(aged 70 years and over) compared to the first subset of the TwinsUK 
cohort which included younger individuals (18-79 years), with subsequently 
higher muscle mass. Therefore, the wide age range of our cohort including 
younger adults may explain the lack of associations between muscle mass 
and protein intake in the current analysis. 
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The mechanisms involved in the relationship between protein intake and 
FFMI cannot be specifically identified due to the nature of our study which 
assessed associations. Nevertheless, current recommendations for the 
preservation of muscle mass, as mentioned above, are limited to older adults 
(Morley et al. 2010), and studies that have shown that protein intake was 
associated with higher muscle mass were limited to participants older than 
50 years. These data suggest that higher protein intake may be more 
beneficial for individuals with very low protein intakes, as in older persons 
the metabolic efficiency is decreased and they require higher protein intake 
for protein synthesis compared to younger persons (Rattan 2010).    
 
The lack of association observed in the current study in relation to 
percentage FFM may be due to the fact that lifestyle factors other than 
protein intake may have a greater influence on muscle mass. Interestingly, 
in this cohort, the effect of age per 10 years [β coefficient (SEM): - 1.8 
(0.11), P < 0.001] and of physical activity [β coefficient (SEM): 1.4 (0.19), 
P < 0.001] was four and three times greater respectively of that of protein 
intake [β coefficient (SEM): - 0.5 (0.09), P < 0.001] on percentage FFM. 
Also, although protein intake was positively associated with FFMI when 
adjusted for age, physical activity, smoking and total body mass, the 
association was not significant. This might be because the effect of age per 
10 years [β coefficient (SEM): - 0.2 (0.03), P < 0.001] and of physical 
activity [β coefficient (SEM): 0.2 (0.05), P < 0.001] was 10 times greater of 
that of protein intake [β coefficient (SEM): 0.02 (0.02), P = 0.389] on FFMI. 
These findings are supported by a number of studies that have previously 
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described negative associations between age and fat free mass (Coin et al. 
2008, Ding et al. 2007, Guo et al. 1999, Janssen et al. 2000, Kyle et al. 
2001, Kyle et al. 2006), and positive associations between regular physical 
activity and fat free mass (Frankel et al. 2006, Roubenoff 2007, van Kan et 
al. 2008, Wolfe 2006). 
 
Yet, although protein is important for maintenance of muscle mass, it is 
likely that other dietary factors such as a more alkaline diet may also be 
relevant. Indeed, a recent cross-sectional study in a subset of women from 
the TwinsUK cohort has reported significant positive associations between a 
more alkaline diet consisting of fruits and vegetables that supply adequate 
amounts of potassium and magnesium and muscle mass indexes as opposed 
to foods with potential acidogenic profile (including meats, fish, eggs, dairy 
and cereals) (Welch et al. 2012).  
 
In the second subset (949 women, 34-83 years) of the current study no 
associations were observed between protein intake and hand grip strength 
and muscle quality. Only one previous cross-sectional study found that 
energy-adjusted protein intake was associated with higher grip strength in 
women aged 59 to 73 years of the Hertfordshire cohort, however this study 
was adjusted for limited confounding factors and included only age, height 
and gender in the multivariate models and no other lifestyle factors that 
potentially influence the relationship between protein intake and grip 
strength, such as physical activity, smoking, menopausal status and use of 
HRT (Robinson et al. 2008). It should be acknowledged that the 
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Hertfordshire cohort was an older cohort with lower mean hand grip 
strength (26.5 kg) compared to the second subset (see above) of the current 
analysis which included younger individuals (34-83 years), with as expected 
higher hand grip strength (28.8 kg). The TwinsUK cohort was younger and 
therefore it might be less likely to observe changes in muscle strength in 
association with diet. This might be due to the fact that other lifestyle 
factors than protein intake may be more important to muscle strength and 
muscle quality. Interestingly, in our cohort, age and physical activity had a 
greater effect on hand grip strength compared to protein intake. For 
example, after multivariate adjustment for relevant confounders, the effect 
of age [ß coefficient (SEM): -0.27 (0.02), P < 0.001] was 135 times greater 
of that of protein intake [ß coefficient (SEM): 0.002 (0.12), P = 0.985] on 
hand grip strength. The size of the association was similar for muscle 
quality and these findings are supported by a number of studies which have 
previously described decreases in muscle strength and muscle quality with 
age (as outlined in Chapter 1, sections 1.2.3, p.14 and 1.2.5, p.16).  
 
Although protein supplementation has not always been proven to be 
successful for the preservation of muscle mass, there is a growing body of 
evidence suggesting that essential amino acids are more efficient at acutely 
stimulating muscle protein synthesis not only in older but in younger adults 
(Fujita and Volpi 2006). Indeed, in an acute (single dose) study among 10 
younger (41.1 ± 8.0 years) and 10 older (70.2 ± 5.1 years) apparently 
healthy adults, ingestion of 113 g lean beef containing 30 g protein and 12 g 
of essential amino acids (1.17 g histidine, 1.04 g isoleucine, 1.98 g leucine, 
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2.40 g lysine, 0.85 g phenylalanine, 1.33 g threonine, 1.37 g valine and 0.95 
g arginine), increased muscle protein synthesis by 50% in both the younger 
and older adult groups (Symons et al. 2007). Among the essential amino 
acids BCAAs (leucine, isoleucine and valine) appear to directly stimulate 
muscle protein synthesis as they act as major carriers of amino nitrogen in 
the skeletal muscle tissue (Laviano et al. 2005). Among the BCAAs leucine 
has been suggested as the most efficient for muscle protein synthesis. 
Leucine is able to activation signalling pathways (such as the mTOR 
signalling pathway) that lead to increased protein translation initiation and 
synthesis in muscle mass (Anthony et al. 2002, Dickinson et al. 2011, Fujita 
et al. 2007). Although in vitro studies suggested that with ageing rat muscle 
may not be stimulated by the effects of a normal postprandial concentration 
of leucine (200 µmol/L) (Dardevet et al. 2000),  more recently it has been 
shown that leucine supplementation as part of a normal mixed nutrient meal 
may improve muscle protein synthesis in both animal (Rieu et al. 2007) and 
human studies (Rieu et al. 2006). Notably, mechanistic studies in old rats 
have shown that supplementation of milk protein with high leucine content 
(β-lactoglobulin, 14.5 % leucine) significantly increased muscle protein 
synthesis compared to supplementation of milk protein with low leucine 
content (casein, 10 % leucine) (Rieu et al. 2007). Also, an acute study 
among 20 healthy males aged 69.9 ± 0.8 years showed that after ingestion of 
a meal supplemented with leucine postprandial muscle protein synthesis was 
improved. The supplemented leucine diet contained 10.2 kcal, 0.4 g protein 
(casein), 1.3 g carbohydrate (dextrine maltose) and 0.36 g fat (vegetable oil) 
per kg body weight, and supplemented with leucine (0.052 g/kg) in order to 
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increase plasma leucine to twice the normal postprandial leucine 
concentration, and isoleucine (0.0116 g/kg) and valine (0.0068 g/kg) in 
order to maintain plasma levels of isoleucine and valine at normal 
postprandial levels. The control diet was supplemented only with alanine 
(0.071 g/kg) which did not affect protein synthesis, but provided the same 
amount of nitrogen as the leucine diet (Rieu et al. 2006). Given the existing 
evidence, the Society for Sarcopenia, Cachexia, and Wasting Disease in 
their review in 2010 has recommended that older adults may consume a 
leucine-enriched balanced amino acid supplement for the preservation of 
muscle mass, however this report does not clarify a suggested dose (Morley 
et al. 2010). 
 
Surprisingly, we found a significant negative associations between essential 
amino acid intake and percentage FFM and positive associations were 
observed between essential amino acid intake and FFMI that were not 
significant after multivariate adjustments for a number of relevant 
confounders, although the FFQ included a range of foods that contribute to 
essential amino acid intake, such as soy products (tofu, soy milk), meat and 
fish, dairy and eggs, as well as legumes. However, it needs to be considered 
that the range of protein intake in this analysis was higher compared to other 
studies that included older participants (Houston et al. 2008, Meng et al. 
2009) than in our study. This may suggest that higher protein intake may be 
more beneficial for individuals with very low protein intakes, as in older 
persons the metabolic efficiency is decreased and they require higher 
protein intake for protein synthesis compared to younger persons (Rattan 
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2010) as mentioned earlier. It is not clear why the significant associations 
that were found were in opposite directions and further investigation is 
required. However, there are currently no observational studies in the 
population on associations between habitual amino acid intake and measures 
of muscle mass, strength and muscle quality. Moreover, there is a paucity of 
studies assessing recommended amino acid dietary intakes in the UK. 
Therefore, comparison of our results with other observational studies was 
not possible.         
 
4.5 Strengths and limitations 
The strengths of this study include the large sample size and the wide age 
range of participants, as most previous studies on sarcopenia examined older 
individuals (Robinson SM et al. 2008, Scott et al. 2010). Moreover, this was 
the first study that directly compared associations between protein and 
essential amino acid intake and indexes of muscle mass, muscle strength 
and muscle quality in a large cohort. Body composition was objectively 
assessed by DEXA scans and an objective measurement was used to assess 
muscle strength, which allowed calculation of muscle quality. A further 
strength is that it is evident that notable changes in skeletal muscle mass 
may occur earlier in adult life (between 30 and 45 years of age), and it is 
important to examine dietary associations with muscle mass in individuals 
of all ages (Cesari and Pahor 2008, Janssen et al. 2000). 
Our study also has a number of limitations. The cross-sectional nature of the 
study limits causal inference, but enables us to generate hypotheses 
regarding associations between protein and amino acid intakes and indexes 
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of muscle mass, strength and muscle quality based on plausible 
mechanisms. Although all analyses were adjusted for potential lifestyle 
factors that influence the relationship between intake of protein, amino acids 
and muscle mass, residual confounding could not be ruled out because of 
the observational nature of the study. In addition, as in all observational 
studies, measurement error in self-reported dietary intakes is inevitable. It is 
also widely acknowledged that the use of FFQs for measuring dietary intake 
has its own limitations related to memory errors, they provide relative than 
absolute intake, they introduce bias due to over- or under-reporting, and 
they may introduce systematic errors as preparation methods are 
inadequately considered (McNeill et al. 2009). Also, FFQs measure food 
intake over a period of one year and reflect the habitual diet over this period 
of time but not lifetime dietary habits (Teucher et al. 2007). Nevertheless, 
the FFQ used in the current study was previously compared with a 7-day 
weighed record in the EPIC Norfolk study, and although the two approaches 
to measure dietary intake were different, both methods identified similar 
intakes of macronutrients when these expressed as percentage of total 
energy intake (Bingham et al. 2001). Also, the food frequency questionnaire 
(FFQ) used was previously validated in the EPIC cohort against urinary 
nitrogen for protein intake (McKeown et al. 2001, Tucker et al. 1999, 
Welch et al. 2006). The aim of the current study design was to examine 
associations between dietary intake and a health outcomes, therefore 
ranking individuals according to dietary intake was the most important 
factor and for this the use of FFQ was a suitable approach (Molag et al. 
2007). However, further work is needed to investigate if our findings are 
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replicated in a male population of the same country or in populations from 
different ethnic backgrounds.   
 
4.6 Concluding remarks   
This is one of the first studies to examine simultaneously cross-sectional 
associations between protein and essential amino acid and muscle mass, 
muscle strength and muscle quality in a cohort including younger adults. 
We believe this to be the first study to investigate cross-sectional 
associations between muscle mass and amino acid intake. Additionally, our 
findings extended the existing literature by evaluating the relative 
importance of diet in terms of nutrients and muscle quality to further 
understand the association between muscle strength and muscle mass with 
diet. 
 
In conclusion, a significant negative association was observed between 
protein and essential amino acid intake and percentage FFM. However, 
positive associations were observed between protein and essential amino 
acid intake and FFMI that were not significant after multivariate 
adjustments for a number of relevant confounders. This was possibly due to 
the fact that other factors, such as physical activity may be more important 
than diet in terms of protein and essential amino acids to preserve or 
maintain muscle mass (as assessed by the relevant indexes) and improve or 
maintain muscle strength and quality. Yet, it is likely that other nutrients in 
the diet associated with more alkalinogenic foods may also be relevant for 
muscle mass as recently shown in a subset of the TwinsUK cohort (Welch et 
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al. 2012). Also, it is possible that a longer period of study (such as a 
longitudinal study design) might be a more suitable approach to detect 
associations between dietary intake of protein and amino acids and 
estimates of muscle mass over time. Although in prospective studies higher 
protein intake has been associated with increased lean mass (Houston et al. 
2008, Meng et al. 2009, Scott et al. 2010, Stookey et al. 2005) and muscle 
strength (Robinson et al. 2008) in older people,  it is not yet clear whether 
supplementation studies with protein alone or in combination with physical 
activity may enhance muscle mass and strength as a number of studies have 
not been successful (Borst 2004, Campbell et al. 2001, Campbell 2007). 
However, both short-term (Borsheim et al. 2008, Scognamiglio et al. 2004, 
Solerte et al. 2008) and acute studies using essential amino acid 
supplementation (Symons et al. 2007) and particularly additional 
supplementation with the BCAA leucine (Rieu et al. 2007, Rieu et al. 2006) 
have proven promising for muscle protein synthesis and the maintenance of 
muscle mass and muscle strength. 
 
However, further work is needed from both epidemiological and long-term 
randomised controlled dietary trials to confirm and extend existing findings. 
From a public health perspective, findings from the current study may help 
to improve the knowledge and understanding of the effects of protein and 
amino acids on muscle mass and strength in a healthy population. These 
findings contribute towards the debate on protein and amino acid 
requirements in healthy non frail individuals. Although no associations 
observed for protein, amino acids and muscle mass, strength and quality in 
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this study we wanted to further explore interactions between micronutrients, 
protein and amino acid intake and markers of chronic inflammation 
including CRP in the TwinsUK cohort (see Chapter 6).  
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TABLES 
Table 4.2 Baseline characteristics of female participants from the TwinsUK cohort
1 
Characteristic 
Subset 1 
N=2570, 18-79 yrs 
Subset 2 
N=949, 34-83 yrs 
Age (y) 48.3±12.7
 
59.1±9.30
 
Weight (kg) 65.6±11.2
 
69.2±12.5
 
Height (cm) 162±6.07
 
162±5.93
 
BMI (kg/m
2
) 24.9±4.14
 
26.5±4.73
 
Fat mass (kg) 22.7±7.87
 
25.2±8.30
 
Fat mass % 33.9±7.17
 
35.7±6.28
 
Fat free mass (kg) 39.6±5.30
 
42.0±5.47
 
Fat free mass % 61.1±6.49
 
61.4±6.18
 
Fat free mass index (kg/m
2
) 15.0±1.71
 
16.0±1.82 
Hand grip strength (kg)  28.8±5.95 
Muscle quality (kg/kg)  0.69±0.14 
Physical activity % 
Inactive 
Moderate 
Active 
 
21.9 
53.9 
24.2 
 
39.6 
34.2 
26.2 
Smoking history % 
Never 
Current 
Former 
 
50.2 
18.2 
31.6
 
 
Current smoking % 
Yes 
No 
  
9.79 
90.21 
Menopausal status % 
Premenopausal   
Postmenopausal  
  
10.3 
89.7 
Hormone replacement therapy % 
Yes  
No 
  
9.38 
90.63 
Dietary components 
  
Total energy intake (kcal/d) 1979±524
 
1917±637
 
Protein intake (g/d) 81.3±21.6 83.6±27.4 
Protein intake (% Energy) 16.6±2.62 17.7±2.76 
Amino acids   
Arginine (g/d) 4.44±1.27 4.78±1.63 
Arginine (% Energy) 0.91±0.19 1.01±0.19 
Glutamine (g/d) 16.1±4.43 15.9±5.21 
Glutamine (% Energy) 3.30±0.58 3.35±0.47 
Histidine (g/d) 2.29±0.65 2.39±0.80 
Histidine (% Energy) 0.47±0.09 0.51±0.09 
Isoleucine (g/d) 3.83±1.06 3.94±1.31 
Isoleucine (% Energy) 0.79±0.16 0.83±0.15 
Leucine (g/d) 6.49±1.78 6.63±2.18 
Leucine (% Energy) 1.33±0.26 1.40±0.23 
Lysine (g/d) 5.52±1.63 5.88±2.04 
Lysine (% Energy) 1.14±0.27 1.25±0.27 
Methionine (g/d) 1.87±0.53 1.95±0.66 
Methionine (% Energy) 0.38±0.08 0.41±0.08 
Phenylalanine (g/d) 3.83±1.04 3.88±1.26 
Phenylalanine (% Energy/d) 0.78±0.15 0.82±0.13 
Threonine (g/d) 3.34±0.94 3.46±1.16 
Threonine (% Energy/d) 0.69±0.14 0.73±0.13 
Tryptophan (g/d) 1.05±0.29 1.07±0.35 
Tryptophan (% Energy/d) 0.22±0.04 0.23±0.04 
Valine (g/d) 4.53±1.24 4.62±1.52 
Valine (% Energy) 0.93±0.18 0.98±0.16 
1
 Values are means ± standard deviations (mean ± SDs) unless indicated 
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Table 4.3 The associations between protein, essential amino acid intakes and fat free 
mass (kg) in 2570 women from the TwinsUK cohort aged 18-79 years
1
 
 Fat free mass (kg) 
Quintiles of 
nutrient intake 
Q1 Q2 Q3 Q4 Q5 
P for 
trend 
Energy intake 
(kcal/d)  
Unadjusted  
Adjusted model
2
 
 
 
39.1±0.3 
38.9±0.2 
 
 
39.8±0.3 
39.8±0.2 
 
 
39.5±0.2 
39.7±0.2 
 
 
39.4±0.2 
39.7±0.2 
 
 
40.4±0.3 
40.1±0.2 
 
 
0.010 
0.002 
Protein (%E) 
Unadjusted  
Adjusted model 
 
39.5±0.3 
39.6±0.2 
 
39.9±0.3 
40.0±0.2 
 
39.6±0.3 
39.8±0.2 
 
39.5±0.3 
39.4±0.2 
 
39.6±0.3 
39.4±0.2 
 
0.76 
0.12 
Arginine (%E) 
Unadjusted  
Adjusted model 
 
39.6±0.3 
39.8±0.2 
 
39.8±0.3 
39.7±0.2 
 
39.7±0.2 
39.8±0.2 
 
39.6±0.2 
39.6±0.2 
 
39.6±0.3 
39.4±0.2 
 
0.86 
0.23 
Glutamine (%E) 
Unadjusted  
Adjusted model 
 
39.4±0.3 
39.5±0.2 
 
39.7±0.2 
39.9±0.2 
 
39.5±0.2 
39.6±0.2 
 
39.8±0.3 
39.7±0.2 
 
39.7±0.2 
39.5±0.2 
 
0.27 
0.68 
Histidine (%E) 
Unadjusted  
Adjusted model 
 
39.5±0.2 
39.8±0.2 
 
39.6±0.3 
39.6±0.2 
 
39.6±0.2 
39.8±0.2 
 
39.7±0.2 
39.7±0.2 
 
39.7±0.3 
39.4±0.2 
 
0.57 
0.41 
Isoleucine (%E) 
Unadjusted  
Adjusted model 
 
39.4±0.3 
39.7±0.2 
 
39.7±0.3 
39.8±0.2 
 
39.7±0.2 
39.7±0.2 
 
39.7±0.3 
39.7±0.2 
 
39.7±0.3 
39.4±0.2 
 
0.59 
0.31 
Leucine (%E) 
Unadjusted  
Adjusted model 
 
39.5±0.3 
39.7±0.2 
 
39.6±0.3 
39.8±0.2 
 
39.7±0.2 
39.6±0.2 
 
39.8±0.3 
39.7±0.2 
 
39.6±0.3 
39.4±0.2 
 
0.64 
0.30 
Lysine (%E) 
Unadjusted  
Adjusted model 
 
39.5±0.3 
39.7±0.2 
 
39.9±0.3 
40.0±0.2 
 
39.6±0.2 
39.7±0.2 
 
39.6±0.2 
39.5±0.2 
 
39.6±0.3 
39.3±0.2 
 
0.72 
0.09 
Methionine (%E) 
Unadjusted  
Adjusted model 
 
39.6±0.3 
39.7±0.2 
 
39.6±0.3 
39.8±0.2 
 
39.7±0.2 
39.7±0.2 
 
39.8±0.3 
39.7±0.2 
 
39.6±0.3 
39.3±0.2 
 
0.86 
0.25 
Phenylalanine 
(%E) 
Unadjusted  
Adjusted model 
 
 
39.4±0.3 
39.6±0.2 
 
 
39.7±0.3 
39.8±0.2 
 
 
39.7±0.2 
39.8±0.2 
 
 
39.8±0.3 
39.7±0.2 
 
 
39.6±0.2 
39.3±0.2 
 
0.60 
0.41 
Threonine (%E) 
Unadjusted  
Adjusted model 
 
39.6±0.3 
39.7±0.2 
 
39.7±0.3 
39.8±0.2 
 
39.7±0.2 
39.8±0.2 
 
39.5±0.2 
39.5±0.2 
 
39.7±0.3 
39.4±0.2 
 
0.82 
0.20 
Tryptophan (%E) 
Unadjusted  
Adjusted model 
 
39.3±0.2 
39.5±0.2 
 
39.7±0.2 
39.9±0.2 
 
39.6±0.2 
39.5±0.2 
 
39.8±0.3 
39.8±0.2 
 
39.8±0.3 
39.4±0.2 
 
0.25 
0.76 
Valine (%E) 
Unadjusted  
Adjusted model 
 
39.4±0.3 
39.6±0.2 
 
39.8±0.3 
39.9±0.2 
 
39.8±0.2 
39.8±0.2 
 
39.7±0.3 
39.7±0.2 
 
39.5±0.2 
39.3±0.2 
 
0.76 
0.33 
1 
Values are means and SEM for fat free mass (kg) by quintiles of nutrient intake. 
2
 Adjusted for age (years), physical activity (inactive, moderately active, active), smoking history 
(never, former, current), and total body mass (kg).   
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Table 4.4 The associations between protein, essential amino acid intakes and 
percentage fat free mass in 2570 women from the TwinsUK cohort aged 18-79 years
1
 
 Percentage fat free mass 
Quintiles of 
nutrient intake 
Q1 Q2 Q3 Q4 Q5 
P for 
trend 
Energy intake 
(kcal/d)  
Unadjusted  
Adjusted model
2
 
 
 
60.47±0.3 
60.48±0.3 
 
 
61.09±0.3 
61.17±0.3 
 
 
61.15±0.3 
61.28±0.3 
 
 
61.49±0.3 
61.64±0.3 
 
 
61.27±0.3 
60.90±0.3 
 
 
0.04 
0.19 
Protein (%E) 
Unadjusted  
Adjusted model 
 
62.36±0.3 
61.87±0.3 
 
61.76±0.3 
61.53±0.3 
 
61.31±0.3 
61.31±0.3 
 
60.42±0.3 
60.65±0.3 
 
59.61±0.3 
60.11±0.3 
 
<0.001 
<0.001 
Arginine (%E) 
Unadjusted  
Adjusted model 
 
62.44±0.3 
61.98±0.3 
 
61.64±0.3 
61.30±0.3 
 
61.15±0.3 
61.19±0.3 
 
60.78±0.3 
60.95±0.3 
 
59.46±0.3 
60.05±0.3 
 
<0.001 
<0.001 
Glutamine (%E) 
Unadjusted  
Adjusted model 
 
61.92±0.3 
61.73±0.3 
 
61.83±0.3 
61.62±0.3 
 
61.34±0.3 
61.24±0.3 
 
60.58±0.3 
60.66±0.3 
 
59.80±0.3 
60.21±0.3 
 
<0.001 
<0.001 
Histidine (%E) 
Unadjusted  
Adjusted model 
 
62.79±0.3 
62.26±0.3 
 
61.44±0.3 
61.18±0.3 
 
61.20±0.3 
61.27±0.3 
 
60.59±0.3 
60.74±0.3 
 
59.44±0.3 
60.02±0.3 
 
<0.001 
<0.001 
Isoleucine (%E) 
Unadjusted  
Adjusted model 
 
62.53±0.3 
62.09±0.3 
 
61.94±0.3 
61.60±0.3 
 
61.08±0.3 
61.06±0.3 
 
60.62±0.3 
60.80±0.3 
 
59.30±0.3 
59.92±0.3 
 
<0.001 
<0.001 
Leucine (%E) 
Unadjusted  
Adjusted model 
 
62.63±0.3 
62.16±0.3 
 
61.57±0.3 
61.42±0.3 
 
61.14±0.3 
61.07±0.3 
 
60.66±0.3 
60.77±0.3 
 
59.48±0.3 
60.05±0.3 
 
<0.001 
<0.001 
Lysine (%E) 
Unadjusted  
Adjusted model 
 
62.65±0.3 
61.99±0.3 
 
61.76±0.3 
61.62±0.3 
 
61.06±0.3 
61.16±0.3 
 
60.42±0.3 
60.57±0.3 
 
59.58±0.3 
60.13±0.3 
 
<0.001 
<0.001 
Methionine (%E) 
Unadjusted  
Adjusted model 
 
62.47±0.3 
61.93±0.3 
 
61.99±0.3 
61.75±0.3 
 
60.89±0.3 
61.00±0.3 
 
60.62±0.3 
60.74±0.3 
 
59.49±0.3 
60.06±0.3 
 
<0.001 
<0.001 
Phenylalanine 
(%E) 
Unadjusted  
Adjusted model 
 
 
62.21±0.3 
61.83±0.3 
 
 
61.80±0.3 
61.54±0.3 
 
 
61.42±0.3 
61.33±0.3 
 
 
60.59±0.3 
60.74±0.3 
 
 
59.45±0.3 
60.02±0.3 
 
 
<0.001 
<0.001 
Threonine (%E) 
Unadjusted  
Adjusted model 
 
62.71±0.3 
62.14±0.3 
 
61.82±0.3 
61.57±0.3 
 
61.01±0.3 
61.07±0.3 
 
60.55±0.3 
60.72±0.3 
 
59.37±0.3 
59.96±0.3 
 
<0.001 
<0.001 
Tryptophan 
(%E) Unadjusted  
Adjusted model 
 
62.37±0.3 
61.88±0.3 
 
62.11±0.3 
61.88±0.3 
 
60.96±0.3 
60.89±0.3 
 
60.71±0.3 
60.87±0.3 
 
59.33±0.3 
59.96±0.3 
 
<0.001 
<0.001 
Valine (%E) 
Unadjusted  
Adjusted model 
 
62.46±0.3 
61.98±0.3 
 
61.93±0.3 
61.62±0.3 
 
61.06±0.3 
61.03±0.3 
 
60.52±0.3 
60.72±0.3 
 
59.49±0.3 
60.11±0.3 
 
<0.001 
<0.001 
1 
Values are means and SEM for percentage fat free mass by quintiles of nutrient intake.  
2
 Adjusted for age (years), physical activity (inactive, moderately active, active), and smoking 
history (never, former, current). 
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Table 4.5 The associations between protein, essential amino acid intakes and fat free 
mass index (kg/m
2
) in 2570 women from the TwinsUK cohort aged 18-79 years
1
 
 Fat free mass index (kg/m
2
) 
Quintiles of 
nutrient intake 
Q1 Q2 Q3 Q4 Q5 
P for 
trend 
Energy intake 
(kcal/d)  
Unadjusted  
Adjusted model
2
 
 
 
14.97±0.1 
14.92±0.1 
 
 
15.09±0.1 
15.09±0.1 
 
 
14.98±0.1 
15.01±0.1 
 
 
14.99±0.1 
15.08±0.1 
 
 
15.07±0.1 
15.02±0.1 
 
 
0.68 
0.50 
Protein (%E) 
Unadjusted  
Adjusted model 
 
14.87±0.1 
14.82±0.1 
 
15.01±0.1 
14.98±0.1 
 
14.95±0.1 
14.96±0.1 
 
15.07±0.1 
15.09±0.1 
 
15.21±0.1 
15.27±0.1 
 
0.004 
0.37 
Arginine (%E) 
Unadjusted  
Adjusted model 
 
14.95±0.1 
15.05±0.1 
 
14.93±0.1 
14.95±0.1 
 
15.03±0.1 
15.05±0.1 
 
14.98±0.1 
14.97±0.1 
 
15.24±0.1 
15.10±0.1 
 
0.02 
0.62 
Glutamine (%E) 
Unadjusted  
Adjusted model 
 
14.85±0.1 
14.91±0.1 
 
14.99±0.1 
15.06±0.1 
 
14.91±0.1 
14.95±0.1 
 
15.12±0.1 
15.07±0.1 
 
15.25±0.1 
15.12±0.1 
 
<0.001 
0.07 
Histidine (%E) 
Unadjusted  
Adjusted model 
 
14.90±0.1 
15.03±0.1 
 
14.94±0.1 
14.96±0.1 
 
14.95±0.1 
14.99±0.1 
 
15.09±0.1 
15.06±0.1 
 
15.23±0.1 
15.08±0.1 
 
0.002 
0.37 
Isoleucine (%E) 
Unadjusted  
Adjusted model 
 
14.86±0.1 
14.98±0.1 
 
14.94±0.1 
15.00±0.1 
 
15.00±0.1 
15.00±0.1 
 
15.12±0.1 
15.09±0.1 
 
15.22±0.1 
15.07±0.1 
 
0.001 
0.29 
Leucine (%E) 
Unadjusted  
Adjusted model 
 
14.88±0.1 
14.99±0.1 
 
14.93±0.1 
14.99±0.1 
 
15.00±0.1 
15.00±0.1 
 
15.15±0.1 
15.09±0.1 
 
15.21±0.1 
15.07±0.1 
 
0.001 
0.26 
Lysine (%E) 
Unadjusted  
Adjusted model 
 
14.94±0.1 
15.05±0.1 
 
14.95±0.1 
14.99±0.1 
 
15.01±0.1 
15.03±0.1 
 
14.99±0.1 
14.95±0.1 
 
15.22±0.1 
15.08±0.1 
 
0.022 
0.93 
Methionine (%E) 
Unadjusted  
Adjusted model 
 
14.91±0.1 
15.01±0.1 
 
14.92±0.1 
14.99±0.1 
 
15.00±0.1 
14.99±0.1 
 
15.05±0.1 
15.02±0.1 
 
15.23±0.1 
15.09±0.1 
 
0.004 
0.42 
Phenylalanine 
(%E) 
Unadjusted  
Adjusted model 
 
 
14.89±0.1 
14.98±0.1 
 
 
14.96±0.1 
15.01±0.1 
 
 
14.91±0.1 
14.95±0.1 
 
 
15.15±0.1 
15.11±0.1 
 
 
15.20±0.1 
15.06±0.1 
 
 
0.002 
0.29 
Threonine (%E) 
Unadjusted  
Adjusted model 
 
14.90±0.1 
15.02±0.1 
 
14.94±0.1 
15.00±0.1 
 
14.96±0.1 
14.97±0.1 
 
15.05±0.1 
15.03±0.1 
 
15.26±0.1 
15.10±0.1 
 
0.002 
0.42 
Tryptophan 
(%E) Unadjusted  
Adjusted model 
 
14.83±0.1 
14.93±0.1 
 
14.96±0.1 
15.06±0.1 
 
14.93±0.1 
14.92±0.1 
 
15.14±0.1 
15.12±0.1 
 
15.26±0.1 
15.09±0.1 
 
<0.001 
0.11 
Valine (%E) 
Unadjusted  
Adjusted model 
 
14.85±0.1 
14.96±0.1 
 
14.93±0.1 
15.00±0.1 
 
15.01±0.1 
15.00±0.1 
 
15.15±0.1 
15.12±0.1 
 
15.17±0.1 
15.04±0.1 
 
0.001 
0.26 
1 
Values are means and SEM for fat free mass index by quintiles of nutrient intake.  
2
 Adjusted for age (years), physical activity (inactive, moderately active, active), smoking history 
(never, former, current), and total body mass (kg).   
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Table 4.6 The associations between protein, essential amino acid intakes and hand grip 
strength (kg) in 949 women from the TwinsUK cohort aged 34-83 years
1
 
 Hand grip strength (kg) 
Quintiles of 
nutrient intake 
Q1 Q2 Q3 Q4 Q5 
P for 
trend 
Energy intake 
(kcal/d)  
Unadjusted  
Adjusted model
2
 
 
 
28.7±0.4 
28.7±0.3 
 
 
28.7±0.5 
28.9±0.4 
 
 
28.2±0.4 
28.3±0.4 
 
 
29.1±0.5 
28.9±0.4 
 
 
29.3±0.4 
29.1±0.4 
 
 
0.26 
0.61 
Protein (%E) 
Unadjusted  
Adjusted model 
 
29.2±0.4 
28.8±0.2 
 
28.2±0.5 
28.8±0.2 
 
29.4±0.4 
28.8±0.2 
 
28.6±0.4 
28.7±0.2 
 
28.5±0.5 
28.8±0.2 
 
0.42 
0.88 
Arginine (%E) 
Unadjusted  
Adjusted model 
 
28.68±0.4 
28.77±0.4 
 
29.13±0.4 
28.86±0.4 
 
28.95±0.4 
28.85±0.3 
 
28.74±0.5 
28.75±0.4 
 
28.41±0.5 
28.68±0.4 
 
0.51 
0.81 
Glutamine (%E) 
Unadjusted  
Adjusted model 
 
28.96±0.4 
28.55±0.3 
 
28.58±0.5 
28.76±0.4 
 
28.66±0.4 
28.84±0.4 
 
29.07±0.4 
28.95±0.3 
 
28.64±0.5 
28.82±0.4 
 
0.91 
0.55 
Histidine (%E) 
Unadjusted  
Adjusted model 
 
29.16±0.4 
28.47±0.4 
 
28.72±0.4 
29.22±0.4 
 
28.76±0.4 
28.39±0.4 
 
28.76±0.4 
28.69±0.3 
 
28.51±0.5 
29.15±0.4 
 
0.38 
0.64 
Isoleucine (%E) 
Unadjusted  
Adjusted model 
 
29.24±0.4 
28.91±0.4 
 
28.29±0.5 
28.01±0.4 
 
29.16±0.4 
29.36±0.4 
 
28.65±0.4 
28.62±0.4 
 
28.58±0.5 
29.00±0.4 
 
0.50 
0.51 
Leucine (%E) 
Unadjusted  
Adjusted model 
 
29.30±0.4 
29.00±0.3 
 
27.90±0.5 
27.78±0.4 
 
29.47±0.4 
29.69±0.3 
 
28.56±0.4 
28.35±0.4 
 
28.68±0.5 
29.09±0.4 
 
0.69 
0.54 
Lysine (%E) 
Unadjusted  
Adjusted model 
 
28.97±0.4 
28.63±0.4 
 
29.04±0.5 
28.86±0.4 
 
28.64±0.4 
28.96±0.4 
 
28.56±0.5 
28.35±0.4 
 
28.70±0.5 
29.11±0.4 
 
0.47 
0.71 
Methionine (%E) 
Unadjusted  
Adjusted model 
 
29.38±0.4 
28.85±0.4 
 
28.27±0.5 
28.38±0.3 
 
28.88±0.4 
29.02±0.4 
 
29.14±0.5 
28.98±0.4 
 
28.25±0.5 
28.69±0.4 
 
0.35 
0.82 
Phenylalanine 
(%E) 
Unadjusted  
Adjusted model 
 
 
29.06±0.4 
28.91±0.3 
 
 
28.38±0.4 
28.09±0.4 
 
 
29.39±0.5 
29.49±0.4 
 
 
28.71±0.4 
28.55±0.4 
 
 
28.38±0.5 
28.87±0.4 
 
 
0.48 
0.76 
Threonine (%E) 
Unadjusted  
Adjusted model 
 
29.42±0.4 
28.93±0.4 
 
28.43±0.4 
28.34±0.4 
 
29.00±0.5 
29.04±0.4 
 
28.57±0.4 
28.59±0.4 
 
28.49±0.5 
29.01±0.4 
 
0.24 
0.74 
Tryptophan (%E) 
Unadjusted  
Adjusted model 
 
29.32±0.4 
29.05±0.3 
 
28.20±0.5 
28.05±0.4 
 
29.13±0.4 
29.05±0.4 
 
29.01±0.4 
29.02±0.3 
 
28.25±0.5 
28.74±0.4 
 
0.35 
0.77 
Valine (%E) 
Unadjusted  
Adjusted model 
 
29.21±0.4 
28.87±0.3 
 
28.26±0.5 
28.05±0.4 
 
29.58±0.4 
29.60±0.3 
 
28.28±0.5 
28.26±0.4 
 
28.59±0.5 
29.14±0.4 
 
0.40 
0.53 
1 
Values are means and SEM for hand grip strength (kg) by quintiles of nutrient intake.  
2
 Adjusted for age (years),
 
physical activity (inactive, moderately active, active), current smoking 
(yes/no), height (m), menopausal status (premenopausal/postmenopausal) and for HRT use 
(yes/no).  
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Table 4.7 The associations between protein, essential amino acid intakes and muscle 
quality (kg/kg) in 949 women from the TwinsUK cohort aged 34-83 years
1
 
 Muscle quality (kg/kg) 
Quintiles of 
nutrient intake 
Q1 Q2 Q3 Q4 Q5 
P for 
trend 
Energy intake 
(kcal/d)  
Unadjusted  
Adjusted model
2
 
 
 
0.69±0.01 
0.69±0.01 
 
 
0.69±0.01 
0.69±0.01 
 
 
0.68±0.01 
0.68±0.01 
 
 
0.69±0.01 
0.69±0.01 
 
 
0.70±0.01 
0.70±0.01 
 
 
0.93 
0.93 
Protein (%E) 
Unadjusted  
Adjusted model 
 
0.70±0.01 
0.69±0.01 
 
0.69±0.01 
0.69±0.01 
 
0.71±0.01 
0.70±0.01 
 
0.69±0.01 
0.69±0.01 
 
0.67±0.01 
0.68±0.01 
 
0.14 
0.18 
Arginine (%E) 
Unadjusted  
Adjusted model 
 
0.69±0.01 
0.69±0.01 
 
0.70±0.01 
0.70±0.01 
 
0.70±0.01 
0.70±0.01 
 
0.69±0.01 
0.69±0.01 
 
0.67±0.01 
0.68±0.01 
 
0.31 
0.24 
Glutamine (%E) 
Unadjusted  
Adjusted model 
 
0.69±0.01 
0.69±0.01 
 
0.70±0.01 
0.70±0.01 
 
0.69±0.01 
0.69±0.01 
 
0.70±0.01 
0.70±0.01 
 
0.67±0.01 
0.67±0.01 
 
0.37 
0.28 
Histidine (%E) 
Unadjusted  
Adjusted model 
 
0.69±0.01 
0.69±0.01 
 
0.70±0.01 
0.70±0.01 
 
0.70±0.01 
0.70±0.01 
 
0.68±0.01 
0.68±0.01 
 
0.68±0.01 
0.68±0.01 
 
0.12 
0.22 
Isoleucine (%E) 
Unadjusted  
Adjusted model 
 
0.69±0.01 
0.69±0.01 
 
0.69±0.01 
0.69±0.01 
 
0.71±0.01 
0.71±0.01 
 
0.69±0.01 
0.69±0.01 
 
0.67±0.01 
0.68±0.01 
 
0.20 
0.37 
Leucine (%E) 
Unadjusted  
Adjusted model 
 
0.69±0.01 
0.70±0.01 
 
0.69±0.01 
0.68±0.01 
 
0.71±0.01 
0.71±0.01 
 
0.68±0.01 
0.68±0.01 
 
0.68±0.01 
0.68±0.01 
 
0.21 
0.28 
Lysine (%E) 
Unadjusted  
Adjusted model 
 
0.69±0.01 
0.69±0.01 
 
0.70±0.01 
0.70±0.01 
 
0.70±0.01 
0.70±0.01 
 
0.68±0.01 
0.68±0.01 
 
0.68±0.01 
0.68±0.01 
 
0.16 
0.23 
Methionine (%E) 
Unadjusted  
Adjusted model 
 
0.70±0.01 
0.69±0.01 
 
0.69±0.01 
0.69±0.01 
 
0.71±0.01 
0.71±0.01 
 
0.69±0.01 
0.69±0.01 
 
0.67±0.01 
0.67±0.01 
 
0.09 
0.20 
Phenylalanine 
(%E) 
Unadjusted  
Adjusted model 
 
 
0.69±0.01 
0.69±0.01 
 
 
0.69±0.01 
0.69±0.01 
 
 
0.71±0.01 
0.71±0.01 
 
 
0.69±0.01 
0.69±0.01 
 
 
0.67±0.01 
0.67±0.01 
 
 
0.20 
0.27 
Threonine (%E) 
Unadjusted  
Adjusted model 
 
0.70±0.01 
0.69±0.01 
 
0.70±0.01 
0.69±0.01 
 
0.70±0.01 
0.70±0.01 
 
0.68±0.01 
0.68±0.01 
 
0.67±0.01 
0.68±0.01 
 
0.05 
0.19 
Tryptophan (%E) 
Unadjusted  
Adjusted model 
 
0.70±0.01 
0.70±0.01 
 
0.68±0.01 
0.68±0.01 
 
0.70±0.01 
0.70±0.01 
 
0.70±0.01 
0.70±0.01 
 
0.67±0.01 
0.67±0.01 
 
0.15 
0.24 
Valine (%E) 
Unadjusted  
Adjusted model 
 
0.70±0.01 
0.70±0.01 
 
0.69±0.01 
0.68±0.01 
 
0.71±0.01 
0.71±0.01 
 
0.68±0.01 
0.68±0.01 
 
0.67±0.01 
0.68±0.01 
 
0.10 
0.29 
1 
Values are means and SEM for muscle quality (kg/kg) by quintiles of nutrient intake.  
2
 Adjusted for age (years), physical activity (inactive, moderately active, active), current smoking 
(yes/no), height (m), menopausal status (premenopausal/postmenopausal) and for HRT use 
(yes/no).   
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Chapter 5 
Associations between diet quality scores and 
indexes of muscle mass, muscle strength and 
muscle quality 
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5.0 Introduction  
As an extension to previous chapters, this chapter will investigate the 
association of the “whole diet” assessed by diet quality scores and indexes 
of muscle mass, muscle strength and muscle quality. In recent years, it has 
been suggested that research should focus on examining associations 
between the “whole” diet, alongside individual foods and nutrients, and 
health status, as we consume a variety of foods and not simply nutrients. It 
is proposed that benefits in health status are more likely to be determined by 
the total diet Jacobs et al. (2009). Diet scores examining dietary patterns of 
a population have been used for more than a decade as an approach to study 
the relationship between overall diet and chronic disease risk, because they 
examine nutrient and food synergies and interactions instead of examining a 
single nutrient’s effect in relation to disease risk (Hu 2002). Growing 
evidence has also related these diet scores to overall health (Maynard M et 
al. 2004). Diet scores are either based on government based 
recommendations for a healthy diet or designed to allow comparisons with 
other eating patterns such as the Mediterranean diet or the Dietary Approach 
to Stop Hypertension diet (Fung et al. 2008, Huijbregts et al. 1997a, 
Patterson et al. 1994, Trichopoulou et al. 1995). Diet scores are used to 
establish adherence of an individual or a group’s diet to a particular dietary 
pattern (i.e. Mediterranean, Western-style diet, prudent diet, etc) and to 
evaluate the intake of a group of foods rather than the intake of a single 
nutrient or dietary component.  
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The role of the “whole” diet, in terms of healthy eating patterns, on 
sarcopenia has not yet been researched. To date, 20 distinct indexes have 
been constructed to assess overall diet quality (Waijers et al. 2007). The 
current analysis, investigating associations between indices of muscle mass 
and diet will focus on five predefined diet scores, the Mediterranean Diet 
score (MDS), the Healthy Diet Indicator (HDI), the Diet Quality Index 
(DQI), the Alternate Healthy Eating Index (AHEI), and the DASH-style 
score (based on the Dietary Approaches to Stop Hypertension diet), which 
have been used widely in relation to health outcomes previously (de Koning 
et al. 2011, Kourlaba and Panagiotakos 2009). Overall, better diet quality as 
assessed previously by these five most common scores has been associated 
with reduced mortality and decreased cardiovascular disease risk (Akbaraly 
et al. 2011, Fung et al. 2008, Huijbregts et al. 1997a, McCullough et al. 
2002, Patterson et al. 1994, Seymour et al. 2003, Trichopoulou et al. 1995).  
 
Diet quality, as assessed by the five predefined diet scores, may also be 
important for the conservation of muscle mass because they consist of food 
components high in nutrients which are known to be involved in the biology 
of human muscle (Frassetto et al. 1998, Song et al. 2007, Song et al. 2005), 
reduce oxidative stress and inflammation (Ferrucci et al. 2005, Helmersson 
et al. 2005, Young et al. 2004) or have been shown to be beneficial in 
supplementation studies (Børsheim et al. 2008, Dawson-Hughes 2008, 
Scognamiglio et al. 2004). In addition, higher adherence to the selected diet 
scores has also been associated with lower levels of plasma inflammation 
 155 
 
markers (Chrysohoou et al. 2004, Dai et al. 2008, Fung et al. 2008, Fung et 
al. 2005), which further adds to the rationale for their selection.   
 
Currently the most popular approach to evaluate the overall diet is the 
Mediterranean dietary pattern. The Mediterranean diet, as assessed by the 
Mediterranean Diet Score (MDS) has been associated with low mortality 
risk (Serra-Majem et al. 2004, Trichopoulou et al. 2003, Trichopoulou et al. 
1995, Trichopoulou et al. 2005). The MDS has been defined as a pattern 
high in plant foods (fruits, vegetables, cereals, beans, nuts and seeds), 
minimally processed, seasonally fresh foods, olive oil (as the main source of 
dietary lipids) low to moderate consumption of dairy products (mainly 
cheese and yogurt), low frequency and amounts of red meat, and low to 
moderate consumption of wine (Trichopoulou et al. 1995).  
 
Higher adherence to the MDS has also been inversely associated with 
oxidative stress as measured by the ratio of reduced to oxidised glutathione 
(GSH/GSSG) (Dai et al. 2008) and with lower plasma levels of 
inflammation markers (such as Interleukin-6, C-reactive protein, 
homocysteine, fibrinogen and lower white blood cell counts) (Chrysohoou 
et al. 2004, Dai et al. 2008, Fung et al. 2005). Therefore, this type of diet 
consisting of components, such as fruit and vegetables (which represent the 
greatest source of vitamins C and E, magnesium, potassium and 
carotenoids) may be beneficial for muscle mass by potentially preventing 
the damage to muscle tissue from reactive oxygen species and further 
preventing the expression of pro-inflammatory cytokines in muscle (Block 
 156 
 
et al. 2009, Frassetto et al. 1997, Meng and Yu 2010, Sebastian et al. 1994, 
Walston et al. 2006).   
 
The HDI was developed in the Netherlands according to the World Health 
Organization’s guidelines for the prevention of chronic disease (Huijbregts 
et al. 1997) and has been reported to be inversely associated with all-cause 
mortality in men from 3 European countries, including the Netherlands, and 
in Dutch elderly men but not in women (Huijbregts et al. 1997a, Huijbregts 
et al. 1997b).  
 
The DQI was developed based on U.S. recommendations and has been 
positively related to lower risk of all-cause mortality and CVD mortality, 
but not cancer mortality and also to markers of inflammation and 
endothelial dysfunction (Fung et al. 2005, Patterson et al. 1994, Seymour et 
al. 2003, Waijers et al. 2007). However, both the HDI and DQI scores 
account for high intakes in fruit and vegetables, nuts, and whole grains. It 
has been well established that higher intakes of nuts, whole grains and fruit 
and vegetables, as well as dietary patterns high in these food components 
are associated with lower concentrations of inflammation markers 
(Chrysohoou et al. 2004, Esmaillzadeh et al. 2006, Esposito et al. 2004, 
Fung et al. 2001, Lopez-Garcia et al. 2004, Lutsey et al. 2007, Nettleton et 
al. 2006). Also, these two scores account for low intakes of saturated fatty 
acids. Saturated fatty acid intakes, and dietary patterns high in saturated 
fatty acids have been significantly and positively associated with markers of 
inflammation (Esmaillzadeh et al. 2007, Fung et al. 2001, Lopez-Garcia et 
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al. 2004, Nettleton et al. 2006). Therefore, greater adherence to both these 
scores, which assign positive scoring at high intakes of fruits and 
vegetables, nuts and whole grains, as well as negative scoring at high 
intakes of saturated fatty acids may positively contribute to a better 
inflammatory status and potentially benefit muscle mass. 
 
The AHEI was devised as an improved version of the original Healthy 
Eating Index (HEI). The HEI was originally developed in 1995 from the 
U.S. Department of Agriculture to measure adherence to the Dietary 
Guidelines for Americans and the food guide pyramid (My Pyramid), and 
was later revised in 2005 (HEI-2005), according to the updated Dietary 
guidelines for Americans (U.S. Health and Human Services and U.S. 
Department of Agriculture, 2005 (Kennedy et al. 1995). The AHEI has been 
inversely associated with major biomarkers of chronic disease risk, 
essentially CVD risk, including lower concentrations of markers of 
inflammation and endothelial dysfunction (Fung et al. 2005). Additionally, 
the AHEI assigns a high score to items such as fruits and vegetables, nuts 
and protein, particularly from fish and poultry and dietary fiber that are high 
in nutrients that have been previously shown to be associated with muscle 
mass, such as vitamins C and E, potassium, magnesium, carotenoids, protein 
and essential amino acids (see Chapters 3, section 3.0 and 4, section 4.0).  
 
The DASH-style score is based on the Dietary Approaches to Stop 
Hypertension diet, and monitors adherence to the DASH style pattern. The 
DASH diet has been shown to be related to lower blood pressure and low-
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density lipoprotein cholesterol in intervention trials (Appel et al. 1997, 
Obarzanek et al. 2001, Sacks et al. 2001). Also, greater adherence to the 
DASH-style score has been associated with lower risk of coronary heart 
disease, stroke and lower plasma levels of inflammation markers CRP and 
IL-6 (Fung et al. 2008). In addition, the dietary components of the DASH-
style diet, such as fruits, nuts, vegetables, and whole grains are major 
sources of vitamins C and E, potassium, magnesium and carotenoids that 
have been previously shown to be associated with muscle mass (see 
Chapters 3, section 3.0). Also, lean meats may provide amounts of dietary 
protein and essential amino acids important for muscle mass (Aubertin-
Leheudre and Adlercreutz 2009). Therefore, adherence to this score may be 
important for the conservation of muscle mass. 
 
In summary, there are limited studies on associations between habitual diet 
(mainly based on nutrient intake) and muscle mass, muscle strength and no 
studies on muscle quality (Robinson SM et al. 2008, Scott et al. 2010). In 
addition, three of the measures described above, the MDS, the HDI and the 
DQI have also been negatively associated with body composition (mainly 
BMI) and with the risk of obesity in adults (Boynton et al. 2008, Mendez et 
al. 2006, Panagiotakos et al. 2006, Quatromoni et al. 2006, Schröder et al. 
2004). To date, there is only one previous longitudinal study among 690 
men and women aged 65 years and over which has examined associations 
between the Mediterranean diet score and muscle strength, as a component 
of frailty over 6 years follow-up, although no associations were observed 
(Talegawkar et al. 2012). However, there are currently no studies examining 
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the relative importance of the overall diet quality on body composition, 
specifically muscle mass indexes, hand grip strength and muscle quality. It 
is likely that this would provide a useful insight into the potential role of the 
overall diet to maintain muscle mass, muscle strength and muscle quality. 
 
5.1 Aims of the study 
The aim of this study was to derive five predefined diet scores, the MDS, 
HDI, DQI, AHEI, and DASH-style score, and examine the hypothesis that 
greater adherence to these five scores is associated with greater muscle mass 
as assessed by three indexes, fat free mass (FFM, kg), percentage fat free 
mass (FFM%) and fat free mass index (FFMI, kg/m
2
), among women aged 
18-79 years from the TwinsUK cohort (Subset 1). An additional aim of this 
study was to examine the hypothesis that greater adherence to the five 
derived diet scores was associated with greater muscle strength assessed by 
hand grip strength (kg) and muscle quality (muscle strength divided by 
muscle mass) (kg/kg) in women aged 34-83 years from the TwinsUK cohort 
(Subset 2).   
 
5.2 Covariate plan and statistical analysis 
All analyses were performed using STATA statistical software (version 
11.0; STATA Corp, USA). The analyses were performed treating twins as 
individuals as previous studies have shown that participants from the 
TwinsUK registry were similar to age-matched singleton women in the 
distribution of common traits and outcomes (Andrew et al. 2001). Muscle 
quality was calculated as the ratio of hand grip strength (kg) to lean mass 
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(kg). Robust cluster regression was applied for continuous variables (such as 
age, energy intake, and total body mass) and Chi-square test for categorical 
variables (such as physical activity and smoking history), to test for 
differences in participant baseline characteristics across quartiles of the 
derived diet scores (Table 5.2). One-way ANOVA was applied to test for 
differences in nutrient intakes across quartiles of the five derived diet scores 
(Table 5.3). The percentage difference in intake of different food groups 
between extreme quartiles of the five derived diet scores was calculated as: 
(quartile 1 - quartile 4 / quartile 1)* 100 for Subset 1 (Figure 5.1) and 
Subset 2 (Figure 5.2). 
 
Prior to statistical analysis an analysis plan with justification for all 
confounding factors in the multivariate model was developed as described 
in Chapter 2, section 2.2.4, p.. Multivariate regression analysis was used to 
assess associations between the five derived diet scores and indexes of 
muscle mass, hand grip strength and muscle quality using the robust cluster 
regression option in STATA. These models take into account clustering of 
individuals when calculating standard errors of the mean  (Richards et al. 
2007) to ensure familial aggregation within twin pairs was accounted for.  
 
As age has a great influence on muscle mass, strength, and muscle quality 
all analyses were adjusted for age (in years) (Cruz-Jentoft et al. 2010, Lynch 
et al. 1999). Models were then also adjusted for physical activity and 
smoking status, as regular physical activity has been associated with 
increased muscle mass and strength (Frankel et al. 2006, Heath and Stuart 
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2002, Kuh et al. 2002, Roubenoff 2007, van Kan et al. 2008, Wolfe 2006), 
and smoking has been shown to increase the risk of sarcopenia (Morse et al. 
2007, Petersen et al. 2007, Wüst et al. 2008). Energy intake (kcal/d) was 
also included in the multivariate models for the MDS (Trichopoulou et al. 
1995), AHEI (McCullough et al. 2002) and the DASH-style score (Fung et 
al. 2008) as these scores do not take into account energy intake, in contrast 
to the HDI and DQI (Huijbregts et al. 1997, Patterson et al. 1994). Total 
body mass (kg) was included as a covariate in the evaluation of associations 
between diet and FFM and FFMI as described in Chapter 2, section 2.2.5, p. 
57 (Subset 1) (Tables 5.4, 5.5, 5.6). Additional adjustments were made for 
hand grip strength and muscle quality including height, menopausal status 
(premenopausal or postmenopausal), and hormone replacement therapy use 
(HRT) (no or yes), as these factors have been previously shown to affect 
muscle strength and muscle quality (Subset 2) (Tables 5.8, 5.9) (Carville et 
al. 2006, Cooper et al. 2008, Greeves et al. 1999, Greising et al. 2009, 
Jerome et al. 1991, Kurina et al. 2004, Neder et al. 1999, Sipila et al. 2001).   
  
In order to examine the relative importance of diet quality and other lifestyle 
characteristics on indexes of muscle mass, muscle strength and muscle 
quality regression analysis was performed with all independent variables 
standardised to represent a similar scale. For Subset 1 (2570 women, aged 
18-79 years), diet quality indices were measured in quartiles, age in 10 year 
categories, smoking habit in two categories (current v never and former v 
never), physical activity in three categories (inactive, moderate, and active), 
energy intake per 1000 kcal, and total body mass in kg (Table 5.7). For 
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Subset 2 (949 women, aged 34-83 years), diet quality indices were 
measured in quartiles, age in 10 year categories, current smoking (yes/no), 
physical activity (inactive, moderate, and active), height in cm, energy 
intake per 1000 kcal, menopausal status (postmenopausal v premenopausal), 
and hormone replacement therapy (no/yes) (Table 5.10).  In the subset of 
2570 women, age was inversely correlated with FFM (r = -0.2, P < 0.001) 
and percentage FFM (r = -0.4, P < 0.001), but not with FFMI (r = -0.006, P 
= 0.76). Therefore, for FFMI further analysis was not stratified by age. 
However, since age was  inversely correlated with hand grip strength (r = -
0.5, P < 0.001) and muscle quality (r = -0.4, P < 0.001) analysis in the 
subset of 949 women was further stratified by age using two categories, less 
than 50 years and more than 50 years. 
  
5.3 Results 
Descriptive characteristics of the two subsets of the TwinsUK cohort are 
shown in Table 5.1. For the first subset (n = 2570 women) the mean (±SD) 
age of participants was 48.3 ± 12.7 years and mean (±SD) BMI was 24.9 ± 
4.14 kg/m
2
. Mean FFM (±SD) was 39.6 ± 5.30 kg, percentage FFM 61.1 ± 
6.49 %, and FFMI 15 ± 1.71 kg/m
2
. More than one-half of the participants 
were moderately active (54 %), and 18.2 % were current smokers. The mean 
(±SD) MDS was 4.48 ± 1.79 points, HDI score was 3.44 ± 1.34 points, DQI 
was 11.7 ± 2.03 points, AHEI was 51.5 ± 11.2 points, and the DASH-style 
score was 23.4 ± 5.67 points. Mean (±SD) energy intake was 1979 ± 524 
kcal/d (Table 5.1). 
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For the second subset (n = 960 women) the mean (±SD) age of participants 
was 59.1 ± 9.30 years and the mean (±SD) BMI was 26.5 ± 4.73 kg/m
2
. 
Mean hand grip strength was 28.8 ± 5.95 kg, and muscle quality was 0.69 ± 
0.14 kg/kg. Mean (±SD) percentage FM was 35.7 ± 6.28 %, and percentage 
FFM was 61.4 ± 6.18 %. In relation to physical activity, 34.2 % of 
participants were moderately active and few were current smokers (9.8 %). 
The mean (±SD) MDS was 4.42 ± 1.47 points, HDI score was 3.38 ± 1.25 
points, DQI was 11.6 ± 1.96 points, AHEI was 53.3 ± 11.0 points, and the 
DASH-style score was 23.5 ± 5.74 points. Mean (±SD) energy intake was 
1917 ± 637 kcal/d. Notable differences in body composition were observed 
between the two subsets of this cohort. Participants in the second subset 
were heavier, had a higher BMI, fat mass, percentage fat mass and estimates 
of fat free mass compared to the first subset of the cohort, which is likely to 
be because body composition measurements in the second subset were taken 
10years later. In terms of fat free mass, differences might be because total 
body weight was greater in the second subset and increases in fat free mass 
are associated with  increases in total body weight (Wells et al. 2002, Wolfe 
2006) (Table 5.1).    
 
The main baseline characteristics of the two subsets across quartiles of the 
five derived diet scores are presented as unadjusted means ± standard errors 
(SEM) in Table 5.2. Levels of statistical significance are reported as P for 
trend. For the first subset age was significantly and positively associated 
with the DQI (P <0.001) and AHEI (P = 0.001), and inversely associated 
with the HDI (P = 0.051). Total body mass was significantly and positively 
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associated with the DQI (P = 0.042) and DASH-style score (P = 0.013), and 
negatively associated with the HDI (P = 0.001). All scores were associated 
moderate physical activity (MDS, P = 0.034; DQI, P = 0.019; AHEI, P < 
0.001; DASH-style score, P = 0.002) with the exception of HDI (P = 0.124); 
and current smoking (MDS, P < 0.001; HDI, P = 0.002; DQI, P < 0.001; 
AHEI, P < 0.001; DASH-style score, P < 0.001).  
 
For the second subset, age was inversely associated with the MDS and HDI 
(P < 0.001 for both). Women who scored high for the HDI, DQI and AHEI 
were less likely to be current smokers (P for trend = 0.011, < 0.001 and 
0.001, respectively). Women who scored high for the MDS and AHEI were 
more likely to be postmenopausal (P for trend < 0.001 and 0.024, 
respectively), and those with higher AHEI were more likely to be physically 
active (P for trend < 0.001) (Table 5.2). 
 
A comparison of nutrient intakes between the highest and the lowest quartile 
of the derived diet scores are presented in Table 5.3. For subset 1, protein 
intake (as % Energy) was positively associated with the DQI, AHEI and 
DASH-style scores (P < 0.05 for all). Higher intakes of vitamin C, 
magnesium and total carotene were positively associated with higher 
adherence to all scores (P < 0.001 for vitamin C and magnesium, and P < 
0.05 for total carotene). Higher vitamin D intake was positively associated 
with higher MDS, AHEI and DASH-style scores (P < 0.001 for all). Higher 
vitamin E, potassium and selenium intakes were positively associated with 
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higher adherence to all scores (P < 0.001 for vitamin E and selenium, and P 
> 0.05 for potassium) except for the DQI. 
For subset 2, higher intakes of vitamin C, magnesium, potassium and total 
carotene  were positively associated with higher adherence to all scores (P < 
0.05 for all) apart from total carotene and the DQI (P > 0.05). Also, higher 
vitamin D, E and selenium intakes were positively associated with higher 
MDS, AHEI and DASH-style scores (P < 0.001 for all) (Table 5.3).  
The percentage difference in different food groups of the two subsets 
between extreme quartiles of the five derived diet scores is shown in 
Figures 5.1 and 5.2, respectively. For subset 1, percentage difference in 
intake of fruit and vegetables, whole grains, nuts and legumes was 
positively and significantly associated with all scores (P < 0.001 for all), 
apart from nut and legume intake and the DQI (Figure 5.1). For subset 2, 
percentage difference in intake of fruit and vegetables, whole grains, nuts 
and legumes was positively and significantly associated with all scores (P < 
0.001 for all), apart from nut intake and the HDI and legume intake and the 
DQI (Figure 5.2). Percentage difference in intake of dairy products and 
meat was positively associated with the DASH-style score (P < 0.001) for 
both subsets 1 and 2. 
 
Subset 1 (2570 women, 18-79 years) 
Fat free mass (FFM) 
In multivariate analyses, when comparing extreme quartiles of the five 
derived diet scores, FFM was positively and significantly associated with 
the MDS by 1.97 %,  HDI by 1.67%, DQI by 2.28 %, AHEI by 2.46 %, and 
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DASH-style score by 2.13 %, compared to the lowest quartile of each score 
(P for difference < 0.05 for all) (Table 5.4). 
 
Percentage fat free mass (FFM %) 
In the multivariate model, mean percentage FFM was positively and 
significantly associated with a 4 point difference in the MDS (difference in 
FFM% 1.15 %), a 3 point difference in the HDI (difference 2.07 %), and a 
13 points difference in the AHEI (1.64 %) (P < 0.05 for all). The 
associations were not significant for the DQI and the DASH-style scores 
(Table 5.5).  
 
Fat free mass index (FFMI) 
After multivariate adjustment, mean FFMI that was positively and 
significantly associated with a 4 point difference in the MDS, by 1.41 %, a 3 
point difference in the HDI, by 1.34 %, a 5 point difference in the DQI by 
2.30 %, 13 points difference in the AHEI by 1.28 %, and 27 points 
difference in the DASH-style score by 2.62 % (P < 0.05 for all) (Table 5.6). 
 
Relative comparison of associations between diet quality scores, lifestyle 
characteristics and fat free mass indexes in subset 1 
Higher fat free mass (kg) was significantly associated with greater 
adherence to all five diet scores. The greatest magnitude of association was 
observed between FFM and the AHEI score, with an increase of 0.31 kg per 
quartile of the AHEI score (P = 0.001). Compared with the diet scores, FFM 
(kg) was inversely associated with age per 10 yrs for all five diet scores and 
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this association was 4-5 times the scale of the association with the diet 
scores (P for all < 0.001). Both current and former smoking was positively 
associated with FFM and this was of a similar scale to age (P < 0.001). 
Also, a one category increase in physical activity was positively associated 
with FFM, with the greatest association for the HDI and the DQI (with an 
increase of 0.74 kg per category of physical activity) (P < 0.001) for both 
scores, although this association was smaller than age and smoking (Table 
5.7).  
 
Higher percentage FFM was significantly associated with greater adherence 
to all diet scores with the exception of DQI and the DASH-style scores for 
which the association was not significant. The relative associations with age 
per 10 years (P for all < 0.001) and current smoking (P for all < 0.05) and 
physical activity (P for all < 0.001) were of a similar scale to FFM for all 
diet scores (Table 5.7). 
 
Higher fat free mass index (kg/m
2
) was significantly associated with greater 
adherence to all five diet scores (P for all < 0.05).  Again the relative 
associations for age, current smoking and physical activity were of a similar 
scale to those of FFM for all scores (Table 5.7).  
 
Overall, the greatest magnitude of association was an almost 2 % decrease 
in percentage FFM for an increase in age per 10 years for all diet scores (P 
for all < 0.05); and an increase of almost 1.4 % in percentage FFM for every 
category in physical activity for all diet scores (P for all < 0.05) (Table 5.7). 
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Subset 2 (949 women, 34-83 years) 
Hand grip strength and muscle quality 
In multivariate models, no associations were observed between the five diet 
scores and hand grip strength (Table 5.8) and muscle quality (Table 5.9). In 
further analyses, where we stratified by age no significant associations were 
observed.     
 
Relative comparison of associations between diet quality scores, lifestyle 
characteristics and hand grip strength and muscle quality in subset 2 
When examining the relative associations between diet quality scores, 
lifestyle factors and hand grip strength and muscle quality, the greatest 
magnitude of association was observed between age per 10 years and 
physical activity and hand grip strength, and age per 10 years and muscle 
quality (Table 5.10). Hand grip strength (kg) was inversely associated with 
age per 10 yrs by 2.70 kg per quartile of all diet scores (P < 0.001 for all). 
Also, a 1 category increase in physical activity was positively associated 
with hand grip strength by 0.50 kg on average per category of physical 
activity (P < 0.05 for all). Muscle quality (kg/kg) was also inversely 
associated with age per 10 years by 0.06 kg/kg on average for all five diet 
scores (P < 0.001 for all) (Table 5.10).  
 
5.4 Discussion  
This study is one of the first cross-sectional studies to show that there was a 
positive association between diet quality as assessed by the MDS, HDI, 
DQI, AHEI and DASH-style scores and fat free mass (FFM, kg); the MDS, 
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HDI and AHEI scores and percentage fat free mass (FFM %); and the MDS, 
HDI, DQI, AHEI and DASH-style scores and fat free mass index (FFMI, 
kg/m
2
) in a cohort of women across a wide age range. However, 
associations between diet quality and muscle strength and muscle quality 
were not observed in this population. Only one previous longitudinal study 
among 690 men and women aged 65 years and over has examined 
associations between the Mediterranean diet score and muscle strength, 
although no associations were observed over 6 years of follow-up 
(Talegawkar et al. 2012). The current study highlighted the influence of diet 
quality assessed by five of the most commonly used diet quality scores, 
previously inversely associated with the risk of mortality, cardiovascular 
disease risk factors, and with the prevention of chronic disease risk 
(Akbaraly et al. 2011, Fung et al. 2008, Huijbregts et al. 1997a, 
McCullough et al. 2002, Patterson et al. 1994, Seymour et al. 2003, 
Trichopoulou et al. 1995). 
 
Diet quality scores and indexes of muscle mass 
The current study observed significantly higher FFM (kg) with higher 
adherence to all five diet quality scores. Differences in FFM between higher 
and lower adherence to the diet scores were 0.77 kg for the MDS (P = 
0.001), 0.66 kg for the HDI (P = 0.023), 0.89 kg for the DQI (P = 0.002), 
0.96 kg for the AHEI (P = 0.001), and 0.84 kg for the DASH-style score (P 
= 0.011). These differences equated to a relative mean difference of between 
2% and 3% for FFM (Table 5.4).    
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Also, the results indicated that higher percentage FFM was significantly 
associated with and higher adherence to the MDS, HDI and AHEI. 
Differences in percentage FFM between higher and lower adherence to the 
diet scores ranged from 0.7-1.3 % for three of the scores (MDS, AHEI and 
HDI, respectively). These differences equated to differences that were 
between 2% and 3% of the mean percentage FFM for the population. No 
associations were found between percentage FFM and the DQI and DASH-
style scores in the current study. This is most likely because those who 
scored higher for the DQI and DASH-style score had a higher total body 
mass and for the DASH-style score were also older compared to those who 
scored higher for the MDS, HDI and AHEI (Tables 5.2 and 5.5). 
 
Significant positive associations were also observed between the FFMI and 
higher adherence to all five diet quality scores. Differences in FFMI 
between higher and lower adherence to the diet scores were ranged between 
0.2-0.4 % for the MDS, HDI, DQI, AHEI (P = 0.028) and DASH-style 
score. These differences equated to differences that were between 1.3% and 
3% of the mean FFMI for the population (Table 5.6).    
These associations remained significant after adjustments for age, physical 
activity, smoking status, energy intake (for MDS, AHEI and DASH-style), 
and total body mass and equated to a scale of effect that was between 37% 
and 63% of the scale of the observed association with 10 years of age for 
FFMI (Table 5.7). 
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There are currently no studies examining the influence of a better diet 
quality on indexes of muscle mass. However, looking to our data, 
interestingly, the magnitude of the findings in this analysis was similar of 
that observed for the association between vitamin C and magnesium intakes 
and indexes of muscle mass described in Chapter 3, section 3.4, p. 87, 89. 
These findings may be explained either because higher diet scores were 
associated to higher intakes of vitamin C and magnesium (Table 5.3) or 
because plant-based nutrients individually are more important than the 
“whole diet”. These findings also point towards the need to identify whether 
public health recommendations for the maintenance of healthy muscles in 
relation to diet should focus on eating patterns or individual dietary 
components. 
     
The derived diet scores had distinct similarities and differences (see 
APPENDICES II, p. 329 and III, p. 332). Three of the scores consisted of 
9 components (including the MDS, HDI, and AHEI); and the other two 
scores (DQI and DASH-style) consisted of 8 components. Key difference 
between the scores were that the MDS, AHEI and DASH-style were 
focused mainly on intake of significant food groups (characterised by higher 
intakes in fruits and vegetables-either grouped or separately, nuts and 
legumes, whole grains, and low intakes in red processed meat). In contrast, 
the HDI and DQI scores were mainly focused on intake of nutrients 
(characterised by higher intakes in polyunsaturated fatty acids, average 
intakes in protein, and low intake in saturated fatty acids and cholesterol). 
Yet, the MDS, AHEI, and DASH-style were based on overall dietary 
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patterns, and the HDI and DQI were based on healthy eating guidelines. No 
specific statistical weighting for individual components was used in any of 
the five scores with all scores assuming that all food groups and nutrients 
contributed equally to the diet quality.     
 
There were also differences in the methodologies used to construct the 
scores. The MDS used the median intake of dietary components as the cut-
off between healthy and unhealthy intakes, whereas the DASH-style score 
used quintiles to classify intakes of dietary components, with a “healthy” 
point assigned only if the quantity consumed was in the highest quintile.  In 
contrast, the HDI, DQI, and the AHEI were cut-point specific scores based 
on healthy eating guidelines. Overall, these differences suggest that the 
DASH-style score gives more weight to high adherence to a better quality 
diet compared with the other four scores. However, it is likely that the use 
of the median as a cut-off value will not reflect a healthy level of intake per 
se, and will be different among different populations, but an advantage is 
that half of the sample will score positively and half negatively for each 
component, which ensures that each component distinguishes well between 
individuals (Waijers et al. 2007). On the other hand there are drawbacks 
with the use of cut-off specific values as it is likely that the intake of a 
specific component may be below the cut-off level for most of the subjects, 
limiting the discriminating power of a component (Kourlaba and 
Panagiotakos 2009, Waijers et al. 2007). 
This analysis indicated that the five derived diet scores measured diet 
quality adequately as they were highly associated with intake of different 
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macro- and micronutrients in this population (Table 5.3). This finding was 
supported by other studies in different populations (Kennedy et al. 1995, 
Patterson et al. 1994). Interestingly, when translating the differences in 
nutrient intakes between extreme quartiles of the five diet scores into 
comparable amounts of food, the differences in vitamin C intake, for 
example, between extreme quartiles of the diet scores equated to 1.6 
portions of oranges for the MDS, 1.5 portions for the HDI, 1 portion for the 
DQI, 2.3 portions for the AHEI and 2 portions for the DASH-style score 
(assuming one portion of oranges to be 120 g for adults).   
 
Most of the scores captured variability of dietary constituents that have been 
previously associated with muscle mass (as it was outlined in Chapter 1, 
section 1.3, p. 21). However, there were a few differences in nutrient intake 
across quartiles of the five diet scores which may offer some explanation as 
to why associations between the percentage FFM and the DQI and DASH-
style scores were not seen in this study. When different dietary constituents 
across quartiles of the five diet quality scores were analysed, it was 
observed that nutrients that have been previously associated with muscle 
mass, such as vitamins C and E, selenium, magnesium, potassium and total 
carotene were significantly and positively associated with higher adherence 
to the MDS, HDI and AHEI. Although higher adherence to the DQI score 
was also positively associated with protein, vitamin C and potassium, it was 
however negatively and significantly associated with vitamins D and E, and 
selenium, important dietary components related to muscle mass (as outlined 
in Chapter 1, section 1.3, p. 21, 22). The observed negative associations 
 174 
 
between dietary components important for muscle mass and the DQI may 
offer some explanation as to why this score was not associated with the 
percentage FFM in this cohort. 
 
Additionally, even though the DASH-style score consisted of components 
high in nutrients important for muscle mass, such as protein, vitamins C, E 
and D, magnesium, potassium, total carotene, and selenium; and also higher 
adherence was significantly and positively associated with intakes of these 
nutrients, a higher adherence to this score was not associated with 
percentage FFM. This finding suggests that the way the indexes of muscle 
mass were calculated may have lead to the differences observed. It is well 
documented that in order to evaluate FFM in relation to body size and 
nutritional status, FFM should be considered in relation to height, because 
FFM expressed in absolute weight or as a percentage of body weight is not 
usually adequate because FFM increases with height. FFMI (weight/height
2
) 
which eliminates differences associated with height is an important marker 
of health and disease status (Coin et al. 2008, Heymsfield et al. 2011, Kyle 
et al. 2003). An example, of the relationship between height and FFM is that 
FFM might be similar between a healthy, well-nourished man and a similar 
aged but taller subject with protein - energy malnutrition (VanItallie et al. 
1990).      
 
To further evaluate whether the findings were due to the potential protective 
effect of a better quality diet or due to an overall healthy lifestyle, analyses 
was calculated for age per 10 years, smoking habit, physical activity, energy 
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intake per 1000 calories, and total body fat to enable comparison. Findings 
suggested that there was a strong effect of age on all three indexes of muscle 
mass with the greatest magnitude of association equivalent to 2 % decrease 
in percentage FFM for an increase in age per 10 years (P for all < 0.05). 
This finding reflects data from the literature that shows that loss of muscle 
mass increases with age (Fielding et al. 2011, Morley et al. 2001). Also, 
physical activity was significantly positively associated with higher indexes 
of muscle mass, with the greatest magnitude of association equivalent to 1.4 
% higher percentage FFM per category of physical activity. This finding 
was of a similar magnitude to those from an intervention study among older 
men and women (aged 65.5 ± 3.7 years) that found positive effects of 
physical activity combined with antioxidant supplementation on muscle 
mass; a 1.1 % increase in percentage FFM after 6 months of resistance 
training and antioxidant supplementation (Bobeuf et al. 2010).   
 
However, although lifestyle factors had an effect on indexes of muscle 
mass, the association of the diet quality scores with indexes of muscle mass  
remained significant for all scores (with the exception of the percentage 
FFM and the DQI and DASH-style) even after accounting for all relevant 
lifestyle factors. 
 
Diet quality scores and hand grip strength and muscle quality 
In the current study no associations were observed between diet quality and 
hand grip strength and muscle quality. Age and physical activity showed the 
greatest influence on these two measurements. When examining the relative 
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associations between diet quality scores, lifestyle factors and hand grip 
strength, the greatest magnitude of association was observed between age 
per 10years and hand grip strength. Hand grip strength (kg) was negatively 
associated with age per 10 years by 2.70 kg on average for all five diet 
scores (P < 0.001 for all). Only one previous longitudinal study among 690 
men and women aged (≥ 65 years)  has examined associations between the 
Mediterranean diet score and muscle strength, and although no associations 
were observed (Talegawkar et al. 2012) the authors did not offer an 
explanation for this finding neither did they report the mean value for grip 
strength.  
 
In a number of clinical and epidemiological studies, hand grip strength has 
been suggested as an important measurement for overall health and 
nutritional status (Norman et al. 2011). Low hand grip strength has been 
associated with an increased risk of disability, morbidity and mortality in 
both men and women (≥ 45 years) and with a decline in quality of life in 
older individuals, and has been suggested to be a useful marker of muscle 
function and sarcopenia (Cruz-Jentoft et al. 2010, Gale et al. 2007, 
Laukkanen et al. 1995, Rantanen 2003, Rantanen et al. 1999, Rantanen et 
al. 2003, Sayer et al. 2006, Syddall et al. 2003). Mean (SD) hand grip 
strength in women from the TwinsUK cohort was 28.8 (5.9) kg, higher 
compared to the mean (SD) hand grip strength [26.5 (5.7) kg] in women 
from a previous UK based cohort (Robinson et al. 2008). However, the 
TwinsUK cohort was younger (34-83 years) and this may explain this 
observed difference, since age is a strong independent factor of grip strength 
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(Norman et al. 2011). Therefore, it is likely that the lack of association 
observed in the current study between diet quality and hand grip strength 
might be due to the fact that the cohort included younger adults as well as 
older individuals, however stratification for age did not alter our findings. 
 
In relation to muscle quality (kg/kg) there was a negative association with 
age per 10 years by 0.06 kg/kg on average for all five diet scores (P < 
0.001). Muscle quality is defined as the ratio of muscle strength per unit of 
muscle mass, and has been suggested as an approach to measure the quality 
of muscles (Goodpaster et al. 2006, Lynch et al. 1999). It has been 
positively associated with age and functional incapacities (Goodpaster et al. 
2006, Lynch et al. 1999). However, in the current study no associations 
were observed with diet quality, even after stratification for age. Muscle 
quality does integrate muscle strength in its calculation, however, as muscle 
strength was not associated with diet quality in our analyses this may be the 
reason why muscle quality was not also associated with diet quality. In 
addition, analyses in the current study showed that after multivariate 
adjustment for relevant confounders, the influence of age was six (for the 
AHEI) to 200 (for the MDS) times greater of that of diet quality scores on 
muscle quality (Newman et al. 2003). Moreover, the effect of physical 
activity was one (for the AHEI) to 27 times greater (for the MDS) of that of 
diet quality scores on muscle quality. Notably, intervention programmes 
have shown that after 9 weeks strength training for three days per week, 
muscle quality (assessed as the ratio of strength divided by the muscle 
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volume of the trained muscle group) was increased in older women aged 65-
73 years by 16 % from baseline (Tracy et al. 1999).  
Muscle quality has not been previously used in nutritional studies, as to date 
there is no standardised protocol to assess muscle quality, although research 
is on-going in this field (Barbat-Artigas et al. 2012). However, further 
studies using more validated methods are needed in order to integrate this 
important measurement in future dietary intervention studies on sarcopenia.    
The mechanisms involved in the relationship between diet quality (assessed 
by diet quality indices) and indexes of muscle mass cannot be specifically 
identified due to the nature of our study which assessed associations. 
Nevertheless, findings from epidemiological studies that have shown that 
dietary patterns characterised by increased consumption of fruits and 
vegetables, whole grains, dietary fiber and low intakes of saturated and trans 
fatty acids were associated with lower levels of markers of inflammation, 
oxidative stress, and endothelial dysfunction, offer support to these findings  
(Baer et al. 2004, Dai et al. 2008, Esmaillzadeh et al. 2007, Esposito et al. 
2004, Fung et al. 2001, Fung et al. 2001, Lopez-Garcia et al. 2004, Lopez-
Garcia et al. 2005, Mozaffarian et al. 2004, Nettleton et al. 2006). Indeed, 
adherence to the Mediterranean diet, which is characterised by a high intake 
in fruits, vegetables, and whole grains, and lower consumption of red meat 
and saturated fats has been associated with lower circulating levels of the 
inflammatory marker, IL-6 (Chrysohoou et al. 2004). It has also been shown 
that the alternate Mediterranean score (aMED) and the Alternate Healthy 
Eating Index (AHEI) are significantly associated with lower plasma both 
IL-6 and CRP (P < 0.05 for both), independent of obesity, and after 
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multivariate adjustment (Fung et al. 2005). Furthermore, in another cross-
sectional investigation among women who were selected for a previous 
nested case-control study of diabetes from the Nurse’s Health cohort Study, 
62% of whom were overweight, it was observed that higher adherence to the 
Alternate Healthy Eating Index (AHEI) score was associated with a 
significantly 41% lower  plasma CRP, 10% lower TNF-a receptor II levels 
(sTNF-aRII) and 22% lower IL-6 in the higher compared with lower 
adherence to the score (Fargnoli et al. 2008). In addition, a randomised, 
crossover design trial among type II diabetic patients who consumed the 
DASH-style diet for 8 weeks showed a mean decrease of 27 % in plasma 
CRP after the DASH-style diet period (Azadbakht et al. 2011). Chronic 
inflammation is an inevitable consequence of the ageing process and may 
further cause loss of myocytes and reduced function of skeletal muscle mass 
(Gianni et al. 2004, Mecocci et al. 1999, Morley et al. 2001, Pansarasa et al. 
1999). In addition,  it has been suggested that the development of age-
associated declines in muscle mass, muscle strength, physical function, 
mobility and frailty have been attributed partly to the inflammation that 
occurs with the ageing process (Chung et al. 2009, Howard et al. 2007). 
Consequently, the greater associations we found between  muscle mass and 
the healthy diet scores may be partly explained due to the anti-inflammatory 
effects of an overall healthier diet containing food components high in the 
nutrients previously found to be related to muscle mass (as outlined in 
Chapter 1, section 1.3, p. 21, 22, and Chapter 3, section 3.0, p. 82).  
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Minor differences in absolute values for different scores were observed 
between the two subsets due to particular differences in the way that the 
scores were constructed (which were outlined in Chapter 2, section 2.2.4.1, 
p. 56). Mean values in the current study were similar to mean values in UK, 
European and US populations, with a mean MDS of 4.5 points for the EPIC-
PANACEA cohort (Romaguera et al. 2010), mean DASH-style score of 23 
points among US women from the Nurses’ Health Study (Fung et al. 2008), 
and a mean DQI score 8.6 points among adults from the American 
Nationwide Food Consumption Survey (NFCS) (Patterson et al. 1994). 
However, the HDI score differed between different populations, with a 
mean HDI of 2.5 points for Finland, 4 points for Italy, and 3.5 points for a 
Swedish sample population, although in the Swedish cohort the HDI was 
modified from the traditional score to include fish intake (based on the 
Nordic Nutrition recommendations from 2004) (Sjögren et al. 2010). The 
HDI score for the TwinsUK cohort was between the scores for other 
European populations which is likely to be reflective of differences in 
dietary intake with other studies. Also, the mean DQI score was higher in 
the TwinsUK cohort and the NFCS most likely because in the current cohort 
the scoring of the original score was reversed so that a higher score 
indicated higher diet quality, to enable comparison with the other four 
scores. The mean AHEI score for the current cohort was higher compared 
with that from the US women from the Nurses’ Health Study, which was 
38.4 points. However, for the development of AHEI for the TwinsUK 
cohort the criterion for the maximum dietary fiber intake was based on the 
Daily Reference Value (DRV) for non-starch polysaccharides (NSP) for the 
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UK population, which is 18 g/d, compared with 15 g/d which is the 
maximum daily intake for cereal fiber for the US population studied from 
the Harvard cohorts (McCullough et al. 2002).  Overall, the mean of the 
scores for the current cohort was comparable with that of other populations.    
 
5.5 Strengths and limitations 
The strengths of this study include the large sample size and the wide age 
range of participants, as most previous studies on sarcopenia focused only 
on older individuals (Robinson et al. 2008, Scott et al. 2010). Moreover, this 
was the first study that directly compared five diet quality scores based on 
adherence to dietary patterns or to dietary recommendations with indexes of 
muscle mass, muscle strength and muscle quality in a large cohort. Also, 
many nutrients and food groups were significantly related to the derived diet 
quality scores, suggesting that the diet quality scores developed for the 
TwinsUK cohort captured aspects of diet quality. An additional strength was 
that two of the scores have been previously validated. Indeed, two modified 
versions of the Mediterranean diet score measured by an FFQ were recently 
shown to produce similar findings to conducting 10 to 12  24 h dietary 
recalls (Benítez-Arciniega et al. 2011). Yet, it has been previously shown 
that the Diet Quality Index (DQI) has been validated against plasma 
biomarkers of vitamin C, a-tocopherol, β-cryptoxanthin and phospholipid 
fatty acids (Neuhouser et al. 2003). Body composition was objectively 
assessed by DEXA scans and an objective measurement was used to assess 
muscle strength, which allowed calculation of muscle quality. 
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Our study also has limitations. The cross-sectional nature of the study limits 
causal inference, but enables us to generate hypotheses regarding 
associations between diet quality and indexes of muscle mass, strength and 
muscle quality based on plausible mechanisms of action. Another limitation 
is that no specific statistical weighting for each component has been used 
regarding the construction of each score, assuming that all food groups and 
nutrients contributed equally to the diet quality. Higher adherence to the diet 
scores may be an indicator of a healthy lifestyle, and even though all 
analyses were adjusted for lifestyle factors, residual confounding could not 
be ruled out because of the observational nature of the study. In addition, as 
in all observational studies, measurement error in self-reported dietary 
intakes is inevitable. It is also widely acknowledged that the use of FFQs for 
measuring dietary intake has its own limitations related to memory errors, 
they provide relative than absolute intake, they introduce bias due to over- 
or under-reporting, and they may introduce systematic errors as preparation 
methods are inadequately considered (McNeill et al. 2009). Also, FFQs 
measure food intake over a period of one year and reflect the habitual diet 
over this period of time but not lifetime dietary habits (Teucher et al. 2007). 
Nevertheless, the FFQ used in the current study was previously compared 
and validated against a 7-day weighed record in the EPIC Norfolk study, 
and although the two approaches to measure dietary intake were different, 
both methods identified similar intakes of macronutrients when these 
expressed as percentage of total energy intake (Bingham et al. 2001). Also, 
this FFQ was previously validated against urinary and plasma biomarkers of 
intake, such as urinary nitrogen for protein intake, urinary potassium and 
 183 
 
sodium, plasma ascorbic acid and plasma n-3 PUFAs (McKeown et al. 
2001, Welch et al. 2006). In addition, it has been shown previously that 
serum β-cryptoxanthin and zeaxanthin concentrations were moderately 
correlated with dietary carotenoids intakes measured by an FFQ (Tucker et 
al. 1999). In order to examine associations between dietary intake and 
health outcomes participants need to be ranked according to their usual 
dietary intake and FFQs have been shown to rank individuals well (Molag et 
al. 2007). The observed findings relate to women and further work is 
needed to investigate if these findings are replicated in a male population of 
the same country or in populations from different ethnic backgrounds.   
 
5.6 Concluding remarks 
This is one of the first studies to our knowledge to show that diet quality 
assessed by five predefined diet quality scores is associated with muscle 
mass in women of different ages. This is also one of the first studies to 
examine cross-sectional associations between diet quality and muscle 
strength and muscle quality. Findings from the current study extend the 
results from previous cross-sectional studies by focusing on the overall diet 
quality instead of a food group or a nutrient in association with muscle mass 
and muscle strength. Additionally, our findings extended the existing 
literature by evaluating the importance of diet quality and muscle quality to 
further understand the association between muscle strength and muscle 
quality.  
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In conclusion, the greatest associations were observed between the AHEI 
and FFM, the HDI and percentage FFM, and the DASH-style score and the 
FFMI and were equivalent to 2.5 %, 2 % and 2.6 % of the population mean 
for FFM, percentage FFM and FFMI, respectively. Although the strength of 
the associations were modest, this was observed after analyses was 
accounted for age, smoking, physical activity, body fat and energy intake, 
factors that are known to affect muscle mass.  Nevertheless, associations 
were not observed between diet quality and muscle strength and muscle 
quality possibly due to the fact that other factors, such as age and physical 
activity may be more important than diet quality in improving or 
maintaining muscle strength and quality. Yet, it is also possible that a 
longitudinal study design might be a more suitable approach to detect 
associations between diet quality and muscle strength and muscle quality.    
Despite their differences, the derived diet scores reflected a common pattern 
characterised by high intakes in fruit and vegetables, nuts, legumes, dietary 
fiber/and or whole grains, and low intake of red and processed meat, and 
saturated fat, suggesting that plant derived sources of vitamin C, 
magnesium, potassium and carotenoids may be important for muscle mass. 
In addition, examining dietary patterns and health outcomes may lead to 
recommendations which are more likely to be used for public health 
purposes (Tucker 2010). Although further work is needed to examine 
associations between other diet quality scores or dietary patterns and muscle 
mass, muscle strength and muscle quality, results from the current analysis 
suggest that it is important for adult women to consume a variety of foods to 
ensure greater muscle mass. From a public health perspective, these findings 
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will help to improve the knowledge and understanding of the effects of 
dietary and lifestyle factors on muscle mass and strength and provide useful 
information in the developing and planning dietary intervention trials to 
improve conservation of muscle mass and strength in adult life. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 186 
 
TABLES 
Table 5.1 Baseline characteristics of female subjects from the TwinsUK cohort
1 
Characteristic 
Subset 1 
n=2570, 18-79 
yrs
 
Subset 2 
n=949, 34-83 
yrs 
Age (y) 48.3±12.7
 
59.1±9.3
 
Weight (kg) 65.6±11.2
 
69.2±12.5
 
Height (cm) 162±6.1
 
162±5.9
 
BMI (kg/m
2
) 24.9±4.1
 
26.5±4.7
 
Fat mass (kg) 22.7±7.9
 
25.2±8.3
 
Fat mass % 33.9±7.2
 
35.7±6.3
 
Fat free mass (kg) 39.6±5.3
 
42.0±5.5
 
Fat free mass % 61.1±6.5
 
61.4±6.2
 
Fat free mass index (kg/m
2
) 15.0±1.7
 
16.0±1.8 
Hand grip strength (kg)  28.8±5.9 
Muscle quality (kg/kg)  0.69±0.14 
Physical activity % 
Inactive 
Moderate 
Active 
 
21.9 
53.9 
24.2
 
 
39.6 
34.2 
26.2 
Smoking history % 
Never 
Current 
Former 
 
50.2 
18.2 
31.6
 
 
Current smoking % 
Yes 
No 
  
9.79 
90.21 
Menopausal status % 
Premenopausal   
Postmenopausal  
  
10.3 
89.7 
Hormone replacement therapy % 
Yes 
 No 
  
9.38 
90.63 
Derived diet scores (points) 
  
Mediterranean Diet Score (MDS) 4.48±1.79
 
4.42±1.47
 
Healthy Diet Indicator (HDI) 3.44±1.34
 
3.38±1.25
 
Diet Quality Index (DQI) 11.7±2.0
 
11.6±2.0
 
Alternate Healthy Eating Index (AHEI)  51.5±11.2 53.3±11.0 
Dietary Approach to Stop Hypertension score 
(DASH-style) 
 
23.4±5.7
 
 
23.5±5.7
 
Dietary components 
  
Energy intake (kcal/d) 1979±524
 
1917±637 
MDS 
  
Fruit & nuts group (g/d) 252±195
 
283±209
 
Vegetables group (g/d) 280±157
 
325±178
 
Ratio of mono- and poly- to saturated fat 1.49±0.37
 
1.60±0.39
 
Milk & dairy group (g/d) 421±197
 
390±205
 
Meat group (g/d)
 
86.8±48.6
 
88.1±48.3
 
Fish group (g/d)
 
35.6±27.5
 
44.8±43.7
 
Legumes intake (g/d)
 
23.3±26.3
 
23.5±26.0
 
Cereals intake (g/d)
 
209±103
 
208±125
 
Alcohol intake (g/d) 
 
9.98±13.5
 
9.45±11.7
 
HDI
   
Fruit & vegetables group  (g/d)
 
584±315
 
662±336
 
Complex carbohydrates group  (% Energy/d)
 
47.6±18.5
 
49.3±20.4
 
Dietary fiber group (g/d)
 
20.3±7.6
 
21.0±8.5
 
Pulses & nuts group (g/d)
 
26.3±27.7
 
26.8±26.8
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Mono- & disaccharides group (% Energy/d) 23.8±5.8
 
24.7±5.7
 
Protein intake (% Energy/d)
 
16.6±2.6
 
17.7±2.8
 
Saturated fat intake (%Energy/d)
 
11.7±2.9
 
11.5±2.7
 
Polyunsaturated fat intake (% Energy/d)
 
6.43±1.59
 
6.91±1.87
 
Cholesterol intake (mg/d)
 
224±88
 
238±128
 
DQI
   
Fruit & vegetables group  (servings/d)
 
7.29±3.92
 
7.97±3.97
 
Total fat (% Energy/d)
 
31.3±5.6
 
31.7±5.2
 
Complex carbohydrates (servings/d) 3.85±2.0 3.44±1.9 
Saturated fat (% Energy/d) 11.7±3.0 11.5±2.7 
Cholesterol (mg/d) 224±88 238±128 
Protein (% RDA) 147±25.3 155±28.1 
Sodium intake (mg/d)
 
2259±758
 
2329±963
 
Calcium  intake (mg/d)
 
1134±374
 
1066±404
 
AHEI   
Vegetables (servings/d) 3.48±1.95 4.68±2.62 
Fruit (servings/d) 3.10±2.42 2.77±2.03 
Nuts and soy protein (servings/d) 0.10±0.25 0.62±0.52 
Ratio of white to red meat 2.63±5.63 2.50±7.68 
Dietary fiber (g/d) 20.3±7.6 21.0±8.5 
Trans fat (% energy) 1.10±0.38 1.09±0.35 
Polyunsaturated to saturated fat ratio 0.59±0.23 0.64±0.25 
Vitamin supplement use % (yes/no) 53.5 / 46.5 41.0 / 59.0 
Alcohol (servings/d) 0.77±1.02 0.68±0.86 
DASH-style score
   
Fruits intake (servings/d)
 
4.02±2.82
 
3.25±2.17
 
Vegetables intake (servings/ d)
 
3.26±1.91
 
4.68±2.62
 
Nuts & legumes intake (servings/d)
 
0.54±0.46
 
0.62±0.52
 
Whole grains intake (servings/d)
 
1.85±1.65
 
1.89±1.46
 
Low-fat dairy intake (servings/d)
  
0.93±0.66
 
0.93±0.64
 
Sodium (mg/d) 2259±758 2329±963 
Red & processed meat intake (servings/d)
 
1.00±0.58
 
1.08±0.62
 
Sweetened beverages intake (servings/d)
 
0.39±0.81
 
0.43±0.82
 
1
 Values are means ± standard deviations unless indicated 
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Table 5.2 Baseline characteristics of female subjects from the TwinsUK cohort across the derived diet scores quartiles
1 
 MDS HDI DQI AHEI DASH-style 
Subset 1 Q1 Q4 P Q1 Q4 P Q1 Q4 P Q1 Q4 P Q1 Q4 P 
N  776 774  650 528  709 557  653 572  677 641  
Age (y) 48.3±0.6 48.8±0.5 0.357 49.2±0.5 47.6±0.6 0.051 46.6±0.6 49.3±0.6 <0.001 46.5±0.6 49.2±0.6 0.001 47.1±0.5 48.7±0.6 0.114 
Total body mass(kg) 22.6±0.3 22.4±0.3 0.642 23.2±0.3 21.7±0.3 0.001 22.2±0.3 22.9±0.3 0.042 22.2±0.3 21.8±0.3 0.620 22.2±0.3 23.5±0.4 0.013 
Total energy (kcal/d)  1879±18.9 2112±19.6 <0.001 1959±22.1 2108±23.2 <0.001 2186±23.3 1816±18.0 <0.001 1868±20.8 2079±22.9 <0.001 1547±15.4 2440±18.3 <0.001 
Physical activity %   0.034   0.124   0.019   <0.001   0.002 
Inactive 25.9 19.8  24.0 18.6  26.6 18.5  25.8 14.2  25.7 19.0  
Moderate 51.3 54.5  50.6 54.4  50.4 55.6  54.7 57.5  55.7 54.5  
Active 22.8 25.7  25.4 27.0  23.0 25.9  19.5 28.3  18.6 26.5  
Smoking history %   <0.001   0.003   <0.001   <0.001   <0.001 
Never  51.9 50.5  47.4 52.5  46.0 50.3  45.0 51.8  44.1 58.7  
Current 22.9 14.1  23.1 13.3  26.0 12.9  27.1 12.9  24.7 12.9  
Former 25.2 35.4  29.5 34.2  28.0 36.8  27.9 35.3  31.2 28.4  
Subset 2 Q1 Q4 P Q1 Q4 P Q1 Q4 P Q1 Q4 P Q1 Q4 P 
N  262 232  231 185  246 167  250 220  241 201  
Age (y) 60.8±0.6 57.3±0.7 <0.001 60.6±0.7 57.2±0.7 <0.001 59.6±0.8 59.0±0.8 0.316 59.2±0.7 58.2±0.7 0.247 59.7±0.7 59.4±0.7 0.542 
Height (cm) 161±0.4 162±0.4 0.094 162±0.4 161±0.5 0.663 162±0.5 162±0.5 0.932 161±0.4 162±0.5 0.186 161±0.4 162±0.4 0.191 
Total energy (kcal/d) 1698±32.5 2121±42.2 <0.001 1879±42.4 2020±43.5 0.009 2283±55.9 1712±29.4 <0.001 1736±37.4 1981±43.9 <0.001 1399±24.0 2560±54.7 <0.001 
Physical activity %   0.184   0.236   0.553   <0.001   0.117 
Inactive  43.1 32.8  41.1 35.1  41.9 35.3  48.8 31.8  44.0 30.9  
Moderate  32.8 35.3  33.8 31.4  33.7 38.9  33.6 33.6  33.2 37.8  
Active  24.1 31.9  25.1 33.5  24.4 27.8  17.6 34.6  22.8 31.3  
Current smoking %   0.377   0.011   <0.001   0.001   0.162 
No 87.8 92.24  86.2 95.68  82.1 94.0  84.4 95.0  87.1 90.0  
Yes  12.2 7.76  13.8 4.32  17.9 6.00  15.6 5.00  12.9 10.0  
Menopausal status %   0.004   0.095   0.885   0.024   0.603 
Premenopausal  6.50 16.0  8.20 13.5  9.76 9.00  12.4 14.1  10.0 11.4  
Postmenopausal  93.5 84.0  91.7 86.5  90.24 91.0  87.6 85.9  90.0 88.6  
HRT %   0.245   0.712   0.603   0.967   0.099 
No  90.0 93.5  88.8 90.0  89.4 91.0  90.4 91.36  92.0 92.5  
Yes  10.0 6.50  11.2 10.0  10.6 9.00  9.60 8.64  8.00 7.50  
1
 Values are means and robust standard errors (SEM), unless indicated 
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Table 5.3 Nutrient intakes across the derived diet scores quartiles
1 
 MDS HDI  DQI AHEI DASH-style 
Subset 1 
Q1 
(2.3±0.8)
1
 
Q4 
(6.6±0.8) 
Q1 
(1.7±0.5) 
Q4 
(5.4±0.6) 
Q1 
(9.1±1.1) 
Q4 
(14.3±0.5) 
Q1 
(37.1±14.3) 
Q4 
(66.5±5.1) 
Q1 
(16.3±2.4) 
Q4 
(30.7±2.5) 
N  776 774 650 528 709 557 653 572 677 641 
Total energy (kcal/d)  1879±496 2112±516 1959±534 2108±515 2186±592 1816±412 1868±523 2079±518 1547±388 2440±444 
Protein (% E) 16.8±2.8 16.6±2.5
b
 17.2±2.3 16.1±2.7 16.5±2.6 17.0±2.7 16.3±2.7 16.8±2.6
a
 16.1±2.9 16.9±2.50 
Carbohydrate (% E) 50.1±6.7 53.1±6.3 44.5±5.3 52.5±6.2 47.2±5.4 56.8±6.4 45.3±6.6 51.6±5.5 46.6±7.1 50.1±5.54 
Fat (% E) 32.9±5.6 29.7±5.3 35.4±4.4 27.2±5.0 36.4±4.0 25.0±3.6 33.9±5.5 28.5±5.4 32.2±6.1 30.4±5.08 
Vitamin C (mg/d) 114±55.1 203±88.5 123±59.3 202±85.7 129±72.3 187±87.2 98.6±42.2 224±95.1 100±51.1 214±81.4 
Vitamin D (μg/d) 2.32±1.2 3.00±1.52 2.88±1.40 2.50±1.23 3.00±1.77 2.30±1.11 2.34±1.28 2.87±1.65 1.88±0.99 3.28±1.53 
Vitamin E (mg/d) 9.59±3.9 13.5±4.8 11.3±4.6 12.4±4.7 12.3±5.1 10.4±3.8 9.36±4.14 13.6±4.7 8.08±3.25 14.9±4.43 
Magnesium (mg/d) 307±76.0 391±95.2 315±79.8 403±93.7 338±95.1 359±85.4 290±72.6 404±94.5 257±55.9 438±76.9 
Potassium (mg/d) 3630±841 4426±1028 3750±913 4486±923 3988±1084 4055±920
b
 3417±799 4575±1021 3031±638 4980±870 
Selenium (μg/d) 44.1±13.1 60.7±17.7 51.4±16.2 55.0±17.5 53.4±20.0 51.2±15.0 43.2±14.1 61.3±20.9 38.1±11.4 65.3±18.1 
Carotene (μg/d) 2678±1523 4343±2197 3018±1499 4150±2214 3074±1652 3846±2221 2418±1343 4730±2431 2382±1380 4587±2029 
           
Subset 2 
Q1 
(2.6±0.6)
1
 
Q4 
(6.3±0.6) 
Q1 
(2.2±0.7) 
Q4 
(5.2±0.8) 
Q1 
(9.0±1.2) 
Q4 
(14.3±0.5) 
Q1 
(39.6±5.9) 
Q4 
(67.5±5.3) 
Q1 
(16.2±2.3) 
Q4 
(31.5±2.3) 
N  262 232 231 185 246 167 250 220 241 201 
Total energy (kcal/d)  1698±501 2121±597 1879±610 2020±590
a
 2283±843 1712±379 1736±564 1981±607 1399±350 2560±740 
Protein (% E) 17.9±3.0 17.3±2.5
a
 18.3±2.8 16.8±2.8 17.9±2.9 17.7±2.7
b
 17.5±2.8 17.7±2.8
b
 17.6±3.1 17.7±2.6
b
 
Carbohydrate (% E) 45.6±7.2 48.3±5.6 43.3±5.9 51.8±6.0 42.9±6.0 51.4±5.9 45.6±6.8 48.9±5.9 45.7±6.7 48.3±5.6
a
 
Fat (% E) 32.8±5.6 31.1±4.9
a
 35.8±4.5 27.6±4.6 36.8±4.6 26.0±3.5 33.0±5.6 29.9±5.1 32.2±5.6 31.4±5.0
b
 
Vitamin C (mg/d) 137±65.9 214±89.4 143±68.7 218±97.2 168±100 197±86.4
a
 122±56.4 231±91.2 118±51.9 248±107 
Vitamin D (μg/d) 2.17±1.04 3.00±1.40 2.72±1.43 2.51±1.25
b
 3.36±2.54 2.23±1.04 2.18±1.11 3.01±2.43 1.79±0.84 3.65±2.60 
Vitamin E (mg/d) 9.65±4.27 13.7±5.4 11.2±5.1 12.4±5.2
b
 13.4±7.5 10.1±3.4 8.67±3.97 14.2±6.2 7.52±2.81 15.8±6.8 
Magnesium (mg/d) 300±88.2 406±105 317±98.1 404±106 374±140 352±73.8
a
 286±80.4 408±109 250±57.5 472±116 
Potassium (mg/d) 3523±968 4467±1090 3687±1052 4446±1159 4324±1520 3918±772 3394±895 4448±1119 2944±626 5302±1264 
Selenium (μg/d) 41.3±12.7 61.9±21.4 49.4±16.6 54.6±20.4
b
 59.6±36.3 49.6±16.1 40.2±14.7 65.5±37.2 36.8±12.7 70.5±36.6 
Carotene (μg/d) 3371±2021 5139±2933 3677±2389 4686±2665
a
 4316±3088 4109±2154
b
 2933±1620 5401±2660 2909±1657 5759±4658 
1
 Values are means and standard deviations (SDs); P for trend < 0.001, except for those annotated as: a) P for trend between 0.0001 and 0.04, and b) P for trend > 0.05 
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Figure 5.1: Percentage difference in intake of different food groups between 
extreme quartiles of the five derived diet scores in Subset 1 (n=2570 women) from 
the TwinsUK cohort. Values are differences in means (unadjusted) from quartile 4 
to 1. Quartiles 1 and 4 differed significantly (P <0.05, ANOVA) for all variables 
except dairy products (HDI). 
 
 
Figure 5.2: Percentage difference in intake of different food groups between 
extreme quartiles of the five derived diet scores in Subset 2 (n=949 women) from 
the TwinsUK cohort. Values are differences in means (unadjusted) from quartile 4 
to 1. Quartiles 1 and 4 differed significantly (P <0.05, ANOVA) for all variables 
except dairy products (MDS, HDI, AHEI) and nuts (HDI). 
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Table 5.4 The associations between fat free mass (kg) and the derived diet scores 
quartiles in 2570 women from the TwinsUK cohort aged 18-79 years
1
 
 Fat free mass (kg) 
Quartiles Q1 Q2 Q3 Q4 
P for 
trend 
MDS (points) 
Unadjusted  
Adjusted model
2
 
2
3
 
38.99±0.21 
39.15±0.19 
4 
39.86±0.24 
39.64±0.21 
5 
40.15±0.27 
40.00±0.22 
6 
39.83±0.20 
39.92±0.18 
 
0.002 
0.001 
HDI (points) 
Unadjusted  
Adjusted model
2
 
2 
39.53±0.24 
39.45±0.21 
3 
39.61±0.21 
39.49±0.18 
4 
39.62±0.22 
39.65±0.19 
5 
39.88±0.24 
40.11±0.22 
 
0.313 
0.023 
DQI (points) 
Unadjusted  
Adjusted model
2
 
9 
39.05±0.24 
39.00±0.20 
12 
39.82±0.19 
39.84±0.17 
13 
40.04±0.29 
40.01±0.25 
14 
39.85±0.24 
39.89±0.21 
 
0.012 
0.002 
AHEI (points) 
Unadjusted  
Adjusted model
2
 
17 
38.96±0.23 
38.97±0.21 
21 
39.93±0.23 
39.76±0.20 
25 
40.03±0.22 
39.96±0.19 
30 
39.66±0.23 
39.93±0.21 
 
0.023 
0.001 
DASH-style 
(points) 
Unadjusted  
Adjusted model
2
 
36.5 
39.18±0.23 
39.35±0.23 
49.5 
39.25±0.23 
39.35±0.20 
54.5 
39.66±0.22 
39.70±0.20 
63.5 
40.50±0.23 
40.19±0.22 
 
<0.001 
  0.011 
1
 Values are means and SEM for fat free mass (kg) by quartiles of the derived diet scores  
2
 Adjusted for age (years), physical activity (inactive, moderately active, active), smoking 
status (never, current, former), energy intake (kcal/d) (only for MDS, AHEI, and DASH-style), 
and total body mass (kg) 
3 
Values are medians 
 
 
 
Table 5.5 The associations between percentage fat free mass and the derived diet 
scores quartiles in 2570 women from the TwinsUK cohort aged 18-79 years
1
 
 Percentage fat free mass 
Quartiles Q1 Q2 Q3 Q4 
P for 
trend 
MDS (points) 
Unadjusted  
Adjusted model
2
 
 
60.90±0.27 
60.92±0.25 
 
60.74±0.31 
60.59±0.28 
 
61.11±0.29 
61.07±0.26 
 
61.52±0.26 
61.62±0.24 
 
0.057 
0.018 
HDI (points) 
Unadjusted  
Adjusted model
2
 
 
60.54±0.27 
60.67±0.26 
 
60.84±0.25 
60.83±0.22 
 
61.13±0.28 
61.14±0.25 
 
62.09±0.30 
61.93±0.28 
 
<0.001 
  0.001 
DQI (points) 
Unadjusted  
Adjusted model
2
 
 
61.26±0.27 
60.96±0.25 
 
61.29±0.25 
61.26±0.23 
 
60.66±0.34 
61.01±0.32 
 
60.88±0.28 
61.05±0.25 
 
0.153 
0.985 
AHEI (points) 
Unadjusted  
Adjusted model
2
 
 
61.20±0.28 
60.87±0.26 
 
60.69±0.29 
60.74±0.26 
 
60.78±0.27 
61.00±0.24 
 
61.83±0.28 
61.87±0.30 
 
0.142 
0.007 
DASH-style 
(points) 
Unadjusted  
Adjusted model
2
 
 
61.28±0.28 
61.17±0.29 
 
60.86±0.28 
61.05±0.27 
 
61.32±0.26 
61.25±0.24 
 
60.91±0.30 
60.89±0.29 
 
0.580 
0.679 
1
 Values are means and SEM for percentage fat free mass by quartiles of the derived diet 
scores  
2
 Adjusted for age (years), physical activity (inactive, moderately active, active), smoking 
status (never, current, former), and energy intake (kcal/d) (only for MDS, AHEI, and DASH-
style) 
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Table 5.6 The associations between fat free mass index (kg/m
2
) and the derived 
diet scores quartiles in 2570 women from the TwinsUK cohort aged 18-79 years
1
 
 Fat free mass index (kg/m
2
) 
Quartiles Q1 Q2 Q3 Q4 
P for 
trend 
MDS (points) 
Unadjusted  
Adjusted model
2
 
 
14.86±0.07 
14.88±0.06 
 
15.09±0.08 
15.04±0.07 
 
15.15±0.09 
15.11±0.07 
 
15.05±0.06 
15.09±0.06 
 
0.039 
0.012 
HDI (points) 
Unadjusted  
Adjusted model
2
 
 
15.00±0.08 
14.95±0.07 
 
14.99±0.07 
14.95±0.06 
 
15.06±0.07 
15.07±0.06 
 
15.06±0.07 
15.15±0.07 
 
0.451 
0.015 
DQI (points) 
Unadjusted  
Adjusted model
2
 
 
14.79±0.08 
14.79±0.07 
 
15.02±0.06 
15.03±0.05 
 
15.29±0.10 
15.26±0.09 
 
15.12±0.07 
15.13±0.07 
 
<0.001 
<0.001 
AHEI (points) 
Unadjusted  
Adjusted model
2
 
 
14.83±0.08 
14.85±0.07 
 
15.13±0.07 
15.07±0.07 
 
15.17±0.07 
15.14±0.06 
 
15.00±0.07 
15.04±0.07 
 
0.190 
0.028 
DASH-style 
(points) 
Unadjusted  
Adjusted model
2
 
 
14.87±0.07 
14.86±0.07 
 
14.95±0.07 
14.94±0.07 
 
15.00±0.08 
15.04±0.07 
 
15.27±0.07 
15.25±0.07 
 
<0.001 
<0.001 
1
 Values are means and SEM for fat free mass index by quartiles of the derived diet scores  
2
 Adjusted for age (years), physical activity (inactive, moderately active, active), smoking 
status (never, current, former), energy intake (kcal/d) (only for MDS, AHEI, and DASH-style), 
and total body mass (kg) 
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Table 5.7 Relative associations between diet quality scores, lifestyle characteristics and fat free mass indices in 2570 women aged 18-79 years  
 MDS HDI DQI AHEI DASH-style 
Fat free mass (kg) ß SEM P ß SEM P ß SEM P ß SEM P ß SEM P 
Diet score per quartile 0.27 0.08 0.001 0.22 0.09 0.017 0.28 0.09 0.002 0.31 0.09 0.001 0.28 0.11 0.012 
Age (per 10 y) -1.16 0.09 <0.001 -1.16 0.09 <0.001 -1.19 0.09 <0.001 -1.17 0.09 <0.001 -1.17 0.09 <0.001 
Smoking habit 
Current v never 
Former v never  
 
1.19 
0.80 
 
0.26 
0.23 
 
<0.001 
<0.001 
 
1.09 
0.79 
 
0.26 
0.23 
 
<0.001 
0.001 
 
1.15 
0.78 
 
0.26 
0.23 
 
<0.001 
0.001 
 
1.21 
0.83 
 
0.26 
0.23 
 
<0.001 
<0.001 
 
1.17 
0.86 
 
0.26 
0.23 
 
<0.001 
<0.001 
Physical activity 0.71 0.15 <0.001 0.74 0.15 <0.001 0.74 0.15 <0.001 0.67 0.15 <0.001 0.70 0.15 <0.001 
Energy intake (per 1000 cal) 0.59 0.19 0.002 Not adjusted for energy intake 0.66 0.19 0.001 0.37 0.24 0.114 
Total body mass (kg) 0.32 0.02 <0.001 0.33 0.02 <0.001 0.32 0.02 <0.001 0.32 0.02 <0.001 0.32 0.02 <0.001 
Percentage fat free mass                
Diet score per quartile  0.26 0.11 0.016 0.41 0.11 <0.001 0.009 0.11 0.934 0.32 0.12 0.007 -0.07 0.15 0.637 
Age (per 10 y) -1.85 0.12 <0.001 -1.84 0.11 <0.001 -1.85 0.12 <0.001 -1.88 0.12 <0.001 -1.86 0.12 <0.001 
Smoking habit 
Current v never 
Former v never  
 
1.11 
-0.08 
 
0.34 
0.29 
 
0.001 
0.786 
 
1.11 
-0.05 
 
0.34 
0.29 
 
0.001 
0.855 
 
1.06 
-0.03 
 
0.34 
0.29 
 
0.002 
0.909 
 
1.12 
-0.05 
 
0.34 
0.29 
 
0.001 
0.863 
 
1.00 
-0.04 
 
0.34 
0.29 
 
0.004 
0.895 
Physical activity 1.38 0.19 <0.001 1.37 0.19 <0.001 1.40 0.19 <0.001 1.34 0.19 <0.001 1.39 0.19 <0.001 
Energy intake (per 1000 cal) -0.06 0.25 0.801 Not adjusted for energy intake  0.02 0.25 0.928 0.20 0.32 0.526 
Fat free mass index (kg/m
2
)                
Diet score per quartile 0.07 0.03 0.012 0.07 0.03 0.013 0.11 0.03 <0.001 0.07 0.03 0.028 0.12 0.04 0.001 
Age (per 10 y) -0.18 0.03 <0.001 -0.19 0.03 <0.001 -0.19 0.03 <0.001 -0.19 0.03 <0.001 -0.19 0.03 <0.001 
Smoking habit 
Current v never 
Former v never  
 
0.41 
0.18 
 
0.08 
0.08 
 
<0.001 
0.018 
 
0.40 
0.19 
 
0.08 
0.08 
 
<0.001 
0.015 
 
0.42 
0.18 
 
0.08 
0.08 
 
<0.001 
0.018 
 
0.41 
0.19 
 
0.08 
0.08 
 
<0.001 
0.012 
 
0.42 
0.20 
 
0.08 
0.08 
 
<0.001 
0.009 
Physical activity 0.18 0.05 0.001 0.18 0.05 <0.001 0.18 0.05 0.001 0.17 0.05 0.001 0.17 0.05 0.001 
Energy intake (per 1000 cal) 0.06 0.06 0.387 Not adjusted for energy intake 0.07 0.07 0.276 -0.08 0.08 0.340 
Total body mass (kg) 0.10 0.006 <0.001 0.11 0.006 <0.001 0.10 0.006 <0.001 0.11 0.006 <0.001 0.10 0.006 <0.001 
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Table 5.8 The associations between hand grip strength (kg) and the derived diet 
scores quartiles in 949 women from the TwinsUK cohort aged 34-83 years
1
 
 Hand grip strength (kg) 
Quartiles Q1 Q2 Q3 Q4 
P for 
trend 
MDS (points) 
Unadjusted  
Adjusted model
2
 
 
28.49±0.40 
29.03±0.33 
 
28.37±0.40 
28.46±0.33 
 
28.27±0.44 
28.24±0.37 
 
29.93±0.41 
29.26±0.34 
 
0.023 
0.824 
HDI (points) 
Unadjusted  
Adjusted model
2
 
 
28.60±0.41 
29.00±0.33 
 
28.51±0.38 
28.65±0.30 
 
29.30±0.41 
29.07±0.36 
 
28.72±0.41 
28.24±0.37 
 
0.441 
0.292 
DQI (points) 
Unadjusted  
Adjusted model
2
 
 
28.73±0.43 
28.88±0.34 
 
28.53±0.32 
28.64±0.25 
 
29.54±0.56 
29.12±0.50 
 
28.59±0.47 
28.52±0.41 
 
0.723 
0.758 
AHEI (points) 
Unadjusted  
Adjusted model
2
 
 
28.36±0.39 
28.62±0.33 
 
29.22±0.41 
29.32±0.34 
 
28.36±0.41 
28.45±0.35 
 
29.10±0.45 
28.60±0.38 
 
0.458 
0.557 
DASH-style 
(points) 
Unadjusted  
Adjusted model
2
 
 
28.62±0.42 
29.01±0.39 
 
28.47±0.41 
28.63±0.36 
 
29.43±0.41 
29.08±0.33 
 
28.36±0.39 
28.18±0.42 
 
0.796 
0.442 
1 
Values are means and SEM for hand grip strength (kg) by quartiles of the derived diet 
scores 
2 
Adjusted for age (years), physical activity (inactive, moderate active, active), current 
smoking (yes/no), energy intake (kcal/d) (only for MDS, AHEI and DASH-style), menopausal 
status (premenopausal/postmenopausal) and HRT use (yes/no)   
 
 
 
Table 5.9 The associations between muscle quality (kg/kg) and the derived diet 
scores quartiles in 949 women from the TwinsUK cohort aged 34-83 years
1
 
 Muscle quality (kg/kg) 
Quartiles Q1 Q2 Q3 Q4 
P for 
trend 
MDS (points) 
Unadjusted  
Adjusted model
2
 
 
0.69±0.01 
0.70±0.01 
 
0.68±0.01 
0.68±0.01 
 
0.67±0.01 
0.67±0.01 
 
0.71±0.01 
0.70±0.01 
 
0.202 
0.937 
HDI (points) 
Unadjusted  
Adjusted model
2
 
 
0.68±0.01 
0.69±0.01 
 
0.69±0.01 
0.69±0.01 
 
0.70±0.01 
0.70±0.01 
 
0.69±0.01 
0.67±0.01 
 
0.457 
0.337 
DQI (points) 
Unadjusted  
Adjusted model
2
 
 
0.69±0.01 
0.69±0.01 
 
0.69±0.01 
0.69±0.01 
 
0.70±0.01 
0.70±0.01 
 
0.68±0.01 
0.68±0.01 
 
0.933 
0.516 
AHEI (points) 
Unadjusted  
Adjusted model
2
 
 
0.68±0.01 
0.68±0.01 
 
0.69±0.01 
0.70±0.01 
 
0.68±0.01 
0.68±0.01 
 
0.70±0.01 
0.69±0.01 
 
0.384 
0.765 
DASH-style 
(points) 
Unadjusted  
Adjusted model
2
 
 
0.70±0.01 
0.70±0.01 
 
0.69±0.01 
0.69±0.01 
 
0.70±0.01 
0.70±0.01 
 
0.67±0.01 
0.66±0.01 
 
0.150 
0.034 
1 
Values are means and SEM for hand grip strength (kg) by quartiles of the derived diet 
scores 
2 
Adjusted for age (years), physical activity (inactive, moderate active, active), current 
smoking (yes/no), energy intake (kcal/d) (only for MDS, AHEI and DASH-style), menopausal 
status (premenopausal/postmenopausal) and HRT use (yes/no)   
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Table 5.10 Relative associations between diet quality scores, lifestyle characteristics and muscle strength and muscle quality in 949 women aged 34-83 years  
 
MDS HDI DQI AHEI DASH-style 
ß SEM P ß SEM P ß SEM P ß SEM P ß SEM P 
Hand grip 
strength (kg) 
               
Diet score per 
quartile 
0.03 0.15 0.826 -0.16 0.16 0.294 -0.05 0.17 0.749 -0.09 0.16 0.558 -0.16 0.21 0.440 
Age (per 10 y) -2.70 0.22 <0.001 -2.70 0.22 <0.001 -2.70 0.22 <0.001 -2.70 0.22 <0.001 -2.70 0.22 <0.001 
Current smoking 
yes v no 
 
-0.25 
 
0.57 
 
0.665 
 
-0.33 
 
0.57 
 
0.565 
 
-0.28 
 
0.57 
 
0.624 
 
-0.30 
 
0.57 
 
0.600 
 
-0.29 
 
0.57 
 
0.616 
Physical activity 0.49 0.21 0.020 0.49 0.21 0.018 0.49 0.21 0.018 0.51 0.21 0.018 0.51 0.21 0.016 
Height (cm) 0.27 0.03 <0.001 0.27 0.03 <0.001 0.27 0.03 <0.001 0.27 0.03 <0.001 0.27 0.03 <0.001 
Energy intake (per 
1000 cal) 
 
-0.03 
 
0.27 
 
0.912 
 
Not adjusted for energy intake 
 
0.01 
 
0.27 
 
0.971 
 
0.16 
 
0.35 
 
0.647 
Menopausal status 
postmenopausal v 
premenopausal  0.75 0.70 0.281 0.75 0.69 0.278 0.76 0.70 0.277 0.76 0.70 0.278 0.75 0.70 0.283 
HRT 
yes v no 
 
-0.29 
 
0.60 
 
0.630 
 
-0.31 
 
0.60 
 
0.603 
 
-0.29 
 
0.59 
 
0.623 
 
-0.29 
 
0.59 
 
0.621 
 
-0.27 
 
0.59 
 
0.647 
Muscle quality 
(kg/kg) 
  
 
  
 
  
 
      
Diet score per 
quartile  
0.0003 0.004 0.934 -0.004 0.004 0.339 -0.003 0.004 0.507 0.001 0.004 0.763 -0.01 0.005 0.034 
Age (per 10 y) -0.06 0.006 <0.001 -0.06 0.006 <0.001 -0.06 0.006 <0.001 -0.06 0.006 <0.001 -0.06 0.006 <0.001 
Current smoking 
yes v no 
 
0.00001 
 
0.01 
 
0.999 
 
-0.002 
 
0.01 
 
0.909 
 
-0.001 
 
0.01 
 
0.928 
 
0.0007 
 
0.01 
 
0.962 
 
-0.002 
 
0.01 
 
0.887 
Physical activity 0.008 0.005 0.159 0.008 0.005 0.156 0.008 0.005 0.154 0.007 0.005 0.186 0.009 0.005 0.102 
Height (cm) -0.0006 0.0009 0.465 -0.0007 0.0009 0.434 -0.0006 0.0009 0.455 -0.0006 0.0009 0.459 -0.0006 0.0009 0.482 
Energy intake (per 
1000 cal) 
 
-0.003 
 
0.007 
 
0.668 
 
Not adjusted for energy intake 
 
-0.003 
 
0.007 
 
0.622 
 
0.009 
 
0.009 
 
0.348 
Menopausal status 
postmenopausal v 
premenopausal  0.02 0.02 0.264 0.02 0.02 0.255 0.02 0.02 0.249 0.02 0.02 0.268 0.02 0.02 0.259 
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HRT 
yes v no 
 
-0.002 
 
0.01 
 
0.887 
 
-0.002 
 
0.01 
 
0.866 
 
-0.002 
 
0.01 
 
0.884 
 
-0.002 
 
0.01 
 
0.881 
 
-0.001 
 
0.01 
 
0.958 
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Chapter 6 
Associations between micronutrients, 
protein, essential amino acid intakes and 
C-reactive protein levels
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6.0 Introduction 
Inflammation and inflammatory cytokines are associated with muscle loss, 
as described in Chapter 1 (section 1.4, p. 32) and C-reactive protein (CRP) 
is the most commonly studied marker of inflammation (Heinrich et al. 
1990). Diet is one factor that plays a major role in the regulation of chronic 
inflammation as dietary constituents have the potential to exert anti-
inflammatory as well as pro-inflammatory effects (Cavicchia et al. 2009). 
Diverse dietary components, such as vitamins C, E and D, magnesium, 
potassium and selenium, and carotenoids exert anti-inflammatory effects via 
a range of mechanisms including decreasing inflammatory mediator 
production through effects on cell signalling and gene expression and by 
reducing production of oxidants (Calder et al. 2009). Therefore, the 
relationship between a range of dietary factors and C-reactive protein was 
investigated in the TwinsUK cohort. 
 
Nutrition may contribute to the regulation of the uncontrolled inflammatory 
processes, help with the maintenance and control of homeostasis and 
potentially reduce the risk of disease (Calder et al. 2009). Vitamin C, in the 
form of ascorbic acid, which is its functional form, is involved in the 
inflammatory process and immune mechanisms possibly through its ability 
to scavenge a variety of reactive oxygen and nitrogen species (Carr and Frei 
1999).  Vitamin E acts mainly in the lipid phase by interrupting lipid and 
especially unsaturated fatty acids’ peroxidation (Kamal-Eldin and 
Appelqvist 1996). The constituents of vitamin E are α- and γ-tocopherol, 
which have different functions. Specifically, α-tocopherol acts as an 
 199 
 
inhibitor of lipid peroxidation and protects LDL particles from oxidation 
(Winklhofer-Roob et al. 2003). However, γ-tocopherol can decrease 
markers of oxidative stress, such as LDL oxidation and superoxides and is 
potentially more effective than α-tocopherol (Liu et al. 1999, Saldeen et al. 
1999). In relation to vitamin D, there is evidence that 1-alpha, 25-
Dihydroxyvitamin D(3) [1,25-(OH)(2)D(3)], the active metabolite of 
vitamin D(3) acts as an inhibitor of the inflammatory response (Nagpal et al. 
2005). Moreover, low vitamin D concentrations have been associated with 
an increased risk of developing rheumatoid arthritis (Hillman et al. 1994), 
multiple sclerosis (Munger et al. 2004) and type I diabetes (Mathieu and 
Badenhoop 2005).  
 
Although there is currently limited evidence for an anti-inflammatory effect 
of potassium intake in humans, there is evidence of the anti-inflammatory 
effect of three potassium salts of N,N-disubstituted 4-
aminoazobenzenesulfonic acids in rats with adjuvant arthritis (Kazemekaite 
et al. 2008). Magnesium is an essential micronutrient which acts as a 
cofactor in multiple enzymatic reactions in the human body. Notably, there 
are a number of studies indicating an inverse association between dietary 
magnesium intake and metabolic and inflammatory conditions, such as 
hypertension (Song et al. 2006), metabolic syndrome (He et al. 2006), 
insulin resistance (Paolisso and Barbagallo 1997), type 2 diabetes (Song et 
al. 2004), dyslipidemia (Song et al. 2005), and cardiovascular disease (Al-
Delaimy et al. 2004). These findings are supported by experimental data 
from animal studies indicating that dietary magnesium deficiency may 
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induce an inflammatory response (Malpuech-Brugere et al. 2000). Although 
there are findings from observational and animal studies, the underlying 
biological mechanisms for such metabolic effects of magnesium are not yet 
entirely clear. Also, selenium is a cofactor of peroxidases and detoxifies 
lipid peroxides, instead of scavenging free radicals or interrupting 
peroxidation chain reactions (Paolisso et al. 1999) as other nutrients with 
potential anti-inflammatory action do. This may have a different impact on 
blood CRP concentrations in response to dietary intake of selenium, which 
remains to be elucidated in in vitro and in vivo studies. Moreover, selenium 
may also inhibit the activation of the nuclear factor kappa-B (NF-kB), which 
is a signaling pathway that has been associated with increased inflammatory 
response and its activation has been associated with the production of pro-
inflammatory cytokines, such as interleukin-6 (IL-6) and tumor necrosis 
factor-α (TNF- α) (Duntas 2009). 
 
Dietary carotenoids may also scavenge free radicals, which are produced 
intracellularly during the oxidative processes and particularly α- and β-
carotene are part of cell membranes constituted of two lipid layers (Olson 
1999). Consequently, lower levels of these carotenoids can result to 
increased lipid oxidation and potentially to modulation of inflammation 
(Blackwell and Christman 1997, Kontush et al. 2000). 
 
In addition, it has been recently suggested that the pro-inflammatory status 
of muscle cells, observed in ageing but also in pathological conditions (such 
as cancer and sepsis) could be modulated by the branched-chain amino acids 
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(BCAAs) particularly leucine, which has been suggested to enhance protein 
translation initiation and thus attenuates proteolysis, contributing to negative 
protein turnover (Nicastro et al. 2012). Moreover, under inflammatory 
conditions, leucine may indirectly attenuate inflammation through 
transamination to glutamate and further activation of glutamine synthesis (a 
conditionally essential amino acid) (Nicastro et al. 2012). This may be 
explained by the fact that glutamine may play a major role on the NF-kB 
signaling pathway, attenuating local inflammation (Fillmann et al. 2007, 
Hubert-Buron et al. 2006). Glutamine is a substrate that is used by 
inflammatory cells, such as macrophages, under pathological conditions 
(Pithon-Curi et al. 2004). However, this process usually occurs only in 
situations of increased need of glutamine synthesis. Arginine plays an 
important role in multiple metabolic processes, including modulation of 
immune function (Wu and Morris 1998). Arginine is also considered as a 
conditionally essential amino acid as the endogenous synthesis of arginine 
may not be sufficient to meet the metabolic needs of the organism, 
particularly in infants and children during growth (Wu et al. 2004), and in 
acute catabolic conditions, including sepsis (Argaman et al. 2003) and burns 
(Yu et al. 1996). It is noteworthy that dietary protein and essential amino 
acid intakes play a major role in various chronic (such as cancer and chronic 
obstructive pulmonary disease) and acute disease (such as sepsis and burn 
injury) states, where inflammation is present and protein catabolism is 
enhanced (Jonker et al. 2012). These diseases are related to low protein 
synthesis, loss of body protein pool and enhanced skeletal muscle wasting. 
Therefore, it has been argued that modifying the protein and essential amino 
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acid content of the diet may positively affect the balance of muscle protein 
synthesis and breakdown, and may activate muscle protein anabolism in 
chronic and acute disease states (Eley et al. 2007, Jonker et al. 2012, Peters 
et al. 2011).  
      
The most common studied marker of inflammation is C-reactive protein 
(CRP), which is an acute phase protein and which increases dramatically 
during an acute phase response in man (Heinrich et al. 1990). CRP is 
synthesised in the liver, and may be mediated by a number of cytokines, but 
mainly IL-6 (Shoelson et al. 2007). In addition to liver derived CRP, data 
have shown that adipose tissue itself may contribute to obesity associated 
increases in CRP levels (Berg and Scherer 2005). It has also been reported 
that CRP levels are higher in obese individuals who are insulin resistant and 
decrease with weight loss and improvement in insulin sensitivity (Kopp et 
al. 2003, McLaughlin et al. 2002). Conversely,  IL-6 production by human 
adipose tissue increases with obesity and may induce  hepatic CRP synthesis 
and promote the onset of insulin resistance (Bastard et al. 2006, de Luca and 
Olefsky 2008). The association between elevated levels of circulating CRP 
and increased cardiovascular risk from observational data is quite robust 
with more than 20 prospective  studies, to date, providing evidence that 
high-sensitivity CRP is an independent predictor of a number of CVD 
events, such as myocardial infarction, stroke, peripheral arterial disease, and 
sudden cardiac death, even in apparently healthy subjects (Calabrò et al. 
2009).  
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Although several observational studies have examined associations between 
plasma/serum nutrient levels (Boekholdt et al. 2006, Erlinger TP et al. 2001, 
Ford et al. 2003, Kritchevsky et al. 2000, van Herpen-Broekmans et al. 
2004, Walston et al. 2006, Wang et al. 2008, Wannamethee et al. 2006), 
intake of supplements with potential antioxidant properties (Chacko et al. 
2011, Scheurig et al. 2008) and different inflammatory markers, including 
CRP, there are few studies to date which have examined associations 
between habitual dietary intake and the inflammatory marker CRP (Chacko 
et al. 2010, de Oliveira Otto et al. 2011, Floegel et al. 2011, Helmersson et 
al. 2009, Song et al. 2007). It is thought that nutrient biomarkers may 
provide a stronger association with disease outcomes than those based on 
dietary assessments due to measurement errors occurring with dietary 
questionnaires (Giovannucci 2013). However, it is also argued that blood 
concentrations of nutrients may reflect other exposures (such as smoking 
and alcohol consumption) (Dietrich et al. 2003), and genetic , physiological, 
metabolic (Lee et al. 2012) and pathophysiological processes (Giovannucci 
2013, Zhang et al. 2012). Therefore, in order to investigate the beneficial 
health effects of nutrients with potential anti-inflammatory properties it is 
also important that epidemiological studies examine associations between 
the habitual intake of specific nutrients and markers of disease outcomes, 
such as CRP. 
 
One previous prospective study among 704 men from the Uppsala 
Longitudinal Study of Adult Men (ULSAM) aged 70 years at baseline found 
that dietary intake of ascorbic acid and α-tocopherol were inversely 
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associated with plasma high-sensitive CRP (hsCRP) at baseline and after 7 
years of follow-up. However, higher β-carotene intake was not associated 
with hsCRP at baseline and the authors do not provide any data of 
associations at follow-up (Helmersson et al. 2009). Four cross-sectional 
studies have examined associations between the habitual dietary intake of 
different nutrients including vitamins C and E, total carotene, β-carotene, 
selenium and magnesium and blood CRP concentrations (Chacko et al. 
2010, de Oliveira Otto et al. 2011, Floegel et al. 2011, Song et al. 2007). 
The Multiethnic-Ethnic Study of Atherosclerosis (MESA) among 5181 men 
and women aged 45 to 84 years found no significant associations between 
vitamins C and E, magnesium and β-carotene  intakes and the inflammatory 
marker CRP (de Oliveira Otto et al. 2011). However, in the National Health 
and Nutrition Examination Survey (NHANES) among 8335 US adults aged 
≥ 19 years old, it was observed that higher vitamin C, E, and total carotene 
intakes were inversely associated with the odds of increased serum CRP 
concentrations, after adjustment for age, gender, ethnicity, total energy 
intake and BMI (Floegel et al. 2011). Also, higher habitual magnesium 
intake has been inversely associated with plasma CRP concentrations in 
women from both the Nurse’s Health Study (NHS) cohort (Song et al. 2007) 
and the Women’s Health Initiative Observational Study (WHI-OS) cohort 
(Chacko et al. 2010) who were aged 43 to 69 years and 50 to 79 years, 
respectively. However, to our knowledge, there are currently no studies 
examining associations between a more complete range of nutrients and 
protein and essential amino acids with potential anti-inflammatory 
properties and the global inflammatory marker of CRP.     
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6.1 Aims 
The aims were to test the hypothesis that habitual dietary intake of a range 
of micronutrients with the potential to act against oxidative stress and with 
potential anti-inflammatory properties (shown in Table 6.1) are inversely 
associated with C-reactive protein (CRP) levels, among women aged 18-79 
years from the TwinsUK cohort. Additionally, to examine the hypothesis 
that habitual dietary intake of protein and essential amino acids, which have 
been previously shown to influence inflammation, are inversely associated 
with C-reactive protein (CRP) in the same subset of the TwinsUK cohort. In 
addition to the nine essential amino acids (histidine, leucine, isoleucine, 
lysine, methionine, phenylalanine, threonine, tryptophan, and valine) two 
conditionally essential amino acids were included (arginine and glutamine) 
as shown in Table 6.1, as they were previously shown to modulate 
inflammation (section 6.0, p. 198).    
 
The nutrients included are presented in (Table 6.1). 
Table 6.1 Nutrients included in the analysis 
Vitamins Minerals Carotenoids Macronutrients  Amino acids  
Vitamin C (mg/d) Magnesium 
(mg/d) 
-carotene (µg/d) Protein (% En/d) Arginine (% En/d) 
Vitamin E (mg/d) Potassium 
(mg/d) 
ß-carotene (µg/d)  Glutamine (% En/d) 
Vitamin D (µg/d) Selenium (µg/d) Total carotene (µg/d)  Histidine (% En/d) 
  ß-cryptoxanthin (µg/d)  Isoleucine (% En/d) 
  Lycopene (µg/d)  Leucine (% En/d) 
  Lutein (µg/d)  Lysine (% En/d) 
  Zeaxanthin (µg/d)  Methionine (% En/d) 
    Phenylalanine (% En/d) 
    Threonine (% En/d) 
    Tryptophan (% En/d) 
    Valine (% En/d) 
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6.2 Covariate plan and statistical analysis 
All analyses were performed using STATA statistical software (version 
11.0; STATA Corp, USA). Means and standard deviations were calculated 
(Table 6.2) and quintiles of each micronutrient, protein and essential amino 
acid intakes were derived. The analyses were performed treating twins as 
individuals as previous studies have shown that participants from the 
TwinsUK registry were similar to age-matched singleton women in the 
distribution of common traits and outcomes (Andrew et al. 2001). Data on 
dietary intake (FFQ), body composition parameters, and other covariates 
were available for n = 1658 women, aged 18 to 79 years representing 582 
monozygotic (MZ) and 1076 dizygotic (DZ) females who had completed a 
food frequency questionnaire (FFQ) and had fasting blood samples taken to 
measure C-reactive protein (CRP) between 1996 and 2000 (Moayyeri et al. 
2012, Teucher et al. 2007). 
 
Prior to conducting statistical analysis, an analysis plan with justification for 
each confounding factor in the multivariate model was developed as 
described in Chapter 2, section 2.2.5, p. 57. Multivariate regression analysis 
was used to assess associations between micronutrient, protein and essential 
amino acid intakes and plasma CRP concentrations using the robust cluster 
regression option in STATA. These models take into account clustering of 
individuals when calculating standard errors of the mean (Richards et al. 
2007) to ensure familial aggregation within twin pairs was accounted for. 
The plasma concentration of CRP was transformed and analyzed on the 
natural logarithmic scale in order to meet the criterion of normality for the 
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linear models. Values were subsequently back transformed into geometric 
means and 95% confidence intervals (CI) for presentation. Amino acid 
intakes were expressed as percentage of energy intake rather than total 
intakes to enable comparisons between people with different total food and 
energy intakes. 
 
As ageing has been strongly associated with an increased low-grade 
inflammatory status all analyses were adjusted for age (years) (Chung et al. 
2009). Models were also adjusted for physical activity and smoking status, 
as physical activity has been suggested to exert anti-inflammatory properties 
(Gleeson et al. 2011, Petersen and Pedersen 2005) and smoking has been 
suggested to increase inflammation (Lee et al. 2012). Energy intake (kcal/d) 
was also included in the multivariate models. Additional adjustments were 
made for body mass index (kg/m
2
), hormone replacement therapy use 
(HRT) and anti-inflammatory medication (including statins, non-steroid 
anti-inflammatory drugs and aspirin) (no or yes, respectively) as these 
factors have been previously shown to affect inflammatory status and may 
mediate the relationship between diet quality and CRP (Chapter 2, section 
2.2.5, p. 64, 66, 68) (Tables 6.3 and 6.4). 
 
6.3 Results 
Descriptive characteristics of this subset (n = 1658 women, aged 18-79 
years) of the TwinsUK participants are presented in Table 6.2. The mean 
age (±SD) of participants was 49.7 ± 12.5 years and mean (±SD) BMI was 
24.9 ± 4.0 kg/m
2
. Mean (±SD) plasma CRP concentrations were 2.49 ± 2.30 
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mg/L. More than one-half of the participants were moderately active (54.8 
%), and 16.7 % were current smokers. Relatively few participants were 
taking anti-inflammatory medication (6.2 %) or hormone replacement 
therapy (6.3 %). Mean (±SD) energy intake was 1976 ± 512 kcal/d (Table 
6.2). 
 
Micronutrient intake and plasma CRP concentrations (mg/L) 
In multivariate analyses, a higher magnesium intake was associated with 
lower plasma CRP concentrations with a difference in CRP of 0.46 mg/L 
between the highest [mean (SD): 480 (61) mg/d] and lowest [mean (SD): 
232 (30) mg/d] quintiles of intake (P for difference < 0.051). No other 
statistically significant associations were observed for the other nutrients 
although there were trends towards lower CRP with higher nutrient intake 
with vitamin C, vitamin E and potassium   (Table 6.3).  
 
Protein, amino acid intake and plasma CRP concentrations (mg/L) 
In the multivariate model, a higher intake of arginine, glutamine, histidine, 
isoleucine, threonine and tryptophan (as % energy) was associated with 
higher plasma CRP concentrations with a difference of 0.3 mg/L between 
extreme quintiles of intake (P for difference < 0.05 for arginine, glutamine, 
threonine and tryptophan; and P = 0.05 for histidine and isoleucine). There 
were also trends towards significance for leucine, lysine, methionine and 
valine in the same direction as the other amino acids. No associations were 
observed for protein and phenylalanine although the trends were in the same 
direction as the other amino acids (Table 6.4).  
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6.4 Discussion 
In this study using a large cross-sectional population-based sample of 
women aged 18-79 years we evaluated the association between a range of 
micronutrients, protein and essential amino acids and the inflammatory 
marker CRP. This is one of the first cross-sectional studies to examine a 
range of micronutrients and CRP. It is also the first population-based study 
to examine associations between habitual dietary intake of protein and 
essential amino acids in association with a potential predictor of sarcopenia 
risk in a cohort of women across a wide age range. This study observed that 
higher consumption of magnesium was associated with lower plasma levels 
of CRP. It was also observed that higher intakes of arginine, glutamine, 
histidine, isoleucine, threonine and tryptophan were positively associated 
with mean plasma levels of CRP. A few previous studies have evaluated the 
associations between the habitual dietary intake of nutrients including 
vitamins C and E, total carotene, β-carotene (de Oliveira Otto et al. 2011, 
Floegel et al. 2011, Helmersson et al. 2009), and magnesium (Chacko et al. 
2010, Song et al. 2007) and the inflammatory marker CRP, but they did not 
include a full range of micronutrients and carotenoids with potential anti-
inflammatory properties. In addition, there are currently no studies 
evaluating the influence of protein and essential amino acid intakes on 
inflammation.  
 
Micronutrient intake and plasma CRP concentrations (mg/L) 
The current study observed a significant inverse association between higher 
intake of magnesium and the inflammatory marker CRP. The magnitude of 
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the association was a difference of 0.46 mg/L or 25 % in plasma geometric 
mean CRP (P = 0.051) between the highest [mean (SD): 480 (61) mg/d] and 
the lowest [mean (SD): 232 (30) mg/d] quintiles of intake. This association 
was observed after adjustments for age, physical activity, smoking, energy 
intake, anti-inflammatory medication (including aspirin, statins, and 
NSAID) and HRT use and was independent of adiposity (assessed by BMI).  
 
Findings were of a similar magnitude to a previous cross-sectional study 
reporting that higher habitual intake of magnesium was inversely associated 
with plasma concentrations of CRP by 24 % (P = 0.03) among women from 
the Nurse’s Health Study (NHS) cohort aged 43 to 69 years (Song et al. 
2007). Findings from the current analysis were also of a similar trend, 
although of a lower magnitude, to another previous cross-sectional study 
among a multiethnic sample of postmenopausal women from the Women’s 
Health Initiative Observational Study (WHI-OS), aged 50 to 79 years 
(Chacko et al. 2010). The study by Chacko et al. observed an inverse 
association between dietary magnesium intake and plasma concentrations of 
high-sensitive CRP (hsCRP) with a difference of 30 % between highest and 
lowest quintiles of intake (P = 0.005). The  difference between the 
TwinsUK study and that of Chacko et al. may be explained by the fact that 
the women were in a narrower age range with more people in the older age 
groups compared to the current cohort (18-79 years) and low-grade chronic 
inflammation is known to increase with age (Chung et al. 2009, Khansari et 
al. 2009, Woods et al. 2012). Moreover, women from the WHI-OS cohort 
were generally more overweight compared to women from the current 
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analysis. Interestingly, when stratified by race/ethnicity, mean BMI in the 
WHI-OS cohort was 29 kg/m
2
 in white women, 31 kg/m
2
 in African 
American, and 29 kg/m
2
 in Hispanic/Latino women (Chacko et al. 2010) 
compared to the current analysis where mean BMI (24.9 kg/m
2
) was within 
the normal range. It is well established that the adipose tissue secretes a 
number of pro-inflammatory cytokines, such as interleukin-6 (IL-6), which 
further triggers the hepatic synthesis of CRP (Santos et al. 2005, Tilg and 
Moschen 2006, You et al. 2008). Also, it has been shown in vitro that 
mature adipocytes isolated from human adipose tissue were directly 
involved in the release of CRP (Calabro et al. 2005). In addition, mean CRP 
in the WHI-OS cohort was almost two times higher (5.01 mg/L in white 
women, 5.91 mg/L in African American and 4.66 mg/L in Hispanic/Latino 
women) compared to mean CRP in women from the current analysis (2.49 
mg/L). These data suggest that higher magnesium intake may be more 
beneficial among populations with higher plasma CRP concentrations who 
are predisposed to systemic inflammation.  
 
In the current study we did not observe any association between habitual 
intakes of vitamins C and E and plasma CRP concentrations, although there 
are only two previous epidemiological studies (Floegel et al. 2011, 
Helmersson et al. 2009) that observed an inverse association. One of these 
studies was a prospective study among 704 men which observed that dietary 
intakes of ascorbic acid and α-tocopherol were inversely associated with 
plasma CRP concentrations over 7 years follow-up (β coefficient = - 0.14 
and – 0.15, P < 0.001, respectively) after adjustments for BMI, diabetes, 
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hyperlipideamia, hypertension and smoking (Helmersson et al. 2009). 
However, the authors do not provide any information about the mean age of 
participants or about the magnitude of association when plasma CRP 
concentrations were analysed across quartiles of ascorbic acid and α-
tocopherol at follow-up. Also, the analysis was conducted among men and it 
therefore does not allow a direct comparison with our female study. Of 
interest, the study from Helmersson et al. used a 7-day pre-coded food 
record to assess dietary intake when participants were 70 years old and data 
on plasma CRP were taken 7 years later. Therefore, dietary assessment and 
inflammatory status assessment were conducted at different time points, 
which may introduce error.  
 
The second study was a cross-sectional examination among 8335 women 
(50.6 %) and men aged ≥ 19 years from the National Health and Nutrition 
Examination Survey (NHANES) 1999-2002 (Floegel et al. 2011). Results 
from this study showed that intakes of vitamins C and E were inversely 
associated with the probability of having serum CRP concentrations more 
than 3 mg/L in multivariate logistic regression models adjusted for age, 
gender, ethnicity, total energy intake and BMI (OR = 0.74, 95% CI 0.62, 
0.88, P < 0.001). Moreover, intakes of vitamins C and E were assessed by 
one 24h dietary recall in comparison to the current study that used an FFQ, 
which reflects the habitual dietary intake over a period of time and hence 
there were differences in the mean intakes of vitamin C and E between the 
two studies. Of interest the median vitamin C intake in the first quintile of 
intake was 11.7 mg/d in the Floegel et al. study (Floegel et al. 2011) 
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compared to 72.3 mg/d in the current analysis. Although our cohort adjusted 
for a number of covariates that may mediate the association between intakes 
of vitamins C and E and the inflammatory marker CRP, the findings did not 
reach statistical significance. It should be acknowledged that women from 
the NHANES cohort had almost two-fold higher mean serum CRP 
concentrations (4.88 mg/L) compared to our cohort (2.49 mg/L) were also 
more overweight (mean BMI = 27.9 kg/m
2
) compared to our analysis (mean 
BMI = 24.9 kg/m
2
).  
 
The current analysis did not also observe any associations between habitual 
intake of selenium and plasma CRP concentrations. These findings were 
supported by one previous cross-sectional analysis in the NHANES cohort 
among men and women aged 19 years and over, in which selenium intake 
was not associated with CRP concentrations (Floegel et al. 2011). 
Interestingly, selenium is a cofactor of peroxidases and detoxifies lipid 
peroxides, instead of scavenging free radicals or interrupting peroxidation 
chain reactions (Paolisso et al. 1999) as other nutrients with potential anti-
inflammatory action do. This may have a different impact on blood CRP 
concentrations in response to dietary intake of selenium, which remains to 
be elucidated in in vitro and in vivo studies. However, it has been suggested 
that selenium supplementation in chronic inflammatory conditions may 
restore the depleted hepatic and serum selenium levels by increasing the 
biosynthesis of selenoproteins leading to suppression of CRP production 
and attenuating the inflammatory process (Duntas 2009). The lack of 
associations in the current study may be because  the selenium content of 
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foods varies depending on the soil content and other environmental 
conditions (especially the quantity and species of selenium to which the 
animal/plant is exposed) (Fairweather-Tait et al. 2010). This affects the 
form of selenium present in plant and animal sources and may impact on the 
absorption and use of selenium and consequently influence selenium’s 
protective role in inflammation (Rederstorff et al. 2006). Also, food 
composition data may not reflect true selenium composition.             
 
In relation to carotenoids, findings from the current analysis showed an 
inverse association between higher intake of a range of carotenoids and 
plasma CRP concentrations although the association was not statistically 
significant. Results from previous epidemiological studies are also 
contradictory. One previous prospective study among 704 men from the 
Uppsala Longitudinal Study of Adult Men (ULSAM) did not find an 
association between β-carotene and the inflammatory marker CRP both at 
baseline and after 7 years of follow-up (Helmersson et al. 2009). However, 
in a cross-sectional analysis among men and women aged 19 years and over 
from the NHANES cohort, total carotene intake was inversely associated 
with the odds of having elevated serum CRP concentrations after 
adjustments for age, gender, ethnicity, total energy intake and BMI (OR = 
0.70, 95% CI 0.56, 0.87, P < 0.05) (Floegel et al. 2011). 
The authors from the ULSAM study do not offer any information about the 
mean CRP concentrations and the study is only in men, thus comparisons 
with our study or the NHANES study are not possible. Findings from the 
current analysis were different from the study of Floegel et al. and this 
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might be due to the fact that intake of total carotene was assessed by a 24h 
dietary recall, not an FFQ, and hence there were differences in the mean 
intakes of total carotene between the two studies. Of interest the median 
total carotene intake in the first quintile of intake was 29.6 μg as Retinol 
equivalents/d in the Floegel et al. study (Floegel et al. 2011) compared to 
1470 μg/d in the current analysis. Although our cohort adjusted for a 
number of covariates that may mediate the association between intake of 
total carotene and the inflammatory marker CRP, the findings did not reach 
statistical significance.  
        
Notably, findings from our cross-sectional study were supported by those 
from the Multiethnic-Ethnic Study of Atherosclerosis (MESA) among 5181 
men and women aged 45 to 84 years showing no associations between 
vitamins C and E, and β-carotene  intakes and the inflammatory marker 
CRP (de Oliveira Otto et al. 2011). Participants from the MESA study were 
older (45 to 84 years) and more overweight (mean BMI = 27.9 kg/m
2
) 
compared to the TwinsUK cohort aged 18 to 79 years (mean BMI = 24.9 
kg/m
2
). 
 
In the current study mean CRP concentrations (2.49 mg/L) were three-fold 
lower compared with the NHANES 1999-2002 study (4.88 mg/L) (Floegel 
et al. 2011) and two-fold higher compared with the MESA cohort (1.79 
mg/L). However, in both the current analysis and the MESA study plasma 
CRP concentrations were lower than 3 mg/L, which represents a high risk 
for cut point for cardiovascular disease according to the American Heart 
 216 
 
Association Consensus panel and the Centers for Disease Control and 
Prevention (CDC/AHA) (de Ferranti and Rifai 2007) suggesting  that 
associations with diet may only be observed when population ranges of CRP 
are higher.  
 
In relation to vitamin D, the current study did not observe any associations 
with CRP, although it is evident that 1-alpha, 25-Dihydroxyvitamin D(3) 
[1,25-(OH)(2)D(3)], the active metabolite of vitamin D(3), acts as an 
inhibitor of the inflammatory response (Nagpal et al. 2005). Moreover, 
vitamin D concentrations have been inversely associated with the 
inflammatory marker CRP in patients with rheumatoid arthritis (Oelzner et 
al. 1998) and frailty (Abdulrab and Heun 2008). However, there are no 
population studies examining associations between the habitual dietary 
intake of vitamin D neither in healthy individuals nor in disease to enable 
comparisons with our study. 
 
Interestingly, the current analysis observed an inverse association between 
higher potassium intake and plasma CRP concentrations although the 
association was not statistically significant. There are currently no studies in 
the literature examining associations between habitual potassium intake and 
plasma CRP, however, there is evidence of the anti-inflammatory effects of 
three potassium salts of N,N-disubstituted 4-aminoazobenzenesulfonic acids 
in rats with adjuvant arthritis (Kazemekaite et al. 2008). Also, findings from 
epidemiological studies have shown that dietary patterns characterised by 
increased consumption of fruits and vegetables (the main sources of 
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potassium) were associated with lower levels of markers of inflammation 
including CRP and may offer support to results from the current study 
(Esmaillzadeh et al. 2006, Lopez-Garcia et al. 2004, Nettleton et al. 2006). 
 
The lack of significant associations observed in the current study might be 
due to the fact that other lifestyle factors than diet have a greater effect on 
plasma CRP concentrations. Of interest, in this cohort, BMI and physical 
activity had a greater effect on CRP for all nutrients. For example, after 
multivariate adjustment for relevant confounders, the effect of BMI [β 
coefficient (95 % CI): 0.09 (0.08, 0.09), P < 0.001] was 15 times greater of 
that of vitamin C intake [β coefficient (95 % CI): -0.006 (-0.04, 0.03), P = 
0.771] on CRP. This finding reflects data from previous epidemiological 
(Choi et al. 2013, Festa et al. 2001, Hodge et al. 2010, Khoo et al. 2011) 
and experimental studies (Calabro et al. 2005) showing that BMI and the 
adipose tissue are associated with higher CRP concentrations. The observed 
effect of physical activity [β coefficient (95 % CI): -0.13 (-0.27, 0.01), P = 
0.07] was 22 times greater of that of vitamin C intake [β coefficient (95 % 
CI): -0.006 (-0.04, 0.03), P = 0.771] on CRP. The effects of physical activity 
on inflammation are conflicting. In a recent review which evaluated the 
relationship between the inflammatory marker CRP and exercise, it was 
reported that interventions that were based just on increasing the physical 
activity had no effect on the inflammatory marker CRP (Michigan et al. 
2011). However, intervention programmes that were based on lifestyle 
changes including both exercise and healthy diet reported decreases on 
CRP, probably related to weight reduction. Also, findings from a 
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randomised controlled trial among obese postmenopausal women aged 50-
75 years, mean CRP was reduced by 10 % in exercisers and increased by 12 
% in the control group from baseline after an exercise intervention 
programme of one year (Campbell et al. 2009).  
 
Overall, this study showed that higher magnesium intake was significantly 
inversely associated with plasma CRP concentrations in women across a 
wide age range, after adjustments for age, physical activity, smoking, 
energy intake, anti-inflammatory medication (including aspirin, statins, and 
NSAID) and HRT use and BMI. The mechanisms involved in the 
relationship between magnesium intake and the inflammatory marker CRP 
cannot be specifically identified due to the nature of the study which 
assessed cross-sectional associations. Magnesium is an essential 
micronutrient which acts as a cofactor in multiple enzymatic reactions in the 
human body. Notably, there are a number of studies indicating an inverse 
association between dietary magnesium intake and metabolic and 
inflammatory conditions, such as hypertension (Song et al. 2006), metabolic 
syndrome (He et al. 2006), insulin resistance (Paolisso and Barbagallo 
1997), type 2 diabetes (Song et al. 2004), dyslipidemia (Song et al. 2005), 
and cardiovascular disease (Al-Delaimy et al. 2004). These findings are 
supported by experimental data from animal studies indicating that dietary 
magnesium deficiency may induce an inflammatory response (Malpuech-
Brugere et al. 2000). Although there are findings from observational and 
animal studies, the underlying biological mechanisms for such metabolic 
effects of magnesium are not yet entirely clear. However, there is one recent 
 219 
 
randomised, crossover, pilot trial in 14 overall healthy, overweight 
individuals (BMI ≥ 25 kg/m2) who were randomly assigned to receive 
magnesium citrate (500 mg/d) or placebo for four weeks with one month 
wash-out period. This study found an up-regulation of 24 genes and down-
regulation of 36 genes including genes that were related to metabolic and 
inflammatory pathways such as C1q and tumor necrosis factor-related 
protein 9 (C1QTNF9) and pro-platelet basic protein (PPBP) (Chacko et al. 
2011). In this study gene expression profiling revealed an effect on 
inflammatory metabolic pathways and it also showed a significant increase 
in the inflammatory marker IL-6 in response to magnesium supplementation 
(Chacko et al. 2011). Findings from this small study provide further 
evidence of the importance of magnesium in metabolic and inflammatory 
pathways although future studies in large populations would need to be 
conducted to investigate these preliminary findings further.  
 
Findings were not significant for associations between the other 
micronutrients and plasma CRP concentrations possibly because other 
lifestyle factors, such as BMI and physical activity had a greater effect in 
this cohort.                  
 
Protein, amino acid intake and plasma CRP concentrations (mg/L) 
A novel finding of the current analysis was the significant positive 
association between higher intakes of arginine, glutamine, histidine, 
isoleucine, threonine and tryptophan (as % energy) and the inflammatory 
marker CRP. The magnitude of association was a difference of 0.3 mg/L in 
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plasma geometric mean CRP between extreme quintiles of intake (P for 
difference < 0.05 for arginine, glutamine, threonine and tryptophan; and P = 
0.05 for histidine and isoleucine). There were also trends towards 
significance for leucine, lysine, methionine and valine. No associations were 
observed for protein and phenylalanine although the trends were in the same 
direction as the other amino acids. These associations were observed after 
adjustments for age, physical activity, smoking, anti-inflammatory 
medication (including aspirin, statins, and NSAID) and HRT use and was 
independent of adiposity (assessed by BMI).  
 
There are currently no population studies examining associations between 
the habitual dietary intake of essential amino acids and inflammatory 
markers. However, two previous supplementation studies providing oral 
administration of protein enriched with the branched-chain amino acids 
(BCAAs) leucine, isoleucine and valine in malnourished elderly with 
catabolic status (Bonnefoy et al. 2010) and in patients with liver cirrhosis 
(Ohno et al. 2008) have shown a small decrease in the inflammatory marker 
CRP. However, an example of a relationship between amino acids and 
inflammation from other chronic disease relationships exists with 
cardiovascular disease. A recent cross-sectional analysis from the Rotterdam 
Study among 3086 subjects aged 55 years and over showed that higher 
intakes of glutamic acid, arginine, lysine, and cysteine intakes (as % of 
protein intake) were not associated with blood pressure or risk of 
hypertension (Altorf-van der Kuil et al. 2013). The same study also 
observed that a higher intake of tyrosine (0.3 % of protein) was inversely 
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and significantly associated to systolic blood pressure (P for trend = 0.05) 
by 2.4 mmHg but not to diastolic blood pressure (P for trend = 0.35) 
(Altorf-van der Kuil et al. 2013). 
 
In relation to protein there are also currently no population studies 
examining association between the habitual protein intake and inflammatory 
markers. To our knowledge, there is only one previous randomised 
controlled dietary intervention among overweight and obese men and 
women (BMI 27-34 kg/m
2
) aged 18-56 years, although this study was 
designed to investigate weight loss on different diets (Due et al. 2005). In 
this study participants were randomly assigned to an ad libitum fat reduced 
diet (30% of energy), either high in protein (25% of energy) and low in 
carbohydrate (45% of energy) (HPLC) or high in carbohydrate (58% 
energy) and low in protein (12% of energy) (HCLP) during six months. 
After six months of intervention, both the HPLC and the HCLP groups 
showed a non-significant decrease in serum CRP concentrations by 0.5 
mg/L (21%, P = 0.06) and 0.8 mg/L (28%, P = 0.09), respectively. 
Moreover, the difference between the two groups was not significant, 
although the authors do not provide the exact p value of difference. In 
addition, in multiple regression analyses there was no influence of protein 
intake (as % energy) on CRP after six months of intervention; however data 
for these findings were not shown (Due et al. 2005). Although these 
findings are not directly comparable with ours (due to the weight loss 
occurring during that study) they indicate that the action of proteins is not 
neutral, as might have previously been expected. Also the study design was 
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different from our current study and it is noteworthy that in the current 
analysis protein intake in the lower quintile was 13.2 % of energy and in the 
higher quintile 20.5 % of energy, almost 5 % lower compared to the HPLC 
diet in the study of Due et al. (Due et al. 2005).                   
 
The mechanisms involved in the relationship between protein, essential 
amino acids and the inflammatory marker CRP cannot specifically 
identified due to the nature of this study which assessed cross-sectional 
associations. Nevertheless, it is noteworthy that dietary protein and essential 
amino acid intakes play a major role in various chronic (such as cancer and 
chronic obstructive pulmonary disease) and acute disease (such as sepsis 
and burn injury) states, where inflammation is present and protein 
catabolism is enhanced (Jonker et al. 2012). Given that protein breakdown 
and muscle wasting is increased in these conditions, it has been argued that 
modifying the protein and essential amino acid content of the diet may 
positively affect the balance of muscle protein synthesis and breakdown, 
and may activate muscle protein anabolism in chronic and acute disease 
states (Eley et al. 2007, Jonker et al. 2012, Peters et al. 2011).  However, it 
needs to be considered that the protein intake that is associated with the 
lowest rate of catabolism in conditions with high systemic inflammation is 
greater than the minimum protein intake that is required to achieve a neutral 
protein balance in healthy individuals (Guadagni and Biolo 2009). Although 
the protein requirement in healthy individuals is defined as the lowest 
protein intake sufficient to achieve neutral protein balance, this definition 
cannot be applied in situations characterized by increased catabolism 
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(Guadagni and Biolo 2009), as in these situations a higher protein intake is 
required to modulate metabolic and immune functions ranging from 1.3 to 
1.5 g protein/kg/d (Biolo 2013). In the TwinsUK cohort the average protein 
intake per kg body weight per day was 1.3 g protein/kg/d higher compared 
to the average recommended nutrient intake (0.8 g protein/kg/d) for the UK 
population in accordance with the UK report of the Panel on Dietary 
Reference Values of the Committee on Medical Aspects of Food Policy. 
However, neutral protein balance and optimal protein/amino acid intake 
may not always have an effect on inflammation for populations that have a 
normal weight, BMI and CRP concentrations and the biological 
mechanisms underlying such a relationship are largely unknown. 
Nevertheless, given these are the first observations that we know about, they 
would appear to be novel findings.   
 
6.5 Strengths and limitations 
The strengths of this study include the large sample size and the fact that 
this was the first population study that directly compared a full range of 
micronutrients and carotenoids with potential anti-inflammatory properties 
in association with plasma CRP concentrations. In addition, this was the 
first study that evaluated the influence of protein and essential amino acid 
intakes on the inflammatory marker CRP. Also, the FFQ used in the current 
study was previously compared and validated against a 7-day weighed 
record in the EPIC Norfolk study, and although the two approaches to 
measure dietary intake were different, both methods identified similar 
intakes of macronutrients when these were expressed as percentage of total 
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energy intake (Bingham et al. 2001). This FFQ was also validated against 
urinary and plasma biomarkers of intake, such as urinary nitrogen for 
protein intake, urinary potassium and sodium, plasma ascorbic acid and 
plasma n-3 PUFAs (McKeown et al. 2001, Welch et al. 2006). In addition, 
it has been shown previously that serum β-cryptoxanthin and zeaxanthin 
concentrations were moderately correlated with dietary carotenoids intakes 
measured by an FFQ (Tucker et al. 1999). Furthermore, in order to examine 
associations between dietary intake and health outcomes participants need to 
be ranked according to their usual dietary intake and FFQs have been shown 
to rank individuals well (Molag et al. 2007). 
 
In the current analyses multiple corrections were not performed as the 
hypothesis of the study was well defined a priori, and the mechanisms 
linking the associations between different nutrients and the inflammatory 
marker CRP were independent. Multiple testing is an important 
consideration in exploratory studies (Benjamini 2010). However, since our 
hypotheses were well defined a priori, and the mechanisms linking the 
different exposures and the outcome were independent, then correction for 
multiple testing is not strictly necessary (Bender and Lange 2001). 
 
This study also has a number of limitations. The cross-sectional nature of 
the study limits causal inference, but enables us to generate hypotheses 
regarding associations between the habitual dietary intake of a range of 
micronutrients, protein and essential amino acids and the inflammatory 
marker CRP based on plausible mechanisms. Although all analyses were 
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adjusted for a number of confounding factors, residual confounding may 
still be present because of the observational nature of the study. In addition, 
as in all observational studies, measurement error in self-reported dietary 
intakes is inevitable. It is also widely acknowledged that the use of FFQs for 
measuring dietary intake has its own limitations related to memory errors, 
they provide relative than absolute intake, they introduce bias due to over- 
or under-reporting, and they may introduce systematic errors as preparation 
methods are inadequately considered (McNeill et al. 2009). Also, FFQs 
measure food intake over a period of one year and reflect the habitual diet 
over this period of time but not lifetime dietary habits (Teucher et al. 2007). 
This study was limited in measuring only one biomarker of inflammation, 
which is the widely used CRP, and maybe more markers needed to be 
measured to reflect, in total, the complexity of such associations. The 
observed findings relate to women and further work is needed to investigate 
if these findings are replicated in a male population of the same country or 
in populations from different ethnic backgrounds.  
 
6.6 Concluding remarks 
In conclusion, we found in multivariate analyses that higher magnesium 
intakes were associated with lower plasma CRP concentrations by 25 % 
comparing extreme quintiles of intake. This study also observed that higher 
intakes of arginine, glutamine, histidine, isoleucine, threonine and 
tryptophan were positively associated with CRP levels. Findings from the 
current study extend the results from the few previous cross-sectional 
studies by examining simultaneously associations between a range of 
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micronutrients, protein and essential amino acids with potential anti-
inflammatory properties in women of a wide age range. Although in the 
current analysis we expected an inverse association between dietary protein 
intake and the inflammatory marker CRP, surprisingly we did not observe 
an association between protein and CRP. Also associations between 
essential amino acid intakes and CRP were in the opposite direction to what 
we had expected. To our knowledge to date no other population studies have 
examined the associations between protein and essential amino acid intakes 
and CRP or other inflammatory markers. 
 
The fact that not all amino acids (including leucine, lysine, methionine and 
valine) showed a significant association with CRP may be because these 
amino acids are involved in different pathways of the metabolic chain and 
may differentially influence CRP, although the FFQ included a range of 
foods that contribute to essential amino acid intake, such as soy products 
(tofu, soy milk), meat and fish, dairy, eggs, and legumes. Also, associations 
were not observed for all micronutrients, possibly due to the fact that other 
factors, such as physical activity and body mass index may be more 
important than diet on CRP. Yet, it is also possible that a longitudinal study 
design might be more suitable approach to detect associations between 
nutrient intakes and the inflammatory marker CRP, as it might be more 
likely to observe a difference in the inflammatory status over time due to a 
healthier diet. Additionally, maybe long-term interventions are needed to 
observe an effect and a dose-response relationship in order to define the 
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anti-inflammatory or pro-inflammatory effects of specific nutritional factors 
that can further modulate disease risk. 
 
Results from this study suggest that is important for adult women to 
consume a variety of food sources high in micronutrients, such as 
magnesium to ensure lower plasma concentrations of the inflammatory 
marker CRP. Given the debate on protein and amino acid requirements in 
healthy individuals, and from a public health perspective, the novel findings 
from the current analysis may offer some insight in order to better 
understand whether the habitual dietary protein and amino acid intakes may 
influence inflammation in adult women with normal weight, BMI and CRP 
concentrations. 
The next chapter explores the associations between overall dietary quality 
and the inflammatory marker CRP.  
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TABLES 
Table 6.2 Characteristics of female subjects from the TwinsUK cohort
1 
Characteristic N=1658, 18-79 yrs
 
Age (y) 49.7±12.5 
Weight (kg) 65.5±10.6 
Height (cm) 162±5.96 
BMI (kg/m
2
) 24.9±4.0 
Inflammation marker  
C-reactive protein (CRP) (mg/L)  2.49±2.30 
Physical activity % 
Inactive 
Moderate 
Active 
 
20.5 
54.8 
24.7
 
Smoking history % 
Never 
Current 
Former 
 
50.2 
16.7 
33.1
 
Hormone replacement therapy % 
No 
Yes 
 
93.7  
6.30 
Anti-inflammatory medication %
2
  
No 93.8 
Yes 6.20 
Dietary components  
Total energy intake (kcal/d) 1976±512
 
Protein intake (g/d) 81.4±21.3 
Protein intake (% Energy) 16.7±2.60 
Vitamins  
 
Vitamin C intake (mg/d) 157±78.8
 
Vitamin E intake (mg/d) 11.4±4.4 
Vitamin D intake (µg/d) 2.62±1.39 
Minerals  
 
Magnesium intake (mg/d) 345±90 
Potassium intake (mg/d) 3999±990 
Selenium intake (µg/d) 44.9±16.0
 
Carotenoids  
 
-carotene intake (µg/d) 570±419
 
ß-carotene intake (µg/d) 3135±1761
 
Total carotene intake (µg/d)  3498±1952
 
Lycopene intake (µg/d) 1322±896
 
Lutein intake (µg/d) 2224±1463
 
Zeaxanthin intake (µg/d) 84.4±70.8
 
ß-cryptoxanthin intake (µg/d) 203±191
 
Amino acids 
 
Arginine (g/d) 4.45±1.24
 
Arginine (% Energy/d) 0.92±0.20
 
Glutamine (g/d) 16.1±4.4
 
Glutamine (% Energy/d) 3.31±0.59
 
Histidine (g/d) 2.29±0.63
 
Histidine (% Energy/d) 0.47±0.09
 
Isoleucine (g/d) 3.84±1.04
 
Isoleucine (% Energy/d) 0.79±0.16
 
Leucine (g/d) 6.51±1.75
 
Leucine (% Energy/d) 1.34±0.26 
Lysine (g/d) 5.54±1.60
 
Lysine (% Energy/d) 1.14±0.27
 
Methionine (g/d) 1.87±0.52 
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Methionine (% Energy/d) 0.39±0.08 
Phenylalanine (g/d) 3.83±1.02 
Phenylalanine (% Energy/d) 0.79±0.15 
Threonine (g/d) 3.35±0.92
 
Threonine (% Energy/d) 0.69±0.14
 
Tryptophan (g/d) 1.06±0.28 
Tryptophan (% Energy/d) 0.22±0.04 
Valine (g/d) 4.54±1.22 
Valine (% Energy/d) 0.93±0.18 
1 
Values are presented as mean ± SEM or else indicated 
2
 Aspirin, statins, non-steroidal anti-inflammatory drugs (NSAID) 
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Table 6.3 Associations between nutrient intakes and  C-reactive protein (mg/L) in 1658 women from the TwinsUK cohort
1
 
 C-reactive protein (mg/L) 
Quintiles of nutrient 
intake 
Q1 Q2 Q3 Q4 Q5 
P for 
trend 
Vitamin C (mg/d) 
Unadjusted  
Adjusted model
2
  
 
1.57(1.39,1.78) 
1.60(1.42,1.80) 
 
1.56(1.39,1.75) 
1.54(1.39,1.71) 
 
1.70(1.52,1.90) 
1.72(1.55,1.90) 
 
1.60(1.43,1.78) 
1.61(1.45,1.78) 
 
1.56(1.39,1.75) 
1.53(1.37,1.70) 
0.99 
0.77 
Vitamin D (µg/d) 
Unadjusted  
Adjusted model 
 
1.60(1.42,1.80) 
1.63(1.46,1.82) 
 
1.60(1.43,1.79) 
1.59(1.43,1.77) 
 
1.49(1.33,1.66) 
1.52(1.37,1.68) 
 
1.60(1.43,1.79) 
1.61(1.45,1.80) 
 
1.72(1.54,1.92) 
1.64(1.47,1.84) 
 
0.41 
0.85 
Vitamin E (mg/d) 
Unadjusted  
Adjusted model 
 
1.72(1.53,1.93) 
1.75(1.53,1.99) 
 
1.57(1.41,1.75) 
1.55(1.39,1.72) 
 
1.58(1.42,1.77) 
1.62(1.46,1.80) 
 
1.64(1.47,1.83) 
1.64(1.48,1.81) 
 
1.49(1.33,1.67) 
1.45(1.28,1.65) 
0.19 
0.26 
Magnesium (mg/d) 
Unadjusted  
Adjusted model 
 
1.73(1.54,1.94) 
1.87(1.63,2.13) 
 
1.54(1.38,1.72) 
1.55(1.39,1.73) 
 
1.55(1.38,1.73) 
1.58(1.42,1.75) 
 
1.66(1.48,1.87) 
1.62(1.46,1.81) 
 
1.51(1.36,1.69) 
1.41(1.24,1.59) 
 
0.30 
0.051 
Selenium (µg/d) 
Unadjusted  
Adjusted model 
 
1.61(1.44,1.80) 
1.60(1.44,1.78) 
 
1.42(1.26,1.60) 
1.40(1.26,1.60) 
 
1.68(1.50,1.87) 
1.66(1.50,1.84) 
 
1.63(1.45,1.83) 
1.68(1.50,1.87) 
 
1.67(1.49,1.86) 
1.66(1.49,1.86) 
 
0.23 
0.18 
Potassium (mg/d) 
Unadjusted  
Adjusted model 
 
1.69(1.51,1.89) 
1.77(1.56,2.00) 
 
1.45(1.29,1.62) 
1.48(1.32,1.65) 
 
1.60(1.42,1.79) 
1.62(1.46,1.80) 
 
1.61(1.42,1.82) 
1.59(1.42,1.78) 
 
1.65(1.49,1.84) 
1.54(1.36,1.74) 
 
0.74 
0.45 
Total carotene (µg/d) 
Unadjusted  
Adjusted model 
 
1.59(1.43,1.77) 
1.63(1.47,1.81) 
 
1.46(1.30,1.64) 
1.54(1.38,1.72) 
 
1.65(1.48,1.85) 
1.62(1.45,1.80) 
 
1.70(1.53,1.89) 
1.64(1.49,1.81) 
 
1.59(1.42,1.79) 
1.56(1.41,1.74) 
 
0.39 
0.91 
-carotene (µg/d) 
Unadjusted  
Adjusted model 
 
1.60(1.43,1.79) 
1.66(1.50,1.85) 
 
1.47(1.30,1.65) 
1.53(1.37,1.71) 
 
1.70(1.51,1.90) 
1.60(1.43,1.78) 
 
1.55(1.39,1.73) 
1.57(1.42,1.74) 
 
1.68(1.51,1.88) 
1.63(1.47,1.80) 
 
0.40 
0.92 
ß-carotene (µg/d) 
Unadjusted  
Adjusted model 
 
1.61(1.45,1.80) 
1.66(1.49,1.84) 
 
1.50(1.33,1.69) 
1.57(1.41,1.76) 
 
1.58(1.41,1.78) 
1.57(1.41,1.75) 
 
1.70(1.52,1.89) 
1.63(1.47,1.80) 
 
1.60(1.43,1.79) 
1.56(1.41,1.74) 
 
0.55 
0.64 
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Lutein (µg/d) 
Unadjusted  
Adjusted model 
 
1.63(1.45,1.83) 
1.65(1.48,1.84) 
 
1.59(1.42,1.77) 
1.60(1.44,1.77) 
 
1.60(1.44,1.77) 
1.57(1.43,1.74) 
 
1.66(1.48,1.86) 
1.63(1.47,1.80) 
 
1.52(1.35,1.70) 
1.54(1.38,1.71) 
 
0.58 
0.48 
 
Zeaxanthin (µg/d) 
Unadjusted  
Adjusted model 
 
1.73(1.57,1.92) 
1.68(1.51,1.86) 
 
1.56(1.40,1.73) 
1.56(1.40,1.73) 
 
1.71(1.54,1.89) 
1.69(1.52,1.87) 
 
1.41(1.27,1.57) 
1.43(1.29,1.60) 
 
1.60(1.43,1.78) 
1.65(1.47,1.84) 
 
0.16 
0.49 
ß-cryptoxanthin (µg/d) 
Unadjusted  
Adjusted model 
 
1.64(1.47,1.83) 
1.62(1.46,1.80) 
 
1.61(1.44,1.80) 
1.63(1.47,1.80) 
 
1.65(1.47,1.85) 
1.63(1.47,1.82) 
 
1.57(1.40,1.76) 
1.61(1.45,1.79) 
 
1.52(1.36,1.70) 
1.50(1.34,1.67) 
 
0.33 
0.34 
Lycopene (µg/d) 
Unadjusted  
Adjusted model 
 
1.52(1.36,1.70) 
1.51(1.36,1.67) 
 
1.59(1.41,1.79) 
1.55(1.39,1.73) 
 
1.65(1.48,1.83) 
1.69(1.53,1.85) 
 
1.62(1.46,1.80) 
1.63(1.47,1.81) 
 
1.61(1.43,1.81) 
1.62(1.45,1.81) 
 
0.46 
0.28 
1 
All values are means and SEM for CRP (mg/L) by quintiles of different micronutrient intakes 
2
 Adjusted for age (years), physical activity (inactive, moderately active, active), smoking status (never, current, former), body mass index (kg/m
2
), energy intake (kcal/d), anti-
inflammatory medication (including aspirin, statins, and NSAID) (no/yes) and HRT use (no/yes) 
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Table 6.4 Associations between protein and essential amino acid intakes and C-reactive protein (mg/L) in 1658 women from the TwinsUK cohort
1
 
 C-reactive protein (mg/L) 
Quintiles of nutrient 
intake 
Q1 Q2 Q3 Q4 Q5 P for trend 
Energy intake (kcal/d)  
Unadjusted  
Adjusted model
2
 
 
1.63(1.46,1.82) 
1.59(1.51,1.68) 
 
1.57(1.40,1.76) 
1.59(1.51,1.68) 
 
1.62(1.44,1.81) 
1.60(1.52,1.69) 
 
1.63(1.46,1.82) 
1.60(1.52,1.68) 
 
1.55(1.38,1.74) 
1.60(1.52,1.69) 
 
0.72 
0.73 
Protein (%E) 
Unadjusted  
Adjusted model 
 
1.37(1.22,1.54) 
1.46(1.32,1.62) 
 
1.58(1.42,1.75) 
1.60(1.45,1.77) 
 
1.62(1.45,1.82) 
1.68(1.50,1.87) 
 
1.71(1.52,1.92) 
1.67(1.50,1.86) 
 
1.73(1.56,1.93) 
1.59(1.43,1.75) 
 
0.002 
0.22 
Arginine (%E) 
Unadjusted  
Adjusted model 
 
1.35(1.20,1.52) 
1.42(1.28,1.58) 
 
1.60(1.44,1.78) 
1.65(1.50,1.82) 
 
1.58(1.41,1.75) 
1.61(1.46,1.77) 
 
1.59(1.42,1.78) 
1.57(1.42,1.75) 
 
1.93(1.73,2.15) 
1.75(1.58,1.94) 
 
<0.001 
0.03 
Glutamine (%E) 
Unadjusted  
Adjusted model 
 
1.39(1.24,1.55) 
1.44(1.30,1.60) 
 
1.57(1.41,1.75) 
1.64(1.49,1.81) 
 
1.52(1.35,1.71) 
1.57(1.40,1.76) 
 
1.68(1.50,1.88) 
1.65(1.49,1.84) 
 
1.86(1.68,2.07) 
1.70(1.55,1.87) 
 
<0.001 
0.03 
Histidine (%E) 
Unadjusted  
Adjusted model 
 
1.33(1.18,1.49) 
1.42(1.28,1.58) 
 
1.62(1.46,1.81) 
1.67(1.52,1.84) 
 
1.59(1.42,1.78) 
1.62(1.46,1.81) 
 
1.59(1.42,1.78) 
1.56(1.40,1.73) 
 
1.91(1.72,2.13) 
1.73(1.57,1.91) 
 
<0.001 
0.050 
Isoleucine (%E) 
Unadjusted  
Adjusted model 
 
1.33(1.18,1.50) 
1.42(1.28,1.58) 
 
1.55(1.39,1.73) 
1.62(1.47,1.79) 
 
1.68(1.50,1.88) 
1.67(1.50,1.85) 
 
1.62(1.44,1.81) 
1.61(1.44,1.80) 
 
1.86(1.67,2.07) 
1.68(1.52,1.85) 
 
<0.001 
0.050 
Leucine (%E) 
Unadjusted  
Adjusted model 
 
1.36(1.21,1.52) 
1.45(1.30,1.61) 
 
1.59(1.43,1.77) 
1.63(1.48,1.80) 
 
1.63(1.46,1.82) 
1.65(1.49,1.83) 
 
1.60(1.43,1.80) 
1.59(1.42,1.77) 
 
1.85(1.66,2.05) 
1.68(1.53,1.86) 
 
0.001 
0.09 
Lysine (%E) 
Unadjusted  
Adjusted model 
 
1.32(1.17,1.48) 
1.41(1.27,1.56) 
 
1.67(1.49,1.86) 
1.72(1.56,1.91) 
 
1.57(1.40,1.75) 
1.58(1.42,1.75) 
 
1.62(1.45,1.81) 
1.60(1.44,1.77) 
 
1.87(1.68,2.08) 
1.71(1.55,1.89) 
 
<0.001 
0.07 
Methionine (%E) 
Unadjusted  
Adjusted model 
 
1.40(1.24,1.57) 
1.49(1.34,1.65) 
 
1.48(1.33,1.65) 
1.55(1.40,1.72) 
 
1.70(1.52,1.90) 
1.68(1.51,1.87) 
 
1.60(1.43,1.79) 
1.59(1.42,1.76) 
 
1.86(1.67,2.06) 
1.69(1.54,1.87) 
 
<0.001 
0.09 
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Phenylalanine (%E) 
Unadjusted  
Adjusted model 
 
1.39(1.23,1.56) 
1.45(1.30,1.61) 
 
1.55(1.39,1.73) 
1.62(1.46,1.79) 
 
1.63(1.46,1.81) 
1.68(1.52,1.87) 
 
1.62(1.44,1.82) 
1.58(1.42,1.77) 
 
1.83(1.65,2.04) 
1.66(1.51,1.83) 
 
0.001 
0.12 
 
Threonine (%E) 
Unadjusted  
Adjusted model 
 
 
1.33(1.18,1.49) 
1.43(1.28,1.59) 
 
 
1.53(1.37,1.70) 
1.60(1.45,1.76) 
 
 
1.65(1.47,1.84) 
1.65(1.48,1.83) 
 
 
1.63(1.46,1.83) 
1.62(1.45,1.80) 
 
 
1.91(1.71,2.12) 
1.72(1.55,1.90) 
 
 
<0.001 
0.02 
Tryptophan (%E) 
Unadjusted  
Adjusted model 
 
1.35(1.20,1.51) 
1.44(1.29,1.59) 
 
1.49(1.34,1.65) 
1.55(1.41,1.71) 
 
1.66(1.48,1.86) 
1.69(1.51,1.88) 
 
1.67(1.49,1.87) 
1.63(1.47,1.81) 
 
1.87(1.69,2.08) 
1.70(1.54,1.87) 
 
<0.001 
0.02 
Valine (%E) 
Unadjusted  
Adjusted model 
 
1.35(1.20,1.51) 
1.43(1.28,1.58) 
 
1.56(1.40,1.74) 
1.63(1.48,1.80) 
 
1.68(1.51,1.88) 
1.70(1.53,1.89) 
 
1.58(1.41,1.78) 
1.55(1.39,1.72) 
 
1.86(1.67,2.06) 
1.70(1.54,1.87) 
 
<0.001 
0.08 
1 
Values are means and SEM for by quintiles of nutrient intake 
2
 Adjusted for age (years), physical activity (inactive, moderately active, active), smoking status (never, current, former), body mass index (kg/m
2
), anti-inflammatory medication 
(including aspirin, statins, and NSAID) (no/yes) and HRT use (no/yes) 
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Chapter 7 
Associations between diet quality scores and 
C-reactive protein levels 
 
 
 
 
 
 
 
 
 
 
 
 235 
 
7.0 Introduction  
There is growing evidence suggesting that chronic inflammation is an 
important underlying aspect of sarcopenia (Cavicchia et al. 2009, Chung et 
al. 2009). The importance of assessing the “whole diet” in relation to 
disease outcomes has been discussed previously (Chapter 5, section 5.0, p. 
153). The associations between the “whole diet”, assessed using diet quality 
scores and inflammatory markers will therefore be investigated in this 
chapter. As an extension to Chapter 6, this chapter investigates the 
association of diet quality scores and the inflammatory marker C-reactive 
protein (CRP). 
 
To date, very few epidemiological studies have examined associations 
between diet quality and inflammation markers. Results from the ATTICA 
cohort study (men and women, aged 18 to 89 years) showed that a higher 
adherence to a traditional Mediterranean diet, assessed using the 
Mediterranean diet score, was associated with 20% lower CRP values (P = 
0.015) compared to lower adherence in an unadjusted model. After 
multivariate adjustment, including age, gender, smoking, physical activity, 
education status, presence of hypertension, diabetes, hypercholesterolemia, 
family history of coronary heart disease, and body mass index the authors 
reported a decrease of 0.21 mg/L in plasma CRP per 10 unit increase in the 
MDS (P < 0.05) (Chrysohoou et al. 2004). Furthermore, in the Nurse’s 
Health Study it was found that higher adherence to the Alternate Healthy 
Eating Index (AHEI) and the alternate Mediterranean score (aMED) was 
negatively associated with plasma CRP concentrations by 30% and 24% (P 
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< 0.05) respectively, independent of obesity (Fung et al. 2005). In another 
Nurse’s Health Study (women aged 34 to 59 years) it was reported that 
higher adherence to the DASH-style score was negatively associated with 
plasma concentrations of CRP by 20.4 % (P = 0.008) compared to lower 
adherence to the score (Fung et al. 2008). Data from this cohort have also 
shown that  among women (aged 38 to 69 years) , 62% of whom were 
overweight and free from CVD, cancer and diabetes at baseline, that higher 
adherence to the Alternate Healthy Eating Index (AHEI) score was 
negatively associated with plasma CRP by 41% (P < 0.05), compared to 
lower adherence to the score (Fargnoli et al. 2008). 
 
Although to date a number of population studies have examined the relative 
influence of diet quality scores on inflammation, to our knowledge, there are 
currently no population studies that have examined the full range of diet 
quality scores in association with inflammatory markers. Therefore, to 
further provide insight into the potential role of diet quality on inflammation 
as assessed by the established inflammatory marker CRP, a predictor for an 
increased risk of sarcopenia (Cesari et al. 2004, Schaap et al. 2006) the 
potential influence of diet quality on inflammation related sarcopenia was 
examined.  
 
7.1 Aims 
The aim of this study was to derive five predefined diet scores including the 
MDS, HDI, DQI, AHEI, and DASH-style score, and examine the hypothesis 
that greater adherence to these five scores is negatively associated with 
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plasma levels of CRP (mg/L), among women aged 18-79 years from the 
TwinsUK cohort. 
 
7.2 Covariate plan and statistical analysis 
All analyses were performed using STATA statistical software (version 
11.0; STATA Corp, USA). Means and standard deviations were calculated 
(Table 7.1) and quintiles of CRP and quartiles of the five diet scores were 
also derived. Robust cluster regression was applied for continuous variables 
(such as age, energy intake, and BMI) and Chi-square test for categorical 
variables (such as physical activity and smoking history), to test for 
differences in participant baseline characteristics across quintiles of CRP 
(Table 7.2). 
 
The analyses were performed treating twins as individuals as previous 
studies have shown that participants from the TwinsUK registry are similar 
to age-matched singleton women in the distribution of common traits and 
outcomes (Andrew et al. 2001). Data on dietary intake (food frequency 
questionnaire, FFQ), body composition parameters, and other covariates 
were available for 1658 women, aged 18 to 79 years representing 582 
monozygotic (MZ) and 1076 dizygotic (DZ) females who had completed a 
FFQ and had fasting blood samples taken to measure C-reactive protein 
(CRP) between 1996 and 2000 (Moayyeri et al. 2012, Teucher et al. 2007). 
 
Prior to conducting statistical analysis an analysis plan with justification for 
all confounding factors in the multivariate model was developed as 
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described in Chapter 2, section 2.2.5, p. 57. Multivariate regression analysis 
was used to assess associations between the five derived diet scores and 
plasma CRP using the robust cluster regression option in STATA. These 
models take into account clustering when calculating standard errors of the 
mean and the dependency of twin pairs as related individuals (Richards et 
al. 2007) to ensure familial aggregation was controlled for. The plasma 
concentration of CRP was transformed and analyzed on the natural 
logarithmic scale in order to meet the criterion of normality for the linear 
models. Values were subsequently back transformed into geometric means 
and 95% confidence intervals (CI) for presentation. 
 
As ageing has been strongly associated with an increased low-grade 
inflammatory status all analyses were adjusted for age (years) (Chung et al. 
2009). Models were also adjusted for physical activity and smoking status, 
as physical activity has been suggested to exert anti-inflammatory properties 
(Gleeson et al. 2011, Petersen and Pedersen 2005) and smoking has been 
suggested to increase inflammation (Lee et al. 2012). Energy intake (kcal/d) 
was also included in the multivariate models for the MDS (Trichopoulou et 
al. 1995), AHEI (Kennedy et al. 1995) and DASH-style score (Fung et al. 
2008) as these scores do not take into account energy intake in contrast to 
the HDI (Huijbregts et al. 1997) and DQI (Patterson et al. 1994). Additional 
adjustments were made for body mass index (kg/m
2
), hormone replacement 
therapy use (HRT) and anti-inflammatory medication (including statins, non 
steroid anti-inflammatory drugs and aspirin) (no or yes, respectively) as 
these factors have been previously shown to affect inflammatory status and 
 239 
 
may mediate the relationship between diet quality and CRP (Chapter 2, 
section 2.2.5, p. 64, 66, 68) (Table 7.3). 
 
In order to examine the relative importance of diet quality and other lifestyle 
characteristics on inflammatory marker CRP, regression analysis was 
performed with all independent variables standardised to similar scale of 
measurements. The diet quality indices were measured in quartiles, age in 
10 year categories, smoking habit in two categories (current v never and 
former v never), physical activity in three categories (inactive, moderate, 
and active), body mass index in kg/m
2
, energy intake per 1000 kcal, anti-
inflammatory medication and hormone replacement therapy use (no/yes), 
respectively. The plasma concentration of CRP was not transformed in this 
analysis to enable presentation of the data (Table 7.4). 
 
7.3 Results 
Descriptive characteristics of this subset (n = 1658 women, aged 18-79 
years) of the TwinsUK cohort are presented in Table 7.1. The mean age 
(±SD) of participants was 49.7 ± 12.5 years and mean (±SD) BMI was 24.9 
± 4.0 kg/m
2
. Mean (±SD) plasma CRP concentrations were 2.49 ± 2.30 
mg/L. More than half of the participants were moderately active (54.8 %), 
and 16.7% were current smokers. Few participants reported taking anti-
inflammatory medication (6.2 %) or were using hormone replacement 
therapy (6.3 %). The mean (±SD) MDS was 4.54 ± 1.79 points, HDI score 
was 3.45 ± 1.32 points, DQI was 11.8 ± 1.9 points, AHEI was 49.6 ± 11.1 
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points, and the DASH-style score was 23.3 ± 5.6 points. Mean (±SD) energy 
intake was 1976 ± 512 kcal/d. 
 
The main baseline characteristics and the five derived diet scores across 
quintiles of CRP are presented as unadjusted means ± standard errors (SEM) 
in Table 7.2. There was a significant positive association between plasma 
CRP and age, weight and BMI (P for trend < 0.001 for all). Women with a 
higher range of plasma CRP levels (4.24 – 9.86 mg/L) were less likely to be 
active (P < 0.001). In relation to the diet scores, the HDI and AHEI were 
inversely associated with plasma levels of CRP (mg/L) indicating that 
higher diet quality was associated with lower levels of CRP (P for trend = 
0.001 and 0.009, respectively) (Table 7.2). 
 
In multivariate analyses, when comparing extreme quartiles of the five 
derived diet scores, CRP was inversely associated with the HDI by 14 % (P 
for difference = 0.041), and with the AHEI by 12 % (P for difference = 
0.051). The associations were not significant for the MDS, DQI and DASH-
style scores (Table 7.3) 
 
Relative comparison of associations between diet quality scores, lifestyle 
characteristics and C-reactive protein 
Higher adherence to the HDI and AHEI was associated with lower plasma 
levels of CRP. The β-coefficients and standard errors for CRP in each of the 
diet quality scores and lifestyle characteristics represent non-transformed 
values to facilitate analyses and presentation. The magnitude of associations 
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observed were a decrease of 0.10 mg/L in plasma CRP levels per quartile of 
the HDI score (P = 0.044), and a decrease of 0.12 mg/L in plasma CRP 
levels per quartile of the AHEI score (P = 0.018). A one category increase in 
physical activity was associated with 0.2 mg/L lower plasma CRP levels, 
and this association was 1-6 times the scale of the association with the diet 
scores (P for all < 0.05). For every unit increase in BMI there was a 0.2 
mg/L increase in plasma CRP levels. This association was a similar scale of 
that of physical activity for all five diet scores (P for all < 0.001). 
Comparing participants who were not taking anti-inflammatory medication, 
plasma CRP levels were 0.5 mg/L higher for the MDS, DQI and DASH-
style scores compared to women who reported taking anti-inflammatory 
medication (P for all < 0.05) (Table 7.4).  
 
7.4 Discussion 
In this study using a large population-based sample of women aged 18-79 
years we evaluated the association between diet quality, as assessed by the 
five most commonly used predefined diet scores, the MDS, HDI, DQI, 
AHEI and DASH-style score and the inflammatory marker CRP. This is one 
of the first cross-sectional studies to examine a range of diet scores in 
association with a potential predictor of sarcopenia risk in a cohort of 
women across a wide age range. This study observed an inverse association 
between higher adherence to the HDI and AHEI scores and mean plasma 
levels of CRP highlighting the influence of diet quality on inflammation. 
Previous population studies have examined the relative influence of diet 
quality scores on inflammatory markers, including CRP associated mainly 
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to outcomes related to cardiovascular disease risk (Chrysohoou et al. 2004, 
Fargnoli et al. 2008, Fung et al. 2008, Fung et al. 2005). 
 
The current analysis observed a significant inverse association between 
higher adherence to the HDI and the inflammatory marker CRP. There are 
currently no studies that have directly evaluated the influence of the HDI 
score on CRP or other inflammatory markers, although higher adherence to 
the HDI has been previously inversely associated with all-cause mortality 
and cognitive impairment (Huijbregts et al. 1997, Huijbregts et al. 1998). In 
addition, a higher HDI score has been previously associated with lower BMI 
in both US and European cohorts (Haveman-Nies et al. 2001). In the current 
study, higher adherence to the HDI was also associated with lower BMI (P 
for trend = 0.005). However, the association observed between the HDI and 
plasma concentrations of CRP in the current analysis was independent of 
obesity. 
 
The magnitude of association between higher (five points) and lower (two 
points) adherence to the HDI score was 0.23 mg/L or 14 % of the population 
geometric mean for CRP (P = 0.041). This association was observed after 
adjustments for age, physical activity, smoking, anti-inflammatory 
medication (including aspirin, statins, and NSAID) and HRT use and was 
independent of adiposity (assessed by BMI). Alternatively, the difference in 
CRP concentration per quartile of the HDI score was - 0.10 mg/L [β 
coefficient (SEM): - 0.10 (0.05), P = 0.044] (Table 7.4). As mentioned 
earlier (sections 7.2 and 7.3), the plasma concentration of CRP was not 
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transformed in analysis presented in Table 7.4 to enable presentation of the 
data. Therefore, p values are different in Tables 7.3 and 7.4, but of interest p 
values were similar when the data on CRP were transformed and analysed 
on the natural logarithmic scale (data not shown). Findings were of a similar 
trend, although of a greater magnitude, to a previous cross-sectional study 
reporting that the difference in CRP concentration per quintile of a diet 
pattern score high in whole grains, fruit, nuts and green leafy vegetables was 
- 0.06 mg/L [β coefficient (SEM): - 0.06 (0.02), P < 0.05], among middle-
aged men and women aged 45-84 years from the MESA cohort (Nettleton et 
al. 2006). This difference may be explained by the fact that the study from 
Nettleton et al. was conducted in an ethnically diverse population and 
included more participants (n = 5089 men and women) compared with the 
current study (n = 1658 women). It also used an empirical method to derive 
dietary patterns, whereas the current study generated diet scores based on a 
priori knowledge. Moreover, the observed size of association was higher in 
the current analysis compared to Nettleton’s et al. study, possibly because 
the dietary pattern derived from Nettleton et al. included less components 
compared to the HDI score that we used in this study.  These components 
included whole grains, fruit, nuts, and green leafy vegetables which have 
previously been associated with CRP levels. 
 
A significant inverse association between higher adherence to the AHEI 
score and inflammatory marker CRP was also observed. The magnitude of 
association between higher (62.5 points) and lower (37.5 points) adherence 
to the AHEI score was 0.20 mg/L or 13 % of the population geometric mean 
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for CRP (P = 0.051). This association was observed after adjustments for 
age, physical activity, smoking, energy intake, anti-inflammatory 
medication (including aspirin, statins, and NSAID) and HRT use and was 
independent of adiposity (assessed by BMI). 
 
There are currently two previous cross-sectional studies that have examined 
associations between the AHEI score and CRP. In one of these studies, 
among women from the Nurse’s Health Study it was observed that a higher 
adherence to the AHEI score was  associated with a 30% decrease in plasma 
CRP concentrations (P < 0.05) independent of obesity and after multivariate 
adjustment (Fung et al. 2005). In another cross-sectional investigation in a 
subgroup of the same cohort, a higher adherence to the AHEI score was 
inversely associated with plasma CRP concentration by 41% (P < 0.05) 
compared to lower adherence to the score among women free from CVD, 
cancer and diabetes at baseline (Fargnoli et al. 2008). Findings from the 
current analysis were of a similar trend although of a lower magnitude to 
these two previous studies. These differences may be explained by the fact 
that in both previous cross-sectional analyses women were in a narrower age 
range with more people in the older age groups  compared to the current 
cohort (18-79 years). Indeed, low-grade chronic inflammation is a common 
and inevitable consequence of the ageing process (Chung et al. 2009, 
Khansari et al. 2009, Woods et al. 2012). Moreover, women from the 
Nurse’s Health Study were more overweight compared to women from the 
current analysis. Interestingly, BMI in the lowest and highest quintiles of the 
AHEI score were 27.5 kg/m
2
 and 25.1 kg/m
2
 in the Fung et al. cross-
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sectional analysis (Fung et al. 2005), and 28.7 kg/m
2
 and 26.9 kg/m
2 
in the 
Fargnoli et al. analysis (Fargnoli et al. 2008). Whereas, in the current 
analysis BMI between the lowest and highest quartiles of the AHEI score 
was within the normal range, i.e. 24.8 kg/m
2
 and 24.5 kg/m
2
, respectively. 
 
Both the HDI and AHEI scores award points to diets high in fruit and 
vegetables, whole grains, nuts and polyunsaturated fatty acids and low in 
saturated fatty acids. It has been well established that higher intakes of fruit 
and vegetables, whole grains, nuts and polyunsaturated fatty acids, as well 
as dietary patterns high in these food components may exert anti-
inflammatory properties and are associated with lower concentrations of 
inflammatory markers including CRP (Brown and Hu 2001, Chrysohoou et 
al. 2004, Esmaillzadeh et al. 2006, Esposito K and et al. 2004, Fung et al. 
2001, Lopez-Garcia et al. 2004, Lutsey et al. 2007, Nettleton et al. 2006). 
Also, saturated fatty acid intakes and dietary patterns high in saturated fatty 
acids may exert pro-inflammatory properties and have been positively 
associated with inflammatory markers including CRP (Esmaillzadeh et al. 
2007, Fung et al. 2001, Lopez-Garcia et al. 2004, Nettleton et al. 2006). 
 
In the current study we did not observe any associations between plasma 
CRP concentrations and the MDS, DQI and DASH-style scores. In relation 
to the MDS our findings were inconsistent with two previous cross-sectional 
studies that have evaluated the association between the MDS and CRP 
(Chrysohoou et al. 2004, Fung et al. 2005).  One of these studies showed 
that in men and women (aged 18 to 89 years) from the ATTICA cohort 
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study adherence to the Mediterranean diet score, was negatively associated 
with CRP by 20% (P = 0.015) (Chrysohoou et al. 2004). However, this 
association was only observed in the unadjusted model. After multivariate 
adjustment the authors reported a decrease in plasma CRP by 0.21 ± 0.12 
mg/L (P < 0.05) per 10 units of the MDS score however, they do not 
provide a percentage difference in plasma CRP levels. Also, the authors do 
not provide a definition for the units they used for the MDS; therefore we 
assumed that 1 point increase in the MDS was associated with 0.021 mg/L 
decrease in plasma CRP. In the current analysis we observed a decrease in 
plasma CRP concentration of 0.030 mg/L per quartile (per 1 point increase) 
in the MDS [β coefficient (SEM): - 0.030 (0.05), P = 0.580] (Table 7.4).  
This finding was of a greater magnitude to that reported in the ATTICA 
study, although our finding did not reach significance even after considering 
a number of covariates that may mediate the relationship between the MDS 
and plasma CRP concentrations. It is noteworthy that the objective of the 
ATTICA study was to examine whether the benefits of the Mediterranean 
diet on heart disease may be explained by its ability to modulate systemic 
inflammation and coagulation (Chrysohoou et al. 2004). Therefore, this 
study adjusted for a number of factors, such as presence of hypertension, 
diabetes, hypercholesterolemia, and family history of coronary heart 
disease. However, these additional factors were not included in our analysis 
which aimed to assess whether greater adherence to the MDS is negatively 
associated with plasma levels of CRP (mg/L). Also, there was a 
considerable difference in the range of the score generated in the Attica 
cohort (0-55 units, although as mentioned above the authors do not provide 
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a definition for the units that they used for the MDS score) compared to a 
range between 0 and 10 points for the TwinsUK cohort, which may be 
indicative of the fact that the scores were constructed in a different way. 
This difference in addition to the fact that the MDS score is generated 
mainly according to the distribution of the foods within a specific cohort 
may provide an explanation why we did not observe an association with 
CRP.     
 
In the second study among women (aged 43 to 69 years) from the Nurses’ 
Health Study it was shown that higher adherence to the alternate 
Mediterranean score (aMED) was associated with 24% lower plasma levels 
of CRP  (P < 0.05) (Fung et al. 2005). In the current study higher adherence 
to the MDS was only associated with a 2.5% decrease in CRP 
concentrations and this association was not significant (P = 0.841) (Table 
7.3). Findings were of a similar trend although of a lower magnitude to that 
reported in the Nurses’ Health Study. This difference may be explained by 
the fact that Fung et al. used a modified version of the original 
Mediterranean score including only whole grain products in the cereal 
group. This may offer an explanation as to why we did not observe a 
significant association in our analysis as we developed the original 
Mediterranean score which includes non-whole grain cereals in addition to 
whole grain products. Indeed, it has been previously shown that diets high 
in whole grains may decrease inflammation (Nettleton et al. 2006) (Schulze 
et al. 2005) and diets high in refined grains are associated with increased 
risk of diseases associated with inflammation, such as diabetes (Schulze and 
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Hu 2005). It is noteworthy that in the study from Fung et al. mean CRP 
concentration in the first quintile of the aMED score was 3.4 ± 4.0 mg/L. 
This concentration was higher compared to the mean CRP concentration in 
the first quartile of the MDS in the current analysis (2.5 ± 2.3 mg/L). The 
median CRP concentration under physiological conditions is 0.8 mg/L and 
CRP levels > 3 mg/L represent a high risk for cardiovascular disease 
according to the American Heart Association Consensus panel and the 
Centres for Disease Control and Prevention (CDC/AHA) (de Ferranti and 
Rifai 2007). This suggests that associations with diet may only be observed 
when population ranges of plasma CRP are higher.   
 
In the current analysis there was also no association between the DASH-
style score and CRP, although one previous cross-sectional study in women 
from the Nurses’ Health Study cohort suggested that the DASH-style score 
was associated with lower plasma levels of CRP by 20 % (Fung et al. 2008). 
However, these findings were observed in a cross-sectional analysis of a 
sub-group from the larger prospective study focusing mainly on the 
influence of the DASH-style score on the incidence of nonfatal myocardial 
infarction, coronary heart disease death and stroke over 24 years of follow-
up. However, the authors do not provide any information about the baseline 
characteristics of this subgroup of women, which does not enable 
comparisons with our study.           
 
No association was also observed for the DQI score. This finding is 
consistent with the only previous cross-sectional study among women aged 
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43 to 69 years from the Nurse’s Health Study. This study has shown that a 
modified version of the DQI, the diet Quality Index Revised (DQI-R) was 
not associated with plasma levels of CRP or other inflammatory markers 
(Fung et al. 2005). 
 
Although the MDS, DQI and the DASH-style scores account for diets high 
in food components, such as fruit and vegetables and whole grains (Brown 
and Hu 2001, Fung et al. 2001, Lopez-Garcia et al. 2004, Nettleton et al. 
2006), and diets low in saturated fat and red processed meat, respectively, 
that have been previously associated with lower levels of CRP 
(Esmaillzadeh et al. 2007), associations in this study did not reach 
significance. However, the DQI score also includes calcium and sodium 
intakes and the DASH-style score includes only sodium intake in its criteria. 
To date, there is no evidence suggesting that calcium intake may be related 
to inflammation. Also, data on sodium intake are conflicting with one cross-
sectional study suggesting that sodium intake (assessed by 24-h urinary 
excretion) was associated with lower systemic inflammatory markers 
(including CRP) (Fogarty et al. 2009), and one randomised double blind 
placebo-controlled  trial reporting no effects of low sodium diet on high-
sensitivity CRP (hs-CRP) (Forrester et al. 2010). Therefore, as sodium and 
calcium are included in the DQI and the DASH-style scores this may impact 
on their ability to detect associations with CRP.    
 
The lack of associations observed in the current study might also be due to 
the fact that other lifestyle factors than diet have a greater influence on CRP. 
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Therefore, to further evaluate whether the findings were due to the potential 
protective effect of a better quality diet or due to an overall healthy lifestyle, 
analyses was calculated for age per 10 years, smoking habit, physical 
activity, body mass index (BMI, kg/m
2
), energy intake per 1000 cal, anti-
inflammatory medication and hormone replacement use to enable 
comparisons (Table 7.4). Interestingly, in this cohort, physical activity had 
a greater relationship with CRP than the MDS, DQI and DASH-style scores. 
After multivariate adjustment for relevant confounders the effect of physical 
activity and BMI was 6 times greater of that of the MDS and DASH-style 
scores and 3 times greater of that of the DQI score on CRP (P < 0.05 for all) 
(Table 7.4). Specifically, there was a strong effect of BMI on CRP and the 
magnitude of association was equivalent to 0.2 mg/L increase in CRP for 
every unit increase in BMI (P for all < 0.001). This finding reflects data 
from previous epidemiological studies showing that a number of obesity 
indices, including BMI are independently associated with higher plasma 
CRP concentrations in various populations (Choi et al. 2013, Festa et al. 
2001, Hodge et al. 2010, Khoo et al. 2011). It is also well established that 
the adipose tissue secretes a number of pro-inflammatory cytokines, such as 
interleukin-6 (IL-6), which further triggers the hepatic synthesis of CRP 
(Santos et al. 2005, Tilg and Moschen 2006, You et al. 2008). In addition, it 
has been shown in vitro that mature adipocytes isolated from human adipose 
tissue were directly involved in the release of CRP (Calabro et al. 2005). 
Also, physical activity was significantly inversely associated with plasma 
levels of CRP with a magnitude of association equivalent to 0.2 mg/L lower 
CRP per category of physical activity in this study. Notably, in a recent 
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review which evaluated the relationship between the inflammatory marker 
CRP and exercise, it was reported that interventions that were based just on 
increasing the physical activity had no effect on the inflammatory marker 
CRP (Michigan et al. 2011). However, intervention programmes that were 
based on lifestyle changes including both exercise and healthy diet reported 
decreases on CRP, probably related to weight reduction. The association 
observed in our cohort was of a similar magnitude of that of a randomised 
controlled trial among obese postmenopausal women aged 50-75 years, in 
which mean CRP was reduced by 0.24 mg/L from baseline after an  exercise 
intervention programme of one year (Campbell et al. 2009).  
 
In the current study although lifestyle factors had an effect on plasma CRP, 
the association of the HDI and AHEI scores remained significant even after 
accounting for all relevant lifestyle factors. Of interest, after multivariate 
adjustment, the effect of these two scores on CRP was similar to the effect 
of 10 years of age. However, the observed findings may be because the 
dietary factors included in the scores are more likely associated with 
beneficial effects on CRP.    
 
The mechanisms involved in the relationship between diet quality and the 
inflammatory marker CRP cannot be specifically identified due to the nature 
of this study which assessed cross-sectional associations. Nevertheless, 
findings from epidemiological studies that have shown that greater 
consumption of fruits and vegetables, whole grains, dietary fiber, nuts and 
seeds and diet patterns high in these components were associated with lower 
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levels of inflammatory markers including CRP offer support to these 
findings (Esmaillzadeh et al. 2006, Lutsey et al. 2007, Nettleton et al. 
2006). In addition, micronutrients included in these foods, such as vitamins 
C (Block et al. 2009) and E (Helmersson et al. 2009), magnesium (Chacko 
et al. 2010, Chacko et al. 2011, Moslehi et al. 2012, Song et al. 2007), 
selenium (Duntas 2009, Scheurig et al. 2007) and carotenoids (Helmersson 
et al. 2009, Walston et al. 2006, Wang et al. 2008) have been associated 
with lower levels of inflammatory markers including CRP. Consequently, 
the inverse associations we found between CRP and healthy diet scores may 
be partly explained due to the anti-inflammatory effects of an overall 
healthier diet containing food components high in nutrients with anti-
inflammatory properties.    
 
7.5 Strengths and limitations 
The strengths of this study include the large sample size and the fact that 
this was the first study that directly compared five of the most commonly 
used predefined diet quality scores based on adherence to dietary patterns or 
to dietary recommendations with plasma levels of CRP. An additional 
strength was that two of the scores have been previously validated by  10 to 
12 24 h dietary recalls (Benítez-Arciniega et al. 2011) and against plasma 
biomarkers of vitamin C, a-tocopherol, β-cryptoxanthin and phospholipid 
fatty acids (Neuhouser et al. 2003). Also, the FFQ used in the current study 
was previously compared and validated against a 7-day weighed record in 
the EPIC Norfolk study, and although the two approaches to measure 
dietary intake were different, both methods identified similar intakes of 
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macronutrients when these were expressed as percentage of total energy 
intake (Bingham et al. 2001). This FFQ was also validated against urinary 
and plasma biomarkers of intake, such as urinary nitrogen for protein intake, 
urinary potassium and sodium, plasma ascorbic acid and plasma n-3 PUFAs 
(McKeown et al. 2001, Welch et al. 2006). In addition, it has been shown 
previously that serum β-cryptoxanthin and zeaxanthin concentrations were 
moderately correlated with dietary carotenoids intakes measured by an FFQ 
(Tucker et al. 1999). Furthermore, in order to examine associations between 
dietary intake and health outcomes participants need to be ranked according 
to their usual dietary intake and FFQs have been shown to rank individuals 
well (Molag et al. 2007). 
 
This study also has a number of limitations. The cross-sectional nature of 
the study limits causal inference, but enables us to generate hypotheses 
regarding associations between diet quality and the inflammatory marker 
CRP based on plausible mechanisms. Higher adherence to the diet scores 
may be an indicator of a healthy lifestyle besides diet, and even though all 
analyses were adjusted for lifestyle factors, residual confounding cannot be 
ruled out because of the observational nature of the study. In addition, as in 
all observational studies, measurement error in self-reported dietary intakes 
is inevitable. It is also widely acknowledged that the use of FFQs for 
measuring dietary intake has its own limitations related to memory errors, 
they provide relative than absolute intake, they introduce bias due to over- 
or under-reporting, and they may introduce systematic errors as preparation 
methods are inadequately considered (McNeill et al. 2009). Also, FFQs 
 254 
 
measure food intake over a period of one year and reflect the habitual diet 
over this period of time but not lifetime dietary habits (Teucher et al. 2007). 
Another limitation is that no specific statistical weighting for each 
component has been used regarding the construction of each score, 
assuming that all food groups and nutrients contributed equally to the diet 
quality. The observed findings relate to women and further work is needed 
to investigate if these findings are replicated in a male population of the 
same country or in populations from different ethnic backgrounds.   
 
7.6 Concluding remarks  
In conclusion, we found that a better diet quality as assessed by two 
predefined derived diet scores was inversely associated with CRP in women 
of a wide age range, the HDI by 14 % (P = 0.041) and the AHEI by 13 % (P 
= 0.051) of the population geometric mean for CRP. These associations 
were observed after accounting for age, physical activity, smoking, energy 
intake, BMI, anti-inflammatory medication and use of hormone replacement 
therapy. Findings from the current study extend the results from previous 
cross-sectional studies by focusing on the overall diet quality developed 
based on a priori knowledge instead of patterns derived based on empirical 
methods in association with the inflammatory marker CRP. Nevertheless, 
associations were not observed for all diet quality scores possibly due to the 
fact that other factors, such as physical activity and body mass index may be 
more important than diet on CRP. Yet, it is also possible that a longitudinal 
study design might be more suitable approach to detect associations 
between diet quality and the inflammatory marker CRP, as it might be more 
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likely to observe a difference in the inflammatory status over time due to a 
healthier diet. Additionally, maybe long-term interventions are needed to 
observe an effect and a dose-response relationship needs to be demonstrated 
in order to define the anti-inflammatory or pro-inflammatory effects of 
specific nutritional factors that can further modulate disease risk. 
 
Despite their differences, the derived diet scores reflected a common pattern 
characterised by high intakes in fruit and vegetables, nuts, legumes, dietary 
fiber and/or whole grains, and low intake of red and processed meat, and 
saturated fat, suggesting that plant derived sources of vitamin C, magnesium 
and carotenoids may be important for the inflammatory status. Results from 
this study suggest that is important for adult women to consume a variety of 
foods to ensure lower plasma concentrations of the inflammatory marker 
CRP. From a public health perspective, these findings will help to improve 
the knowledge and understanding of the effects of dietary and lifestyle 
factors on CRP, which is predictive for the development of chronic diseases, 
and provide useful information in developing and planning dietary 
intervention trials to improve the inflammatory status in adult life.  
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TABLES 
Table 7.1 Baseline characteristics of female subjects from the TwinsUK cohort
1 
Characteristic N=1658, 18-79 yrs
 
Age (y) 49.7±12.5 
Weight (kg) 65.5±10.6 
Height (cm) 162±5.96 
BMI (kg/m
2
) 24.9±4.0 
Inflammation marker  
C-reactive protein (CRP) (mg/L)  2.49±2.30 
Physical activity % 
Inactive 
Moderate 
Active 
 
20.5 
54.8 
24.7
 
Smoking history % 
Never 
Current 
Former 
 
50.2 
16.7 
33.1
 
Hormone replacement therapy % 
No 
Yes 
 
93.7  
6.30 
Anti-inflammatory medication %
2
  
No 93.8 
Yes 6.20 
Derived diet scores (points)  
Mediterranean Diet Score (MDS) 4.54±1.79
 
Healthy Diet Indicator (HDI) 3.45±1.32
 
Diet Quality Index (DQI) 11.8±1.9
 
Alternate Healthy Eating Index (AHEI)  49.6±11.1 
Dietary Approach to Stop Hypertension score (DASH-style) 23.3±5.6
 
Dietary components 
 
Energy intake (kcal/d) 1976±512
 
MDS
3
 
 
Fruit & nuts group (g/d) 254±192
 
Vegetables group (g/d) 276±156
 
Ratio of mono- and poly- to saturated fat 1.49±0.37
 
Milk & dairy group (g/d) 426±197
 
Meat group (g/d)
 
86.4±47.5
 
Fish group (g/d)
 
36.3±27.8
 
Legumes intake (g/d)
 
22.8±26.6
 
Cereals intake (g/d)
 
208±101
 
Alcohol intake (g/d) 
 
10.1±13.8
 
HDI
  
Fruit & vegetables group  (g/d)
 
583±302
 
Complex carbohydrates group  (% Energy/d)
 
47.5±18.2
 
Dietary fiber group (g/d)
 
20.4±7.5
 
Pulses & nuts group (g/d)
 
25.6±27.6
 
Mono- & disaccharides group (% Energy/d) 23.9±5.7
 
Protein intake (% Energy/d)
 
16.7±2.6
 
Saturated fat intake (%Energy/d)
 
11.6±2.9
 
Polyunsaturated fat intake (% Energy/d)
 
6.45±1.57
 
Cholesterol intake (mg/d)
 
224±86
 
DQI
  
Fruit & vegetables group  (servings/d)
 
7.39±3.83
 
Total fat (% Energy/d)
 
30.9±5.5
 
Complex carbohydrates (servings/d) 3.82±1.91 
Saturated fat (% Energy/d) 11.6±2.93 
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Cholesterol (mg/d) 224±86 
Protein (% RDA) 147±24 
Sodium intake (mg/d)
 
2258±733
 
Calcium  intake (mg/d)
 
1144±378
 
AHEI  
Vegetables (servings/d) 3.54±2.01 
Fruit (servings/d) 3.14±2.39 
Nuts and soy protein (servings/d) 0.10±0.21 
Ratio of white to red meat 2.75±6.09 
Dietary fiber (g/d) 20.4±7.5 
Trans fat (% energy) 1.11±0.38 
Polyunsaturated to saturated fat ratio 0.59±0.23 
Vitamin supplement use % (yes/no) 54.4 / 45.6 
Alcohol (servings/d) 0.78±1.05 
DASH-style score
  
Fruits intake (servings/d)
 
4.06±2.73
 
Vegetables intake (servings/ d)
 
3.32±1.98
 
Nuts & legumes intake (servings/d)
 
0.52±0.40
 
Whole grains intake (servings/d)
 
1.85±1.63
 
Low-fat dairy intake (servings/d)
  
0.95±0.66
 
Sodium (mg/d) 2258±733 
Red & processed meat intake (servings/d)
 
0.99±0.56
 
Sweetened beverages intake (servings/d)
 
0.38±0.79
 
1 
Values are presented as mean ± SEM or else indicated 
2
 Aspirin, statins, non-steroidal anti-inflammatory drugs (NSAID) 
3 
Values represent the mean for the variables used in construction of the dietary scores  
 
 
 
 
 
 
 258 
 
Table 7.2 Baseline characteristics of 1658 female subjects from the TwinsUK cohort across C-reactive protein (mg/L) quintiles
1
 
 Q1 
(0.16-0.62) 
Q2 
(0.63-1.20) 
Q3 
(1.21-2.21) 
Q4 
(2.22-4.23) 
Q5 
(4.24-9.86) 
P for 
trend  
N 341 325 331 331 330  
Age (y) 46.9±0.8 48.7±0.7 51.3±0.7 50.3±0.8 51.2±0.8 <0.001 
Weight (kg) 60.8±0.5 63.1±0.5 65.6±0.6 67.5±0.7 70.4±0.8 <0.001 
Height (cm) 162±0.4 163±0.3 162±0.4 162±0.4 161±0.4 0.006 
BMI (kg/m
2
) 23.1±0.2 23.8±0.2 25.0±0.2 25.6±0.2 27.2±0.3 <0.001 
Physical activity %       
Inactive 17.0 20.0 18.4 16.9 30.0 <0.001 
Moderate 54.8 54.5 60.1 54.4 50.3  
Active 28.2 25.5 21.5 28.7 19.7  
Smoking history %       
Never 54.8 48.6 46.8 49.5 50.9 0.416 
Current 13.5 19.1 18.4 15.1 17.6  
Former 31.7 32.3 34.7 35.4 31.5  
Hormone replacement therapy %       
No  91.5 95.7 91.8 94.2 93.7 0.083 
Yes  8.5 4.3 8.2 5.8 6.3  
Anti-inflammatory medication %
2
       
No  94.1 94.8 94.3 94.0 92.1 0.674 
Yes  5.9 5.2 5.7 6.0 7.9  
Derived diet scores (points)       
Mediterranean Diet Score (MDS) 4.55±0.11 4.54±0.11 4.66±0.10 4.59±0.10 4.38±0.10 0.378 
Healthy Diet Indicator (HDI) 3.61±0.08 3.48±0.07 3.47±0.08 3.45±0.07 3.23±0.07 0.001 
Diet Quality Index (DQI) 11.7±0.12 11.8±0.11 12.0±0.11 11.8±0.11 11.5±0.11 0.295 
Alternate Healthy Eating Index (AHEI) 50.8±0.7 49.1±0.6 50.8±0.6 49.5±0.6 48.0±0.6 0.009 
Dietary Approach to Stop Hypertension score 
(DASH-style) 
23.5±0.31 23.1±0.32 23.3±0.33 23.3±0.31 23.5±0.33 0.828 
Energy intake (kcal/d) 1996±28.5 1972±29.1 1956±28.8 1961±27.8 1992±31.3 0.834 
Inflammation markers       
CRP (mg/L) 0.41±0.01 0.91±0.01 1.67±0.02 3.11±0.03 6.42±0.09 <0.001 
1 
Values are means and standard errors (SEM) by quintiles of CRP (mg/L) 
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Table 7.3 The associations between C-reactive protein (mg/L) and the derived diet scores 
quartiles in 1658 female subjects from the TwinsUK cohort aged 18-79 years
1
 
 C-reactive protein (mg/L) 
Quartiles Q1 Q2 Q3 Q4 
P for 
trend 
MDS (points) 
Unadjusted  
Adjusted model
2
 
3
3
 
1.61 (1.46,1.79) 
1.62 (1.48,1.78)  
4 
1.58 (1.41,1.77) 
1.56 (1.41,1.72) 
5 
1.68 (1.51,1.86) 
1.63 (1.47,1.80) 
6 
1.54 (1.41,1.69) 
1.58 (1.45,1.73) 
 
0.651 
0.841 
HDI (points) 
Unadjusted  
Adjusted model
2
 
2 
1.68 (1.51,1.87) 
1.65 (1.49,1.82)  
3 
1.72 (1.57,1.88) 
1.68 (1.54,1.82) 
4 
1.61 (1.46,1.77) 
1.62 (1.47,1.77) 
5 
1.34 (1.20,1.50) 
1.42 (1.28,1.57) 
 
0.004 
0.041 
DQI (points) 
Unadjusted  
Adjusted model
2
 
9 
1.62 (1.46,1.80) 
1.68 (1.53,1.85)  
12 
1.57 (1.44,1.70) 
1.56 (1.45,1.68) 
13 
1.63 (1.43,1.86) 
1.55 (1.37,1.76) 
14 
1.60 (1.44,1.77) 
1.59 (1.44,1.74) 
 
0.992 
0.417 
AHEI (points) 
Unadjusted  
Adjusted model
2
 
37.5 
1.67 (1.50,1.86) 
1.68 (1.52,1.85)  
46.5 
1.76 (1.59,1.95) 
1.67 (1.52,1.83) 
53.5 
1.56 (1.41,1.72) 
1.56 (1.42,1.71) 
62.5 
1.40 (1.26,1.56) 
1.48 (1.34,1.63) 
 
0.009 
0.051 
DASH-style 
(points) 
Unadjusted  
Adjusted model
2
 
 
17 
1.61 (1.46,1.77) 
1.61 (1.45,1.79)  
 
21 
1.49 (1.35,1.65) 
1.52 (1.38,1.68) 
 
25 
1.65 (1.49,1.82) 
1.71 (1.56,1.87) 
 
30 
1.64 (1.48,1.82) 
1.54 (1.38,1.73) 
 
 
0.486 
0.948 
1
 Values are geometric means and 95% confidence intervals (CI) of C-reactive protein (mg/L) by quartiles of the 
derived diet scores  
2
 Adjusted for age (years), physical activity (inactive, moderately active, active), smoking status (never, current, 
former), body mass index (kg/m
2
), energy intake (kcal/d) (only for MDS, AHEI, and DASH-style), anti-inflammatory 
medication (including aspirin, statins, and NSAID) (no/yes) and HRT use (no/yes) 
3
 Values are medians of the diet scores 
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Table 7.4 Relative associations between diet quality scores, lifestyle characteristics and C-reactive protein (mg/L) in 1658 female subjects from the TwinsUK cohort aged 18-
79 years  
 MDS HDI DQI AHEI DASH-style 
C-reactive protein (mg/L) ß SEM P ß SEM P ß SEM P ß SEM P ß SEM P 
Diet score per quartile -0.03 0.05 0.580 -0.10 0.05 0.044 -0.06 0.05 0.202 -0.12 0.05 0.018 0.03 0.06 0.690 
Age (per 10 y) 0.10 0.05 0.055 0.10 0.05 0.089 0.10 0.05 0.056 0.10 0.05 0.056 0.10 0.05 0.056 
 
Smoking habit 
Current v never 
Former v never  
0.18 
0.01 
 
0.16 
0.13 
 
0.278 
0.931 
 
 
0.15 
0.003 
 
 
0.17 
0.13 
 
 
0.352 
0.982 
 
 
0.16 
0.005 
 
 
0.16 
0.13 
 
 
0.332 
0.971 
 
 
0.15 
0.03 
 
 
0.16 
0.13 
 
 
0.355 
0.812 
 
 
0.19 
0.004 
 
 
0.16 
0.13 
 
 
0.248 
0.972 
Physical activity -0.18 0.08 0.033 -0.19 0.02 0.042 -0.17 0.08 0.037 -0.16 0.08 0.053 -0.18 0.08 0.028 
 
Body mass index (kg/m
2
) 0.19 0.02 <0.001 
0.19 0.02 <0.001  0.19  0.02  <0.001 0.19 0.02 <0.001 0.19 0.02 <0.001 
Energy intake (per 1000 cal) 0.11 0.11 0.311 Not adjusted for energy intake 0.14 0.11 0.204 0.07 0.14 0.638 
Anti-inflammatory medication 
No v Yes  0.52 0.26 0.047 0.51 0.26 0.053 0.52 0.26 0.048 0.51 0.27 0.056 0.53 0.26 0.045 
HRT 
No v Yes -0.25 0.23 0.289 -0.25 0.23 0.279 -0.24 0.23 0.292 -0.23 0.23 0.330 -0.25 0.23 0.286 
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Chapter 8 
 
Association between C-reactive protein levels and 
indexes of muscle mass and 
the potential attenuation by dietary constituents 
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8.0 Introduction 
Ongoing research on ageing and sarcopenia suggests a link between 
sarcopenia and inflammation (Chung et al. 2009). The ageing process is 
associated with a gradual, chronic production and increase of pro-
inflammatory cytokines (Roubenoff et al. 1998). Age-related cytokine 
production is a risk factor leading to the predisposition to sarcopenia, as the 
pro-inflammatory environment triggers catabolism and protein breakdown 
and therefore leads to imbalances in the synthesis of muscle tissue (Morley 
and Baumgartner 2004, Roubenoff and Hughes 2000).  
 
Chronic low-grade inflammation is considered detrimental to skeletal 
muscle mass and strength in both humans and animal models (Howard et al. 
2007, Siu et al. 2008). The potential underlying mechanisms have been 
previously described in Chapter 1 (section 1.4, p. 32) (Chung et al. 2009, 
Janssen-Heininger et al. 2000). 
 
Epidemiological evidence has also observed an inverse relationship between 
muscle mass, strength and function and inflammatory cytokines (Barbieri et 
al. 2003, Cesari et al. 2005, Payette et al. 2003, Schaap et al. 2006, Schaap 
et al. 2009, Visser et al. 2002). In the Health, Aging and Body Composition 
(Health ABC) study among men and women aged 70-79 years, it was 
observed that per standard deviation increase in IL-6, grip strength was 1.1 
to 2.4 kg lower (Visser et al. 2002). Also participants with high levels of IL-
6 (> 1.80 pg/ml) and TNF-a (> 3.20 pg/ml) had a smaller muscle area, less 
appendicular muscle mass, lower knee extensor strength and grip strength. 
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A report from the InCHIANTI cohort found that among men and women 
aged 20-102 years, IL-6 was an independent predictor of hand grip strength 
and muscle power (Barbieri et al. 2003). In a cohort of older adults aged 72 
to 92 years, from the Framingham Heart study, IL-6 was a significant 
predictor of fat free mass over two years follow-up (Payette et al. 2003). 
Another report from the InCHIANTI cohort among men and women aged 
more than 65 years showed that there was an independent association 
between IL-6 and CRP and muscle strength and poor physical performance 
(Cesari et al. 2004). In the Longitudinal Aging Study Amsterdam (LASA) 
among men and women with a mean age of 74.6 years, high IL-6 and CRP 
were associated with a two to three fold higher risk of losing greater than 40 
% of muscle strength, however no associations were found with 
appendicular muscle mass (Schaap et al. 2006). Similarly, in the Health, 
Aging and Body Composition (Health ABC) study among men and women 
aged 70-79 years, it was observed that TNF-a levels and its soluble 
receptors were associated with a five year decline in cross-sectional muscle 
area and hand grip strength (Schaap et al. 2009).   
 
These findings were also supported by animal studies showing that 
administration of IL-6 and TNF-a in rats was associated with changes in 
muscle metabolism, including increased skeletal muscle protein breakdown, 
decreased protein synthesis rate, decreased amino acid concentration of 
skeletal muscle, and muscle wasting (Goodman 1991, Hoshino et al. 1991).  
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A number of nutrients have been associated with muscle mass and strength.  
Protein (Campbell et al. 2001, Castaneda et al. 1995), amino acids 
(Borsheim et al. 2008, Scognamiglio et al. 2004, Solerte et al. 2008) and 
vitamin D (Dawson-Hughes 2008) have been shown to be beneficial in 
supplementation studies, and magnesium and potassium are known to play 
an important role in muscle metabolism (Frassetto et al. 1998, Song et al. 
2007, Song et al. 2005). Furthermore, vitamins C, E and selenium and 
carotenoids are known to reduce oxidative stress and have anti-
inflammatory properties (Ferrucci et al. 2005, Helmersson et al. 2005, 
Young et al. 2004). The results from Chapter 3 (section 3.3, p. 87) showed 
strong, positive associations with magnesium, potassium, vitamin C, 
carotene, and β-carotene. 
 
Diet also plays a major role in the regulation of chronic inflammation as 
dietary constituents have the potential to exert anti-inflammatory as well as 
pro-inflammatory effects (Cavicchia et al. 2009). The potential mechanisms 
linking diverse dietary constituents, such as magnesium, potassium, vitamin 
C, carotene, β-carotene, arginine and glutamine, the “whole diet” and both 
muscle mass and the inflammatory marker CRP have been described in 
detail in previous chapters (Chapter 3, section 3.4, p. 91; Chapter 4, section 
4.0, p. 124; Chapter 5, section 5.4, p. 168; Chapter 6, section 6.0, p. 198; 
Chapter 7, section 7.4, p .241). 
 
Inflammation has been shown to influence loss of muscle mass in other 
studies and in the current study was associated (cross-sectionally) with 
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indexes of fat free mass. I also found that certain nutrients are associated 
with the inflammatory marker (CRP) and investigated the association 
between CRP and muscle mass and dietary factors to determine whether diet 
would influence the association between CRP and muscle mass. To our 
knowledge there are currently no studies examining if both the habitual 
intake of nutrients that have been previously associated with muscle mass or 
have shown to exert anti-inflammatory properties and the “whole diet” 
mediate the known association between muscle mass and inflammation. 
This could offer valuable data for the implementation of dietary intervention 
trials for the prevention of sarcopenia by targeting inflammation. I 
hypothesised that if diet reduced the association between CRP and muscle 
mass in the statistical models that this would be interpreted as an influence 
of diet on the association between CRP and muscle. 
 
8.1 Aims 
The aims of this chapter were firstly to test the hypothesis that muscle mass, 
as assessed by three indexes, fat free mass (FFM, kg), percentage fat free 
mass (FFM%) and fat free mass index (FFMI, kg/m
2
), was inversely 
associated with C-reactive protein (CRP) levels, among women aged 18-79 
years from the TwinsUK participants, and whether diet would mediate the 
proposed association between muscle mass and CRP levels in this cohort.          
 
8.2 Covariate plan and statistical analysis 
All analyses were performed using STATA statistical software (version 
11.0; STATA Corp, USA). The selection of dietary constituents that may 
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mediate the association between muscle mass and CRP levels was decided a 
priori. Thus, nutrients and diet scores that showed a greater association with 
either indexes of muscle mass (such as magnesium, vitamin C, carotene, β-
carotene, potassium, MDS, HDI, AHEI, and DASH-style scores) in Chapter 
3 (section 3.4, p. 91) and Chapter 5 (section 5.4, p. 168) or CRP levels (such 
as magnesium, HDI, AHEI scores) in Chapter 6 (section 6.4, p. 209) and 
Chapter 7 (section 7.4, p. 241) were included. In relation to essential amino 
acids, although a significant positive association with CRP levels was 
observed with higher intakes of arginine, glutamine, histidine, isoleucine, 
threonine and tryptophan (as % energy) (Chapter 6, section 6.3, p. 207), 
only glutamine and arginine were included in the current analysis as these 
amino acids have been suggested to play an important role in inflammatory 
processes related to muscle wasting (Nicastro et al. 2012, Pithon-Curi et al. 
2004, Wu et al. 2004, Wu and Morris 1998). Moreover, glutamine was the 
amino acid with the highest intake in this cohort. 
 
The analyses were performed treating twins as individuals, as previous 
studies have shown that participants from the TwinsUK registry were 
similar to age-matched singleton women in the distribution of common 
traits and outcomes (Andrew et al. 2001). Data on dietary intake (FFQ), 
body composition parameters, and other covariates were available for n = 
1658 women, aged 18 to 79 years representing 582 monozygotic (MZ) and 
1076 dizygotic (DZ) females who had completed a food frequency 
questionnaire (FFQ) and had fasting blood samples taken to measure C-
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reactive protein (CRP) between 1996 and 2000 (Moayyeri et al. 2012, 
Teucher et al. 2007). 
 
Prior to conducting statistical analysis  an analysis plan with justification for 
each confounding factor in the multivariate models was developed as 
described in Chapter 2, section 2.2.5, p. 57.  
Briefly, factors that have been previously shown to affect either muscle 
mass or the inflammatory status or both and may mediate the relationship 
between muscle mass and CRP were included in the multivariate models 
(Model 1 in Tables 8.1, 8.4, and 8.7). These factors were age (years), 
physical activity and smoking status, body mass index (kg/m
2
), hormone 
replacement therapy use (HRT) and anti-inflammatory medication 
(including statins, non-steroid anti-inflammatory drugs and aspirin) (no or 
yes, respectively) (Chapter 2, section 2.2.5, p. 57, 58, 60, 64, 66, 68).  
 
The analyses were performed in a three-step process. First, multivariate 
regression analysis was used to assess associations between indexes of 
muscle mass (FFM, FFM% and FFMI) across quintiles of plasma CRP 
concentrations using the robust cluster regression option in STATA (Model 
1, Tables 8.1, 8.4 and 8.7). Model 1 was adjusted for age, physical activity, 
smoking, BMI, anti-inflammatory medication and HRT use. Robust cluster 
regression takes into account clustering of individuals when calculating 
standard errors of the mean (Richards et al. 2007) to ensure familial 
aggregation within twin pairs was accounted for.  
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Second, nutrient intakes or diet quality scores that may mediate the 
relationship between muscle mass and CRP were added in the model (as 
quintiles for nutrients and as quartiles for diet scores) to assess the change in 
the β-coefficient for the association between indexes of muscle mass and 
CRP levels, per quintile of nutrient intakes or per quartile of diet scores 
(Model 2, Tables 8.1, 8.4 and 8.7). Thirdly, this analysis was repeated with 
additional adjustment for energy intake (as linear term) with exception of 
the HDI that already takes energy intake into account (Model 3, Tables 8.1, 
8.4 and 8.7). To understand the effect of any attenuation of the relationship 
between CRP and muscle mass by dietary factors after multivariate 
analyses, the percentage difference in β-coefficients between Model 1 and 
Model 3 was calculated using the following formula: 
[(β-coefficient in Model 1 - β-coefficient in Model 3) / β-coefficient in 
Model 1] x 100. 
This model was applied to all the nutrients and dietary patterns except the 
HDI where the comparison was between Model 1 and Model 2, since energy 
was not included in this analysis, as explained earlier. This percentage 
difference (%) in β-coefficients between Model 1 and Model 3 provides an 
estimate of the potential attenuation of diet on the relationship between CRP 
and muscle mass. A positive finding indicates that the nutrient/diet score 
improves the association between indexes of muscle mass and CRP levels or 
reduces the impact of CRP on indexes of muscle mass, and a negative 
finding indicates that the nutrient/diet score does not improve the 
association between indexes of muscle mass and CRP levels, or increases 
the impact of CRP on indexes of muscle mass. 
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Since age was inversely and significantly correlated with indexes of muscle 
mass, this analysis was stratified by age using two categories, less than 50 
years (Tables 8.2, 8.5 and 8.8) and more than 50 years (Tables 8.3, 8.6 and 
8.9). 
 
8.3 Results 
Descriptive characteristics of this subset (n = 1658 women, aged 18-79 
years) of the TwinsUK participants have been previously described in 
Chapter 6 (section 6.3, p. 207 and Table 6.2, p. 228). Briefly, the mean age 
(±SD) of participants was 49.7 ± 12.5 years, mean (±SD) BMI was 24.9 ± 
4.0 kg/m
2
, and mean (±SD) plasma CRP concentrations were 2.49 ± 2.30 
mg/L. 
In the multivariate analyses, higher plasma CRP levels were associated with 
lower indexes of muscle mass. The magnitude of associations observed was 
a decrease of 0.18 kg in FFM (P =0.028), 1.22 % in percentage FFM (P < 
0.001), and 0.07 kg/m
2
 in FFMI (P = 0.001) per quintile of plasma CRP 
levels (Model 1 in Tables 8.1, 8.4 and 8.7 (first foot note), respectively).  
After stratification for age, higher plasma CRP levels were significantly 
associated with lower percentage FFM (Tables 8.5, 8.6) and FFMI (Tables 
8.8, 8.9), but not FFM (Tables 8.2, 8.3) for women aged less than 50 years 
and the more than 50 years, respectively. The greatest magnitude of 
associations observed was a decrease of 1.34 % in percentage FFM (P < 
0.001) per quintile of plasma CRP levels in women aged more than 50years 
(Model 1 in Tables 8.6 (first foot note)).  
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After the addition of nutrients or diet quality scores (Model 2 in Table 8.1) 
and energy intake (Model 3 in Table 8.1) in the model, the associations 
between FFM and CRP levels were attenuated (after the addition of 
magnesium, vitamin C, carotene, β-carotene, and potassium intakes, and the 
MDS, HDI and AHEI scores). In contrast, intakes of arginine and glutamine 
did not attenuate the association, and the addition of the DASH-style score 
in the multivariate model did not alter the association (Table 8.1). The 
greatest percentage difference in β coefficients between Model 1 and Model 
3 was observed with the addition of magnesium (6.67%) and the AHEI 
(7.78%) and HDI (5.00%) scores for the association between FFM and CRP 
levels (Table 8.1). After stratification for age and the addition of nutrients 
and diet quality scores (Model 2 in Tables 8.2 and 8.3), and energy intake 
(Model 3 in Tables 8.2 and 8.3) in the model, the associations between 
FFM and CRP levels were not attenuated in both age groups.   
 
The association between percentage FFM and CRP levels was reduced after 
the addition of magnesium, arginine and glutamine intakes, and the MDS, 
HDI, AHEI and DASH-style scores in the model. In contrast, intake of 
carotene did not improve the association, and the addition of vitamin C, β-
carotene, and potassium intakes did not alter the association (Table 8.4). 
The greatest percentage difference in β coefficients between Model 1 and 
Model 3 was observed with the addition of magnesium (0.74%), arginine 
(0.99%), the HDI (1.07%) and AHEI (0.99%) scores for the association 
between percentage FFM and CRP levels (Table 8.4). After stratification 
for age and the addition of nutrients and diet quality scores (Model 2 in 
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Tables 8.5 and 8.6), and energy intake (Model 3 in Tables 8.5 and 8.6) in 
the model, the associations between percentage FFM and CRP levels were 
reduced after the addition of magnesium, vitamin C, carotene, β-carotene, 
arginine, glutamine, and the MDS, HDI, AHEI for women aged less than 50 
years. In contrast, intake of potassium and the addition of the DASH-style 
score in the multivariate model did not improve the association (Table 8.5). 
For women aged over 50 years, the associations between percentage FFM 
and CRP levels were reduced after the addition of magnesium, vitamin C, 
carotene, β-carotene, potassium, arginine, glutamine, and the HDI, AHEI 
and DASH-style scores. The addition of the MDS score in the multivariate 
model did not alter the association (Table 8.6).  
 
The association between FFMI and CRP levels was improved after the 
addition of magnesium, vitamin C, carotene, β-carotene, and potassium 
intakes, the MDS, HDI and AHEI scores in the model. In contrast, intake of 
glutamine did not improve the association, and the addition of arginine and 
the DASH-style score in the multivariate model did not alter the association 
(Table 8.7). The greatest percentage difference in β coefficients between 
Model 1 and Model 3 was observed with the addition of magnesium 
(5.41%), potassium (2.70%) and the HDI (5.41%) and AHEI (4.05%) scores 
for the association between FFMI and CRP levels (Table 8.7). After 
stratification for age and the addition of nutrients and diet quality scores 
(Model 2 in Tables 8.8 and 8.9) and energy intake (Model 3 in Tables 8.8 
and 8.9) in the model, the associations between FFMI and CRP levels were 
reduced after the addition of magnesium, vitamin C, carotene, β-carotene, 
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potassium, arginine, glutamine, and the MDS, HDI, AHEI and DASH-style 
scores for women aged less than 50 years (Table 8.8). For women aged over 
50 years, the associations between FFMI and CRP levels were reduced after 
the addition of magnesium, vitamin C, carotene, β-carotene, potassium, and 
the HDI, AHEI and DASH-style scores. The addition of arginine, glutamine 
and the MDS score in the multivariate model did not reduce the association 
(Table 8.9).  
 
8.4 Discussion 
In this study using a large cross-sectional population-based sample of 
women aged 18-79 years we evaluated the association between indexes of 
muscle mass and the inflammatory marker CRP and the potential mediation 
by dietary components. This is the first population-based study to examine 
the influence of a range of nutrients and diet quality scores (that have been 
associated with either indexes of muscle mass or CRP levels in previous 
chapters of the current thesis) on the association between muscle mass and 
CRP levels. This study observed that higher concentrations of CRP were 
associated with lower indexes of muscle mass. It was also shown that 
magnesium, vitamin C, carotene, β-carotene, potassium intakes, and the 
MDS, HDI and AHEI scores reduced the impact of CRP on FFM and FFMI; 
and magnesium, arginine, glutamine intakes, and the MDS, HDI, AHEI and 
DASH-style scores improved the association between percentage FFM and 
CRP levels. There is currently only one recent longitudinal study showing 
that lower protein intake was associated with a greater decline in muscle 
strength in individuals with high levels of inflammatory markers including 
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CRP (Bartali et al. 2012). This study differed to the current study in that, 
although it was longitudinal, the study was designed to measure different 
objectives, it did not include a complete range of nutrients or diet quality 
scores that may potentially mediate the inflammation and muscle mass 
relationship, and examined only muscle strength. 
The current study observed a significant inverse association between higher 
levels of CRP and all three indexes of muscle mass. The magnitude of the 
associations observed was a decrease of 0.18 kg in FFM (P =0.028), 1.22 % 
in percentage FFM (P < 0.001), and 0.07 kg/m
2
 in FFMI (P = 0.001) per 
quintile of plasma CRP levels (Model 1 in Tables 8.1, 8.2 and 8.3). These 
associations were observed after adjustments for age, physical activity, 
smoking, anti-inflammatory medication (including aspirin, statins, and 
NSAID) and HRT use and were independent of adiposity (assessed by BMI 
for FFM and FFMI). These findings were consistent with one previous 
cross-sectional study from the Health, Aging and Body Composition 
(Health ABC) cohort that observed that participants (aged 70-79 years) with 
high levels of interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-a) 
had a smaller muscle area and less appendicular muscle mass (Visser et al. 
2002). However, this study included both men and women of a different age 
range, inflammation was measured by different markers, and muscle mass 
was assessed by different measurements so it is difficult to draw direct 
comparisons with our study. 
 
Findings from the current study were not consistent with data from the 
Longitudinal Aging Study Amsterdam (LASA) among men and women 
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with a mean age of 74.6 years (Schaap et al. 2006). In this study high CRP 
levels (>6.1 μg/mL) were not associated with appendicular muscle mass 
after three years of follow-up. Although the authors adjusted for a number 
of confounding factors including several inflammation-related chronic 
diseases and three years weight change, it might be possible that other 
subclinical diseases may have been present in the study population and may 
have confounded the observed associations (Schaap et al. 2006). 
It is noteworthy that in the current study although analysis was adjusted for 
a number of confounding factors, the effect of CRP on indexes of muscle 
mass was 1.5- for FFM, 3- for FFMI and 7.2- times greater than that of age 
for FFM, FFMI and %FFM, respectively.  Of interest the ß-coefficient (95 
% CI) for FFMI was -0.074 (-0.12, -0.03), P = 0.001 compared to the ß-
coefficient (95 % CI) for age which was -0.025 (-0.03, -0.02), P < 0.001. 
 
The current analysis observed that magnesium intake mediated the 
association between CRP levels and indexes of muscle mass by reducing the 
association observed between CRP and all three indexes of muscle mass 
with a range of difference between 0.74 to 6.67 %. Furthermore, the 6.67 % 
reduction in the association between CRP and FFM (kg) reported per 
quintile of magnesium intake equated to a 43 mg/d mean difference in 
magnesium intake between the lower (315 mg/d) and the higher (358 mg/d) 
intake in the third quintile. We chose the range difference in the third 
quintile as equivalent of one quintile as a reference for the mean quintile 
difference. In food terms, this difference would correspond to consumption 
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of 1.8 portions of whole meal bread per day (64.8 g/d) from the habitual diet 
(assuming 1 portion of whole meal bread to be 36 g for adults). 
 
The mechanisms involved in the impact of magnesium intake on the 
association between muscle mass and the inflammatory marker CRP cannot 
be specifically identified due to the nature of the study which was designed 
to assess cross-sectional associations. A number of previous studies 
however, have indicated an inverse association between dietary magnesium 
intake and metabolic and inflammatory conditions, and its importance in 
metabolic and inflammatory pathways has been acknowledged in Chapter 6 
(section 6.4, p. 218 and 219). The important role of magnesium (an essential 
micronutrient which acts as a cofactor in multiple enzymatic reactions in the 
human body) on muscle metabolism, specifically on the function of muscle 
mitochondria, the control of oxidative stress, and its potential anti-
inflammatory properties have also been discussed in Chapter 3 (section 3.4, 
p. 97 and 98) and offers support to our findings.        
 
The current analysis also observed a greater effect of the HDI and AHEI 
scores on the association between CRP levels and indexes of muscle mass. 
The greatest percentage difference in β coefficients between Model 1 and 
Model 3 was observed for the AHEI score which mediated the impact of 
CRP on FFM (kg) by almost 8 %. In other words, for every 9 points 
increase in the AHEI score there was an 8 % improvement in the association 
between CRP and FFM. Although the strength of the association was 
modest, this was observed after analyses was accounted for age, physical 
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activity, smoking, anti-inflammatory medication (including aspirin, statins, 
and NSAID) and HRT use and were independent of adiposity (assessed by 
BMI) factors that are known to affect both muscle mass and CRP. When 
translating the differences in nutrient intakes between extreme quartiles of 
the AHEI score into comparable amounts of food, the differences in vitamin 
C intake, for example, between extreme quartiles of the diet scores (which 
was shown in Chapter 5, Table 5.3, p. 189) equated to 2.2 portions of 
oranges for the AHEI (assuming one portion of oranges to be 120 g for 
adults).   
 
Again, the mechanisms involved in the influence of improved diet quality 
(assessed by diet quality indices) on the association between CRP levels and 
indexes of muscle mass cannot be specifically identified due to the cross-
sectional nature of our study. Nevertheless, findings from previous 
epidemiological studies have shown that dietary patterns characterised by 
increased consumption of fruits and vegetables, whole grains, dietary fiber 
and low intakes of saturated and trans fatty acids were associated with lower 
levels of markers of inflammation, oxidative stress, and endothelial 
dysfunction, offer support to the current findings (Baer et al. 2004, Dai et al. 
2008, Esmaillzadeh et al. 2007, Esposito et al. 2004, Fung et al. 2001, Fung 
et al. 2001, Lopez-Garcia et al. 2004, Lopez-Garcia et al. 2005, Mozaffarian 
et al. 2004, Nettleton et al. 2006). Moreover, the Alternate Healthy Eating 
Index (AHEI) has been significantly associated with lower plasma CRP 
levels in diverse populations, including women (Fargnoli et al. 2008, Fung 
et al. 2005). The development of age-associated declines in muscle mass, 
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muscle strength, physical function, mobility and frailty have been attributed, 
in part, to the inflammation that occurs with the ageing process (Chung et 
al. 2009, Howard et al. 2007). Notably, although age is known to be highly 
correlated with both muscle mass (Cruz-Jentoft et al. 2010, Lynch et al. 
1999) and inflammation (Chung et al. 2009), in the current study after 
multivariate analysis, the effect of the AHEI score [ß coefficient (95 % CI): 
0.33 (-0.14, -0.52), P = 0.001] on the association between CRP levels and 
FFM was almost 3 times greater of that of age [ß coefficient (95 % CI): -
0.12 (-0.14, -0.10), P < 0.001]. This finding indicates that diet quality may 
be a beneficial factor in attenuating the negative association between 
inflammation and muscle mass, independent of age.     
Our findings indicated similar patterns for vitamin C, carotene, β-carotene, 
potassium and the MDS score for both FFM and FFMI. The observed 
impact of healthy diet scores on the association between CRP levels and 
muscle mass, may be partly explained by the anti-inflammatory effects of an 
overall healthier diet containing food components high in nutrients, such as 
magnesium, vitamin C, potassium and carotenoids. 
 
In relation to the essential amino acids, arginine and glutamine, it was 
observed that they did not mediate the association between FFM, FFMI and 
CRP levels (Tables 8.1 and 8.2, respectively). This finding was expected as 
in previous analyses in the same participants from the TwinsUK study in 
Chapter 6 (section 6.3, p. 207) higher intakes of arginine and glutamine 
were associated with higher CRP levels, although the biological 
mechanisms underlying such a relationship are largely unknown, and these 
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are the first observations that we know about in an overall healthy 
population.   
However, these dietary constituents did not attenuate the association 
between CRP levels and percentage FFM in a similar pattern to FFM and 
FFMI. As previously discussed in Chapter 5 (section 5.4, p. 168) the way 
the indexes of muscle mass were calculated may have led to the differences 
observed. It is well documented that in order to evaluate FFM in relation to 
body size and nutritional status, FFM should be considered in relation to 
height, because FFM expressed in absolute weight or as a percentage of 
body weight is not adequate because FFM increases with height. Fat free 
mass index (weight/height
2
) which eliminates differences associated with 
height is an important marker of health and disease status (Coin et al. 2008, 
Heymsfield et al. 2011, Kyle et al. 2003). Moreover, percentage FFM has a 
large variation in the current analysis (38.8-80.6 %) which might have 
influenced the results. 
 
After stratification for age, the current analyses showed that results 
remained the same for the older group of women aged more than 50 years. 
Therefore, although age is a major determinant of muscle mass, it does not 
make a difference in the direction of mediation between indexes of muscle 
mass and CRP levels by the dietary constituents studied. Interestingly, the 
percentage attenuation of dietary intake of magnesium, vitamin C, carotene, 
β-carotene, and potassium, on the association between FFMI and CRP 
levels was higher in the older group of women compared to the whole 
sample. This finding may indicate that intake of these dietary constituents is 
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important for older ages and may improve the negative impact of 
inflammation as per CRP on muscle mass. In addition, the percentage 
attenuation of dietary intake of magnesium, vitamin C, carotene, β-carotene, 
potassium, arginine and glutamine, and a healthier dietary patterns such as 
the MDS, HDI, AHEI and DASH-style score, on the association between 
FFMI and CRP levels was also higher in the younger group of women 
compared to the whole sample. This finding may further indicate that it is 
important for women in this age group to consume a variety of plant-based 
constituents and a healthier diet higher in fruits and vegetables, whole 
grains, nuts, dietary fiber and low in red and processed meat and saturated 
fats in order to potentially prevent the negative impact of inflammation as 
per CRP on muscle mass.  
 
8.5 Strengths and limitations 
The strengths of this study include the large sample size and the fact that 
this was the first study to examine the influence of a range of nutrients and 
diet quality scores (that have been associated with either indexes of muscle 
mass or CRP levels in previous chapters of the current thesis) on the 
association between muscle mass and CRP levels. Also, the FFQ used in the 
current study was previously compared and validated against a 7-day 
weighed record in the EPIC Norfolk study, and although the two approaches 
to measure dietary intake were different, both methods identified similar 
intakes of macronutrients when these were expressed as percentage of total 
energy intake (Bingham et al. 2001). This FFQ was also validated against 
urinary and plasma biomarkers of intake, such as urinary nitrogen for 
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protein intake, urinary potassium and sodium, plasma ascorbic acid and 
plasma n-3 PUFAs (McKeown et al. 2001, Welch et al. 2006). In addition, 
it has been shown previously that serum β-cryptoxanthin and zeaxanthin 
concentrations were moderately correlated with dietary carotenoids intakes 
measured by an FFQ (Tucker et al. 1999). Furthermore, in order to examine 
associations between dietary intake and health outcomes participants need to 
be ranked according to their usual dietary intake and FFQs have been shown 
to rank individuals well (Molag et al. 2007). 
 
This study also has a number of limitations. The cross-sectional nature of 
the study limits causal inference, but enables us to generate hypotheses 
regarding associations between indexes of muscle mass and the 
inflammatory marker CRP and the potential mediation by dietary 
constituents based on plausible mechanisms. In addition, the analysis was 
performed in a population of a wide age range of participants with relatively 
low CRP levels and this hypothesis may be more important in older people 
with higher CRP levels. On the other hand, this is the first study to 
investigate this in a cohort including older people. Ideally this hypothesis 
would have been better investigated in an intervention study. 
In addition, as in all observational studies, measurement error in self-
reported dietary intakes is inevitable. It is also widely acknowledged that the 
use of FFQs for measuring dietary intake has its own limitations related to 
memory errors, they provide relative than absolute intake, they introduce 
bias due to over- or under-reporting, and they may introduce systematic 
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errors as preparation methods are inadequately considered (McNeill et al. 
2009). Also, FFQs measure food intake over a period of one year and reflect 
the habitual diet over this period of time but not lifetime dietary habits 
(Teucher et al. 2007). Another limitation is that no specific statistical 
weighting for each component has been used regarding the construction of 
each score, assuming that all food groups and nutrients contributed equally 
to the diet quality. The observed findings relate to women and further work 
is needed to investigate if these findings are replicated in a male population 
of the same country or in populations from different ethnic backgrounds.   
  
8.6 Concluding remarks 
In conclusion, we found in multivariate analyses that higher CRP levels 
were associated with lower FFM by 0.18 kg, percentage FFM by 1.22 %, 
and FFMI by 0.07 kg/m
2
 per quintile of plasma CRP levels. Intakes of 
magnesium, vitamin C, carotene, β-carotene, potassium, and the MDS, HDI 
and AHEI scores appeared to reduce the impact of CRP on FFM and FFMI; 
and magnesium, arginine, glutamine intakes, and the MDS, HDI, AHEI and 
DASH-style scores appeared to reduce the association between percentage 
FFM and CRP levels. Notably, although age is known to be highly 
correlated with both muscle mass (Cruz-Jentoft et al. 2010, Lynch et al. 
1999) and inflammation (Chung et al. 2009), findings from the current 
analysis indicated that diet quality may be a beneficial factor in attenuating 
the negative association between inflammation and muscle mass, 
independent of age. Notably, in additional stratification for age analyses, 
results remained the same regarding the direction of mediation of indexes 
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muscle mass by CRP levels by the dietary constituents studied. However, 
the percentage attenuation by a variety of plant-based constituents and 
healthier dietary patterns (higher in fruits and vegetables, whole grains, nuts, 
dietary fiber and low in red and processed meat and saturated fats) appeared 
to be higher in the women aged over 50 years, suggesting that following 
these dietary patterns may potentially be beneficial, reducing the negative 
impact of inflammation as per CRP on muscle mass in older women.  
 
To our knowledge, to date, no other population studies have examined the 
influence of a number of dietary constituents on the association between 
muscle mass and CRP levels or other inflammatory markers. 
Results from this study suggest that for adult women a healthier dietary 
pattern characterised by high intakes in fruit and vegetables, nuts, legumes, 
dietary fiber and/or whole grains, as well as consumption of food sources of 
vitamin C, magnesium, potassium and carotenoids, and low intakes of red 
and processed meat and saturated fat, may be important in reducing the 
negative impact of CRP levels on muscle mass seen with age. From a public 
health perspective, the novel findings from the current analysis may offer 
some insight in order to better understand whether and to what extent 
dietary and lifestyle factors may impact on the association between muscle 
mass and inflammation in adult women with normal weight, BMI and CRP 
concentrations. These preliminary findings may also provide useful 
information in developing and planning dietary intervention trials for the 
prevention of sarcopenia by targeting inflammation.    
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TABLES 
Table 8.1 The association between fat free mass (FFM, kg) and 
quintiles of CRP and potential mediation by dietary constituents 
 
FFM-CRP1 
β-
coefficient 
(Model 2)2 
P 
β-
coefficient 
(Model 3)3 
P 
Percentage 
difference (%) in 
β-coefficients 
between Model 
1 and Model 34 
Per quintile     
Magnesium  -0.166 0.041 -0.168 0.039 6.67 
Vitamin C -0.178 0.029 -0.178 0.029 1.11 
Carotene -0.178 0.030 -0.178 0.029 1.11 
β-carotene -0.176 0.031 -0.177 0.031 1.67 
Potassium  -0.175 0.033 -0.177 0.031 1.67 
Arginine  -0.187 0.023 -0.181 0.028 -0.56 
Glutamine  -0.186 0.024 -0.181 0.027 -0.56 
Per quartile     
MDS -0.178 0.028 -0.178 0.029 1.11 
HDI -0.171 0.036   5.00 
AHEI -0.167 0.044 -0.166 0.042 7.78 
DASH-style 
score 
 
-0.180 
 
0.028 
 
-0.180 
 
0.028 
 
0 
1
 Model 1: FFM was negatively associated to CRP (β-coefficient for the association 
between FFM and CRP = -0.180, P = 0.028). Adjusted for age, physical activity, 
smoking, BMI, anti-inflammatory medication, HRT use 
2
 Model 2: Adjusted as Model 1 and additionally for nutrient intake or diet scores 
3
 Model 3: Adjusted as Model 2 and for energy intake (apart from HDI) 
4 
Formula for calculation: 
[(β coefficient in Model 1 - β coefficient in Model 3) / β-coefficient in Model 1] x 100 
 
A positive finding indicates that the nutrient/diet score improves the association 
between FFM and CRP levels or reduces the impact of CRP on FFM, and a 
negative finding indicates that the nutrient/diet score does not improve the 
association between FFM and CRP levels or increases the impact of CRP on FFM.   
MDS: Mediterranean diet score; HDI: Healthy Diet Indicator; AHEI: Alternate 
Healthy Eating Index; DASH-style score: based on Dietary Approaches to Stop 
Hypertension diet pattern  
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Table 8.2 The association between fat free mass (FFM, kg) and 
quintiles of CRP and potential mediation by dietary constituents in 
women aged less than 50 years 
 
FFM-CRP1 
β-
coefficient 
(Model 2)2 
P 
β-
coefficient 
(Model 3)3 
P 
Percentage 
difference (%) 
in β-
coefficients 
between Model 
1 and Model 34 
Per quintile     
Magnesium  -0.138 0.219 -0.139 0.218 11.5 
Vitamin C -0.148 0.190 -0.150 0.187 4.46 
Carotene -0.151 0.180 -0.150 0.186 4.46 
β-carotene -0.151 0.182 -0.149 0.187 5.10 
Potassium  -0.145 0.199 -0.149 0.189 5.10 
Arginine  -0.158 0.165 -0.133 0.235 15.3 
Glutamine  -0.160 0.161 -0.138 0.218 12.1 
Per quartile     
MDS -0.143 0.200 -0.140 0.209 10.8 
HDI -0.140 0.215   10.8 
AHEI -0.128 0.252 -0.128 0.256 18.5 
DASH-style 
score 
 
-0.153 
 
0.177 
 
-0.154 
 
0.175 
 
1.91 
1
 Model 1: FFM was negatively associated to CRP (β-coefficient for the association 
between FFM and CRP = -0.157, P = 0.166). Adjusted for age, physical activity, 
smoking, BMI, anti-inflammatory medication, HRT use 
2
 Model 2: Adjusted as Model 1 and additionally for nutrient intake or diet scores 
3
 Model 3: Adjusted as Model 2 and for energy intake (apart from HDI) 
4 
Formula for calculation: 
[(β coefficient in Model 1 - β coefficient in Model 3) / β-coefficient in Model 1] x 100 
 
A positive finding indicates that the nutrient/diet score improves the association 
between FFM and CRP levels or reduces the impact of CRP on FFM, and a 
negative finding indicates that the nutrient/diet score does not improve the 
association between FFM and CRP levels or increases the impact of CRP on FFM.   
MDS: Mediterranean diet score; HDI: Healthy Diet Indicator; AHEI: Alternate 
Healthy Eating Index; DASH-style score: based on Dietary Approaches to Stop 
Hypertension diet pattern 
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Table 8.3 The association between fat free mass (FFM, kg) and 
quintiles of CRP and potential mediation by dietary constituents in 
women aged more than 50 years 
 
FFM-CRP1 
β-
coefficient 
(Model 2)2 
P 
β-
coefficient 
(Model 3)3 
P 
Percentage 
difference (%) 
in β-
coefficients 
between Model 
1 and Model 34 
Per quintile     
Magnesium  -0.145 0.199 -0.145 0.201 8.23 
Vitamin C -0.155 0.172 -0.159 0.162 -0.63 
Carotene -0.156 0.173 -0.159 0.162 -0.63 
β-carotene -0.156 0.174 -0.159 0.164 -0.63 
Potassium  -0.151 0.185 -0.152 0.181 3.80 
Arginine  -0.170 0.138 -0.168 0.142 -6.33 
Glutamine  -0.172 0.132 -0.170 0.137 -7.59 
Per quartile     
MDS -0.166 0.143 -0.167 0.140 -5.69 
HDI -0.157 0.170   0.63 
AHEI -0.153 0.178 -0.156 0.169 1.27 
DASH-style 
score 
 
-0.159 
 
0.164 
 
-0.161 
 
0.159 
 
-1.90 
1
 Model 1: FFM was negatively associated to CRP (β-coefficient for the association 
between FFM and CRP = -0.161, P = 0.158). Adjusted for age, physical activity, 
smoking, BMI, anti-inflammatory medication, HRT use 
2
 Model 2: Adjusted as Model 1 and additionally for nutrient intake or diet scores 
3
 Model 3: Adjusted as Model 2 and for energy intake (apart from HDI) 
4 
Formula for calculation: 
[(β coefficient in Model 1 - β coefficient in Model 3) / β-coefficient in Model 1] x 100 
 
A positive finding indicates that the nutrient/diet score improves the association 
between FFM and CRP levels or reduces the impact of CRP on FFM, and a 
negative finding indicates that the nutrient/diet score does not improve the 
association between FFM and CRP levels or increases the impact of CRP on FFM.   
MDS: Mediterranean diet score; HDI: Healthy Diet Indicator; AHEI: Alternate 
Healthy Eating Index; DASH-style score: based on Dietary Approaches to Stop 
Hypertension diet pattern 
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Table 8.4 The association between percentage fat free mass (FFM %) 
and quintiles of CRP and potential mediation by dietary constituents 
FFM%-CRP
1
 
β-
coefficient 
(Model 2)2 
P 
β-
coefficient 
(Model 3)3 
P 
Percentage 
difference 
(%) in β-
coefficients 
between 
Model 1 and 
Model 34 
Per quintile     
Magnesium  -1.212 <0.001 -1.209 <0.001 0.74 
Vitamin C -1.218 <0.001 -1.218 <0.001 0 
Carotene -1.219 <0.001 -1.219 <0.001 -0.08 
β-carotene -1.218 <0.001 -1.218 <0.001 0 
Potassium  -1.218 <0.001 -1.218 <0.001 0 
Arginine  -1.215 <0.001 -1.206 <0.001 0.99 
Glutamine  -1.219 <0.001 -1.214 <0.001 0.33 
Per quartile     
MDS -1.217 <0.001 -1.217 <0.001 0.08 
HDI -1.205 <0.001   1.07 
AHEI -1.204 <0.001 -1.206 <0.001 0.99 
DASH-style 
score 
 
-1.218 
 
<0.001 
 
-1.217 
 
<0.001 
 
0.08 
1
 Model 1: FFM% was negatively associated to CRP (β-coefficient for the 
association between FFM% and CRP = -1.218, P < 0.001). Adjusted for age, 
physical activity, smoking, anti-inflammatory medication, HRT use 
2
 Model 2: Adjusted as Model 1 and additionally adjusted for nutrient intake or diet 
scores 
3
 Model 3: Adjusted as Model 2 and for energy intake (apart from HDI) 
4 
Formula for calculation: 
[(β coefficient in Model 1 - β coefficient in Model 3) / β-coefficient in Model 1] x 100 
 
A positive finding indicates that the nutrient/diet score improves the association 
between FFM% and CRP levels or reduces the impact of CRP on FFM%, and a 
negative finding indicates that the nutrient/diet score does not improve the 
association between FFM% and CRP levels or increases the impact of CRP on 
FFM%.   
MDS: Mediterranean diet score; HDI: Healthy Diet Indicator; AHEI: Alternate 
Healthy Eating Index; DASH-style score: based on Dietary Approaches to Stop 
Hypertension diet pattern  
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Table 8.5 The association between percentage fat free mass (FFM %) 
and quintiles of CRP and potential mediation by dietary constituents 
in women aged less than 50 years 
FFM%-CRP
1
 
β-
coefficient 
(Model 2)2 
P 
β-
coefficient 
(Model 3)3 
P 
Percentage 
difference 
(%) in β-
coefficients 
between 
Model 1 and 
Model 34 
Per quintile     
Magnesium  -1.026 <0.001 -1.025 <0.001 0.19 
Vitamin C -1.021 <0.001 -1.021 <0.001 0.58 
Carotene -1.026 <0.001 -1.026 <0.001 0.10 
β-carotene -1.025 <0.001 -1.025 <0.001 0.19 
Potassium  -1.027 <0.001 -1.028 <0.001 -0.10 
Arginine  -1.018 <0.001 -1.004 <0.001 2.24 
Glutamine  -1.020 <0.001 -0.999 <0.001 2.73 
Per quartile     
MDS -1.024 <0.001 -1.024 <0.001 0.29 
HDI -0.997 <0.001   2.92 
AHEI -1.007 <0.001 -1.007 <0.001 1.95 
DASH-style 
score 
 
-1.027 
 
<0.001 
 
-1.028 
 
<0.001 
 
-0.10 
1
 Model 1: FFM% was negatively associated to CRP (β-coefficient for the 
association between FFM% and CRP = -1.027, P < 0.001). Adjusted for age, 
physical activity, smoking, anti-inflammatory medication, HRT use 
2
 Model 2: Adjusted as Model 1 and additionally adjusted for nutrient intake or diet 
scores 
3
 Model 3: Adjusted as Model 2 and for energy intake (apart from HDI) 
4 
Formula for calculation: 
[(β coefficient in Model 1 - β coefficient in Model 3) / β-coefficient in Model 1] x 100 
 
A positive finding indicates that the nutrient/diet score improves the association 
between FFM% and CRP levels or reduces the impact of CRP on FFM%, and a 
negative finding indicates that the nutrient/diet score does not improve the 
association between FFM% and CRP levels or increases the impact of CRP on 
FFM%.   
MDS: Mediterranean diet score; HDI: Healthy Diet Indicator; AHEI: Alternate 
Healthy Eating Index; DASH-style score: based on Dietary Approaches to Stop 
Hypertension diet pattern  
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Table 8.6 The association between percentage fat free mass (FFM %) 
and quintiles of CRP and potential mediation by dietary constituents 
in women aged more than 50 years 
FFM%-CRP
1
 
β-
coefficient 
(Model 2)2 
P 
β-
coefficient 
(Model 3)3 
P 
Percentage 
difference 
(%) in β-
coefficients 
between 
Model 1 and 
Model 34 
Per quintile     
Magnesium  -1.319 <0.001 -1.312 <0.001 1.86 
Vitamin C -1.331 <0.001 -1.332 <0.001 0.37 
Carotene -1.328 <0.001 -1.330 <0.001 0.52 
β-carotene -1.328 <0.001 -1.329 <0.001 0.60 
Potassium  -1.332 <0.001 -1.333 <0.001 0.30 
Arginine  -1.339 <0.001 -1.328 <0.001 0.67 
Glutamine  -1.342 <0.001 -1.329 <0.001 0.60 
Per quartile     
MDS -1.337 <0.001 -1.337 <0.001 0 
HDI -1.325 <0.001   0.90 
AHEI -1.326 <0.001 -1.328 <0.001 0.67 
DASH-style 
score 
 
-1.338 
 
<0.001 
 
-1.335 
 
<0.001 
 
0.15 
1
 Model 1: FFM% was negatively associated to CRP (β-coefficient for the 
association between FFM% and CRP = -1.337, P < 0.001). Adjusted for age, 
physical activity, smoking, anti-inflammatory medication, HRT use 
2
 Model 2: Adjusted as Model 1 and additionally adjusted for nutrient intake or diet 
scores 
3
 Model 3: Adjusted as Model 2 and for energy intake (apart from HDI) 
4 
Formula for calculation: 
[(β coefficient in Model 1 - β coefficient in Model 3) / β-coefficient in Model 1] x 100 
 
A positive finding indicates that the nutrient/diet score improves the association 
between FFM% and CRP levels or reduces the impact of CRP on FFM%, and a 
negative finding indicates that the nutrient/diet score does not improve the 
association between FFM% and CRP levels or increases the impact of CRP on 
FFM%.   
MDS: Mediterranean diet score; HDI: Healthy Diet Indicator; AHEI: Alternate 
Healthy Eating Index; DASH-style score: based on Dietary Approaches to Stop 
Hypertension diet pattern  
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Table 8.7 The association between fat free mass index (FFMI, kg/m2) 
and quintiles of CRP and potential mediation by dietary constituents 
FFMI-CRP1 
β-
coefficient 
(Model 2)2 
P 
β-
coefficient 
(Model 3)3 
P 
Percentage 
difference (%) 
in β-coefficients 
between Model 
1 and Model 34 
Per quintile      
Magnesium  -0.071 0.001 -0.070 0.001 5.41 
Vitamin C -0.073 0.001 -0.073 0.001 1.35 
Carotene -0.073 0.001 -0.073 0.001 1.35 
β-carotene -0.073 0.001 -0.073 0.001 1.35 
Potassium  -0.073 0.001 -0.072 0.001 2.70 
Arginine  -0.075 0.001 -0.074 0.001 0 
Glutamine  -0.075 0.001 -0.075 0.001 -1.35 
Per 
quartile 
     
MDS -0.073 0.001 -0.073 0.001 1.35 
HDI -0.070 0.002   5.41 
AHEI -0.070 0.001 -0.071 0.001 4.05 
DASH-style 
score 
 
-0.074 
 
0.001 
 
-0.074 
 
0.001 
 
0 
1
 Model 1: FFMI was negatively associated to CRP (β-coefficient for the 
association between FFMI and CRP = -0.074, P = 0.001). Adjusted for age, 
physical activity, smoking, BMI, anti-inflammatory medication, HRT use 
2
 Model 2: Adjusted as Model 1 and additionally for nutrient intake or diet scores 
3
 Model 3: Adjusted as Model 2 and for energy intake (apart from HDI) 
4 
Formula for calculation: 
[(β coefficient in Model 1 - β coefficient in Model 3) / β-coefficient in Model 1] x 100 
 
A positive finding indicates that the nutrient/diet score improves the association 
between FFMI and CRP levels or reduces the impact of CRP on FFMI, and a 
negative attenuation indicates that the nutrient/diet score does not improve the 
association between FFMI and CRP levels or increases the impact of CRP on 
FFMI.   
MDS: Mediterranean diet score; HDI: Healthy Diet Indicator; AHEI: Alternate 
Healthy Eating Index; DASH-style score: based on Dietary Approaches to Stop 
Hypertension diet pattern  
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Table 8.8 The association between fat free mass index (FFMI, kg/m2) 
and quintiles of CRP and potential mediation by dietary constituents 
in women aged less than 50 years 
FFMI-CRP1 
β-
coefficient 
(Model 2)2 
P 
β-
coefficient 
(Model 3)3 
P 
Percentage 
difference (%) 
in β-
coefficients 
between Model 
1 and Model 34 
Per quintile      
Magnesium  -0.064 0.024 -0.063 0.026 7.35 
Vitamin C -0.065 0.023 -0.065 0.023 4.41 
Carotene -0.065 0.021 -0.065 0.022 4.41 
β-carotene -0.065 0.022 -0.065 0.022 4.41 
Potassium  -0.065 0.022 -0.065 0.023 4.41 
Arginine  -0.067 0.018 -0.064 0.024 5.88 
Glutamine  -0.068 0.018 -0.065 0.021 4.41 
Per quartile      
MDS -0.065 0.021 -0.065 0.022 4.41 
HDI -0.061 0.029   10.3 
AHEI -0.061 0.031 -0.061 0.031 10.3 
DASH-style 
score 
 
-0.067 
 
0.019 
 
-0.067 
 
0.019 
 
1.49 
1
 Model 1: FFMI was negatively associated to CRP (β-coefficient for the 
association between FFMI and CRP = -0.068, P = 0.018). Adjusted for age, 
physical activity, smoking, BMI, anti-inflammatory medication, HRT use 
2
 Model 2: Adjusted as Model 1 and additionally for nutrient intake or diet scores 
3
 Model 3: Adjusted as Model 2 and for energy intake (apart from HDI) 
4 
Formula for calculation: 
[(β coefficient in Model 1 - β coefficient in Model 3) / β-coefficient in Model 1] x 100 
 
A positive finding indicates that the nutrient/diet score improves the association 
between FFMI and CRP levels or reduces the impact of CRP on FFMI, and a 
negative attenuation indicates that the nutrient/diet score does not improve the 
association between FFMI and CRP levels or increases the impact of CRP on 
FFMI.   
MDS: Mediterranean diet score; HDI: Healthy Diet Indicator; AHEI: Alternate 
Healthy Eating Index; DASH-style score: based on Dietary Approaches to Stop 
Hypertension diet pattern 
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Table 8.9 The association between fat free mass index (FFMI, kg/m2) 
and quintiles of CRP and potential mediation by dietary constituents 
in women aged more than 50 years 
FFMI-CRP1 
β-
coefficient 
(Model 2)2 
P 
β-
coefficient 
(Model 3)3 
P 
Percentage 
difference (%) 
in β-
coefficients 
between Model 
1 and Model 34 
Per quintile      
Magnesium  -0.064 0.047 -0.063 0.054 7.35 
Vitamin C -0.066 0.042 -0.066 0.041 2.94 
Carotene -0.066 0.042 -0.066 0.041 2.94 
β-carotene -0.066 0.043 -0.066 0.042 2.94 
Potassium  -0.065 0.044 -0.064 0.047 5.88 
Arginine  -0.090 0.033 -0.070 0.034 -2.94 
Glutamine  -0.070 0.032 -0.070 0.031 -2.94 
Per quartile      
MDS -0.069 0.034 -0.069 0.034 -1.47 
HDI -0.065 0.047   4.41 
AHEI -0.066 0.042 -0.067 0.041 1.47 
DASH-style 
score 
 
-0.067 
 
0.039 
 
-0.067 
 
0.040 
 
1.47 
1
 Model 1: FFMI was negatively associated to CRP (β-coefficient for the 
association between FFMI and CRP = -0.068, P = 0.038). Adjusted for age, 
physical activity, smoking, BMI, anti-inflammatory medication, HRT use 
2
 Model 2: Adjusted as Model 1 and additionally for nutrient intake or diet scores 
3
 Model 3: Adjusted as Model 2 and for energy intake (apart from HDI) 
4 
Formula for calculation: 
[(β coefficient in Model 1 - β coefficient in Model 3) / β-coefficient in Model 1] x 100 
 
A positive finding indicates that the nutrient/diet score improves the association 
between FFMI and CRP levels or reduces the impact of CRP on FFMI, and a 
negative attenuation indicates that the nutrient/diet score does not improve the 
association between FFMI and CRP levels or increases the impact of CRP on 
FFMI.   
MDS: Mediterranean diet score; HDI: Healthy Diet Indicator; AHEI: Alternate 
Healthy Eating Index; DASH-style score: based on Dietary Approaches to Stop 
Hypertension diet pattern  
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9.0 Summary of research findings 
This thesis has described the links between sarcopenia (as muscle mass and 
strength) and inflammation which are also both linked to the ageing process 
(Chung et al. 2009). Chronic low-grade inflammation is a risk factor leading 
to the predisposition of sarcopenia (Morley and Baumgartner 2004, 
Roubenoff and Hughes 2000), and is considered detrimental to skeletal 
muscle mass and strength in both humans and animal models (Howard et al. 
2007, Siu et al. 2008). Diet plays a major role in the regulation of chronic 
inflammation as dietary constituents have the potential to exert anti-
inflammatory as well as pro-inflammatory effects (Cavicchia et al. 2009). 
Moreover, a number of nutrients may be associated with muscle mass and 
strength. Protein (Campbell et al. 2001, Castaneda et al. 1995), amino acids 
(Borsheim et al. 2008, Scognamiglio et al. 2004, Solerte et al. 2008) and 
vitamin D (Dawson-Hughes 2008) have been shown to be beneficial in 
supplementation studies for muscle mass and/or strength, and magnesium 
and potassium are known to play an important role in muscle metabolism 
(Frassetto et al. 1998, Song et al. 2007, Song et al. 2005). Furthermore, 
vitamins C, E, selenium, and carotenoids are known to reduce oxidative 
stress which has been implicated in the aetiology of age-related muscle loss 
and have anti-inflammatory properties (Ferrucci et al. 2005, Helmersson et 
al. 2005, Young et al. 2004). It has also been well established that higher 
intakes of fruit and vegetables, whole grains, nuts and polyunsaturated fatty 
acids, as well as dietary patterns high in these food components may exert 
anti-inflammatory properties and are associated with lower concentrations 
of inflammatory markers including CRP (Brown and Hu 2001, Chrysohoou 
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et al. 2004, Esmaillzadeh et al. 2006, Esposito K and et al. 2004, Fung et al. 
2001, Lopez-Garcia et al. 2004, Lutsey et al. 2007, Nettleton et al. 2006). 
Also, saturated fatty acid intakes and dietary patterns high in saturated fatty 
acids may exert pro-inflammatory properties and have been positively 
associated with inflammatory markers including CRP (Esmaillzadeh et al. 
2007, Fung et al. 2001, Lopez-Garcia et al. 2004, Nettleton et al. 2006). 
[Figure 9.1 (A)]. 
 
However, until now little evidence has existed on the influence of habitual 
dietary intake (either for nutrients or dietary patterns) on muscle mass, 
muscle strength or muscle quality (Robinson SM et al. 2008, Scott et al. 
2010). Moreover, there are currently no studies examining if habitual 
dietary intake of nutrients that have been previously associated with muscle 
mass, or have shown to exert anti-inflammatory properties and the “whole 
diet”, mediate any potential association between muscle mass and 
inflammation. Understanding the ability of diet to mediate the association 
between inflammation and muscle mass could offer valuable data for the 
implementation of dietary intervention trials for the prevention of 
sarcopenia, by targeting inflammation which is known to be influenced by 
diet.    
 
The present investigation aimed to evaluate i) associations between both 
habitual nutrient intake and the “whole diet” and indexes of muscle mass, 
muscle strength and muscle quality, ii) associations between diet and 
inflammation as assessed by the inflammatory marker C-reactive protein 
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(CRP), and iii) examine whether diet mediates the proposed association 
between muscle mass and CRP levels in adult women from the TwinsUK 
participants [Figure 9.1 (A)]. 
 
The findings of the current thesis are summarised in Figure 9.1 (B).  
 
Diet and muscle mass, strength and quality 
Results from the current analyses suggested a significant positive 
association between intakes of vitamins C and E, magnesium, potassium 
and a range of carotenoids and indexes of muscle mass with the scale of 
associations ranging between 1.5-4.6 %, when women were considered as 
singletons. Among the nutrients studied, magnesium appeared to be 
independently predictive for all three indexes of muscle mass after 
accounting for intakes of vitamin C, total carotene and ß-cryptoxanthin. 
Indicatively, when the within-pair analysis was conducted for the 
association between magnesium intake and fat free mass index, associations 
were towards significance, suggesting that potential shared lifestyle and 
genetic factors other than dietary intake of magnesium were driving this 
apparent association. However, these findings need to be verified in other 
twin studies. These factors are not yet known and it would be interesting to 
be investigated in future genetic studies.  
In addition, higher adherence to the Mediterranean Diet score (MDS), 
Healthy Diet Indicator (HDI), Diet Quality Index (DQI), Alternate Healthy 
Eating Index (AHEI), and DASH-style score (based on the Dietary 
Approaches to Stop Hypertension diet) was significantly associated with 
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measurements of muscle mass, with associations ranging between 1-3 %. 
However, no associations were observed for protein and essential amino 
acid intakes. Surprisingly, a significant inverse association between protein, 
essential amino acid intake and percentage FFM was observed. However, it 
needs to be highlighted that the range of protein intake in this analysis was 
higher compared to studies with older participants (Houston et al. 2008, 
Meng et al. 2009). This may suggest that higher protein intake may be more 
beneficial for older individuals with very low protein intakes, as in older 
persons the metabolic efficiency is decreased and they require higher 
protein intake for protein synthesis compared to younger persons (Rattan 
2010). Nevertheless, findings from this study may help to improve the 
knowledge and understanding of the effects of protein and amino acids on 
muscle mass in a healthy population. These findings contribute towards the 
debate on protein and amino acid requirements in healthy non frail 
individuals. 
 
Diet and CRP 
Furthermore, a number of nutrients examined and all diet quality scores 
were inversely associated with plasma levels of the inflammatory marker C-
reactive protein (CRP). The greatest magnitude of association was observed 
for magnesium intake which was associated with lower plasma CRP 
concentrations of 25 % comparing extreme quintiles of intake. Although in 
the current analysis we expected an inverse association between dietary 
protein intake and the inflammatory marker CRP, surprisingly we did not 
observe an association between protein and CRP. Also associations between 
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essential amino acid intakes and CRP were in the opposite direction to what 
we had initially hypothesised. However, neutral protein balance and optimal 
protein/amino acid intake may not always have an effect on inflammation 
for populations that have a normal weight, BMI and CRP concentrations (as 
opposed to populations with higher body weight, BMI and CRP levels) 
(Due et al. 2005), and the biological mechanisms underlying such a 
relationship are largely unknown. Nevertheless, given these are the first 
observations that we know about, they would appear to be novel findings. 
There is debate on the level of protein and amino acid requirements in 
healthy individuals, and from a public health perspective, the novel findings 
from the current analysis may offer some insight to better understand 
whether the habitual dietary protein and amino acid intakes may influence 
inflammation in apparently healthy adult women. This study also observed 
that higher intakes of the essential amino acids arginine, glutamine, 
histidine, isoleucine, threonine and tryptophan were significantly, positively 
associated with CRP levels. This finding was surprising. In relation to the 
“whole diet”, higher adherence to the HDI and AHEI scores was inversely 
associated with CRP levels by 14 % and 13 % of the population geometric 
mean for CRP, respectively. Moreover, we found that higher CRP levels 
were associated with lower indexes of muscle mass with associations 
ranging from 0.1-1.2 %. Of interest, after multivariate adjustment, the 
association between the HDI and AHEI scores and CRP levels was 
equivalent to association of 10 years of age in this cohort. 
This was the first study to examine the influence of a range of nutrients and 
diet quality scores (that have been associated with either indexes of muscle 
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mass or CRP levels in previous chapters of the current thesis) on the 
association between muscle mass and CRP levels.  
 
CRP and muscle mass & mediation by diet 
We also observed that higher CRP levels were associated with lower 
indexes of muscle mass in women aged 18-79 years from the TwinsUK 
participants and the effect of CRP on indexes of muscle mass was 1.5-7.2 
times greater of that of age, after analysis was adjusted for a number of 
confounding factors including age, physical activity, smoking, anti-
inflammatory medication (including aspirin, statins, and NSAID) and HRT 
use and were independent of adiposity (assessed by BMI for FFM and 
FFMI). 
Interestingly, dietary intake of magnesium, potassium, vitamin C, carotene, 
β-carotene, and diet quality including the MDS, HDI, AHEI and DASH-
style scores appeared to reduce the impact of CRP on indexes of muscle 
mass by 1-8 %. Notably, in additional stratification for age analyses, results 
remained the same regarding the direction of mediation of indexes muscle 
mass by CRP levels by the dietary constituents studied. However, the 
percentage attenuation by a variety of plant-based constituents and healthier 
dietary patterns (higher in fruits and vegetables, whole grains, nuts, dietary 
fiber and low in red and processed meat and saturated fats) appeared to be 
higher in the women aged over 50 years, suggesting that following these 
dietary patterns may potentially be beneficial, reducing the negative impact 
of inflammation as per CRP on muscle mass in older women.   
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Our findings extend the results of the few previous studies by examining 
simultaneously associations between the habitual intake of a range of 
micronutrients, protein and amino acids relevant for muscle mass in a cohort 
of women aged 18-79 years. It is evident that notable changes in skeletal 
muscle mass may occur earlier in adult life (between 30 and 45 years of 
age), and it is important to examine dietary associations with muscle mass in 
individuals of all ages (Cesari and Pahor 2008, Janssen et al. 2000). 
Moreover, this was the first study that directly compared five diet quality 
scores based on adherence to dietary patterns or to dietary recommendations 
with indexes of muscle mass, muscle strength and muscle quality in a large 
cohort. In addition, this was the first population study that directly compared 
a full range of micronutrients and carotenoids with potential anti-
inflammatory properties, and evaluated the influence of protein and 
essential amino acid intakes in association with plasma CRP concentrations. 
Findings from the current study also extended the results from previous 
cross-sectional studies by focusing on the overall diet quality developed 
based on a priori knowledge, instead of patterns derived based on empirical 
methods, in association with the inflammatory marker CRP. This was also 
one of the first studies to examine cross-sectional associations between a 
range of micronutrients, protein and amino acids, the “whole diet” and 
muscle strength and muscle quality. Findings were not significant possibly 
because other lifestyle factors, such as physical activity and the ageing 
process itself, had a greater effect in this cohort.   
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These novel findings in this thesis infer that plant-derived dietary 
components and diet scores high in these constituents are achievable from 
the habitual diet and mediate the relationship between muscle mass and 
inflammation. Findings of this thesis also emphasise the importance of 
consumption of a variety of plant-based nutrients and of the overall diet 
quality for the conservation of muscle mass, and shed new light on the 
influence of these dietary components on sarcopenia related inflammation. 
 
9.1 Overview of strengths and limitations 
This work has a number of strengths and limitations. A strength of the 
current analysis was the focus on a cohort of women including younger 
adults compared to previous studies evaluating associations between diet 
and muscle mass (Robinson SM et al. 2008, Scott et al. 2010) or diet and 
inflammation (Chacko et al. 2010, Song et al. 2007) in older populations. 
The wide age range of this cohort may be considered advantageous, as 
declines in muscle mass may occur earlier in adult life (between 30 and 45 
years of age), and it is important to examine dietary associations with 
muscle mass in individuals of all ages (Cesari and Pahor 2008, Janssen et al. 
2000). However, the observed findings relate only to women and further 
work is needed to investigate if these findings are replicated in a male 
population of the same country or in populations from different ethnic 
backgrounds. Although men have, on average, greater amounts of muscle 
mass than women, they have lower survival compared to women, implying 
that sarcopenia may potentially become a greater public health concern 
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among female than male populations (Abellan Van Kan 2009, Roubenoff 
and Hughes 2000). 
 
A limitation of the current study was that we did not measure skeletal 
muscle, but whole body fat free mass. Fat free mass is composed of non-fat 
lean soft tissues and bone mineral content and is an important metabolically 
active component of body composition (Nelson et al. 1992). Skeletal muscle 
mass represents the largest fraction of the fat free body mass (Heymsfield et 
al. 1990) and therefore, whole body fat free mass is commonly used in 
epidemiological studies (Jourdan et al. 2012). Yet, although body 
composition was objectively assessed by DEXA scans, this method involves 
its own limitations. DEXA is the most widely available method to assess 
body composition and muscle mass in both the clinical and research settings 
and it exposes the person to minimal radiation compared to other body 
imaging techniques, such as computed tomography (CT scan) or magnetic 
resonance imaging (MRI) (Cruz-Jentoft et al. 2010, Pahor et al. 2009). 
However, DEXA may overestimate muscle mass (Wang et al. 1996) as it 
does not differentiate between bone-free lean tissue and water and this may 
overestimate muscle mass in older people who may have extracellular fluid 
accumulation (Proctor et al. 1999).  
A further strength was the objective measurement of assess muscle strength, 
which allowed calculation of muscle quality. Grip strength is an important 
measurement for overall health, as it has been associated with an increased 
risk of disability, morbidity and mortality in both men and women, with 
declines in quality of life in older individuals, and has been suggested as a 
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useful marker of muscle function and sarcopenia. Muscle quality which is 
defined as the ratio of muscle strength per unit of muscle mass has been 
used as an approach to measure the quality of muscles. Lower muscle 
quality has been associated with greater age (Lynch et al. 1999) and 
functional incapacities (Goodpaster et al. 2006). Although the preservation 
of muscle mass may be considerably important for the prevention of muscle 
strength loss during ageing, muscle quality may also be important in 
determining the loss of muscle strength with ageing (Barbat-Artigas et al. 
2012). To date, muscle quality has not been widely studied in relation to diet 
as such and this was the first population study that examined such 
associations. 
The cross-sectional nature of the study limits causal inference, but enables 
us to generate hypotheses regarding associations between diet, indexes of 
muscle mass and inflammation based on plausible mechanisms of action. In 
addition, as in all observational studies, measurement error in self-reported 
dietary intakes is inevitable. In this study, dietary intake was not assessed by 
a food diary which is considered as the gold standard but by a food 
frequency questionnaire (FFQ). This FFQ was compared and validated 
against a 7-day weighed record in the EPIC Norfolk study (Bingham et al. 
2001). This FFQ was also validated against urinary and plasma biomarkers 
of intake, such as urinary nitrogen for protein intake, urinary potassium and 
sodium, plasma ascorbic acid and plasma n-3 PUFAs (McKeown et al. 
2001, Welch et al. 2006). In addition, it has been shown previously that 
serum β-cryptoxanthin and zeaxanthin concentrations were moderately 
correlated with dietary carotenoids intakes measured by an FFQ (Tucker et 
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al. 1999). Nevertheless, it is widely acknowledged that the use of FFQs for 
measuring dietary intake has its own limitations related to memory errors 
(McNeill et al. 2009). They provide relative rather than absolute intake, they 
introduce bias due to over- or under-reporting, and they may introduce 
systematic errors as preparation methods are inadequately considered 
(McNeill et al. 2009). Also, FFQs measure food intake over a period of one 
year and reflect the habitual diet over this period of time but not lifetime 
dietary habits (Teucher et al. 2007). As mentioned previously in Chapter 3, 
FFQs have been shown to rank individuals well within populations and have 
the advantage of being capable of use for large studies.   
 
Nevertheless, it is thought that nutrient biomarkers may provide a stronger 
association with disease outcomes than those based on dietary assessments 
due to measurement errors occurring with dietary questionnaires 
(Giovannucci 2013). However, it is also argued that blood concentrations of 
nutrients may reflect other exposures (such as smoking and alcohol 
consumption) (Dietrich et al. 2003), and genetic , physiological, metabolic 
(Lee et al. 2012) and pathophysiological processes (Giovannucci 2013, 
Zhang et al. 2012).  
In our dataset we did not have nutritional status data, therefore it was not 
possible to examine whether muscle mass and inflammation could be 
expected to relate to status of the nutrient. Ideally, assuming that a causal 
association exists, altering the concentration of the biomarker directly 
through the intake of the nutrient would directly affect the disease or 
outcome risk (Giovannucci 2013). It needs, however, to be considered that 
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status is affected by various factors that may also affect disease risk. For 
example, cigarette smoking has been associated with lower plasma ascorbic 
acid concentrations (Wei et al. 2001). In addition, at low doses dietary 
vitamin C is almost completely absorbed, but over a certain range of usual 
dietary intake (30-180 mg/day), absorption may decrease to 75 percent 
because of competing factors in the food (Graumlich et al. 1997). Therefore, 
in order to investigate the beneficial health effects of nutrients with potential 
anti-inflammatory properties it is also important that epidemiological 
studies examine associations between the habitual intake of specific 
nutrients and nutrient status, and markers of disease outcomes, such as CRP 
for inflammation and indexes of muscle mass for sarcopenia. Even though 
status may be a useful marker of intake we need to know how much a 
population is consuming so that we can provide guidelines for population 
intakes for prevention. 
 
In the current analyses, the proportions of women that had intakes lower 
than the RNI/EAR and RDA, were low for the reported intakes of vitamin 
C, magnesium and potassium, and high for the reported intakes of selenium, 
vitamins D and E (Chapter 3, page 101). It is noteworthy that there are 
currently no relevant recommendations in terms of different carotenoid 
intakes for the UK population. It is plausible that overall nutrient adequacy 
may have blunted the ability to detect an association between selenium, 
vitamins C and E and muscle mass or CRP. However, as mentioned above, 
the assessment of dietary intake using FFQs have their own limitations and 
self-reported dietary intakes are inherent limitations to estimating nutrient 
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intakes from a FFQ. Moreover, given the fact that for the sample population 
intakes of selenium, and vitamins D and E were not sufficient and the range 
of adequacy not great, this may have reflected on the ability of the dataset to 
assess effects on muscle mass or CRP concentrations of low and high 
intakes. Greater ranges of adequacy concerning selenium, and vitamins D 
and E may have resulted to a greater ability of the dataset to more 
informative results. Notably, vitamin C, magnesium and potassium are 
found mainly in healthy plant based foods, such as fruit and vegetables, and 
their intake may be a marker of a generally healthy lifestyle behavior. 
However, associations with muscle mass and CRP concentrations remained 
significant even after adjustment for lifestyle factors. 
 
For this thesis, lifetime physical activity was assessed using a physical 
activity questionnaire, which was previously shown to be strongly 
correlated with more in-depth assessment of time spent in physical activity 
in the cohort (Cherkas et al. 2008). A recent review suggest that objectively 
measured physical activity by accelerometers, is a better assessment method 
(Ekelund et al. 2011). This review refers to childhood and youth but similar 
findings may be applicable to adults too. Ideally, objective measures of 
physical activity should complement self-report assessments.     
This study was limited in measuring only one biomarker of inflammation, 
which is the widely used CRP, and more markers are needed to reflect, in 
total, the complexity of associations between diet, muscle mass and 
inflammation.  
 
 306 
 
In this study analyses were adjusted for a number of confounding factors 
that are known to impact the association between diet, muscle mass and 
inflammation, such as age, physical activity, smoking, BMI, medication, 
and use of hormone replacement therapy. However, little is yet known about 
what other factors may affect muscle mass as much of the research in this 
area is relatively new. There might be other factors that may affect the 
association between diet, muscle mass and inflammation and therefore 
residual confounding cannot be ruled out. More factors are yet to be 
identified as this a very fertile field of research. 
 
9.2 Results from this thesis and relationship with public health 
recommendations 
There is a growing body of evidence suggesting that nutrition/diet may be 
an important modifiable factor of sarcopenia (Robinson et al. 2012). 
Currently, nutritional and public health recommendations for the 
management of sarcopenia are limited to protein, essential amino acids, 
mainly leucine and vitamin D intakes (Morley et al. 2010). The Society for 
Sarcopenia, Cachexia and Wasting Disease in their review in 2010 has 
recommended that older adults may ingest between 1.0 and 1.5 g/kg/d of 
protein for the preservation of muscle mass, however this report is limited 
only in older adults and does not specify the corresponding age range for the 
suggested protein intake (Morley et al. 2010). The same report 
recommended that older adults may consume a leucine-enriched balanced 
amino acid supplement for the preservation of muscle mass, although, the 
authors do not clarify a suggested dose. However, the results of our findings 
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point to no beneficial effect of either total protein or specific amino acid 
intakes. In fact they suggest that in this age group protein may not be related 
specifically to muscle mass. However, given the advantages and 
disadvantages of our study it would be wise for protein recommendations to 
remain as they are. 
 
In addition, only very few observational studies have pointed out the 
potential importance of antioxidant nutrients on muscle mass and muscle 
strength (Robinson SM et al. 2008, Scott et al. 2010), however, there is a 
lack of definitive recommendations concerning intakes of antioxidant 
nutrients from the habitual diet. In terms of healthy dietary patterns, only 
one previous observational study found that a pattern characterized by 
higher intakes in fruit and vegetables and wholemeal cereals was associated 
with greater muscle strength in older adults (Robinson et al. 2009).   
 
Notably, the existing recommendations refer to older individuals (although 
age ranges are not defined) when sarcopenia has already become established 
and therefore treatment is important. Given the findings observed in the 
current analysis that diet and muscle mass are also associated in younger 
individuals and importance of prevention, recommendations need to start 
earlier in life as the importance of life-course influences may be predictive 
of muscle mass and strength later in life (Robinson et al. 2012, Sayer et al. 
2004). Nevertheless, there is currently a paucity of data approaching the role 
of nutrition on the preservation of muscle mass from a public health 
preventative point of view.  
 308 
 
Given, the lack of such evidence, we expanded our research in examining 
the associations between other micronutrients and healthy eating patterns 
and muscle mass. The current analysis suggests that it is important for adult 
women of a wide age range (18-79 years) to consume a variety of foods 
high in vitamins C and E, magnesium, potassium and a range of carotenoids 
(nutrients found in foods of plant-based origin, such as fruit and vegetables, 
whole grain products, plant-based oils and nuts) to ensure greater muscle 
mass. Indicatively, a difference of 3.4 % in FFMI reported between extreme 
quintiles of magnesium intake corresponds to consumption of 1.8 portions 
of all bran per day (108 g/d) from the habitual diet (assuming 1 portion of 
all bran to be 60 g for adults). A difference of 3.11 % in FFMI also observed 
between extreme quintiles of vitamin C intake corresponds to consumption 
of two oranges (assuming one portion of oranges to be 120 g for adults) and 
one portion of strawberries (100 g/d), highlighting the importance of 
incorporating more plant-based food components into the habitual diet. 
Indeed, in terms of protection from muscle loss at the population level it 
would appear wise for individuals to follow the 5-a-day recommendations 
for prevention of muscle loss as well as for their other health effects. 
Furthermore, the current study has confirmed that healthy eating patterns 
characterised by high intakes in fruit and vegetables, nuts, legumes, dietary 
fiber/and or whole grains, and low intake of red and processed meat, and 
saturated fat, are likely to be protective for muscle mass. Interestingly, when 
translating the differences in nutrient intakes between extreme quartiles of 
the five diet scores into comparable amounts of food, the differences in 
vitamin C intake, for example, between extreme quartiles of the diet scores 
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equated to 1.6 portions of oranges for the MDS, 1.5 portions for the HDI, 1 
portion for the DQI, 2.3 portions for the AHEI and 2 portions for the 
DASH-style score (assuming one portion of oranges to be 120 g for adults).   
 
The results from this study suggest that is important for adult women (aged 
18-79 years) to consume a variety of food sources high in micronutrients, 
such as magnesium to ensure lower plasma concentrations of the 
inflammatory marker CRP. Similarly, healthy eating patterns which award 
points to diets high in fruit and vegetables, whole grains, dietary fiber, nuts 
and polyunsaturated fatty acids and low in saturated fatty acids (specifically 
the HDI and AHEI scores) may be important for the inflammatory status.  
 
The most exiting finding of the current work was that dietary intake of 
magnesium, potassium, vitamin C, carotene, β-carotene, and diet quality 
including the MDS, HDI, AHEI and DASH-style scores appeared to reduce 
the impact of CRP on indexes of muscle mass by 1-8 %. In regard to 
nutrients, the greatest associations were observed for magnesium intake 
which appeared to reduce the association between FFM (kg) and CRP levels 
by almost 7% per quintile of intake which was equated to a mean difference 
of 43 mg/d. Although the strength of the associations was modest, this was 
observed after analyses was accounted for age, physical activity, smoking, 
anti-inflammatory medication (including aspirin, statins, and NSAID) and 
HRT use and were independent of adiposity (assessed by BMI) factors that 
are known to affect both muscle mass and CRP. In food terms, this 
difference would correspond to consumption of 1.8 portions of whole meal 
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bread per day (64.8 g/d) from the habitual diet (assuming 1 portion of whole 
meal bread to be 36 g for adults). In relation to the “whole diet”, the greatest 
associations were observed for the AHEI score which improved the impact 
of CRP on FFM (kg) by almost 8 % for every 9 points increase in the score. 
When translating the differences in nutrient intakes between extreme 
quartiles of the AHEI score into comparable amounts of food, the 
differences in vitamin C intake, for example, between extreme quartiles of 
the diet scores (which was shown in Chapter 5, Table 5.3, p. 189) equated 
to 2.2 portions of oranges for the AHEI (assuming one portion of oranges to 
be 120 g for adults). 
 
From a public health perspective, the novel findings from the current 
analysis may offer some insight in order to better understand the impact of 
dietary and lifestyle factors on the association between muscle mass and 
inflammation in adult women with normal weight, BMI and CRP 
concentrations. They indicate that eating a diet that includes sufficient 
protein, and is high in a variety of foods high in vitamin C, magnesium, 
potassium and a range of carotenoids (nutrients found in foods of plant-
based origin, such as fruit and vegetables, whole grain products/dietary 
fiber, legumes and nuts) may prevent muscle loss in female populations 
across a wide age range and particularly in women aged over 50 years. 
These preliminary findings may also provide useful information in 
developing and planning dietary intervention trials for the prevention of 
sarcopenia by targeting inflammation.  
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9.3 Future perspectives 
9.3.1 Observational studies 
In terms of future work as far as observational studies are concerned 
[Figure 9.1 (C)], a longitudinal study design might be a more suitable 
approach to detect associations between diet and muscle mass, strength and 
quality, as it is more likely to observe changes in body composition over 
time due a healthier diet. Also, it might be more likely to observe a 
difference in the inflammatory status over time due to a healthier diet. In our 
study we did not apply a longitudinal analysis as very few people had 
dietary data in both FFQs (in subset 1, 2570 women, 18-79 years and subset 
2, 949 women, 34-83 years). 
 
Although, there is growing evidence suggesting that behavioural factors, 
such as diet, physical activity and smoking influence muscle mass, as yet, 
their combined impact is not known. Therefore, it would be interesting to 
derive a simple diet and lifestyle score based, for example, on fruit and 
vegetables intake, physical activity and smoking and examine whether a 
better diet and lifestyle score is predictive of preservation of muscle mass 
later in life.  
 
9.3.2 Intervention trials  
Interventions on sarcopenia may be challenging because of a number of 
methodological issues. The most important considerations are the definition 
of the sarcopenic group, which depends upon the method used to measure 
body composition, and the identification of the target population for 
 312 
 
intervention. This is due to the definitions available for describing sub-
normal values for sarcopenia in different reference populations. For 
example, a cut-point for sarcopenia in older adults has been defined as a 
skeletal muscle index two standard deviations below the mean of young 
male and female (aged 18-40 years) reference groups (Baumgartner et al. 
1998). In this study muscle mass was assessed by DEXA scans and 
estimated as the sum of the muscle mass of the four limbs (appendicular 
skeletal muscle mass); skeletal muscle mass was therefore calculated as the 
ratio of appendicular skeletal muscle mass to height squared. In another 
observational multiethnic cohort of older people (aged 70-79 years), body 
composition was assessed by DEXA scans and participants were classified 
as sarcopenic using two different approaches to adjust lean mass for height 
and body size (Newman et al. 2003). The first was the ratio of appendicular 
muscle mass divided by height squared and the in second approach 
appendicular muscle mass was adjusted for height and body fat. As 
reference values for multiethnic young adults were not available, the gender 
specific 20
th
 percentile was arbitrarily used as a cut-off point for each 
method (Newman et al. 2003). These findings highlight the urgent need of 
reference values for different populations. This information will enable the 
distinction between preventive and treatment interventions on sarcopenia 
(Cesari and Pahor 2008).  
 
A second consideration for interventions on sarcopenia may also be the 
target population. In regard to the target population for intervention trials on 
sarcopenia, only recently, in 2010, the European consensus on definition 
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and diagnosis of sarcopenia has developed a suggested algorithm based on 
gait speed measurement as the most reliable and easiest approach for 
screening subjects in clinical practice and for selection of participants for 
clinical trials (Cruz-Jentoft et al. 2010). This algorithm suggests that 
participants (aged > 65 years) are at risk of sarcopenia if their gait speed is 
>0.8 m/s. The selection of this cut-off point for gait speed was based on the 
fact that it has been previously associated with adverse health outcomes, 
such as disability, cognitive impairment, falls and/or mortality (Abellan van 
Kan et al. 2009). If gait speed is >0.8 m/s then muscle grip strength 
assessment should follow. If the grip strength is normal then the person is 
classified as non sarcopenic, if the grip strength is low (according to 
population specific cut-off values) then muscle mass should be assessed. If 
muscle mass is also low then the person is classified as sarcopenic as 
opposed to normal (Cruz-Jentoft et al. 2010). The consensus suggested that 
this cut-off may also be relevant for younger individuals, nevertheless, this 
report does not specify an age range for the younger population. Again the 
lack of population specific cut-off values for muscle mass and muscle 
strength and the fact that this screening tool has not yet been validated raises 
important considerations for the design of future interventions on 
sarcopenia.        
 
Therefore, in the light of the existing evidence and considering 
methodological issues, future clinical trials for the treatment of age-related 
loss of muscle mass and strength could potentially focus on sarcopenic 
adults [Figure 9.1 (C)] without clinical impairments (such as arthritis, 
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diabetes, cancer, anemia, kidney disease, neurological diseases) as these are 
highly related to body composition modifications and may bias the study 
results (Cesari and Pahor 2008). Exclusion of participants with 
inflammatory diseases, hormonal abnormalities, and use of anti-
inflammatory medication or hormone replacement therapy (in case of 
female participants) are also encouraged as these factors have been indicated 
that contribute to muscle decline (Cesari and Pahor 2008). Other important 
factors that may need to be considered for the selection population for 
clinical trials besides age are gender as there is evidence that muscle mass 
declines are steeper in men compared to women (Janssen et al. 2000, 
Lauretani et al. 2003), and race/ethnicity differences as it has been shown 
that African-American have greater muscle mass compared to Asian, 
Causasian or Hispanic populations (Castaneda and Janssen 2005, Wang et 
al. 2001). In relation to lifestyle factors, total body mass, smoking and 
physical activity need to be considered as they influence muscle mass as 
discussed in previous Chapter 2, section 2.2.5, p. 57. The lack of clinical 
interventions on sarcopenia may be due to the methodological issues 
mentioned earlier and to difficulties related to the selection of the sample 
population or maybe other issues that are yet to be researched. It is certain 
that future work is needed for the formulation of comprehensive assessment 
methods, validated screening tools, identification of outcome measures and 
robust biomarkers of sarcopenia. 
 
Even though treatment is very important when sarcopenia has been 
diagnosed, prevention is also of great importance in our ageing society. 
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There is growing interest in the role of diet and lifestyle in the aetiology of 
sarcopenia (Sayer et al. 2013) and in interventions that encourage behaviour 
changes for the management of sarcopenia (Waters et al. 2010). Most of the 
existing evidence on the potential role of diet on muscle mass and strength 
is observational and limited to protein (Campbell et al. 2001, Castaneda et 
al. 1995), essential amino acids (Borsheim et al. 2008, Scognamiglio et al. 
2004, Solerte et al. 2008) and vitamin D supplementation (Dawson-Hughes 
2008), and low antioxidant status (Cesari et al. 2004, Dominguez et al. 
2006, Lauretani et al. 2008, Semba et al. 2007) in older participants. 
However, given that dietary constituents are often highly correlated, the 
focus on healthy dietary patterns could be more efficient in terms of 
intervention, instead of single nutrient supplementation. Our findings on the 
positive association between diet quality scores and muscle mass may 
strengthen this argument.  
On the other hand physical exercise interventions including progressive 
resistance exercise training have been shown to have positive effects on 
strength and physical function in older adults (Liu and Latham 2009). At 
present the potential implications of long term effects of exercise in 
combination with high protein/amino acid supplementation on sarcopenia 
are largely uncertain (Koopman 2011). Therefore, another consideration for 
future intervention trials on the prevention of muscle mass and strength loss 
may be the possible combined effects of both diet and exercise training 
which may be more effective than either alone. Future research in this 
direction could point towards effective strategies to prevent and/or treat 
sarcopenia.   
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In relation to dietary interventions, the potential influence of the “whole 
diet” for the management of muscle mass and strength loss would be a very 
interesting area of future research as it is still unexplored. Interventions 
designed to change dietary patterns would be expected to change the intake 
of a number of nutrients and thus may be more effective that single nutrient 
supplementations (Sayer et al. 2013). Findings from our population study 
although cross-sectional showed that dietary patterns high in fruits and 
vegetables, whole grains, nuts, dietary fiber that could provide a range of 
nutrients important for muscle mass, such as the plant-derived nutrients 
magnesium, potassium, vitamin C and carotenoids, and low in saturated fat 
and processed meat mediate the relationship between muscle mass and 
inflammation. These findings could provide more evidence-based data for 
the design of future dietary interventions targeting inflammation related 
sarcopenia. Although our study did not show evidence on the associations 
between diet and muscle strength, interventions on diet and sarcopenia 
should capture the bi-dimensionality of this condition by assessing both 
muscle mass and muscle strength.  
Given the existing assessment methods, screening tools, methodological 
issues that were mentioned earlier for the design of clinical trials for 
sarcopenia which may also apply to preventive interventions; and the 
challenges of changing dietary and lifestyle behaviours in the elderly, the 
characteristics of a potential ideal intervention trial combining both nutrition 
and exercise could be the following: 
- Primary objective: To determine the potential effect of a healthy 
dietary pattern high in plant based dietary components such as citrus 
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fruits and cruciferous and green leafy vegetables, whole grain 
products, nuts and dietary fiber and low in saturated fat and 
processed meat, combined with a progressive resistance exercise 
training program on skeletal muscle mass and strength among older 
sarcopenic women. 
- Secondary objective: To measure the changes in inflammatory 
markers, biomarkers of compliance and other biochemical markers 
in response to the interventions.    
- Study design: Randomized controlled human intervention trial, 
parallel design. 
- Inclusion criteria: Older sarcopenic women, aged 65-75 years with 
a gait speed >0.8 m/s and skeletal muscle mass index two standard 
deviations below the reference group of a Caucasian population. 
Able to participate in the study for one year. Recruitment could be 
from the general population. The intervention and control groups 
will be matched for age, BMI and other baseline characteristics to 
control for confounding from these factors. 
- Exclusion criteria: Recent diagnosis of disease, smoking, use of 
dietary supplements, any medication, use of hormone replacement 
therapy, known allergy to nuts. Body mass index >30 kg/m
2
 to 
ensure exclusion of subjects with sarcopenic obesity. Extreme 
physical activity. 
- Intervention: Half of the participants will be encouraged to simple 
changes to dietary habits following a healthier dietary pattern high in 
fruit and vegetables, whole grain products, nuts and dietary fiber and 
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low in saturated fat and processed meat. These participants may also 
be asked to follow a progressive resistance exercise training 
program. The other half of the participants will be asked to follow 
their usual dietary habits and physical activity. 
- Compliance: Compliance of dietary modifications will be monitored 
using food diaries. 
- Assessment of body composition and blood & urine samples: Body 
composition changes will be assessed using DEXA scans and 
measurements may be taken at baseline and at the end of the study. 
Specific measure may include body weight, BMI (kg/m
2
), fat mass 
(%), skeletal muscle mass (kg or %). Muscle strength will be 
assessed by hand grip strength (kg). Fasting blood and urine samples 
will be obtained at baseline, six and twelve months. The effect of 
healthy dietary patterns on muscle mass and strength will be 
measured by biomarkers of intake, such as plasma vitamin C and 
carotenoids and urinary potassium. Physical exercise will ideally be 
accessed by accelerometers complemented by self-report 
assessments. Changes in different inflammatory markers (such as 
CRP, IL-6, TNF-a) will be assessed using validated immune assays.  
 
As a further thought, it would of great interest to study the lifelong 
influences of nutrition on age-related changes in muscle mass and strength. 
Although we were able to identify some physical and lifestyle 
characteristics that influence muscle mass and strength further work is 
needed to identify more factors in order to design effective interventions. 
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Indeed, this is an area that has been very little examined but there is some 
evidence showing that factors that influence growth, such as early nutrition 
(Robinson et al. 2012) or low birth weight (Sayer et al. 2004) may influence 
muscle mass and strength later in life. The approach of lifecourse influences 
on muscle mass and strength has been recently suggested and is indeed an 
exciting area of research that will potentially give us the opportunity to 
understand more about the determinants of muscle mass loss, influences that 
are associated with the peak muscle mass and strength attained at early life 
and potential underlying mechanisms of such associations (Patel 2012). This 
approach suggests that there might be opportunities to preventively 
intervene at earlier stages of life and not just when sarcopenia has already 
been manifested.      
 
Finally, human and animal studies will allow a more in depth understanding 
of the molecular and cellular mechanisms of muscle mass and strength loss. 
This would potentially allow the development of more robust biomarkers to 
test the efficacy of different interventions (Sayer et al. 2013). More 
sophisticated methods related to the integrated personal “omics” profile 
(iPOP), such as high-throughput analytic platforms may predict the 
development of various diseases, including sarcopenia (Chen et al. 2012, 
Ferguson 2012). Moreover, nutrigenomics and metobolomics can 
characterize the nutritional and metabolic status of an individual and may 
provide additional information for the management of diet at the individual 
level (Jones et al. 2012). The “omics” approaches may reveal new horizons 
for the design of dietary interventions tailored to individualized needs, and 
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in general may alter the metabolic phenotype to a healthier profile (Calvani 
et al. 2013).     
 
In terms of the measures of fat free mass, fat free mass index 
(weight/height
2
) seems to be the most suitable and therefore it would be 
useful to be utilised in future research. It is well documented that in order to 
evaluate fat free mass in relation to body size and nutritional status, fat free 
mass should be considered in relation to height, because fat free mass 
expressed in absolute weight or as a percentage of body weight is not 
adequate because it increases with height. Fat free mass index which 
eliminates differences associated with height is an important marker of 
health and disease status (Coin et al. 2008, Heymsfield et al. 2011, Kyle et 
al. 2003). Moreover, percentage fat free mass showed a large variation in 
the current analysis (38.8-80.6 %) which might have influenced the results. 
 
In relation to the diet scoring indices, the MDS used the median intake of 
dietary components as the cut-off between healthy and unhealthy intakes, 
whereas the DASH-style score used quintiles to classify intakes of dietary 
components, with a “healthy” point assigned only if the quantity consumed 
was in the highest quintile.  In contrast, the HDI, DQI, and the AHEI were 
cut-point specific scores based on healthy eating guidelines. These 
differences suggest that the DASH-style score gives more weight to high 
adherence to a better quality diet compared with the other four scores. 
However, it is likely that the use of the median as a cut-off value will not 
reflect a healthy level of intake per se, and will be different among different 
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populations, but an advantage is that half of the sample will score positively 
and half negatively for each component, which ensures that each component 
distinguishes well between individuals (Waijers et al. 2007). On the other 
hand there are drawbacks with the use of cut-off specific values as it is 
likely that the intake of a specific component may be below the cut-off level 
for most of the subjects, limiting the discriminating power of a component 
(Kourlaba and Panagiotakos 2009, Waijers et al. 2007). 
 
Considering the advantages and disadvantages of the different diet scores, 
the use of the AHEI score would be recommended as the most relevant for 
future research in this area. The AHEI score was focused mainly on intake 
of significant food groups (characterised by higher intakes in fruits and 
vegetables, nuts and dietary fiber, and low intakes in red meat). Dietary 
patterns characterised by increased consumption of fruits and vegetables, 
whole grains, dietary fiber and low intakes of saturated and trans fatty acids 
have been previously associated with lower levels of markers of 
inflammation, oxidative stress, and endothelial dysfunction in 
epidemiological studies (Baer et al. 2004, Dai et al. 2008, Esmaillzadeh et 
al. 2007, Esposito et al. 2004, Fung et al. 2001, Fung et al. 2001, Lopez-
Garcia et al. 2004, Lopez-Garcia et al. 2005, Mozaffarian et al. 2004, 
Nettleton et al. 2006). In addition, the associations we found between  
muscle mass and the AHEI dietary pattern may be partly explained due to 
the anti-inflammatory effects of an overall healthier diet containing food 
components high in the nutrients previously found to be related to muscle 
mass (as outlined in Chapter 1, section 1.3, p. 21, 22, and Chapter 3, section 
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3.0, p. 82). Therefore, this score may be more suitable for future studies 
investigating the role of diet on muscle mass. 
The MDS and DASH-style scores, although they consists of similar 
components to the AHEI score; they are however population specific, as the 
MDS score is generated according to the distribution of foods in a given 
dataset, and the DASH-style scores classifies intakes of dietary components 
based on the quintiles.        
In contrast, the HDI and DQI scores were mainly focused on intake of 
nutrients (characterised by higher intakes in polyunsaturated fatty acids, 
average intakes in protein, and low intake in saturated fatty acids and 
cholesterol). Therefore, these two scores would not be recommended in 
future research as they may not be able to capture overall dietary patterns of 
a population.    
 
Overall, combining the knowledge from well-designed human intervention 
trials, epidemiological studies, animal studies, innovative technologies, 
comprehensive imaging and functional assessments and robust screening 
tools may help to uncover the factors that may be linked to sarcopenia and 
provide new approaches for its management, and therefore allow for robust 
recommendations for both prevention and treatment.    
 
In conclusion, my research has shown that consumption of a diet that 
includes sufficient protein, and is high in a variety of foods high in vitamin 
C, magnesium, potassium and a range of carotenoids (nutrients found in 
foods of plant-based origin, such as fruit and vegetables, whole grain 
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products/dietary fiber, legumes and nuts) and a healthy dietary pattern high 
in these food components may prevent muscle loss in a female population 
across a wide age range. The novel findings from the current thesis have 
added to knowledge by better understanding the impact of dietary and 
lifestyle factors on the association between muscle mass and inflammation 
in adult women with normal weight, BMI and CRP concentrations. 
These preliminary findings will form the basis in developing and planning 
dietary intervention trials for the prevention of sarcopenia by targeting 
inflammation. 
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Figure 9.1: A) The interaction of sarcopenia and inflammation as consequences of the ageing process. Diet quality scores, micronutrient, protein & essential amino acid (EAA) intake may 
mediate the relationship between sarcopenia (assessed by indexes of muscle mass, hand grip strength and muscle quality) and inflammation (assessed by C-reactive protein – CRP). B) Results: 
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APPENDICES 
 
APPENDIX I 
PORTION SIZES (IN GRAMS) OF DIFFERENT FOOD COMPONENTS USED TO DERIVE 
THE DIET SCORES 
Apples 100 
Avocado 75 
Baked Beans 135 
Bananas 100 
Bean sprouts 20 
Beer 287 
Beetroot 40 
Biscuits choc 18 
Biscuits plain 10 
Block Marg 5 
Boiled potato 180 
Bran flakes 40 
Broccoli 85 
Brown Bread 36 
Brown Rice 180 
Brussels Sprouts 90 
Bunshome 54 
Bunsready 68 
Butter 5 
Cabbage 95 
Cakeshome 90 
Cakesready 60 
Carrots 60 
Cauliflower 90 
Cereal Bars 33 
Channel Island Milk 585 
Cheerios 40 
Chips 165 
Chips Roast Pots 175.5 
Chocolate bar 55 
Chocolates 7 
Chocs Dark 7 
Chocs Milk 7 
Chol Lower Spread 5 
Cocoa 260 
CocoPops 40 
Coleslaw 45 
Cornflakes 40 
Cream Crackers 7 
Crispbread 10 
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Crisps 28 
Crunchynut Cornflakes 40 
Dairy cheese 40 
Dairy Cottage Cheese 55 
Dairy Desserts 125 
Dairy double 30 
Dairy full fat yogurt 125 
Dairy low fat cheese 30 
Dairy low fat yogurt 125 
Dairy single 15 
Diet fizzy 160 
Dried Fruit 30 
Dried Lentils 70 
Dried Milk 585 
Eggs 50 
Evaporated Milk 585 
Fizzy Soft Drinks 160 
French Dressing 15 
Frosties 40 
Fruit’ n Fibre 40 
Fruit pie home 110 
Fruit pies ready 110 
Fruit Squash 160 
Full Milk 585 
Garlic 5 
Goats Milk 585 
Grapefruit 80 
Grape nuts 40 
Grapes 80 
Green Beans 90 
Green Salad 30 
Green Tea 260 
High Fibre Cereal 40 
Horlicks 260 
Ice Cream 75 
Jam 18 
Just Right Type 40 
Lasagne 420 
Leeks 75 
Liqueurs 50 
Low calorie salad cream 20 
Low Fat Hot Chocolate 18 
Low Fat Spread 5 
Marmite 9 
Marrow 90 
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Mayo 20 
Meat Soup 220 
Melon 200 
Bacon 25 
Beef 128 
Burgers 78 
Corned Beef 30 
Fish Fingers 50 
Fishroe 45 
Friedfish 180 
Ham 23 
Lamb 94 
Liver 40 
Oily fish 96 
Pies 124 
Pork 128 
Poultry 125 
Sausages 40 
Shellfish 60 
Whitefish 120 
Milk Puddings 200 
Muesli 60 
Mushrooms 56 
Nuts 40 
Nuts Salted 25 
Nuts Unsalted 16 
Oat Based Cereal 60 
Onions 60 
Oranges 120 
Other Cereal 40 
Other dressing 50 
Other Soft Margarine 5 
Parsnips 65 
Peaches 70 
Peanut Butter 20 
Pears 170 
Peas 70 
Pickles Chutney 40 
Porridge 160 
Potato Salad 85 
Pufa Margarine 5 
Pure Fruit Juice 160 
Quiche 140 
Red Wine 175 
Rice Krispies 40 
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Rice Milk 585 
Roast Potatoes 200 
Sauces 50 
Semi Skimmed Milk 585 
Shredded Wheat 45 
Shreddies 45 
Skimmed Milk 585 
Soya Milk 585 
SpecialK 40 
Spinach 90 
Spirits 23 
Sponge Pudhome 110 
Sponge Pudready 110 
Start 40 
Strawberries 100 
Sugar Added 6 
Sugar Puff Type 40 
Sultana Bran 40 
Sweet corn 85 
Sweet Peppers 80 
Sweets Toffees 8 
Tea 260 
Tinned Fruit 100 
Tofu 50 
Tomatoes 85 
Very Low Fat Spread 5 
Watercress 20 
Weetabix Type 40 
Wheat Flakes 40 
White Bread 36 
White pasta 230 
White Rice 180 
White Wine 125 
Wholemeal Bread 36 
Wholemeal Pasta 230 
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APPENDIX  II 
 
Subset 1: Food groups and foods included in each of the derived diet scores 
MDS HDI DQI AHEI DASH-style  
Fruit & nuts 
Peaches, watermelon, grapes, 
bananas, grapefruit, pears, 
apples, strawberries, tinned fruit, 
dried fruit, oranges, nuts 
Fruit & vegetables 
Peaches, watermelon, grapes, 
bananas, grapefruit, pears, 
apples, strawberries, tinned 
fruit, dried fruit, oranges, pure 
fruit juice, spinach, parsnips, 
leeks, onions, garlic, cabbage, 
broccoli, Bruccel sprouts, green 
beans, cauliflower, carrots, 
watercress, green salad, 
tomatoes, sweet corn, bean 
sprouts, coleslaw, avocado, 
beetroot, tofu, mushrooms, 
sweet peppers 
Fruit & vegetables 
Peaches, watermelon, grapes, 
bananas, grapefruit, pears, 
apples, strawberries, tinned fruit, 
dried fruit, oranges, pure fruit 
juice, spinach, parsnips, leeks, 
onions, garlic, cabbage, broccoli, 
Bruccel sprouts, green beans, 
cauliflower, carrots, marrow, 
watercress, green salad, 
tomatoes, sweet corn, bean 
sprouts, coleslaw, avocado, 
beetroot, tofu, mushrooms, sweet 
peppers 
Fruit 
Peaches, watermelon, grapes, 
bananas, grapefruit, pears, 
apples, strawberries, tinned fruit, 
dried fruit, oranges 
Fruit 
Peaches, watermelon, grapes, 
bananas, grapefruit, pears, 
apples, strawberries, tinned 
fruit, dried fruit, oranges, pure 
fruit juice 
 
 
Vegetables 
Spinach, parsnips, leeks, onions, 
garlic, peas, cabbage, broccoli, 
Bruccel sprouts, green beans, 
cauliflower, carrots, watercress, 
green salad, tomatoes, sweet 
corn, bean sprouts, coleslaw, 
avocado, beetroot, tofu, 
mushrooms, sweet peppers 
Complex carbohydrates 
Breads, cereals, legumes, peas 
Total fat (%E) 
Daily intake from FFQ 
Vegetables 
Spinach, parsnips, leeks, onions, 
garlic, peas, cabbage, broccoli, 
Bruccel sprouts, green beans, 
cauliflower, carrots, watercress, 
green salad, tomatoes, sweet 
corn, bean sprouts, coleslaw, 
avocado, baked beans, beetroot, 
mushrooms, sweet peppers 
Vegetables 
Spinach, parsnips, leeks, 
onions, garlic, cabbage, 
broccoli, Bruccel sprouts, 
green beans, cauliflower, 
carrots, watercress, green 
salad, tomatoes, sweet corn, 
bean sprouts, coleslaw, 
avocado, beetroot,  
mushrooms, sweet peppers 
Legumes 
Baked beans, dried lentils 
Dietary fiber 
NSP from FFQ (g) 
Complex carbohydrates 
Breads, cereals, legumes, peas 
Nuts & soy protein 
Nuts, tofu 
Nuts & legumes 
Nuts, baked beans, dried 
lentils, peas, tofu 
Fish 
Fried fish, fish fingers, white fish, 
oily fish, shell fish 
Pulses & nuts 
Baked beans, nuts, and dried 
lentils 
Saturated fat (%E) 
Daily intake from FFQ 
Ratio of white (including fish) 
to red meat 
Fried fish, fish fingers, white fish, 
Whole grains 
Bran flakes, sultana bran, fruit 
n fibre, all bran, muesli, 
 330 
 
oily fish, shell fish + poultry TO 
Beef, burgers, pork, lamb, bacon, 
ham, corned beef, sausages, 
pies, liver 
shreddies, shredded wheat, 
weetabix type, grape nuts, 
wheat flakes, oat based, 
brown bread, wholemeal 
bread, crispbread (rye), 
porridge, wholemeal spaghetti, 
brown rice 
Cereals 
Cornflakes, Crunchynut, 
cornflakes, bran flakes, sultana 
bran, fruit n fiber, rice krispies, 
sugar puffs, all bran, muesli, start, 
cheerios, just right type, 
shreddies, shredded wheat, 
weetabix type, special K, coco 
pops, frosties, grape nuts, wheat 
flakes, oat based, other cereal, 
porridge, white bread, brown 
bread, whole meal bread, cream 
crackers, crisp bread, lasagne, 
spaghetti, whole meal pasta, white 
pasta, brown rice, white rice 
Mono- & disaccharides 
Daily intake of total sugars from 
FFQ 
Cholesterol 
Daily intake from FFQ 
Dietary fiber 
NSP from FFQ (g) 
Low fat dairy products 
Semi-skimmed milk, skimmed 
milk, dried skimmed milk, low-
fat yogurt, cottage cheese 
Fat 
Ratio of monounsaturated &  
polyunsaturated to saturated fat 
Protein (%E) 
Daily intake from FFQ 
Protein (%RDA) 
Based on UK RNI: 1.5 g 
protein/kg/day 
Trans fat (%E) 
Daily intake from FFQ 
Sodium 
Daily intake from FFQ 
Dairy products & eggs 
Full milk, semi-skimmed milk, 
skimmed milk, channel island milk, 
dried skimmed milk, soya milk, 
rice milk, goats milk, evaporated 
milk, cottage cheese, cream fresh 
single, cream fresh double, full fat 
yogurt, low fat yogurt, dairy 
desserts, dairy cheese (e.g. 
cheddar, brie, edam), eggs 
Saturated fat (%E) 
Daily intake from FFQ 
Sodium 
Daily intake from FFQ 
Polyunsaturated to saturated 
fat ratio 
Ratio of daily intakes from FFQ 
Red & processed meat 
Beef, burgers, pork, lamb, 
poultry, bacon, ham, corned 
beef, sausages, pies, liver 
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Meat 
Beef, burgers, pork, lamb, poultry, 
bacon, ham, corned beef, 
sausages, pies, liver 
Polyunsaturated fat (%E) 
Daily intake from FFQ 
Calcium (%RDA) 
Based on UK RDA: 525 mg/day  
Vitamin supplement use 
From questionnaire (Yes/no) 
Sweetened beverages 
Fizzy soft drinks (cola, 
lemonade), low calorie diet 
fizzy drinks  
Alcohol 
Daily alcohol intake from FFQ (g) 
Cholesterol 
Daily intake from FFQ  
 Alcoholic drinks 
Beer, spirits, wine, liqueur 
(servings/d) 
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APPENDIX  III 
 
Subset 2: Food groups and foods included in each of the derived diet scores 
MDS HDI DQI AHEI DASH-style  
Fruit & nuts 
Peaches, watermelon, grapes, 
bananas, grapefruit, pears, 
apples, strawberries, tinned fruit, 
dried fruit, oranges, salted nuts, 
unsalted nuts 
Fruit & vegetables 
Peaches, watermelon, grapes, 
bananas, grapefruit, pears, 
apples, strawberries, tinned 
fruit, dried fruit, oranges, pure 
fruit juice, spinach, parsnips, 
leeks, onions, garlic, cabbage, 
broccoli, Bruccel sprouts, green 
beans, cauliflower, carrots, 
watercress, green salad, 
tomatoes, sweet corn, bean 
sprouts, coleslaw, avocado, 
beetroot, tofu, mushrooms, 
sweet peppers 
Fruit & vegetables 
Peaches, watermelon, grapes, 
bananas, grapefruit, pears, 
apples, strawberries, tinned fruit, 
dried fruit, oranges, pure fruit 
juice, spinach, parsnips, leeks, 
onions, garlic, cabbage, broccoli, 
Bruccel sprouts, green beans, 
cauliflower, carrots, marrow, 
watercress, green salad, 
tomatoes, sweet corn, bean 
sprouts, coleslaw, avocado, 
beetroot, tofu, mushrooms, sweet 
peppers 
Fruit 
Peaches, watermelon, grapes, 
bananas, grapefruit, pears, 
apples, strawberries, tinned fruit, 
dried fruit, oranges 
Fruit 
Peaches, watermelon, grapes, 
bananas, grapefruit, pears, 
apples, strawberries, tinned 
fruit, dried fruit, oranges, pure 
fruit juice 
 
 
Vegetables 
Spinach, parsnips, leeks, onions, 
garlic, peas, cabbage, broccoli, 
Bruccel sprouts, green beans, 
cauliflower, carrots, watercress, 
green salad, tomatoes, sweet 
corn, bean sprouts, coleslaw, 
avocado, beetroot, tofu, 
mushrooms, sweet peppers 
Complex carbohydrates 
Breads, cereals, legumes, peas 
Total fat (%E) 
Daily intake from FFQ 
Vegetables 
Spinach, parsnips, leeks, onions, 
garlic, peas, cabbage, broccoli, 
Bruccel sprouts, green beans, 
cauliflower, carrots, watercress, 
green salad, tomatoes, sweet 
corn, beans sprouts, coleslaw, 
avocado, baked beans, beetroot, 
mushrooms, sweet peppers 
Vegetables 
Spinach, parsnips, leeks, 
onions, garlic, cabbage, 
broccoli, Bruccel sprouts, 
green beans, cauliflower, 
carrots, watercress, green 
salad, tomatoes, sweet corn, 
bean sprouts, coleslaw, 
avocado, beetroot,  
mushrooms, sweet peppers 
Legumes 
Baked beans, dried lentils 
Dietary fiber 
NSP from FFQ (g) 
Complex carbohydrates 
Breads, cereals, legumes, peas 
Nuts & soy protein 
Nuts, tofu 
Nuts & legumes 
Nuts, baked beans, dried 
lentils, peas, tofu 
Fish 
Fried fish, fish fingers, white fish, 
oily fish, shell fish 
Pulses & nuts 
Baked beans, salted nuts, 
unsalted nuts, and dried lentils 
Saturated fat (%E) 
Daily intake from FFQ 
Ratio of white (including fish) 
to red meat 
Fried fish, fish fingers, white fish, 
Whole grains 
Bran flakes, sultana bran, fruit 
n fibre, all bran, muesli, 
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oily fish, shell fish + poultry TO 
Beef, burgers, pork, lamb, bacon, 
ham, corned beef, sausages, 
pies, liver 
shreddies, shredded wheat, 
weetabix type, grape nuts, 
wheat flakes, oat based, 
brown bread, wholemeal 
bread, crispbread (rye), 
porridge, wholemeal spaghetti, 
brown rice 
Cereals 
Breakfast cereal, high fiber cereal, 
cereal bars, porridge, white bread, 
brown bread, whole meal bread, 
cream crackers, crisp bread, 
lasagne, spaghetti, whole meal 
pasta, white pasta, brown rice, 
white rice 
Mono- & disaccharides 
Daily intake of total sugars from 
FFQ 
Cholesterol 
Daily intake from FFQ 
Dietary fiber 
NSP from FFQ (g) 
Low fat dairy products 
Semi-skimmed milk, skimmed 
milk, dried skimmed milk, low-
fat yogurt, cottage cheese   
Fat 
Ratio of monounsaturated &  
polyunsaturated to saturated fat 
Protein (%E) 
Daily intake from FFQ 
Protein (%RDA) 
Based on UK RNI: 1.5 g 
protein/kg/day 
Trans fat (%E) 
Daily intake from FFQ 
Sodium 
Daily intake from FFQ 
Dairy products & eggs 
Full milk, semi-skimmed milk, 
skimmed milk, channel island milk, 
dried skimmed milk, soya milk, 
rice milk, goats milk, evaporated 
milk, cottage cheese, cream fresh 
single, cream fresh double, full fat 
yogurt, low fat yogurt, dairy 
desserts, dairy cheese (e.g. 
cheddar, brie, edam), eggs 
Saturated fat (%E) 
Daily intake from FFQ 
Sodium 
Daily intake from FFQ 
Polyunsaturated to saturated 
fat ratio 
Ratio of daily intakes from FFQ 
Red & processed meat 
Beef, burgers, pork, lamb, 
poultry, bacon, ham, corned 
beef, sausages, pies, liver 
 
 
Meat 
Beef, burgers, pork, lamb, poultry, 
bacon, ham, corned beef, 
sausages, pies, liver 
Polyunsaturated fat (%E) 
Daily intake from FFQ 
Calcium (%RDA)  
Based on UK RDA: 525 mg/day  
Vitamin supplement use 
From questionnaire (Yes/no) 
Sweetened beverages 
Fizzy soft drinks (cola, 
lemonade), low calorie diet 
fizzy drinks  
Alcohol 
Daily alcohol intake from FFQ (g) 
Cholesterol 
Daily intake from FFQ  
 Alcoholic drinks 
Beer, spirits, red wine, white 
wine, liqueur (servings/d) 
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